<html lang="en" class="js"><head><link rel="preload" href="/static/fonts/HardingText-Regular-Web-cecd90984f.woff2" as="font" type="font/woff2" crossorigin=""><script async="" src="//cdn.jsdelivr.net/npm/mathjax@2.7.5/MathJax.js?config=TeX-AMS-MML_SVG.js"></script><script async="" src="https://scripts.webcontentassessor.com/scripts/93dabb8d80079a87fec7bb6f67b807fce90e1688f8957ad7ad152bfd58ea01c2"></script><script type="text/javascript" async="" src="https://pagead2.googlesyndication.com/tag/js/gpt.js"></script><script async="" src="https://www.googletagmanager.com/gtm.js?id=GTM-MRVXSHQ"></script><script type="text/javascript" src="https://www.nature.com/SiV_fZZgcuGI3ifmhXWgCbIW7E616IBqn-ELJRdANHEgGDhx-eIUO1RbDt9djWUAeLOdyU2FhyVvcraPA2WhNg=="></script><script src="https://cmp.nature.com/production_live/en/consent-bundle-8-85.js" onload="initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')"></script>
    <title>Modeling transmission of SARS-CoV-2 Omicron in China | Nature Medicine</title>
    
        
<link rel="alternate" type="application/rss+xml" href="https://www.nature.com/nm.rss">


    
        

        <script id="save-data-connection-testing">
            function hasConnection() {
                return navigator.connection || navigator.mozConnection || navigator.webkitConnection || navigator.msConnection;
            }

            function createLink(src) {
                var preloadLink = document.createElement("link");
                preloadLink.rel = "preload";
                preloadLink.href = src;
                preloadLink.as = "font";
                preloadLink.type = "font/woff2";
                preloadLink.crossOrigin = "";
                document.head.insertBefore(preloadLink, document.head.firstChild);
            }

            var connectionDetail = {
                saveDataEnabled: false,
                slowConnection: false
            };

            var connection = hasConnection();
            if (connection) {
                connectionDetail.saveDataEnabled = connection.saveData;
                if (/\slow-2g|2g/.test(connection.effectiveType)) {
                    connectionDetail.slowConnection = true;
                }
            }

            if (!(connectionDetail.saveDataEnabled || connectionDetail.slowConnection)) {
                createLink("/static/fonts/HardingText-Regular-Web-cecd90984f.woff2");
            } else {
                document.documentElement.classList.add('save-data');
            }
        </script>
    

<link rel="preconnect" href="https://cmp.nature.com" crossorigin="">

<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="applicable-device" content="pc,mobile">
<meta name="viewport" content="width=device-width,initial-scale=1.0,maximum-scale=5,user-scalable=yes">
<meta name="360-site-verification" content="5a2dc4ab3fcb9b0393241ffbbb490480">

<script data-test="dataLayer">
    window.dataLayer = [{"content":{"category":{"contentType":"article","legacy":{"webtrendsPrimaryArticleType":"research","webtrendsSubjectTerms":"epidemiology;viral-infection","webtrendsContentCategory":null,"webtrendsContentCollection":null,"webtrendsContentGroup":"Nature Medicine","webtrendsContentGroupType":null,"webtrendsContentSubGroup":"Article","status":null}},"article":{"doi":"10.1038/s41591-022-01855-7"},"attributes":{"cms":null,"deliveryPlatform":"oscar","copyright":{"open":true,"legacy":{"webtrendsLicenceType":"http://creativecommons.org/licenses/by/4.0/"}}},"contentInfo":{"authors":["Jun Cai","Xiaowei Deng","Juan Yang","Kaiyuan Sun","Hengcong Liu","Zhiyuan Chen","Cheng Peng","Xinhua Chen","Qianhui Wu","Junyi Zou","Ruijia Sun","Wen Zheng","Zeyao Zhao","Wanying Lu","Yuxia Liang","Xiaoyu Zhou","Marco Ajelli","Hongjie Yu"],"publishedAt":1652140800,"publishedAtString":"2022-05-10","title":"Modeling transmission of SARS-CoV-2 Omicron in China","legacy":null,"publishedAtTime":null,"documentType":"aplusplus","subjects":"Epidemiology,Viral infection"},"journal":{"pcode":"nm","title":"nature medicine","volume":"28","issue":"7","id":41591,"publishingModel":"Hybrid Access"},"authorization":{"status":true},"features":[{"name":"furtherReadingSection","present":true}],"collection":null},"page":{"category":{"pageType":"article"},"attributes":{"template":"mosaic","featureFlags":[{"name":"nature-onwards-journey","active":false}],"testGroup":null},"search":null},"privacy":{},"version":"1.0.0","product":null,"session":null,"user":null,"backHalfContent":true,"country":"BR","hasBody":true,"uneditedManuscript":false,"twitterId":["o3xnx","o43y9","o3ef7"],"baiduId":"d38bce82bcb44717ccc29a90c4b781ea","japan":false}];
    window.dataLayer.push({
        ga4MeasurementId: 'G-ERRNTNZ807',
        ga360TrackingId: 'UA-71668177-1',
        twitterId: ['3xnx', 'o43y9', 'o3ef7'],
        baiduId: 'd38bce82bcb44717ccc29a90c4b781ea',
        ga4ServerUrl: 'https://collect.nature.com',
        imprint: 'nature'
    });
</script>

<script>
    (function(w, d) {
        w.config = w.config || {};
        w.config.mustardcut = false;

        
        if (w.matchMedia && w.matchMedia('only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)').matches) {
            w.config.mustardcut = true;
            d.classList.add('js');
            d.classList.remove('grade-c');
            d.classList.remove('no-js');
        }
    })(window, document.documentElement);
</script>
 



     
    
    
        
    
    <style>@media only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark) {  .c-article-editorial-summary__container .c-article-editorial-summary__article-title,.c-card--major .c-card__title,.c-card__title,.u-h2,.u-h3,h2,h3{font-weight:700;-webkit-font-smoothing:antialiased;font-family:Harding,Palatino,serif;letter-spacing:-.0117156rem}.c-article-editorial-summary__container .c-article-editorial-summary__article-title,.c-card__title,.u-h3,h3{font-size:1.25rem;line-height:1.4rem}.c-reading-companion__figure-title,.u-h4,h4{font-weight:700;-webkit-font-smoothing:antialiased;line-height:1.4rem}html{line-height:1.15;text-size-adjust:100%;box-sizing:border-box;font-size:100%;height:100%;overflow-y:scroll}body{background:#eee;color:#222;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.125rem;line-height:1.76;margin:0;min-height:100%}details,main{display:block}h1{font-size:2em;margin:.67em 0}a,sup{vertical-align:baseline}a{background-color:transparent;color:#069;overflow-wrap:break-word;text-decoration:underline;text-decoration-skip-ink:auto;word-break:break-word}b{font-weight:bolder}sup{font-size:75%;line-height:0;position:relative;top:-.5em}img{border:0;height:auto;max-width:100%;vertical-align:middle}button,input,select{font-family:inherit;font-size:100%;line-height:1.15;margin:0}button,input{overflow:visible}button,select{text-transform:none}[type=submit],button{-webkit-appearance:button}[type=checkbox]{box-sizing:border-box;padding:0}summary{display:list-item}[hidden]{display:none}button{border-radius:0;cursor:pointer;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}h1{font-weight:700;-webkit-font-smoothing:antialiased;font-family:Harding,Palatino,serif;font-size:2rem;letter-spacing:-.0390625rem;line-height:2.25rem}.c-card--major .c-card__title,.u-h2,.u-h3,h2{font-family:Harding,Palatino,serif;letter-spacing:-.0117156rem}.c-card--major .c-card__title,.u-h2,h2{font-weight:700;-webkit-font-smoothing:antialiased;font-size:1.5rem;line-height:1.6rem}.u-h3{font-size:1.25rem}.c-card__title,.c-reading-companion__figure-title,.u-h3,.u-h4,h4,h5,h6{font-weight:700;-webkit-font-smoothing:antialiased;line-height:1.4rem}.c-article-editorial-summary__container .c-article-editorial-summary__article-title,.c-card__title,h3{font-family:Harding,Palatino,serif;font-size:1.25rem}.c-article-editorial-summary__container .c-article-editorial-summary__article-title,h3{font-weight:700;-webkit-font-smoothing:antialiased;letter-spacing:-.0117156rem;line-height:1.4rem}.c-reading-companion__figure-title,.u-h4,h4{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.125rem;letter-spacing:-.0117156rem}input+label{padding-left:.5em}nav ol,nav ul{list-style:none none}p:empty{display:none}.sans-serif{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.article-page{background:#fff}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;margin-bottom:40px}.c-article-identifiers{color:#6f6f6f;display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3;list-style:none;margin:0 0 8px;padding:0}.c-article-identifiers__item{border-right:1px solid #6f6f6f;list-style:none;margin-right:8px;padding-right:8px}.c-article-identifiers__item:last-child{border-right:0;margin-right:0;padding-right:0}.c-article-title{font-size:1.5rem;line-height:1.25;margin:0 0 16px}@media only screen and (min-width:768px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{display:inline;font-size:1rem;list-style:none;margin:0 8px 0 0;padding:0;width:100%}.c-article-author-list__item{display:inline;padding-right:0}.c-article-author-list svg{margin-left:4px}.c-article-author-list__show-more{display:none;margin-right:4px}.c-article-author-list__button,.js .c-article-author-list__item--hide,.js .c-article-author-list__show-more{display:none}.js .c-article-author-list--long .c-article-author-list__show-more,.js .c-article-author-list--long+.c-article-author-list__button{display:inline}@media only screen and (max-width:539px){.js .c-article-author-list__item--hide-small-screen{display:none}.js .c-article-author-list--short .c-article-author-list__show-more,.js .c-article-author-list--short+.c-article-author-list__button{display:inline}}#uptodate-client,.js .c-article-author-list--expanded .c-article-author-list__show-more{display:none!important}.js .c-article-author-list--expanded .c-article-author-list__item--hide-small-screen{display:inline!important}.c-article-author-list__button,.c-button-author-list{background:#ebf1f5;border:4px solid #ebf1f5;border-radius:20px;color:#666;font-size:.875rem;line-height:1.4;padding:2px 11px 2px 8px;text-decoration:none}.c-article-author-list__button svg,.c-button-author-list svg{margin:1px 4px 0 0}.c-article-author-list__button:hover,.c-button-author-list:hover{background:#069;border-color:transparent;color:#fff}.c-article-info-details{font-size:1rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-article-metrics-bar{display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3}.c-article-metrics-bar__wrapper{margin:16px 0}.c-article-metrics-bar__item{align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-style:normal;font-weight:400;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-main-column{font-family:Harding,Palatino,serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:1.25rem;margin:0;padding-bottom:8px}@media only screen and (min-width:768px){.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{font-size:1.5rem;line-height:1.24}}.c-article-associated-content__container .c-article-associated-content__title{margin-bottom:8px}.c-article-body p{margin-bottom:24px;margin-top:0}.c-article-section{clear:both}.c-article-section__content{margin-bottom:40px;padding-top:8px}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-article-authors-search{margin-bottom:24px;margin-top:0}.c-article-authors-search__item,.c-article-authors-search__title{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.c-article-authors-search__title{color:#626262;font-size:1.05rem;font-weight:700;margin:0;padding:0}.c-article-authors-search__item{font-size:1rem}.c-article-authors-search__text{margin:0}.c-code-block{border:1px solid #eee;font-family:monospace;margin:0 0 24px;padding:20px}.c-code-block__heading{font-weight:400;margin-bottom:16px}.c-code-block__line{display:block;overflow-wrap:break-word;white-space:pre-wrap}.c-article-share-box__no-sharelink-info{font-size:.813rem;font-weight:700;margin-bottom:24px;padding-top:4px}.c-article-share-box__only-read-input{border:1px solid #d5d5d5;box-sizing:content-box;display:inline-block;font-size:.875rem;font-weight:700;height:24px;margin-bottom:8px;padding:8px 10px}.c-article-share-box__button--link-like{background-color:transparent;border:0;color:#069;cursor:pointer;font-size:.875rem;margin-bottom:8px;margin-left:10px}.c-article-editorial-summary__container{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem}.c-article-editorial-summary__container .c-article-editorial-summary__content p:last-child{margin-bottom:0}.c-article-editorial-summary__container .c-article-editorial-summary__content--less{max-height:9.5rem;overflow:hidden}.c-article-editorial-summary__container .c-article-editorial-summary__button{background-color:#fff;border:0;color:#069;font-size:.875rem;margin-bottom:16px}.c-article-editorial-summary__container .c-article-editorial-summary__button.active,.c-article-editorial-summary__container .c-article-editorial-summary__button.hover,.c-article-editorial-summary__container .c-article-editorial-summary__button:active,.c-article-editorial-summary__container .c-article-editorial-summary__button:hover{text-decoration:underline;text-decoration-skip-ink:auto}.c-article-associated-content__container .c-article-associated-content__collection-label{font-size:.875rem;line-height:1.4}.c-article-associated-content__container .c-article-associated-content__collection-title{line-height:1.3}.c-context-bar{box-shadow:0 0 10px 0 rgba(51,51,51,.2);position:relative;width:100%}.c-context-bar__title{display:none}.c-reading-companion{clear:both;min-height:389px}.c-reading-companion__sticky{max-width:389px}.c-reading-companion__scroll-pane{margin:0;min-height:200px;overflow:hidden auto}.c-reading-companion__tabs{display:flex;flex-flow:row nowrap;font-size:1rem;list-style:none;margin:0 0 8px;padding:0}.c-reading-companion__tabs>li{flex-grow:1}.c-reading-companion__tab{background-color:#eee;border:1px solid #d5d5d5;border-image:initial;border-left-width:0;color:#069;font-size:1rem;padding:8px 8px 8px 15px;text-align:left;width:100%}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{background-color:#fff;border-bottom:1px solid #fff;color:#222;font-weight:700}.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__figures-list,.c-reading-companion__references-list{list-style:none;min-height:389px;padding:0}.c-reading-companion__references-list--numeric{list-style:decimal inside}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1rem;padding:0}.c-reading-companion__section-item a{display:block;line-height:1.5;overflow:hidden;padding:8px 0 8px 16px;text-overflow:ellipsis;white-space:nowrap}.c-reading-companion__figure-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:16px 8px 16px 0}.c-reading-companion__figure-item:first-child{border-top:none;padding-top:8px}.c-reading-companion__reference-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:8px 8px 8px 16px}.c-reading-companion__reference-item:first-child{border-top:none}.c-reading-companion__reference-item a{word-break:break-word}.c-reading-companion__reference-citation{display:inline}.c-reading-companion__reference-links{font-size:.813rem;font-weight:700;list-style:none;margin:8px 0 0;padding:0;text-align:right}.c-reading-companion__reference-links>a{display:inline-block;padding-left:8px}.c-reading-companion__reference-links>a:first-child{display:inline-block;padding-left:0}.c-reading-companion__figure-title{display:block;margin:0 0 8px}.c-reading-companion__figure-links{display:flex;justify-content:space-between;margin:8px 0 0}.c-reading-companion__figure-links>a{align-items:center;display:flex}.c-reading-companion__figure-full-link svg{height:.8em;margin-left:2px}.c-reading-companion__panel{border-top:none;display:none;margin-top:0;padding-top:0}.c-cod,.c-reading-companion__panel--active{display:block}.c-cod{font-size:1rem;width:100%}.c-cod__form{background:#ebf0f3}.c-cod__prompt{font-size:1.125rem;line-height:1.3;margin:0 0 24px}.c-cod__label{display:block;margin:0 0 4px}.c-cod__row{display:flex;margin:0 0 16px}.c-cod__row:last-child{margin:0}.c-cod__input{border:1px solid #d5d5d5;border-radius:2px;flex-basis:75%;flex-shrink:0;margin:0;padding:13px}.c-cod__input--submit{background-color:#069;border:1px solid #069;color:#fff;flex-shrink:1;margin-left:8px;transition:background-color .2s ease-out 0s,color .2s ease-out 0s}.c-cod__input--submit-single{flex-basis:100%;flex-shrink:0;margin:0}.c-cod__input--submit:focus,.c-cod__input--submit:hover{background-color:#fff;color:#069}.c-pdf-download__link .u-icon{padding-top:2px}.c-pdf-download{display:flex;margin-bottom:16px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{display:flex;flex:1 1 0%}.c-pdf-download__link:hover{text-decoration:none}.c-pdf-download__text{padding-right:4px}@media only screen and (max-width:539px){.c-pdf-download__text{text-transform:capitalize}}@media only screen and (min-width:540px){.c-pdf-download__text{padding-right:8px}}.c-context-bar--sticky .c-pdf-download{display:block;margin-bottom:0;white-space:nowrap}@media only screen and (max-width:539px){.c-pdf-download .u-sticky-visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}}.c-pdf-container{display:flex;justify-content:flex-end}@media only screen and (max-width:539px){.c-pdf-container .c-pdf-download{display:flex;flex-basis:100%}}.c-pdf-container .c-pdf-download+.c-pdf-download{margin-left:16px}.c-article-extras .c-pdf-container .c-pdf-download{width:100%}.c-article-extras .c-pdf-container .c-pdf-download+.c-pdf-download{margin-left:0}@media only screen and (min-width:540px){.c-context-bar--sticky .c-pdf-download__link{align-items:center;flex:1 1 183px}}@media only screen and (max-width:320px){.c-context-bar--sticky .c-pdf-download__link{padding:16px}}.article-page--commercial .c-article-main-column .c-pdf-button__container .c-pdf-download{display:none}@media only screen and (max-width:1023px){.article-page--commercial .c-article-main-column .c-pdf-button__container .c-pdf-download{display:block}}.c-recommendations-column-switch .c-meta{margin-top:auto}.c-article-recommendations-card__meta-type,.c-meta .c-meta__item:first-child{font-weight:700}.c-article-metrics__heading a,.c-article-metrics__posts .c-card__title a{color:inherit}.c-article-metrics__posts .c-card__title{font-size:1.05rem}.c-article-metrics__posts .c-card__title+span{color:#6f6f6f;font-size:1rem}p{overflow-wrap:break-word;word-break:break-word}.c-ad{text-align:center}@media only screen and (min-width:320px){.c-ad{padding:8px}}.c-ad--728x90{background-color:#ccc;display:none}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 94px)}@media only screen and (min-width:768px){.js .c-ad--728x90{display:none}.js .u-show-following-ad+.c-ad--728x90{display:block}}.c-ad__label{color:#333;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;font-weight:400;line-height:1.5;margin-bottom:4px}.app-author-list{color:#6f6f6f;font-family:inherit;font-size:1rem;line-height:inherit;list-style:none;margin:0;padding:0}.app-author-list>li,.c-breadcrumbs>li,.c-footer__links>li,.js .app-author-list,.u-list-comma-separated>li,.u-list-inline>li{display:inline}.app-author-list>li:not(:first-child):not(:last-child):before{content:", "}.app-author-list>li:not(:only-child):last-child:before{content:" & "}.app-author-list--compact{font-size:.875rem;line-height:1.4}.app-author-list--truncated>li:not(:only-child):last-child:before{content:" ... "}.js .app-author-list__hide{display:none;visibility:hidden}.js .app-author-list__hide:first-child+*{margin-block-start:0}.c-meta{color:inherit;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;line-height:1.4;list-style:none;margin:0;padding:0}.c-meta--large{font-size:1rem}.c-meta--large .c-meta__item{margin-bottom:8px}.c-meta__item{display:inline-block;margin-bottom:4px}.c-meta__item:not(:last-child){border-right:1px solid #d5d5d5;margin-right:4px;padding-right:4px}@media only screen and (max-width:539px){.c-meta__item--block-sm-max{display:block}.c-meta__item--block-sm-max:not(:last-child){border-right:none;margin-right:0;padding-right:0}}@media only screen and (min-width:1024px){.c-meta__item--block-at-lg{display:block}.c-meta__item--block-at-lg:not(:last-child){border-right:none;margin-right:0;padding-right:0}}.c-meta__type{font-weight:700;text-transform:none}.c-skip-link{background:#069;bottom:auto;color:#fff;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;padding:8px;position:absolute;text-align:center;transform:translateY(-100%);z-index:9999}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out 0s}}@media print{.c-skip-link{display:none}}.c-skip-link:link{color:#fff}.c-status-message{align-items:center;box-sizing:border-box;display:flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;position:relative;width:100%}.c-card__summary>p:last-child,.c-status-message :last-child{margin-bottom:0}.c-status-message--boxed{background-color:#fff;border:1px solid #eee;border-radius:2px;line-height:1.4;padding:16px}.c-status-message__heading{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;font-weight:700}.c-status-message__icon{fill:currentcolor;display:inline-block;flex:0 0 auto;height:1.5em;margin-right:8px;transform:translate(0);vertical-align:text-top;width:1.5em}.c-status-message__icon--top{align-self:flex-start}.c-status-message--info .c-status-message__icon{color:#003f8d}.c-status-message--boxed.c-status-message--info{border-bottom:4px solid #003f8d}.c-status-message--error .c-status-message__icon{color:#c40606}.c-status-message--boxed.c-status-message--error{border-bottom:4px solid #c40606}.c-status-message--success .c-status-message__icon{color:#00b8b0}.c-status-message--boxed.c-status-message--success{border-bottom:4px solid #00b8b0}.c-status-message--warning .c-status-message__icon{color:#edbc53}.c-status-message--boxed.c-status-message--warning{border-bottom:4px solid #edbc53}.c-breadcrumbs{color:#000;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;list-style:none;margin:0;padding:0}.c-breadcrumbs__link{color:#666}svg.c-breadcrumbs__chevron{margin:4px 4px 0;fill:#888;height:10px;width:10px}@media only screen and (max-width:539px){.c-breadcrumbs .c-breadcrumbs__item{display:none}.c-breadcrumbs .c-breadcrumbs__item:last-child,.c-breadcrumbs .c-breadcrumbs__item:nth-last-child(2){display:inline}}.c-card{background-color:transparent;border:0;box-shadow:none;display:flex;flex-direction:column;font-size:14px;min-width:0;overflow:hidden;padding:0;position:relative}.c-card--no-shape{background:0 0;border:0;box-shadow:none}.c-card__image{display:flex;justify-content:center;overflow:hidden;padding-bottom:56.25%;position:relative}@supports (aspect-ratio:1/1){.c-card__image{padding-bottom:0}}.c-card__image img{left:0;min-height:100%;min-width:100%;position:absolute}@supports ((-o-object-fit:cover) or (object-fit:cover)){.c-card__image img{height:100%;object-fit:cover;width:100%}}.c-card__body{flex:1 1 auto;padding:16px}.c-card--no-shape .c-card__body{padding:0}.c-card--no-shape .c-card__body:not(:first-child){padding-top:16px}.c-card__title{letter-spacing:-.01875rem;margin-bottom:8px;margin-top:0}[lang=de] .c-card__title{hyphens:auto}.c-card__summary{line-height:1.4}.c-card__summary>p{margin-bottom:5px}.c-card__summary a{text-decoration:underline}.c-card__link:not(.c-card__link--no-block-link):before{bottom:0;content:"";left:0;position:absolute;right:0;top:0}.c-card--flush .c-card__body{padding:0}.c-card--major{font-size:1rem}.c-card--dark{background-color:#29303c;border-width:0;color:#e3e4e5}.c-card--dark .c-card__title{color:#fff}.c-card--dark .c-card__link,.c-card--dark .c-card__summary a{color:inherit}.c-header{background-color:#fff;border-bottom:5px solid #000;font-size:1rem;line-height:1.4;margin-bottom:16px}.c-header__row{padding:0;position:relative}.c-header__row:not(:last-child){border-bottom:1px solid #eee}.c-header__split{align-items:center;display:flex;justify-content:space-between}.c-header__logo-container{flex:1 1 0px;line-height:0;margin:8px 24px 8px 0}.c-header__logo{transform:translateZ(0)}.c-header__logo img{max-height:32px}.c-header__container{margin:0 auto;max-width:1280px}.c-header__menu{align-items:center;display:flex;flex:0 1 auto;flex-wrap:wrap;font-weight:700;gap:8px 8px;line-height:1.4;list-style:none;margin:0 -8px;padding:0}@media print{.c-header__menu{display:none}}@media only screen and (max-width:1023px){.c-header__menu--hide-lg-max{display:none;visibility:hidden}}.c-header__menu--global{font-weight:400;justify-content:flex-end}.c-header__menu--global svg{display:none;visibility:hidden}.c-header__menu--global svg:first-child+*{margin-block-start:0}@media only screen and (min-width:540px){.c-header__menu--global svg{display:block;visibility:visible}}.c-header__menu--journal{font-size:.875rem;margin:8px 0 8px -8px}@media only screen and (min-width:540px){.c-header__menu--journal{flex-wrap:nowrap;font-size:1rem}}.c-header__item{padding-bottom:0;padding-top:0;position:static}.c-header__item--pipe{border-left:2px solid #eee;padding-left:8px}.c-header__item--padding{padding-bottom:8px;padding-top:8px}@media only screen and (min-width:540px){.c-header__item--dropdown-menu{position:relative}}@media only screen and (min-width:1024px){.c-header__item--hide-lg{display:none;visibility:hidden}}@media only screen and (max-width:767px){.c-header__item--hide-md-max{display:none;visibility:hidden}.c-header__item--hide-md-max:first-child+*{margin-block-start:0}}.c-header__link{align-items:center;color:inherit;display:inline-flex;gap:4px 4px;padding:8px;white-space:nowrap}.c-header__link svg{transition-duration:.2s}.c-header__show-text{display:none;visibility:hidden}.has-tethered .c-header__heading--js-hide:first-child+*{margin-block-start:0}@media only screen and (min-width:540px){.c-header__show-text{display:inline;visibility:visible}}.c-header__dropdown{background-color:#000;border-bottom:1px solid #2f2f2f;color:#eee;font-size:.875rem;line-height:1.2;padding:16px 0}@media print{.c-header__dropdown{display:none}}.c-header__heading{display:inline-block;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.25rem;font-weight:400;line-height:1.4;margin-bottom:8px}.c-header__heading--keyline{border-top:1px solid;border-color:#2f2f2f;margin-top:16px;padding-top:16px;width:100%}.c-header__list{display:flex;flex-wrap:wrap;gap:0 16px;list-style:none;margin:0 -8px}.c-header__flush{margin:0 -8px}.c-header__visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.c-header__search-form{margin-bottom:8px}.c-header__search-layout{display:flex;flex-wrap:wrap;gap:16px 16px}.c-header__search-layout>:first-child{flex:999 1 auto}.c-header__search-layout>*{flex:1 1 auto}.c-header__search-layout--max-width{max-width:720px}.c-header__search-button{align-items:center;background-color:transparent;background-image:none;border:1px solid #fff;border-radius:2px;color:#fff;cursor:pointer;display:flex;font-family:sans-serif;font-size:1rem;justify-content:center;line-height:1.15;margin:0;padding:8px 16px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s;width:100%}.u-button svg,.u-button--primary svg{fill:currentcolor}.c-header__input,.c-header__select{border:1px solid;border-radius:3px;box-sizing:border-box;font-size:1rem;padding:8px 16px;width:100%}.c-header__select{-webkit-appearance:none;background-image:url("data:image/svg+xml,%3Csvg height='16' viewBox='0 0 16 16' width='16' xmlns='http://www.w3.org/2000/svg'%3E%3Cpath d='m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z' fill='%23333' fill-rule='evenodd' transform='matrix(0 1 -1 0 11 3)'/%3E%3C/svg%3E");background-position:right .7em top 50%;background-repeat:no-repeat;background-size:1em;box-shadow:0 1px 0 1px rgba(0,0,0,.04);display:block;margin:0;max-width:100%;min-width:150px}@media only screen and (min-width:540px){.c-header__menu--journal .c-header__item--dropdown-menu:last-child .c-header__dropdown.has-tethered{left:auto;right:0}}@media only screen and (min-width:768px){.c-header__menu--journal .c-header__item--dropdown-menu:last-child .c-header__dropdown.has-tethered{left:0;right:auto}}.c-header__dropdown.has-tethered{border-bottom:0;border-radius:0 0 2px 2px;left:0;position:absolute;top:100%;transform:translateY(5px);width:100%;z-index:1}@media only screen and (min-width:540px){.c-header__dropdown.has-tethered{transform:translateY(8px);width:auto}}@media only screen and (min-width:768px){.c-header__dropdown.has-tethered{min-width:225px}}.c-header__dropdown--full-width.has-tethered{padding:32px 0 24px;transform:none;width:100%}.has-tethered .c-header__heading--js-hide{display:none;visibility:hidden}.has-tethered .c-header__list--js-stack{flex-direction:column}.has-tethered .c-header__item--keyline,.has-tethered .c-header__list~.c-header__list .c-header__item:first-child{border-top:1px solid #d5d5d5;margin-top:8px;padding-top:8px}.c-header__item--snid-account-widget{display:flex}.c-header__container{padding:0 4px}.c-header__list{padding:0 12px}.c-header__menu .c-header__link{font-size:14px}.c-header__item--snid-account-widget .c-header__link{padding:8px}.c-header__menu--journal{margin-left:0}@media only screen and (min-width:540px){.c-header__container{padding:0 16px}.c-header__menu--journal{margin-left:-8px}.c-header__menu .c-header__link{font-size:16px}.c-header__link--search{gap:13px 13px}}.u-button{align-items:center;background-color:transparent;background-image:none;border:1px solid #069;border-radius:2px;color:#069;cursor:pointer;display:inline-flex;font-family:sans-serif;font-size:1rem;justify-content:center;line-height:1.3;margin:0;padding:8px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s;width:auto}.u-button--primary{background-color:#069;background-image:none;border:1px solid #069;color:#fff}.u-button--full-width{display:flex;width:100%}.u-display-none{display:none}.js .u-js-hide,.u-hide{display:none;visibility:hidden}.u-hide:first-child+*{margin-block-start:0}.u-visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}@media print{.u-hide-print{display:none}}@media only screen and (min-width:1024px){.u-hide-at-lg{display:none;visibility:hidden}.u-hide-at-lg:first-child+*{margin-block-start:0}}.u-clearfix:after,.u-clearfix:before{content:"";display:table}.u-clearfix:after{clear:both}.u-color-open-access{color:#b74616}.u-float-left{float:left}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-full-height{height:100%}.u-list-reset{list-style:none;margin:0;padding:0}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-justify-content-space-between{justify-content:space-between}.u-mt-32{margin-top:32px}.u-mb-8{margin-bottom:8px}.u-mb-16{margin-bottom:16px}.u-mb-24{margin-bottom:24px}.u-mb-32{margin-bottom:32px}.c-nature-box svg+.c-article__button-text,.u-ml-8{margin-left:8px}.u-pa-16{padding:16px}html *,html :after,html :before{box-sizing:inherit}.c-article-section__title,.c-article-title{font-weight:700}.c-card__title{line-height:1.4em}.c-article__button{background-color:#069;border:1px solid #069;border-radius:2px;color:#fff;display:flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;line-height:1.4;margin-bottom:16px;padding:13px;transition:background-color .2s ease-out 0s,color .2s ease-out 0s}.c-article__button,.c-article__button:hover{text-decoration:none}.c-article__button--inverted,.c-article__button:hover{background-color:#fff;color:#069}.c-article__button--inverted:hover{background-color:#069;color:#fff}.c-header__link{text-decoration:inherit}.grade-c-hide{display:block}.c-nature-box{background-color:#fff;border:1px solid #d5d5d5;border-radius:2px;box-shadow:0 0 5px 0 rgba(51,51,51,.1);line-height:1.3;margin-bottom:24px;padding:16px 16px 3px}.c-nature-box__text{font-size:1rem;margin-bottom:16px}.c-nature-box--access-to-pdf{display:none}@media only screen and (min-width:1024px){.c-nature-box--mobile{display:none}}.c-nature-box .c-pdf-download{margin-bottom:16px!important}.c-nature-box--version{background-color:#eee}.c-nature-box__wrapper{transform:translateZ(0)}.c-nature-box__wrapper--placeholder{min-height:165px}.c-pdf-download__link{padding:13px 24px} } </style>




    
        <link data-test="critical-css-handler" data-inline-css-source="critical-css" rel="stylesheet" href="/static/css/enhanced-article-nature-branded-1dd982e2cc.css" media="only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)" onload="this.media='only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)';this.onload=null">
    
    <noscript>
        <link rel="stylesheet" type="text/css" href="/static/css/enhanced-article-nature-branded-1dd982e2cc.css" media="only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)">
    </noscript>

<link rel="stylesheet" type="text/css" href="/static/css/article-print-c9121fecab.css" media="print">
    



<link rel="apple-touch-icon" sizes="180x180" href="/static/images/favicons/nature/apple-touch-icon-f39cb19454.png">
<link rel="icon" type="image/png" sizes="48x48" href="/static/images/favicons/nature/favicon-48x48-b52890008c.png">
<link rel="icon" type="image/png" sizes="32x32" href="/static/images/favicons/nature/favicon-32x32-3fe59ece92.png">
<link rel="icon" type="image/png" sizes="16x16" href="/static/images/favicons/nature/favicon-16x16-951651ab72.png">
<link rel="manifest" href="/static/manifest.json" crossorigin="use-credentials">
<link rel="mask-icon" href="/static/images/favicons/nature/safari-pinned-tab-69bff48fe6.svg" color="#000000">
<link rel="shortcut icon" href="/static/images/favicons/nature/favicon.ico">
<meta name="msapplication-TileColor" content="#000000">
<meta name="msapplication-config" content="/static/browserconfig.xml">
<meta name="theme-color" content="#000000">
<meta name="application-name" content="Nature">


<script>
    (function () {
        if ( typeof window.CustomEvent === "function" ) return false;
        function CustomEvent ( event, params ) {
            params = params || { bubbles: false, cancelable: false, detail: null };
            var evt = document.createEvent( 'CustomEvent' );
            evt.initCustomEvent( event, params.bubbles, params.cancelable, params.detail );
            return evt;
        }

        CustomEvent.prototype = window.Event.prototype;

        window.CustomEvent = CustomEvent;
    })();
</script>



<!-- Google Tag Manager -->
<script data-test="gtm-head">
    window.initGTM = function() {
        if (window.config.mustardcut) {
            (function (w, d, s, l, i) {
                w[l] = w[l] || [];
                w[l].push({'gtm.start': new Date().getTime(), event: 'gtm.js'});
                var f = d.getElementsByTagName(s)[0],
                        j = d.createElement(s),
                        dl = l != 'dataLayer' ? '&l=' + l : '';
                j.async = true;
                j.src = 'https://www.googletagmanager.com/gtm.js?id=' + i + dl;
                f.parentNode.insertBefore(j, f);
            })(window, document, 'script', 'dataLayer', 'GTM-MRVXSHQ');
        }
    }
</script>
<!-- End Google Tag Manager -->

    <script>
    (function(w,d,t) {
        function cc() {
            var h = w.location.hostname;
            if (h.indexOf('preview-www.nature.com') > -1) return;

            var e = d.createElement(t),
                    s = d.getElementsByTagName(t)[0];

            if (h.indexOf('nature.com') > -1) {
                if (h.indexOf('test-www.nature.com') > -1) {
                    e.src = 'https://cmp.nature.com/production_live/en/consent-bundle-8-85.js';
                    e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
                } else {
                    e.src = 'https://cmp.nature.com/production_live/en/consent-bundle-8-85.js';
                    e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
                }
            } else {
                e.src = '/static/js/cookie-consent-es5-bundle-cb57c2c98a.js';
                e.setAttribute('data-consent', h);
            }
            s.insertAdjacentElement('afterend', e);
        }

        cc();
    })(window,document,'script');
</script>


<script id="js-position0">
    (function(w, d) {
        w.idpVerifyPrefix = 'https://verify.nature.com';
        w.ra21Host = 'https://wayf.springernature.com';
        var moduleSupport = (function() {
            return 'noModule' in d.createElement('script');
        })();

        if (w.config.mustardcut === true) {
            w.loader = {
                index: 0,
                registered: [],
                scripts: [
                    
                        {src: '/static/js/global-article-es6-bundle-c8a573ca90.js', test: 'global-article-js', module: true},
                        {src: '/static/js/global-article-es5-bundle-d17603b9e9.js', test: 'global-article-js', nomodule: true},
                        {src: '/static/js/shared-es6-bundle-e9d2061c95.js', test: 'shared-js', module: true},
                        {src: '/static/js/shared-es5-bundle-1cbf3a8b56.js', test: 'shared-js', nomodule: true},
                        {src: '/static/js/header-150-es6-bundle-5bb959eaa1.js', test: 'header-150-js', module: true},
                        {src: '/static/js/header-150-es5-bundle-994fde5b1d.js', test: 'header-150-js', nomodule: true}
                    
                ].filter(function (s) {
                    if (s.src === null) return false;
                    if (moduleSupport && s.nomodule) return false;
                    return !(!moduleSupport && s.module);
                }),

                register: function (value) {
                    this.registered.push(value);
                },

                ready: function () {
                    if (this.registered.length === this.scripts.length) {
                        this.registered.forEach(function (fn) {
                            if (typeof fn === 'function') {
                                setTimeout(fn, 0); 
                            }
                        });
                        this.ready = function () {};
                    }
                },

                insert: function (s) {
                    var t = d.getElementById('js-position' + this.index);
                    if (t && t.insertAdjacentElement) {
                        t.insertAdjacentElement('afterend', s);
                    } else {
                        d.head.appendChild(s);
                    }
                    ++this.index;
                },

                createScript: function (script, beforeLoad) {
                    var s = d.createElement('script');
                    s.id = 'js-position' + (this.index + 1);
                    s.setAttribute('data-test', script.test);
                    if (beforeLoad) {
                        s.defer = 'defer';
                        s.onload = function () {
                            if (script.noinit) {
                                loader.register(true);
                            }
                            if (d.readyState === 'interactive' || d.readyState === 'complete') {
                                loader.ready();
                            }
                        };
                    } else {
                        s.async = 'async';
                    }
                    s.src = script.src;
                    return s;
                },

                init: function () {
                    this.scripts.forEach(function (s) {
                        loader.insert(loader.createScript(s, true));
                    });

                    d.addEventListener('DOMContentLoaded', function () {
                        loader.ready();
                        var conditionalScripts;
                        
                            conditionalScripts = [
                                {match: 'div[data-pan-container]', src: '/static/js/pan-zoom-es6-bundle-464a2af269.js', test: 'pan-zoom-js',  module: true },
                                {match: 'div[data-pan-container]', src: '/static/js/pan-zoom-es5-bundle-98fb9b653b.js', test: 'pan-zoom-js',  nomodule: true },
                                {match: 'math,span.mathjax-tex', src: '/static/js/math-es6-bundle-23597ae350.js', test: 'math-js', module: true},
                                {match: 'math,span.mathjax-tex', src: '/static/js/math-es5-bundle-6532c6f78b.js', test: 'math-js', nomodule: true}
                            ];
                        

                        if (conditionalScripts) {
                            conditionalScripts.filter(function (script) {
                                return !!document.querySelector(script.match) && !((moduleSupport && script.nomodule) || (!moduleSupport && script.module));
                            }).forEach(function (script) {
                                loader.insert(loader.createScript(script));
                            });
                        }
                    }, false);
                }
            };
            loader.init();
        }
    })(window, document);
</script><script id="js-position1" data-test="global-article-js" defer="" src="/static/js/global-article-es6-bundle-c8a573ca90.js"></script><script id="js-position2" data-test="shared-js" defer="" src="/static/js/shared-es6-bundle-e9d2061c95.js"></script><script id="js-position3" data-test="header-150-js" defer="" src="/static/js/header-150-es6-bundle-5bb959eaa1.js"></script><script id="js-position4" data-test="math-js" async="" src="/static/js/math-es6-bundle-23597ae350.js"></script>










<meta name="robots" content="noarchive">
<meta name="access" content="Yes">


<link rel="search" href="https://www.nature.com/search">
<link rel="search" href="https://www.nature.com/opensearch/opensearch.xml" type="application/opensearchdescription+xml" title="nature.com">
<link rel="search" href="https://www.nature.com/opensearch/request" type="application/sru+xml" title="nature.com">





    
    <script type="application/ld+json">{"mainEntity":{"headline":"Modeling transmission of SARS-CoV-2 Omicron in China","description":"Having adopted a dynamic zero-COVID strategy to respond to SARS-CoV-2 variants with higher transmissibility since August 2021, China is now considering whether, and for how long, this policy can remain in place. The debate has thus shifted towards the identification of mitigation strategies for minimizing disruption to the healthcare system in the case of a nationwide epidemic. To this aim, we developed an age-structured stochastic compartmental susceptible-latent-infectious-removed-susceptible model of SARS-CoV-2 transmission calibrated on the initial growth phase for the 2022 Omicron outbreak in Shanghai, to project COVID-19 burden (that is, number of cases, patients requiring hospitalization and intensive care, and deaths) under hypothetical mitigation scenarios. The model also considers age-specific vaccine coverage data, vaccine efficacy against different clinical endpoints, waning of immunity, different antiviral therapies and nonpharmaceutical interventions. We find that the level of immunity induced by the March 2022 vaccination campaign would be insufficient to prevent an Omicron wave that would result in exceeding critical care capacity with a projected intensive care unit peak demand of 15.6 times the existing capacity and causing approximately 1.55 million deaths. However, we also estimate that protecting vulnerable individuals by ensuring accessibility to vaccines and antiviral therapies, and maintaining implementation of nonpharmaceutical interventions could be sufficient to prevent overwhelming the healthcare system, suggesting that these factors should be points of emphasis in future mitigation policies. Estimates from a new modeling study suggest that current levels of vaccine coverage in China are insufficient to prevent overwhelming the healthcare system, and that, if left untreated, a nationwide Omicron wave could result in up to 1.55 million deaths.","datePublished":"2022-05-10T00:00:00Z","dateModified":"2022-05-10T00:00:00Z","pageStart":"1468","pageEnd":"1475","license":"http://creativecommons.org/licenses/by/4.0/","sameAs":"https://doi.org/10.1038/s41591-022-01855-7","keywords":["Epidemiology","Viral infection","Biomedicine","general","Cancer Research","Metabolic Diseases","Infectious Diseases","Molecular Medicine","Neurosciences"],"image":["https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig1_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig2_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig3_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig4_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig5_HTML.png"],"isPartOf":{"name":"Nature Medicine","issn":["1546-170X","1078-8956"],"volumeNumber":"28","@type":["Periodical","PublicationVolume"]},"publisher":{"name":"Nature Publishing Group US","logo":{"url":"https://www.springernature.com/app-sn/public/images/logo-springernature.png","@type":"ImageObject"},"@type":"Organization"},"author":[{"name":"Jun Cai","url":"http://orcid.org/0000-0001-9495-1226","affiliation":[{"name":"Fudan University, Key Laboratory of Public Health Safety, Ministry of Education","address":{"name":"School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Xiaowei Deng","affiliation":[{"name":"Fudan University, Key Laboratory of Public Health Safety, Ministry of Education","address":{"name":"School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Juan Yang","url":"http://orcid.org/0000-0001-5028-2227","affiliation":[{"name":"Fudan University, Key Laboratory of Public Health Safety, Ministry of Education","address":{"name":"School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China","@type":"PostalAddress"},"@type":"Organization"},{"name":"Fudan University","address":{"name":"Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Kaiyuan Sun","affiliation":[{"name":"Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health","address":{"name":"Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Hengcong Liu","url":"http://orcid.org/0000-0003-2591-2201","affiliation":[{"name":"Fudan University, Key Laboratory of Public Health Safety, Ministry of Education","address":{"name":"School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Zhiyuan Chen","affiliation":[{"name":"Fudan University, Key Laboratory of Public Health Safety, Ministry of Education","address":{"name":"School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Cheng Peng","affiliation":[{"name":"Fudan University, Key Laboratory of Public Health Safety, Ministry of Education","address":{"name":"School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Xinhua Chen","affiliation":[{"name":"Fudan University, Key Laboratory of Public Health Safety, Ministry of Education","address":{"name":"School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Qianhui Wu","affiliation":[{"name":"Fudan University, Key Laboratory of Public Health Safety, Ministry of Education","address":{"name":"School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Junyi Zou","affiliation":[{"name":"Fudan University, Key Laboratory of Public Health Safety, Ministry of Education","address":{"name":"School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Ruijia Sun","affiliation":[{"name":"Fudan University, Key Laboratory of Public Health Safety, Ministry of Education","address":{"name":"School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Wen Zheng","affiliation":[{"name":"Fudan University, Key Laboratory of Public Health Safety, Ministry of Education","address":{"name":"School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Zeyao Zhao","affiliation":[{"name":"Fudan University, Key Laboratory of Public Health Safety, Ministry of Education","address":{"name":"School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Wanying Lu","affiliation":[{"name":"Fudan University, Key Laboratory of Public Health Safety, Ministry of Education","address":{"name":"School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Yuxia Liang","affiliation":[{"name":"Fudan University, Key Laboratory of Public Health Safety, Ministry of Education","address":{"name":"School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Xiaoyu Zhou","affiliation":[{"name":"Fudan University, Key Laboratory of Public Health Safety, Ministry of Education","address":{"name":"School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Marco Ajelli","affiliation":[{"name":"Indiana University School of Public Health","address":{"name":"Laboratory for Computational Epidemiology and Public Health, Department of Epidemiology and Biostatistics, Indiana University School of Public Health, Bloomington, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Hongjie Yu","url":"http://orcid.org/0000-0002-6335-5648","affiliation":[{"name":"Fudan University, Key Laboratory of Public Health Safety, Ministry of Education","address":{"name":"School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China","@type":"PostalAddress"},"@type":"Organization"},{"name":"Fudan University","address":{"name":"Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China","@type":"PostalAddress"},"@type":"Organization"}],"email":"yhj@fudan.edu.cn","@type":"Person"}],"isAccessibleForFree":true,"@type":"ScholarlyArticle"},"@context":"https://schema.org","@type":"WebPage"}</script>




    
    
    


    
    <link rel="canonical" href="https://www.nature.com/articles/s41591-022-01855-7">
    
    
    <meta name="journal_id" content="41591">
    <meta name="dc.title" content="Modeling transmission of SARS-CoV-2 Omicron in China">
    <meta name="dc.source" content="Nature Medicine 2022 28:7">
    <meta name="dc.format" content="text/html">
    <meta name="dc.publisher" content="Nature Publishing Group">
    <meta name="dc.date" content="2022-05-10">
    <meta name="dc.type" content="OriginalPaper">
    <meta name="dc.language" content="En">
    <meta name="dc.copyright" content="2022 The Author(s)">
    <meta name="dc.rights" content="2022 The Author(s)">
    <meta name="dc.rightsAgent" content="journalpermissions@springernature.com">
    <meta name="dc.description" content="Having adopted a dynamic zero-COVID strategy to respond to SARS-CoV-2 variants with higher transmissibility since August 2021, China is now considering whether, and for how long, this policy can remain in place. The debate has thus shifted towards the identification of mitigation strategies for minimizing disruption to the healthcare system in the case of a nationwide epidemic. To this aim, we developed an age-structured stochastic compartmental susceptible-latent-infectious-removed-susceptible model of SARS-CoV-2 transmission calibrated on the initial growth phase for the 2022 Omicron outbreak in Shanghai, to project COVID-19 burden (that is, number of cases, patients requiring hospitalization and intensive care, and deaths) under hypothetical mitigation scenarios. The model also considers age-specific vaccine coverage data, vaccine efficacy against different clinical endpoints, waning of immunity, different antiviral therapies and nonpharmaceutical interventions. We find that the level of immunity induced by the March 2022 vaccination campaign would be insufficient to prevent an Omicron wave that would result in exceeding critical care capacity with a projected intensive care unit peak demand of 15.6 times the existing capacity and causing approximately 1.55 million deaths. However, we also estimate that protecting vulnerable individuals by ensuring accessibility to vaccines and antiviral therapies, and maintaining implementation of nonpharmaceutical interventions could be sufficient to prevent overwhelming the healthcare system, suggesting that these factors should be points of emphasis in future mitigation policies. Estimates from a new modeling study suggest that current levels of vaccine coverage in China are insufficient to prevent overwhelming the healthcare system, and that, if left untreated, a nationwide Omicron wave could result in up to 1.55 million deaths.">
    <meta name="prism.issn" content="1546-170X">
    <meta name="prism.publicationName" content="Nature Medicine">
    <meta name="prism.publicationDate" content="2022-05-10">
    <meta name="prism.volume" content="28">
    <meta name="prism.number" content="7">
    <meta name="prism.section" content="OriginalPaper">
    <meta name="prism.startingPage" content="1468">
    <meta name="prism.endingPage" content="1475">
    <meta name="prism.copyright" content="2022 The Author(s)">
    <meta name="prism.rightsAgent" content="journalpermissions@springernature.com">
    <meta name="prism.url" content="https://www.nature.com/articles/s41591-022-01855-7">
    <meta name="prism.doi" content="doi:10.1038/s41591-022-01855-7">
    <meta name="citation_pdf_url" content="https://www.nature.com/articles/s41591-022-01855-7.pdf">
    <meta name="citation_fulltext_html_url" content="https://www.nature.com/articles/s41591-022-01855-7">
    <meta name="citation_journal_title" content="Nature Medicine">
    <meta name="citation_journal_abbrev" content="Nat Med">
    <meta name="citation_publisher" content="Nature Publishing Group">
    <meta name="citation_issn" content="1546-170X">
    <meta name="citation_title" content="Modeling transmission of SARS-CoV-2 Omicron in China">
    <meta name="citation_volume" content="28">
    <meta name="citation_issue" content="7">
    <meta name="citation_publication_date" content="2022/07">
    <meta name="citation_online_date" content="2022/05/10">
    <meta name="citation_firstpage" content="1468">
    <meta name="citation_lastpage" content="1475">
    <meta name="citation_article_type" content="Article">
    <meta name="citation_fulltext_world_readable" content="">
    <meta name="citation_language" content="en">
    <meta name="dc.identifier" content="doi:10.1038/s41591-022-01855-7">
    <meta name="DOI" content="10.1038/s41591-022-01855-7">
    <meta name="size" content="180947">
    <meta name="citation_doi" content="10.1038/s41591-022-01855-7">
    <meta name="citation_springer_api_url" content="http://api.springer.com/xmldata/jats?q=doi:10.1038/s41591-022-01855-7&amp;api_key=">
    <meta name="description" content="Having adopted a dynamic zero-COVID strategy to respond to SARS-CoV-2 variants with higher transmissibility since August 2021, China is now considering whether, and for how long, this policy can remain in place. The debate has thus shifted towards the identification of mitigation strategies for minimizing disruption to the healthcare system in the case of a nationwide epidemic. To this aim, we developed an age-structured stochastic compartmental susceptible-latent-infectious-removed-susceptible model of SARS-CoV-2 transmission calibrated on the initial growth phase for the 2022 Omicron outbreak in Shanghai, to project COVID-19 burden (that is, number of cases, patients requiring hospitalization and intensive care, and deaths) under hypothetical mitigation scenarios. The model also considers age-specific vaccine coverage data, vaccine efficacy against different clinical endpoints, waning of immunity, different antiviral therapies and nonpharmaceutical interventions. We find that the level of immunity induced by the March 2022 vaccination campaign would be insufficient to prevent an Omicron wave that would result in exceeding critical care capacity with a projected intensive care unit peak demand of 15.6 times the existing capacity and causing approximately 1.55 million deaths. However, we also estimate that protecting vulnerable individuals by ensuring accessibility to vaccines and antiviral therapies, and maintaining implementation of nonpharmaceutical interventions could be sufficient to prevent overwhelming the healthcare system, suggesting that these factors should be points of emphasis in future mitigation policies. Estimates from a new modeling study suggest that current levels of vaccine coverage in China are insufficient to prevent overwhelming the healthcare system, and that, if left untreated, a nationwide Omicron wave could result in up to 1.55 million deaths.">
    <meta name="dc.creator" content="Cai, Jun">
    <meta name="dc.creator" content="Deng, Xiaowei">
    <meta name="dc.creator" content="Yang, Juan">
    <meta name="dc.creator" content="Sun, Kaiyuan">
    <meta name="dc.creator" content="Liu, Hengcong">
    <meta name="dc.creator" content="Chen, Zhiyuan">
    <meta name="dc.creator" content="Peng, Cheng">
    <meta name="dc.creator" content="Chen, Xinhua">
    <meta name="dc.creator" content="Wu, Qianhui">
    <meta name="dc.creator" content="Zou, Junyi">
    <meta name="dc.creator" content="Sun, Ruijia">
    <meta name="dc.creator" content="Zheng, Wen">
    <meta name="dc.creator" content="Zhao, Zeyao">
    <meta name="dc.creator" content="Lu, Wanying">
    <meta name="dc.creator" content="Liang, Yuxia">
    <meta name="dc.creator" content="Zhou, Xiaoyu">
    <meta name="dc.creator" content="Ajelli, Marco">
    <meta name="dc.creator" content="Yu, Hongjie">
    <meta name="dc.subject" content="Epidemiology">
    <meta name="dc.subject" content="Viral infection">
    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa; citation_author=R Viana; citation_volume=603; citation_publication_date=2022; citation_pages=679-686; citation_doi=10.1038/s41586-022-04411-y; citation_id=CR1">
    <meta name="citation_reference" content="Tracking of VOC Omicron. Global Initiative of Sharing All Influenza Data (GISAID) (29 January 2022); 
                  https://www.gisaid.org/hcov19-variants/
                  
                ">
    <meta name="citation_reference" content="Lyngse, F.P. SARS-CoV-2 Omicron VOC transmission in Danish households. Preprint at medRXiv 
                  https://doi.org/10.1101/2021.12.27.21268278
                  
                 (2021).">
    <meta name="citation_reference" content="Pearson, C.A.B. et al. Bounding the levels of transmissibility &amp; immune evasion of the Omicron variant in South Africa. Preprint at medRxiv 
                  https://doi.org/10.1101/2021.12.19.21268038
                  
                 (2021).">
    <meta name="citation_reference" content="Gozzi, N. et al. Preliminary modeling estimates of the relative transmissibility and immune escape of the Omicron SARS-CoV-2 variant of concern in South Africa. Preprint at medRxiv 
                  https://doi.org/10.1101/2022.01.04.22268721
                  
                 (2022).">
    <meta name="citation_reference" content="Lu, L. et al. Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients. Clin. Infect. Dis. ciab1041 (2021).">
    <meta name="citation_reference" content="citation_journal_title=Emerg. Microbes Infect.; citation_title=The significant immune escape of pseudotyped SARS-CoV-2 variant omicron; citation_author=L Zhang; citation_volume=11; citation_publication_date=2022; citation_pages=1-5; citation_doi=10.1080/22221751.2021.2017757; citation_id=CR7">
    <meta name="citation_reference" content="citation_journal_title=N. Engl. J. Med.; citation_title=Differential kinetics of immune responses elicited by covid-19 vaccines; citation_author=A-RY Collier; citation_volume=385; citation_publication_date=2021; citation_pages=2010-2012; citation_doi=10.1056/NEJMc2115596; citation_id=CR8">
    <meta name="citation_reference" content="citation_journal_title=N. Engl. J. Med.; citation_title=Waning immune humoral response to BNT162b2 covid-19 vaccine over 6 months; citation_author=EG Levin; citation_volume=385; citation_publication_date=2021; citation_pages=e84; citation_doi=10.1056/NEJMoa2114583; citation_id=CR9">
    <meta name="citation_reference" content="Xin, Q. et al. Six-month follow-up of a booster dose of coronavac: two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials. Preprint at SSRN 
                  https://doi.org/10.2139/ssrn.3991627
                  
                 (2021).">
    <meta name="citation_reference" content="citation_journal_title=Science; citation_title=Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection; citation_author=M Jennifer; citation_volume=371; citation_publication_date=2021; citation_pages=eabf4063; citation_doi=10.1126/science.abf4063; citation_id=CR11">
    <meta name="citation_reference" content="citation_journal_title=Nat. Commun.; citation_title=Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19; citation_author=AK Wheatley; citation_volume=12; citation_publication_date=2021; citation_doi=10.1038/s41467-021-21444-5; citation_id=CR12">
    <meta name="citation_reference" content="WHO Coronavirus (COVID-19) Dashboard. World Health Organization (5 March 2022); 
                  https://covid19.who.int/
                  
                ">
    <meta name="citation_reference" content="citation_journal_title=Lancet; citation_title=Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study; citation_author=N Wolter; citation_volume=399; citation_publication_date=2022; citation_pages=437-446; citation_doi=10.1016/S0140-6736(22)00017-4; citation_id=CR14">
    <meta name="citation_reference" content="citation_journal_title=JAMA; citation_title=Characteristics and outcomes of hospitalized patients in South Africa during the COVID-19 Omicron wave compared with previous waves; citation_author=C Maslo; citation_volume=327; citation_publication_date=2022; citation_pages=583-584; citation_doi=10.1001/jama.2021.24868; citation_id=CR15">
    <meta name="citation_reference" content="SARS-CoV-2 variants of concern and variants under investigation in England, Technical briefing: update on hospitalisation and vaccine effectiveness for Omicron VOC-21NOV-01 (B.1.1.529). UK Health Security Agency 
                  https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1044481/Technical-Briefing-31-Dec-2021-Omicron_severity_update.pdf
                  
                 (2021).">
    <meta name="citation_reference" content="Wang, L. et al. Incidence Rates and Clinical Outcomes of SARS-CoV-2 Infection With the Omicron and Delta Variants in Children Younger Than 5 Years in the US. JAMA Pediatr. e220945 (2022).">
    <meta name="citation_reference" content="Lewnard, J. A. et al. Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California. Preprint at medRxiv 
                  https://doi.org/10.1101/2022.01.11.22269045
                  
                 (2022).">
    <meta name="citation_reference" content="Iuliano, A. D. et al. Trends in disease severity and health care utilization during the early omicron variant period compared with previous SARS-CoV-2 high transmission periods—United States, December 2020–January 2022. MMWR Morb. Mortal. Wkly Rep. 71, 146–152 (2022).">
    <meta name="citation_reference" content="citation_journal_title=MMWR Morb. Mortal. Wkly Rep.; citation_title=Hospitalizations of children and adolescents with laboratory-confirmed COVID-19—COVID-NET, 14 States, July 2021–January 2022; citation_author=KJ Marks; citation_volume=71; citation_publication_date=2022; citation_pages=271-278; citation_doi=10.15585/mmwr.mm7107e4; citation_id=CR20">
    <meta name="citation_reference" content="Coronavirus (COVID-19) latest insights. UK Office for National Statistics . 
                  https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights
                  
                 (2022).">
    <meta name="citation_reference" content="Press conference held on situation regarding strict prevention and control of COVID-19 epidemic. The State Council Information Office, P.R.C. (19 April 2022); 
                  http://www.gov.cn/xinwen/gwylflkjz193/index.htm
                  
                ">
    <meta name="citation_reference" content="citation_journal_title=China CDC Wkly.; citation_title=The dynamic COVID-zero strategy in China; citation_author=J Liu, M Liu, W Liang; citation_volume=4; citation_publication_date=2022; citation_pages=74-75; citation_doi=10.46234/ccdcw2022.015; citation_id=CR23">
    <meta name="citation_reference" content="COVID-19 Virtual Press conference transcript. World Health Organization (1 February 2022); 
                  https://www.who.int/publications/m/item/covid-19-virtual-press-conference-transcript-1-february-2022
                  
                ">
    <meta name="citation_reference" content="Emergency approval of Brii Biosciences’ COVID-19 neutralizing antibody combination therapy: amubarvimab/romlusevimab combination (BRII-196/BRII-198) therapy. The National Medical Products Administration (NMPA) of China 
                  https://www.nmpa.gov.cn/yaowen/ypjgyw/20211208212528103.html
                  
                 (2021).">
    <meta name="citation_reference" content="Emergency conditional approval of Pfizer’s COVID-19 therapy: nirmatrelvir tablet/ritonavir tablet combination package (i.e., Paxlovid) importation registration. The National Medical Products Administration (NMPA) of China 
                  https://www.nmpa.gov.cn/yaowen/ypjgyw/20220212085753142.html
                  
                 (2022).">
    <meta name="citation_reference" content="McMenamin, M. E. et al. Vaccine effectiveness of two and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong. Preprint at medRxiv 
                  https://doi.org/10.1101/2022.03.22.22272769
                  
                 (2022).">
    <meta name="citation_reference" content="Press conference held on situation regarding strict prevention and control of COVID-19 epidemic. The State Council Information Office, P.R.C. (19 March 2022); 
                  http://www.gov.cn/xinwen/gwylflkjz187/index.htm
                  
                ">
    <meta name="citation_reference" content="Press conference held on situation regarding prevetion and control of COVID-19 epidemic in Shanghai. Shanghai Municipal Health Commission (17 April 2022); 
                  https://j.eastday.com/p/1650166645036759
                  
                ">
    <meta name="citation_reference" content="Press conference held on situation regarding prevetion and control of COVID-19 epidemic in Shandong province. People’s Government of Shandong Province (22 March 2022); 
                  http://www.shandong.gov.cn/vipchat1//home/site/82/3788/article.html
                  
                ">
    <meta name="citation_reference" content="citation_title=China Health Statistics Yearbook 2021; citation_publication_date=2021; citation_id=CR31; citation_publisher=China Union Medical College Press">
    <meta name="citation_reference" content="Ranzani, O. T. et al. Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against the Omicron (B.1.1.529) variant. Preprint at medRxiv 
                  https://doi.org/10.1101/2022.03.30.22273193
                  
                 (2022).">
    <meta name="citation_reference" content="Brii Bio announces Amubarvimab/Romlusevimab combination received approval from NMPA as first COVID-19 neutralizing antibody combination therapy in China. Brii Biosciences (9 December 2021); 
                  https://www.briibio.com/news-detial.php?id=505
                  
                ">
    <meta name="citation_reference" content="citation_journal_title=N. Engl. J. Med.; citation_title=Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19; citation_author=J Hammond; citation_volume=386; citation_publication_date=2022; citation_pages=1397-1408; citation_doi=10.1056/NEJMoa2118542; citation_id=CR34">
    <meta name="citation_reference" content="Barnard, R. C., Davies, N. G., Pearson, C. A. B., Jit, M. &amp; Edmunds, W. J. Projected epidemiological consequences of the Omicron SARS-CoV-2 variant in England, December 2021 to April 2022. Preprint at medRxiv 
                  https://doi.org/10.1101/2021.12.15.21267858
                  
                 (2021).">
    <meta name="citation_reference" content="Ranjan, R. Omicron impact in India: analysis of the ongoing COVID-19 third wave based on global data. Preprint at medRxiv 
                  https://doi.org/10.1101/2022.01.09.22268969
                  
                 (2022).">
    <meta name="citation_reference" content="citation_journal_title=Lancet Public Health; citation_title=Influenza-associated excess respiratory mortality in China, 2010–15: a population-based study; citation_author=L Li; citation_volume=4; citation_publication_date=2019; citation_pages=e473-e481; citation_doi=10.1016/S2468-2667(19)30163-X; citation_id=CR37">
    <meta name="citation_reference" content="United States: Coronavirus Pandemic Country Profile. Our World in Data (19 April 2022); 
                  https://ourworldindata.org/coronavirus/country/united-states
                  
                ">
    <meta name="citation_reference" content="Mesfin, Y. et al. Epidemiology of infections with SARS-CoV-2 Omicron BA.2 variant in Hong Kong, January–March 2022. Preprint at medRxiv 
                  https://doi.org/10.1101/2022.04.07.22273595
                  
                 (2022).">
    <meta name="citation_reference" content="citation_journal_title=Nat. Commun.; citation_title=Hospital load and increased COVID-19 related mortality in Israel; citation_author=H Rossman; citation_volume=12; citation_publication_date=2021; citation_doi=10.1038/s41467-021-22214-z; citation_id=CR40">
    <meta name="citation_reference" content="citation_journal_title=MMWR Morb. Mortal. Wkly Rep.; citation_title=Impact of hospital strain on excess deaths during the COVID-19 pandemic – United States, July 2020–July 2021; citation_author=G French; citation_volume=70; citation_publication_date=2021; citation_pages=1613-1616; citation_doi=10.15585/mmwr.mm7046a5; citation_id=CR41">
    <meta name="citation_reference" content="citation_journal_title=Nat. Commun.; citation_title=Inferring high-resolution human mixing patterns for disease modeling; citation_author=D Mistry; citation_volume=12; citation_publication_date=2021; citation_doi=10.1038/s41467-020-20544-y; citation_id=CR42">
    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave; citation_author=JT Davis; citation_volume=600; citation_publication_date=2021; citation_pages=127-132; citation_doi=10.1038/s41586-021-04130-w; citation_id=CR43">
    <meta name="citation_reference" content="citation_journal_title=JAMA Pediatrics; citation_title=Susceptibility to SARS-CoV-2 infection among children and adolescents compared with adults: a systematic review and meta-analysis; citation_author=RM Viner; citation_volume=175; citation_publication_date=2021; citation_pages=143-156; citation_doi=10.1001/jamapediatrics.2020.4573; citation_id=CR44">
    <meta name="citation_reference" content="citation_journal_title=Nat. Med.; citation_title=Age-dependent effects in the transmission and control of COVID-19 epidemics; citation_author=NG Davies; citation_volume=26; citation_publication_date=2020; citation_pages=1205-1211; citation_doi=10.1038/s41591-020-0962-9; citation_id=CR45">
    <meta name="citation_reference" content="citation_journal_title=Nat. Commun.; citation_title=Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China; citation_author=S Hu; citation_volume=12; citation_publication_date=2021; citation_doi=10.1038/s41467-021-21710-6; citation_id=CR46">
    <meta name="citation_reference" content="citation_journal_title=PLoS Med.; citation_title=Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis; citation_author=D Buitrago-Garcia; citation_volume=17; citation_publication_date=2020; citation_pages=e1003346; citation_doi=10.1371/journal.pmed.1003346; citation_id=CR47">
    <meta name="citation_reference" content="Manica, M. et al. Intrinsic generation time of the SARS-CoV-2 Omicron variant: an observational study of household transmission. Preprint at SSRN 
                  https://doi.org/10.2139/ssrn.4068368
                  
                 (2022).">
    <meta name="citation_reference" content="citation_journal_title=Clin. Infect. Dis.; citation_title=Case fatality risk of the first pandemic wave of novel coronavirus disease 2019 (COVID-19) in China; citation_author=X Deng; citation_volume=73; citation_publication_date=2021; citation_pages=e79-e85; citation_doi=10.1093/cid/ciaa578; citation_id=CR49">
    <meta name="citation_reference" content="Halloran, M. E., Longini, I. M., Struchiner, C. J. &amp; Longini, I. M. Design and Analysis of Vaccine Studies (Springer, 2010).">
    <meta name="citation_reference" content="citation_journal_title=Lancet; citation_title=Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study; citation_author=CH Hansen, D Michlmayr, SM Gubbels, K Mølbak, S Ethelberg; citation_volume=397; citation_publication_date=2021; citation_pages=1204-1212; citation_doi=10.1016/S0140-6736(21)00575-4; citation_id=CR51">
    <meta name="citation_reference" content="Provisional Data Analysis On COVID-19 Reported Death Cases. Center for Health Protection of the Department of Health (29 April 2022); 
                  https://www.covidvaccine.gov.hk/pdf/death_analysis.pdf
                  
                ">
    <meta name="citation_reference" content="Statistics on 5th Wave of COVID-19. Center for Health Protection of the Department of Health (29 April 2022); 
                  https://www.covidvaccine.gov.hk/pdf/5th_wave_statistics.pdf
                  
                ">
    <meta name="citation_reference" content="Modelling the fifth wave of COVID-19 in Hong Kong. D24H@HKSTP and HKU WHO Collaborating Centre on Infectious Disease Epidemiology and Modelling (21 March 2022); 
                  https://sph.hku.hk/en/News-And-Events/Press-Releases/2022/TBC
                  
                ">
    <meta name="citation_reference" content="citation_journal_title=N. Engl. J. Med.; citation_title=Clinical characteristics of coronavirus disease 2019 in China; citation_author=W-j Guan; citation_volume=382; citation_publication_date=2020; citation_pages=1708-1720; citation_doi=10.1056/NEJMoa2002032; citation_id=CR55">
    <meta name="citation_reference" content="citation_journal_title=MMWR Morb. Mortal. Wkly Rep.; citation_title=Clinical characteristics and outcomes among adults hospitalized with laboratory-confirmed SARS-CoV-2 infection during periods of B. 1.617. 2 (Delta) and B. 1.1. 529 (Omicron) variant predominance—one hospital, California, July 15–September 23, 2021, and December 21, 2021–January 27, 2022; citation_author=ME Modes; citation_volume=71; citation_publication_date=2022; citation_pages=217-223; citation_doi=10.15585/mmwr.mm7106e2; citation_id=CR56">
    <meta name="citation_reference" content="citation_journal_title=Lancet Respiratory Med.; citation_title=Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study; citation_author=L Piroth; citation_volume=9; citation_publication_date=2021; citation_pages=251-259; citation_doi=10.1016/S2213-2600(20)30527-0; citation_id=CR57">
    <meta name="citation_reference" content="citation_journal_title=BMC Med.; citation_title=COVID-19 length of hospital stay: a systematic review and data synthesis; citation_author=EM Rees; citation_volume=18; citation_publication_date=2020; citation_doi=10.1186/s12916-020-01726-3; citation_id=CR58">
    <meta name="citation_reference" content="citation_journal_title=Lancet Regional Health – Eur.; citation_title=Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: a retrospective national surveillance data analysis; citation_author=N Lefrancq; citation_volume=5; citation_publication_date=2021; citation_pages=10087; citation_id=CR59">
    <meta name="citation_reference" content="citation_journal_title=Lancet Infect. Dis.; citation_title=Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study; citation_author=J Zhang; citation_volume=20; citation_publication_date=2020; citation_pages=793-802; citation_doi=10.1016/S1473-3099(20)30230-9; citation_id=CR60">
    <meta name="citation_reference" content="citation_journal_title=Nat. Commun.; citation_title=The effect of COVID-19 vaccination in Italy and perspectives for living with the virus; citation_author=V Marziano; citation_volume=12; citation_publication_date=2021; citation_doi=10.1038/s41467-021-27532-w; citation_id=CR61">
    <meta name="citation_reference" content="citation_journal_title=JAMA Netw. Open; citation_title=Association of age with likelihood of developing symptoms and critical disease among close contacts exposed to patients with confirmed SARS-CoV-2 infection in Italy; citation_author=P Poletti; citation_volume=4; citation_publication_date=2021; citation_pages=e211085-e211085; citation_doi=10.1001/jamanetworkopen.2021.1085; citation_id=CR62">
    <meta name="citation_reference" content="Situation Regarding Prevention and Control of COVID-19 Epidemic in Shanghai. Shanghai Municipal Health Commission (29 April 2022); 
                  http://wsjkw.sh.gov.cn/xwfbh/index.html
                  
                ">
    <meta name="citation_reference" content="citation_journal_title=Lancet Infect. Dis.; citation_title=Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis; citation_author=WS Hart; citation_volume=22; citation_publication_date=2022; citation_pages=P603-P610; citation_doi=10.1016/S1473-3099(22)00001-9; citation_id=CR64">
    <meta name="citation_reference" content="citation_journal_title=Nat. Hum. Behav.; citation_title=Despite vaccination, China needs non-pharmaceutical interventions to prevent widespread outbreaks of COVID-19 in 2021; citation_author=J Yang; citation_volume=5; citation_publication_date=2021; citation_pages=1009-1020; citation_doi=10.1038/s41562-021-01155-z; citation_id=CR65">
    <meta name="citation_reference" content="Press conference held on situation regarding prevetion and control of COVID-19 epidemics in the coming autumn and winter season and vaccination. The State Council Information Office, P.R.C. (24 October 2021); 
                  http://www.gov.cn/xinwen/gwylflkjz169/index.htm
                  
                ">
    <meta name="citation_reference" content="FAQ on booster immunization for COVID-19 vaccines. National Health Commission of China (15 November 2021); 
                  http://www.nhc.gov.cn/xcs/s7847/202111/67a59e40580d4b4687b3ed738333f6a9.shtml
                  
                ">
    <meta name="citation_reference" content="Press conference held on situation regarding strict prevetion and control of COVID-19 epidemic. The State Council Information Office, P.R.C. (12 April 2022); 
                  http://www.gov.cn/xinwen/gwylflkjz192/index.htm
                  
                ">
    <meta name="citation_reference" content="Relevant requirements on organization and implementation of COVID-19 booster vaccination. National Health Commission of China (17 February 2022); 
                  https://m.weibo.cn/status/4737882239533991
                  
                ">
    <meta name="citation_reference" content="citation_journal_title=BMC Med.; citation_title=Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint; citation_author=X Chen; citation_volume=20; citation_publication_date=2022; citation_doi=10.1186/s12916-022-02249-9; citation_id=CR70">
    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants; citation_author=K Wang; citation_volume=603; citation_publication_date=2022; citation_pages=919-925; citation_doi=10.1038/s41586-022-04466-x; citation_id=CR71">
    <meta name="citation_reference" content="citation_journal_title=Lancet Infect. Dis.; citation_title=Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial; citation_author=Y Zhang; citation_volume=21; citation_publication_date=2021; citation_pages=181-192; citation_doi=10.1016/S1473-3099(20)30843-4; citation_id=CR72">
    <meta name="citation_reference" content="citation_journal_title=Cell Res.; citation_title=Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine; citation_author=Y Cao; citation_volume=32; citation_publication_date=2022; citation_pages=107-109; citation_doi=10.1038/s41422-021-00596-5; citation_id=CR73">
    <meta name="citation_reference" content="citation_journal_title=Nat. Med.; citation_title=Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination; citation_author=E Pérez-Then; citation_volume=28; citation_publication_date=2022; citation_pages=481-485; citation_doi=10.1038/s41591-022-01705-6; citation_id=CR74">
    <meta name="citation_reference" content="Peiris, M. et al. Neutralizing antibody titres to SARS-CoV-2 Omicron variant and wild-type virus in those with past infection or vaccinated or boosted with mRNA BNT162b2 or inactivated CoronaVac vaccines. Preprint at Res. Sq. 
                  https://doi.org/10.21203/rs.3.rs-1207071/v1
                  
                 (2022).">
    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift; citation_author=E Cameroni; citation_volume=602; citation_publication_date=2022; citation_pages=664-670; citation_doi=10.1038/s41586-021-04386-2; citation_id=CR76">
    <meta name="citation_reference" content="Pfizer’s novel COVID-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of phase 2/3 EPIC-HR study. Pfizer (5 November 2021); 
                  https://www.pfizer.com/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate
                  
                ">
    <meta name="citation_author" content="Cai, Jun">
    <meta name="citation_author_institution" content="School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China">
    <meta name="citation_author" content="Deng, Xiaowei">
    <meta name="citation_author_institution" content="School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China">
    <meta name="citation_author" content="Yang, Juan">
    <meta name="citation_author_institution" content="School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China">
    <meta name="citation_author_institution" content="Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China">
    <meta name="citation_author" content="Sun, Kaiyuan">
    <meta name="citation_author_institution" content="Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, USA">
    <meta name="citation_author" content="Liu, Hengcong">
    <meta name="citation_author_institution" content="School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China">
    <meta name="citation_author" content="Chen, Zhiyuan">
    <meta name="citation_author_institution" content="School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China">
    <meta name="citation_author" content="Peng, Cheng">
    <meta name="citation_author_institution" content="School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China">
    <meta name="citation_author" content="Chen, Xinhua">
    <meta name="citation_author_institution" content="School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China">
    <meta name="citation_author" content="Wu, Qianhui">
    <meta name="citation_author_institution" content="School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China">
    <meta name="citation_author" content="Zou, Junyi">
    <meta name="citation_author_institution" content="School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China">
    <meta name="citation_author" content="Sun, Ruijia">
    <meta name="citation_author_institution" content="School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China">
    <meta name="citation_author" content="Zheng, Wen">
    <meta name="citation_author_institution" content="School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China">
    <meta name="citation_author" content="Zhao, Zeyao">
    <meta name="citation_author_institution" content="School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China">
    <meta name="citation_author" content="Lu, Wanying">
    <meta name="citation_author_institution" content="School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China">
    <meta name="citation_author" content="Liang, Yuxia">
    <meta name="citation_author_institution" content="School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China">
    <meta name="citation_author" content="Zhou, Xiaoyu">
    <meta name="citation_author_institution" content="School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China">
    <meta name="citation_author" content="Ajelli, Marco">
    <meta name="citation_author_institution" content="Laboratory for Computational Epidemiology and Public Health, Department of Epidemiology and Biostatistics, Indiana University School of Public Health, Bloomington, USA">
    <meta name="citation_author" content="Yu, Hongjie">
    <meta name="citation_author_institution" content="School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China">
    <meta name="citation_author_institution" content="Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China">
    <meta name="access_endpoint" content="https://www.nature.com/platform/readcube-access">
    <meta name="twitter:site" content="@naturemedicine">
    <meta name="twitter:card" content="summary_large_image">
    <meta name="twitter:image:alt" content="Content cover image">
    <meta name="twitter:title" content="Modeling transmission of SARS-CoV-2 Omicron in China">
    <meta name="twitter:description" content="Nature Medicine - Estimates from a new modeling study suggest that current levels of vaccine coverage in China are insufficient to prevent overwhelming the healthcare system, and that, if left...">
    <meta name="twitter:image" content="https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig1_HTML.png">
    

    
    
    <meta property="og:url" content="https://www.nature.com/articles/s41591-022-01855-7">
    <meta property="og:type" content="article">
    <meta property="og:site_name" content="Nature">
    <meta property="og:title" content="Modeling transmission of SARS-CoV-2 Omicron in China - Nature Medicine">
    <meta property="og:description" content="Estimates from a new modeling study suggest that current levels of vaccine coverage in China are insufficient to prevent overwhelming the healthcare system, and that, if left untreated, a nationwide Omicron wave could result in up to 1.55 million deaths.">
    <meta property="og:image" content="https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig1_HTML.png">
    

    <script>
        window.eligibleForRa21 = 'false'; 
    </script>
<style type="text/css">.cc-banner{background-color:#01324b;border:none!important;bottom:0;box-sizing:border-box;color:#fff!important;left:0;line-height:1.3;margin:auto 0 0;max-width:100%;outline:0;overflow:visible;padding:0;position:fixed;right:0;width:100%;z-index:99999}.cc-banner::backdrop{background-color:#0000004d}.cc-banner *{color:inherit!important}.cc-banner:focus{box-shadow:none;outline:0}.cc-banner a{color:#fff!important;text-decoration:underline}.cc-banner a:active,.cc-banner a:focus,.cc-banner a:hover{color:inherit;text-decoration:none}.cc-banner a:focus{outline:3px solid #08c!important}.cc-banner h2,.cc-banner h3,.cc-banner h4,.cc-banner h5,.cc-banner h6{font-family:sans-serif;font-style:normal;font-weight:700;margin:0 0 .5em}.cc-banner .cc-h2,.cc-banner h2{font-size:18px}.cc-banner .cc-h3,.cc-banner h3{font-size:16px}.cc-banner .cc-h4,.cc-banner .cc-h5,.cc-banner .cc-h6,.cc-banner h4,.cc-banner h5,.cc-banner h6{font-size:14px}.cc-banner .cc-button{font-size:16px}.cc-banner__content{background-color:#01324b;display:flex;flex-direction:column;margin:0 auto;max-height:90vh;max-width:100%;padding:16px;position:relative}.cc-banner__content:focus{outline:0}@media (min-width:680px){.cc-banner__content{padding:12px}}@media (min-width:980px){.cc-banner__content{max-height:60vh;padding-bottom:20px;padding-top:20px}}@media (min-width:1320px){.cc-banner__content{padding-bottom:40px;padding-top:40px}}.cc-banner__container{display:flex;flex-direction:column;margin:auto;max-width:1320px;overflow:auto}.cc-banner__title{background:none!important;border:0;flex-shrink:0;font-size:18px!important;font-size:22px!important;font-weight:700!important;letter-spacing:normal;margin:0 0 12px!important;padding:0}@media (min-width:680px){.cc-banner__title{font-size:24px!important;margin:0 0 16px!important}}@media (min-width:1320px){.cc-banner__title{font-size:26px!important;margin:0 0 24px!important}}.cc-banner__body{display:flex;flex-direction:column;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif!important;overflow-x:hidden;overflow-y:auto;padding:3px 3px 16px}@media (min-width:980px){.cc-banner__body{flex-direction:row}}.cc-banner__policy p{font-size:16px!important;margin:0;max-width:none;padding:0}.cc-banner__policy p:not(:last-child){margin:0 0 16px}@media (min-width:980px){.cc-banner__policy p:not(:last-child){margin:0 0 24px}}.cc-banner__policy p a{font-size:16px!important;font-weight:700}.cc-banner__footer{box-shadow:none;flex-shrink:0;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif !important!important;margin:0;padding:12px 0 3px 3px;position:relative}@media (min-width:380px){.cc-banner__footer{align-items:stretch;display:flex;flex-wrap:wrap}}@media (min-width:680px){.cc-banner__footer{box-shadow:none;flex-wrap:nowrap;width:40%}}.cc-banner__footer .cc-banner__button{flex:1 1 auto;font-weight:700;overflow:hidden;padding:.5em 1em;width:100%}@media (min-width:680px){.cc-banner__footer .cc-banner__button{max-width:275px}}.cc-banner__footer .cc-banner__button:not(:last-child){margin-bottom:12px}@media (min-width:680px){.cc-banner__footer .cc-banner__button:not(:last-child){margin-bottom:0;margin-right:16px}}@media (min-width:980px){.cc-banner__footer .cc-banner__button:not(:last-child){margin-right:24px}}@media (min-width:680px){html[dir=rtl] .cc-banner__footer .cc-banner__button:not(:last-child){margin-left:16px!important;margin-right:0!important}}@media (min-width:980px){html[dir=rtl] .cc-banner__footer .cc-banner__button:not(:last-child){margin-left:24px!important;margin-right:0!important}}.cc-banner__button-preferences{padding-left:0;padding-right:0}@media (min-width:380px){.cc-banner__button-preferences{flex:0 0 auto;margin:auto}}@media (min-width:680px){.cc-banner__button-preferences{margin:0}}@media (min-width:380px) and (max-width:680px){.cc-banner__button-break{display:block}}@media (min-width:680px){.cc-banner--is-tcf .cc-banner__footer{width:auto}}@media (min-width:980px){.cc-banner--is-tcf .cc-banner__footer{padding-right:48px;width:66%}}.cc-banner--is-tcf .cc-banner__stacks-intro{font-size:16px!important}.cc-banner--is-tcf .cc-banner__stacks{margin:16px 0 0}@media (min-width:980px){.cc-banner--is-tcf .cc-banner__stacks{display:flex;flex:0 0 33%;flex-direction:column;margin:0 0 0 48px;overflow:auto}}.cc-banner--is-tcf .cc-banner__stacks-intro{font-size:16px;margin:0 0 12px}.cc-banner--is-tcf .cc-banner__stacks-details{padding:0 3px}.cc-banner--is-tcf .cc-banner .cc-details{border-color:#fff3!important}.cc-box{border-radius:10px;padding:12px}.cc-box--info{background-color:#eff6fb}.cc-box--light{background-color:#faf9f6}.cc-button{border:2px solid #0000;border-radius:32px!important;color:inherit;cursor:pointer;font-size:14px;font-weight:700!important;left:auto;line-height:1.2;margin:0;padding:.5em 1em;right:auto;text-transform:none!important;transition:all .2s}@media (min-width:680px){.cc-button{font-size:14px;padding:.75em 1em}}.cc-button--sm{font-size:12px;padding:2px 8px!important}.cc-button--primary{background-color:#025e8d!important;border-color:#025e8d!important;color:#fff!important}.cc-button--primary:focus{outline:3px solid #08c}.cc-button--primary:focus,.cc-button--primary:hover,.cc-button--secondary{background-color:#fff!important;border-color:#025e8d!important;color:#025e8d!important}.cc-button--secondary:focus{background-color:#025e8d!important;border-color:#fff!important;color:#fff!important;outline:3px solid #08c!important}.cc-button--secondary:hover{background-color:#025e8d!important;border-color:#025e8d!important;color:#fff!important}.cc-button--secondary:active{border:2px solid #01324b!important}.cc-button--secondary.cc-button--contrast{border-color:#fff!important}.cc-button--secondary.cc-button--contrast:hover{background-color:initial!important;color:#fff!important}.cc-button--tertiary{background-color:#f0f7fc!important;background-image:none;border:2px solid #f0f7fc;color:#025e8d!important;text-decoration:underline!important;text-underline-offset:.25em}.cc-button--tertiary:focus{outline:3px solid #08c!important}.cc-button--tertiary:hover{text-decoration-thickness:.25em}.cc-button--tertiary:active{color:#013c5b}.cc-button--link{background-color:initial!important;border-color:#0000!important;border-radius:0!important;color:inherit!important;padding:0!important;text-decoration:underline!important;width:inherit!important}.cc-button--link:focus{outline:3px solid #08c}.cc-button--link:hover{background-color:initial!important;box-shadow:none;text-decoration:none}.cc-button--text{border-radius:0;padding:0}.cc-button--details{padding-right:24px!important;position:relative;width:auto}.cc-button--details:after,.cc-button--details:before{background-color:currentColor;content:"";position:absolute;transition:transform .25s ease-out}.cc-button--details:before{height:10px;margin-top:-5px;right:12px;top:50%;width:2px}.cc-button--details:after{height:2px;margin-top:-1px;right:8px;top:50%;width:10px}.cc-button--details.cc-active:before{transform:rotate(90deg);transform-origin:center}.cc-button--details.cc-active:after{display:none}.cc-details{border-bottom:1px solid #0000001a;padding:12px 0;position:relative;width:100%}.cc-details__summary{align-items:center;display:flex;font-size:14px;font-weight:700;list-style-type:none}.cc-details__summary:focus,.cc-details__summary:focus-visible{outline:3px solid #08c!important;will-change:auto}.cc-details__title{align-items:baseline;display:flex}.cc-details__title h2,.cc-details__title h3,.cc-details__title h4,.cc-details__title h5{line-height:1.4;margin:0!important;padding:0!important}.cc-details__title svg{flex-shrink:0;height:auto;margin-right:8px;position:relative;top:-1px;transition:all .2s;width:auto}.cc-details[open] .cc-details__title svg{top:2px;transform:rotate(90deg)}.cc-details__switch{margin-left:auto}.cc-details__section{padding:16px 0 0 18px}.cc-details__section p{margin:0}.cc-details__section p:not(:last-child){margin-bottom:12px}details summary::-webkit-details-marker{display:none}.cc-radio{align-items:center;display:flex;position:relative}.cc-radio *{cursor:pointer}.cc-radio__input{height:22px;left:0;position:absolute;top:0;width:22px}.cc-radio__input:focus{outline:none}.cc-radio__label{color:inherit;font-size:14px;font-weight:700;line-height:23px;margin:0;padding-left:28px}.cc-radio__label:after,.cc-radio__label:before{background-color:#fff;content:"";display:block;position:absolute;transition:transform .25s ease-out}.cc-radio__label:before{border:1px solid #777;border-radius:50%;height:22px;left:0;top:0;width:22px}.cc-radio__label:after{border:7px solid #025e8d;border-radius:50%;height:0;left:4px;opacity:0;top:4px;width:0}.cc-radio__input:focus+.cc-radio__label:before{box-shadow:0 0 0 2px #08c;outline:none}.cc-radio__label--hidden{display:none}.cc-radio__input:checked+.cc-radio__label:after{opacity:1}.cc-radio__input:disabled{cursor:default}.cc-radio__input:disabled+.cc-radio__label{cursor:default;opacity:.5}.cc-switch *{cursor:pointer}.cc-switch{align-items:center;display:flex;line-height:1}.cc-switch__label{cursor:pointer;display:inline-block;font-size:14px;font-weight:700;margin:0;-webkit-user-select:none;user-select:none}.cc-switch__input[type=checkbox]{-webkit-appearance:none;appearance:none;background-color:#fff!important;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http://www.w3.org/2000/svg' viewBox='-4 -4 8 8'%3E%3Ccircle r='3' fill='rgba(0, 0, 0, 0.25)'/%3E%3C/svg%3E")!important;background-position:0!important;background-repeat:no-repeat!important;border:1px solid #777!important;border-radius:16px!important;height:18px!important;margin:0 8px 0 0!important;transition:background-position .2s ease-in-out!important;width:32px!important}.cc-switch__input[type=checkbox]:focus{background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http://www.w3.org/2000/svg' viewBox='-4 -4 8 8'%3E%3Ccircle r='3' fill='%2380b3cc'/%3E%3C/svg%3E")!important}.cc-switch__input[type=checkbox]:checked{background-color:#025e8d!important;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http://www.w3.org/2000/svg' viewBox='-4 -4 8 8'%3E%3Ccircle r='3' fill='%23fff'/%3E%3C/svg%3E")!important;background-position:100%!important}.cc-switch__input[type=checkbox]:checked~.cc-switch__label>.cc-switch__text-off,.cc-switch__input[type=checkbox]:not(:checked)~.cc-switch__label>.cc-switch__text-on{display:none}.cc-switch__input[type=checkbox]:hover{cursor:pointer;outline:none}.cc-switch__input[type=checkbox]:focus-visible{cursor:pointer;outline:3px solid #fc0}.cc-switch__input[type=checkbox]:checked:before{background-color:none!important;color:#0000!important}html[dir=rtl] .cc-switch__input[type=checkbox]{margin-left:8px!important;margin-right:0!important}.cc-list>ul,ul.cc-list{list-style-type:disc;margin-left:0;padding-left:0}.cc-list>ul>li,ul.cc-list>li{margin-left:1em}.cc-list>ul>li:not(:last-child),ul.cc-list>li:not(:last-child){margin-bottom:4px}.cc-list__title{margin-bottom:8px!important}.cc-list--inline>ul,ul.cc-list--inline{display:flex;flex-wrap:wrap;list-style-type:none}.cc-list--inline>ul>li,ul.cc-list--inline>li{margin:0 .5em .5em 0}.cc-overlay{background-color:#0000004d;z-index:99998}.cc-overlay,.cc-preferences{bottom:0;left:0;position:fixed;right:0;top:0}.cc-preferences{background-color:#050a14f2!important;border:0;box-sizing:border-box;color:#111;font-family:sans-serif!important;line-height:1.4;margin:auto;max-height:100vh;overflow:auto;padding:0;z-index:100000}.cc-preferences:focus{outline:none}.cc-preferences *,.cc-preferences :after,.cc-preferences :before{box-sizing:inherit!important}.cc-preferences h2,.cc-preferences h3,.cc-preferences h4,.cc-preferences h5,.cc-preferences h6{font-family:sans-serif;font-style:normal;font-weight:700;margin:0 0 .5em}.cc-preferences .cc-h2,.cc-preferences h2{font-size:18px}.cc-preferences .cc-h3,.cc-preferences h3{font-size:16px}.cc-preferences .cc-h4,.cc-preferences .cc-h5,.cc-preferences .cc-h6,.cc-preferences h4,.cc-preferences h5,.cc-preferences h6{font-size:14px}.cc-preferences a{color:#025e8d;text-decoration:underline}.cc-preferences a:hover{color:inherit;text-decoration:none}.cc-preferences h3{background:none;color:#111;padding:0;text-transform:none}dialog.cc-preferences{background-color:initial}dialog.cc-preferences::backdrop{background-color:#000000e6}.cc-preferences__dialog{display:flex;flex-direction:column;margin:auto;max-height:100vh;max-width:860px;padding:12px;position:relative}.cc-preferences__dialog>:last-child{border-bottom-left-radius:10px;border-bottom-right-radius:10px}@media (min-width:980px){.cc-preferences__dialog{padding:16px}}.cc-preferences__close{background:#0000!important;border:1px solid #ececec;border-radius:50%;color:#111!important;cursor:pointer;font-family:Times New Roman,serif;font-size:40px;height:40px;left:auto;line-height:1;margin-top:-20px;padding:0!important;position:absolute;right:20px;top:50%;width:40px}.cc-preferences__close:focus{outline:3px solid #08c}.cc-preferences__close-label{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.cc-preferences__header{background:#fff!important;border-bottom:1px solid #0000001a;border-top-left-radius:10px;border-top-right-radius:10px;padding:16px;position:relative;text-align:center}.cc-preferences__title{background:none!important;color:#111!important;font-family:sans-serif!important;font-size:18px!important;font-weight:700!important;margin:0!important;padding:0 16px 0 0!important}@media (min-width:480px){.cc-preferences__title{padding-right:0!important}}@media (min-width:980px){.cc-preferences__title{font-size:22px!important}}.cc-preferences__body{background:#fff!important;flex:1 1 auto;min-height:200px;overflow-x:hidden;overflow-y:auto;padding:16px}.cc-preferences__footer{background:#fff!important;border-top:1px solid #d0d0d0;box-shadow:0 0 5px 0 #0003;margin-bottom:0;padding:12px;position:relative}@media (min-width:480px){.cc-preferences__footer{align-items:stretch;display:flex}}.cc-preferences__footer>.cc-button{display:block;width:100%}@media (min-width:480px){.cc-preferences__footer>.cc-button{flex:1 1 auto}}@media (min-width:980px){.cc-preferences__footer>.cc-button{flex-basis:auto}}@media (min-width:480px){.cc-preferences__footer>.cc-button:not(:first-child){margin-left:12px}}.cc-preferences__footer>.cc-button:not(:last-child){margin-bottom:8px}@media (min-width:480px){.cc-preferences__footer>.cc-button:not(:last-child){margin-bottom:0}}.cc-preferences__categories{list-style:none;margin:0;padding:0}.cc-preferences__category:not(:last-child){border-bottom:1px solid #0000001a;margin-bottom:12px;padding-bottom:12px}.cc-preferences__category-description{font-size:14px;margin:0 0 8px;padding:0}.cc-preferences__category-footer{align-items:center;display:flex;justify-content:space-between}.cc-preferences__status{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.cc-preferences__controls{display:flex;margin:0}.cc-preferences__controls>:not(:last-child){margin-right:12px}.cc-preferences__always-on{font-size:14px;font-weight:700;padding-left:26px;position:relative}.cc-preferences__always-on:before{background:#0000!important;border:solid;border-top-color:#0000;border-width:0 0 4px 4px;content:"";display:block;height:10px;left:0;position:absolute;top:2px;transform:rotate(-45deg);width:18px}.cc-preferences__details{background-color:#eff6fb!important;border-radius:10px;font-size:14px;margin:12px 0 0;padding:12px}.cc-preferences__cookie-list,.cc-preferences__provider-list{list-style:none;margin:0;padding:0}.cc-preferences__provider-list{columns:170px}.cc-preferences__cookie-title{font-size:1em;font-style:normal;font-weight:400;margin:0}.cc-preferences__cookie-description{font-size:1em;margin:0 0 8px}.cc-preferences__cookie-domain,.cc-preferences__cookie-lifespan{border-left:1px solid #999;color:#666;margin-left:8px;padding-left:4px}body.cc-has-preferences-open{overflow:hidden;position:relative}.cc-table{border-collapse:collapse;width:100%}.cc-table tbody tr{border-top:1px solid #0000001a}.cc-table td,.cc-table th{font-size:14px;padding:4px 8px;vertical-align:top}.cc-table+.cc-table{margin-top:8px}.cc-table--purposes td:first-child,.cc-table--purposes th:first-child{width:70%}@media (min-width:680px){.cc-table--purposes td:first-child,.cc-table--purposes th:first-child{width:80%}}.cc-table--purposes td:last-child,.cc-table--purposes th:last-child{padding-left:8px;width:40%}@media (min-width:680px){.cc-table--purposes td:last-child,.cc-table--purposes th:last-child{width:30%}}.cc-tabs,.cc-tabs>ul{background-color:#faf9f6;display:flex;list-style:none;margin:0;padding:0}.cc-tabs__panel{border-top:1px solid #ececec;margin-top:-1px}.cc-tabs__button{background-color:initial;border:0;border-left:1px solid #0000;border-right:1px solid #0000;color:#111;font-size:16px;font-weight:700;margin:0;padding:15px 16px 12px;position:relative}.cc-tabs__button:before{background-color:initial;content:"";display:block;height:3px;left:0;position:absolute;top:0;width:100%}.cc-tabs__button.cc-active{background-color:#fff;border-color:#025e8d #ececec #ececec;color:#111}.cc-tabs__button.cc-active:before{background-color:#025e8d}.cc-tabs__content{background-color:#fff;display:none;font-size:14px;padding:16px}.cc-tabs__section:not(:first-child){padding-top:24px}.cc-tcf{font-size:14px;margin-top:16px}.cc-tcf__list{list-style:none;margin:0;padding:0}.cc-vendor-count{color:#666;font-size:16px;margin:0 0 8px}.cc-hide{display:none!important}.cc-show{display:block!important}.cc-external-link{background-color:#ececec;background-image:url("data:image/svg+xml;base64,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");background-position:right 8px center;background-repeat:no-repeat;background-size:10px auto;border-radius:3px;box-shadow:0 1px 0 #0003;color:#111!important;display:inline-block;font-size:12px;padding:4px 26px 4px 8px;text-decoration:none!important}.cc-external-link:hover{text-decoration:underline!important}.cc-m-0{margin:0!important}.cc-grey{color:#666}</style><script async="" type="text/javascript" src="https://injections.readcube.com/nature/inject.fa744f3f.js"></script><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 2px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 2px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: 1em}
.MathJax_MenuRadioCheck.RTL {right: 1em; left: auto}
.MathJax_MenuLabel {padding: 2px 2em 4px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #CCCCCC; margin: 4px 1px 0px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: Highlight; color: HighlightText}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style><style type="text/css">.MJX_Assistive_MathML {position: absolute!important; top: 0; left: 0; clip: rect(1px, 1px, 1px, 1px); padding: 1px 0 0 0!important; border: 0!important; height: 1px!important; width: 1px!important; overflow: hidden!important; display: block!important; -webkit-touch-callout: none; -webkit-user-select: none; -khtml-user-select: none; -moz-user-select: none; -ms-user-select: none; user-select: none}
.MJX_Assistive_MathML.MJX_Assistive_MathML_Block {width: 100%!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1em; bottom: 1.5em; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MJXp-script {font-size: .8em}
.MJXp-right {-webkit-transform-origin: right; -moz-transform-origin: right; -ms-transform-origin: right; -o-transform-origin: right; transform-origin: right}
.MJXp-bold {font-weight: bold}
.MJXp-italic {font-style: italic}
.MJXp-scr {font-family: MathJax_Script,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-frak {font-family: MathJax_Fraktur,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-sf {font-family: MathJax_SansSerif,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-cal {font-family: MathJax_Caligraphic,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-mono {font-family: MathJax_Typewriter,'Times New Roman',Times,STIXGeneral,serif}
.MJXp-largeop {font-size: 150%}
.MJXp-largeop.MJXp-int {vertical-align: -.2em}
.MJXp-math {display: inline-block; line-height: 1.2; text-indent: 0; font-family: 'Times New Roman',Times,STIXGeneral,serif; white-space: nowrap; border-collapse: collapse}
.MJXp-display {display: block; text-align: center; margin: 1em 0}
.MJXp-math span {display: inline-block}
.MJXp-box {display: block!important; text-align: center}
.MJXp-box:after {content: " "}
.MJXp-rule {display: block!important; margin-top: .1em}
.MJXp-char {display: block!important}
.MJXp-mo {margin: 0 .15em}
.MJXp-mfrac {margin: 0 .125em; vertical-align: .25em}
.MJXp-denom {display: inline-table!important; width: 100%}
.MJXp-denom > * {display: table-row!important}
.MJXp-surd {vertical-align: top}
.MJXp-surd > * {display: block!important}
.MJXp-script-box > *  {display: table!important; height: 50%}
.MJXp-script-box > * > * {display: table-cell!important; vertical-align: top}
.MJXp-script-box > *:last-child > * {vertical-align: bottom}
.MJXp-script-box > * > * > * {display: block!important}
.MJXp-mphantom {visibility: hidden}
.MJXp-munderover, .MJXp-munder {display: inline-table!important}
.MJXp-over {display: inline-block!important; text-align: center}
.MJXp-over > * {display: block!important}
.MJXp-munderover > *, .MJXp-munder > * {display: table-row!important}
.MJXp-mtable {vertical-align: .25em; margin: 0 .125em}
.MJXp-mtable > * {display: inline-table!important; vertical-align: middle}
.MJXp-mtr {display: table-row!important}
.MJXp-mtd {display: table-cell!important; text-align: center; padding: .5em 0 0 .5em}
.MJXp-mtr > .MJXp-mtd:first-child {padding-left: 0}
.MJXp-mtr:first-child > .MJXp-mtd {padding-top: 0}
.MJXp-mlabeledtr {display: table-row!important}
.MJXp-mlabeledtr > .MJXp-mtd:first-child {padding-left: 0}
.MJXp-mlabeledtr:first-child > .MJXp-mtd {padding-top: 0}
.MJXp-merror {background-color: #FFFF88; color: #CC0000; border: 1px solid #CC0000; padding: 1px 3px; font-style: normal; font-size: 90%}
.MJXp-scale0 {-webkit-transform: scaleX(.0); -moz-transform: scaleX(.0); -ms-transform: scaleX(.0); -o-transform: scaleX(.0); transform: scaleX(.0)}
.MJXp-scale1 {-webkit-transform: scaleX(.1); -moz-transform: scaleX(.1); -ms-transform: scaleX(.1); -o-transform: scaleX(.1); transform: scaleX(.1)}
.MJXp-scale2 {-webkit-transform: scaleX(.2); -moz-transform: scaleX(.2); -ms-transform: scaleX(.2); -o-transform: scaleX(.2); transform: scaleX(.2)}
.MJXp-scale3 {-webkit-transform: scaleX(.3); -moz-transform: scaleX(.3); -ms-transform: scaleX(.3); -o-transform: scaleX(.3); transform: scaleX(.3)}
.MJXp-scale4 {-webkit-transform: scaleX(.4); -moz-transform: scaleX(.4); -ms-transform: scaleX(.4); -o-transform: scaleX(.4); transform: scaleX(.4)}
.MJXp-scale5 {-webkit-transform: scaleX(.5); -moz-transform: scaleX(.5); -ms-transform: scaleX(.5); -o-transform: scaleX(.5); transform: scaleX(.5)}
.MJXp-scale6 {-webkit-transform: scaleX(.6); -moz-transform: scaleX(.6); -ms-transform: scaleX(.6); -o-transform: scaleX(.6); transform: scaleX(.6)}
.MJXp-scale7 {-webkit-transform: scaleX(.7); -moz-transform: scaleX(.7); -ms-transform: scaleX(.7); -o-transform: scaleX(.7); transform: scaleX(.7)}
.MJXp-scale8 {-webkit-transform: scaleX(.8); -moz-transform: scaleX(.8); -ms-transform: scaleX(.8); -o-transform: scaleX(.8); transform: scaleX(.8)}
.MJXp-scale9 {-webkit-transform: scaleX(.9); -moz-transform: scaleX(.9); -ms-transform: scaleX(.9); -o-transform: scaleX(.9); transform: scaleX(.9)}
.MathJax_PHTML .noError {vertical-align: ; font-size: 90%; text-align: left; color: black; padding: 1px 3px; border: 1px solid}
</style></head>
<body class="article-page"><div id="MathJax_Message" style="display: none;"></div><dialog class="cc-banner" data-cc-banner="" data-nosnippet="" aria-labelledby="cc-banner-label" open="">
		<div class="cc-banner__content" autofocus="" tabindex="-1">
			<div class="cc-banner__container">
				<div class="cc-banner__header">
					<h2 class="cc-banner__title" id="cc-banner-label">Your privacy, your choice</h2>
				</div>
				<div class="cc-banner__body">
					<div class="cc-banner__policy">
						<p>We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.</p><p>By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.</p><p>See our <a href="https://www.nature.com/info/privacy" data-cc-action="privacy">privacy policy</a> for more information on the use of your personal data.</p><p><button type="button" data-cc-action="preferences" class="cc-button cc-button--link cc-button--text">Manage preferences</button> for further information and to change your choices.</p>
					</div>
					
				</div>
				<div class="cc-banner__footer">
					
			<button data-cc-action="accept" class="cc-button cc-button--secondary cc-button--contrast cc-banner__button cc-banner__button-accept">Accept all cookies</button>
			
		
				</div>
			</div>
		</div>
	</dialog>

<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-MRVXSHQ"
                  height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>



<div class="position-relative cleared z-index-50 background-white" data-test="top-containers">
    <a class="c-skip-link" href="#content">Skip to main content</a>



<div class="c-grade-c-banner u-hide">
    <div class="c-grade-c-banner__container">
        
        <p>Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
            the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
            Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
            and JavaScript.</p>

    </div>
</div>

    

    

    
    
        <div class="u-hide u-show-following-ad"></div>

    <aside class="c-ad c-ad--728x90" style="display: none !important;">
        <div class="c-ad__inner" data-container-type="banner-advert">
            <p class="c-ad__label">Advertisement</p>
            
        
            
    <div id="div-gpt-ad-top-1" class="div-gpt-ad advert leaderboard js-ad text-center hide-print grade-c-hide" data-ad-type="top" data-test="top-ad" data-pa11y-ignore="" data-gpt="" data-gpt-unitpath="/285/medicine.nature.com/article" data-gpt-sizes="728x90" data-gpt-targeting="type=article;pos=top;artid=s41591-022-01855-7;doi=10.1038/s41591-022-01855-7;subjmeta=174,2514,255,308,692,699;kwrd=Epidemiology,Viral+infection">
        <noscript>
            <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/285/medicine.nature.com/article&amp;sz=728x90&amp;c=-860613052&amp;t=pos%3Dtop%26type%3Darticle%26artid%3Ds41591-022-01855-7%26doi%3D10.1038/s41591-022-01855-7%26subjmeta%3D174,2514,255,308,692,699%26kwrd%3DEpidemiology,Viral+infection">
                <img data-test="gpt-advert-fallback-img"
                     src="//pubads.g.doubleclick.net/gampad/ad?iu=/285/medicine.nature.com/article&amp;sz=728x90&amp;c=-860613052&amp;t=pos%3Dtop%26type%3Darticle%26artid%3Ds41591-022-01855-7%26doi%3D10.1038/s41591-022-01855-7%26subjmeta%3D174,2514,255,308,692,699%26kwrd%3DEpidemiology,Viral+infection"
                     alt="Advertisement"
                     width="728"
                     height="90"></a>
        </noscript>
    </div>

        
    
        </div>
    </aside>


    <header class="c-header" id="header" data-header="" data-track-component="nature-150-split-header" style="border-color:#e40428">
        <div class="c-header__row">
            <div class="c-header__container">
                <div class="c-header__split">
                    
                    
                    <div class="c-header__logo-container">
                        
                        <a href="/nm" data-track="click" data-track-action="home" data-track-label="image">
                            <picture class="c-header__logo">
                                <source srcset="https://media.springernature.com/full/nature-cms/uploads/product/nm/header-95e59e63930e5d6009bad2c23a42ab2d.svg" media="(min-width: 875px)">
                                <img src="https://media.springernature.com/full/nature-cms/uploads/product/nm/header-95e59e63930e5d6009bad2c23a42ab2d.svg" height="32" alt="Nature Medicine">
                            </picture>
                        </a>
                    
                    </div>
                    
                    <ul class="c-header__menu c-header__menu--global">
                        <li class="c-header__item c-header__item--padding c-header__item--hide-md-max">
                            <a class="c-header__link" href="https://www.nature.com/siteindex" data-test="siteindex-link" data-track="click" data-track-action="open nature research index" data-track-label="link">
                                <span>View all journals</span>
                            </a>
                        </li>
                        <li class="c-header__item c-header__item--padding c-header__item--pipe">
                            <a class="c-header__link c-header__link--search" href="javascript:;" data-header-expander="" data-test="search-link" data-track="click" data-track-action="open search tray" data-track-label="button" role="button" aria-haspopup="true" aria-expanded="false">
                                <svg role="img" aria-hidden="true" focusable="false" height="22" width="22" viewBox="0 0 18 18" xmlns="http://www.w3.org/2000/svg"><path d="M16.48 15.455c.283.282.29.749.007 1.032a.738.738 0 01-1.032-.007l-3.045-3.044a7 7 0 111.026-1.026zM8 14A6 6 0 108 2a6 6 0 000 12z"></path></svg><span>Search</span>
                            </a><div id="search-menu" class="c-header__dropdown c-header__dropdown--full-width has-tethered u-js-hide" data-track-component="nature-150-split-header" hidden="">
    <div class="c-header__container">
        <h2 class="c-header__visually-hidden">Search</h2>
        <form class="c-header__search-form" action="/search" method="get" role="search" autocomplete="off" data-test="inline-search">
            <label class="c-header__heading" for="keywords">Search articles by subject, keyword or author</label>
            <div class="c-header__search-layout c-header__search-layout--max-width">
                <div>
                    <input type="text" required="" class="c-header__input" id="keywords" name="q" value="">
                </div>
                <div class="c-header__search-layout">
                    <div>
                        <label for="results-from" class="c-header__visually-hidden">Show results from</label>
                        <select id="results-from" name="journal" class="c-header__select">
                            
                                
                                    <option value="" selected="">All journals</option>
                                    <option value="nm">This journal</option>
                                
                            
                        </select>
                    </div>
                    <div>
                        <button type="submit" class="c-header__search-button">Search</button>
                    </div>
                </div>

            </div>
        </form>

        <div class="c-header__flush">
            <a class="c-header__link" href="/search/advanced" data-track="click" data-track-action="advanced search" data-track-label="link">
                Advanced search
            </a>
        </div>

        <h3 class="c-header__heading c-header__heading--keyline">Quick links</h3>
        <ul class="c-header__list">
            <li><a class="c-header__link" href="/subjects" data-track="click" data-track-action="explore articles by subject" data-track-label="link">Explore articles by subject</a></li>
            <li><a class="c-header__link" href="/naturecareers" data-track="click" data-track-action="find a job" data-track-label="link">Find a job</a></li>
            <li><a class="c-header__link" href="/authors/index.html" data-track="click" data-track-action="guide to authors" data-track-label="link">Guide to authors</a></li>
            <li><a class="c-header__link" href="/authors/editorial_policies/" data-track="click" data-track-action="editorial policies" data-track-label="link">Editorial policies</a></li>
        </ul>
    </div>
</div>
                        </li>
                        <li class="c-header__item c-header__item--padding c-header__item--snid-account-widget c-header__item--pipe">
                            
                                <a class="c-header__link eds-c-header__link" id="identity-account-widget" data-track="click_login" data-track-context="header" href="https://idp.nature.com/auth/personal/springernature?redirect_uri=https://www.nature.com/articles/s41591-022-01855-7"><span class="eds-c-header__widget-fragment-title">Log in</span></a>
                            
                        </li>
                    </ul>
                </div>
            </div>
        </div>
        
            <div class="c-header__row">
                <div class="c-header__container" data-test="navigation-row">
                    <div class="c-header__split">
                        <ul class="c-header__menu c-header__menu--journal">
                            
                                <li class="c-header__item c-header__item--dropdown-menu" data-test="explore-content-button">
                                    <a href="javascript:;" class="c-header__link" data-header-expander="" data-test="menu-button--explore" data-track="click" data-track-action="open explore expander" data-track-label="button" role="button" aria-haspopup="true" aria-expanded="false">
                                        <span><span class="c-header__show-text">Explore</span> content</span><svg role="img" aria-hidden="true" focusable="false" height="16" viewBox="0 0 16 16" width="16" xmlns="http://www.w3.org/2000/svg"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"></path></svg>
                                    </a><nav class="c-header__dropdown has-tethered u-js-hide" aria-labelledby="Explore-content" data-test="Explore-content" id="explore" data-track-component="nature-150-split-header" hidden="">
            <div class="c-header__container">
                <h2 id="Explore-content" class="c-header__heading c-header__heading--js-hide">Explore content</h2>
                <ul class="c-header__list c-header__list--js-stack">
                    
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/research-articles" data-track="click" data-track-action="research articles" data-track-label="link" data-test="explore-nav-item">
                                    Research articles
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/reviews-and-analysis" data-track="click" data-track-action="reviews &amp; analysis" data-track-label="link" data-test="explore-nav-item">
                                    Reviews &amp; Analysis
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/news-and-comment" data-track="click" data-track-action="news &amp; comment" data-track-label="link" data-test="explore-nav-item">
                                    News &amp; Comment
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/podcast" data-track="click" data-track-action="podcasts" data-track-label="link" data-test="explore-nav-item">
                                    Podcasts
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/current-issue" data-track="click" data-track-action="current issue" data-track-label="link" data-test="explore-nav-item">
                                    Current issue
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/collections" data-track="click" data-track-action="collections" data-track-label="link" data-test="explore-nav-item">
                                    Collections
                                </a>
                            </li>
                        
                    
                </ul>
                <ul class="c-header__list c-header__list--js-stack">
                    
                        <li class="c-header__item">
                            <a class="c-header__link" href="https://www.facebook.com/Nature-Medicine-193691346949/" data-track="click" data-track-action="facebook" data-track-label="link">Follow us on Facebook
                            </a>
                        </li>
                    
                    
                        <li class="c-header__item">
                            <a class="c-header__link" href="https://twitter.com/naturemedicine" data-track="click" data-track-action="twitter" data-track-label="link">Follow us on Twitter
                            </a>
                        </li>
                    
                    
                    
                        <li class="c-header__item c-header__item--hide-lg">
                            <a class="c-header__link" href="https://www.nature.com/my-account/alerts/subscribe-journal?list-id=5" rel="nofollow" data-track="nav_sign_up_for_alerts" data-track-action="Sign up for alerts" data-track-external="" data-track-label="link (mobile dropdown)">Sign up for alerts<svg role="img" aria-hidden="true" focusable="false" height="18" viewBox="0 0 18 18" width="18" xmlns="http://www.w3.org/2000/svg"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill="#fff"></path></svg>
                            </a>
                        </li>
                    
                    
                        <li class="c-header__item c-header__item--hide-lg">
                            <a class="c-header__link" href="https://www.nature.com/nm.rss" data-track="click" data-track-action="rss feed" data-track-label="link">
                                <span>RSS feed</span>
                            </a>
                        </li>
                    
                </ul>
            </div>
        </nav>
                                </li>
                            
                            
                                <li class="c-header__item c-header__item--dropdown-menu">
                                    <a href="javascript:;" class="c-header__link" data-header-expander="" data-test="menu-button--about-the-journal" data-track="click" data-track-action="open about the journal expander" data-track-label="button" role="button" aria-haspopup="true" aria-expanded="false">
                                        <span>About <span class="c-header__show-text">the journal</span></span><svg role="img" aria-hidden="true" focusable="false" height="16" viewBox="0 0 16 16" width="16" xmlns="http://www.w3.org/2000/svg"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"></path></svg>
                                    </a><nav class="c-header__dropdown has-tethered u-js-hide" aria-labelledby="About-the-journal" id="about-the-journal" data-test="about-the-journal" data-track-component="nature-150-split-header" hidden="">
                <div class="c-header__container">
                    <h2 id="About-the-journal" class="c-header__heading c-header__heading--js-hide">About the journal</h2>
                    <ul class="c-header__list c-header__list--js-stack">
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/aims" data-track="click" data-track-action="aims &amp; scope" data-track-label="link">
                                    Aims &amp; Scope
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/journal-information" data-track="click" data-track-action="journal information" data-track-label="link">
                                    Journal Information
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/journal-impact" data-track="click" data-track-action="journal metrics" data-track-label="link">
                                    Journal Metrics
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/editors" data-track="click" data-track-action="about the editors" data-track-label="link">
                                    About the Editors
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/research-cross-journal-editorial-team" data-track="click" data-track-action="research cross-journal editorial team" data-track-label="link">
                                    Research Cross-Journal Editorial Team
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/reviews-cross-journal-editorial-team" data-track="click" data-track-action="reviews cross-journal editorial team" data-track-label="link">
                                    Reviews Cross-Journal Editorial Team
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/statistics-advisory-panel" data-track="click" data-track-action="statistical advisory panel" data-track-label="link">
                                    Statistical Advisory Panel
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/our-publishing-models" data-track="click" data-track-action="our publishing models" data-track-label="link">
                                    Our publishing models
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/editorial-values-statement" data-track="click" data-track-action="editorial values statement" data-track-label="link">
                                    Editorial Values Statement
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/editorial-policies" data-track="click" data-track-action="editorial policies" data-track-label="link">
                                    Editorial Policies
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/content" data-track="click" data-track-action="content types" data-track-label="link">
                                    Content Types
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/web-feeds" data-track="click" data-track-action="web feeds" data-track-label="link">
                                    Web Feeds
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/contact" data-track="click" data-track-action="contact" data-track-label="link">
                                    Contact
                                </a>
                            </li>
                        
                    </ul>
                </div>
            </nav>
                                </li>
                                
                                    <li class="c-header__item c-header__item--dropdown-menu" data-test="publish-with-us-button">
                                        <a href="javascript:;" class="c-header__link c-header__link--dropdown-menu" data-header-expander="" data-test="menu-button--publish" data-track="click" data-track-action="open publish with us expander" data-track-label="button" role="button" aria-haspopup="true" aria-expanded="false">
                                            <span>Publish <span class="c-header__show-text">with us</span></span><svg role="img" aria-hidden="true" focusable="false" height="16" viewBox="0 0 16 16" width="16" xmlns="http://www.w3.org/2000/svg"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"></path></svg>
                                        </a><nav class="c-header__dropdown has-tethered u-js-hide" aria-labelledby="Publish-with-us-label" id="publish-with-us" data-test="publish-with-us" data-track-component="nature-150-split-header" hidden="">
                <div class="c-header__container">
                    <h2 id="Publish-with-us-label" class="c-header__heading c-header__heading--js-hide">Publish with us</h2>
                    <ul class="c-header__list c-header__list--js-stack">
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/submission-guidelines" data-track="click" data-track-action="submission guidelines" data-track-label="link">
                                    Submission Guidelines
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/for-reviewers" data-track="click" data-track-action="for reviewers" data-track-label="link">
                                    For Reviewers
                                </a>
                            </li>
                        
                        
                            <li class="c-header__item">
                                <a class="c-header__link" data-test="nature-author-services" data-track="nav_language_services" data-track-context="header publish with us dropdown menu" data-track-action="manuscript author services" data-track-label="link manuscript author services" href="https://authorservices.springernature.com/go/sn/?utm_source=For+Authors&amp;utm_medium=Website_Nature&amp;utm_campaign=Platform+Experimentation+2022&amp;utm_id=PE2022">
                                    Language editing services
                                </a>
                            </li>
                        
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/open-access-funding" data-test="funding-eligibility-link" data-track="click_explore_funding" data-track-context="header publish with us" data-track-action="funding eligibility">Open access funding</a>
                            </li>
                        
                        
                            <li class="c-header__item c-header__item--keyline">
                                <a class="c-header__link" href="https://mts-nmed.nature.com/cgi-bin/main.plex" data-track="click_submit_manuscript" data-track-context="submit link in Nature header dropdown menu" data-track-action="submit manuscript" data-track-label="link (publish with us dropdown menu)" data-track-external="" data-gtm-criteo="submit-manuscript">Submit manuscript<svg role="img" aria-hidden="true" focusable="false" height="18" viewBox="0 0 18 18" width="18" xmlns="http://www.w3.org/2000/svg"><path d="m15 0c1.1045695 0 2 .8954305 2 2v5.5c0 .27614237-.2238576.5-.5.5s-.5-.22385763-.5-.5v-5.5c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-9v3c0 1.1045695-.8954305 2-2 2h-3v10c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h7.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-7.5c-1.1045695 0-2-.8954305-2-2v-10.17157288c0-.53043297.21071368-1.0391408.58578644-1.41421356l3.82842712-3.82842712c.37507276-.37507276.88378059-.58578644 1.41421356-.58578644zm-.5442863 8.18867991 3.3545404 3.35454039c.2508994.2508994.2538696.6596433.0035959.909917-.2429543.2429542-.6561449.2462671-.9065387-.0089489l-2.2609825-2.3045251.0010427 7.2231989c0 .3569916-.2898381.6371378-.6473715.6371378-.3470771 0-.6473715-.2852563-.6473715-.6371378l-.0010428-7.2231995-2.2611222 2.3046654c-.2531661.2580415-.6562868.2592444-.9065605.0089707-.24295423-.2429542-.24865597-.6576651.0036132-.9099343l3.3546673-3.35466731c.2509089-.25090888.6612706-.25227691.9135302-.00001728zm-.9557137-3.18867991c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm-8.5-3.587-3.587 3.587h2.587c.55228475 0 1-.44771525 1-1zm8.5 1.587c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill="#fff"></path></svg>
                                </a>
                            </li>
                        
                    </ul>
                </div>
            </nav>
                                    </li>
                                
                            
                            
                        </ul>
                        <ul class="c-header__menu c-header__menu--hide-lg-max">
                            
                                <li class="c-header__item" data-test="alert-link">
                                    <a class="c-header__link" href="https://journal-alerts.springernature.com/subscribe?journal_id=41591" rel="nofollow" data-track="nav_sign_up_for_alerts" data-track-action="Sign up for alerts" data-track-label="link (desktop site header)" data-track-external="">
                                        <span>Sign up for alerts</span><svg role="img" aria-hidden="true" focusable="false" height="18" viewBox="0 0 18 18" width="18" xmlns="http://www.w3.org/2000/svg"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill="#222"></path></svg>
                                    </a>
                                </li>
                            
                            
                                <li class="c-header__item c-header__item--pipe">
                                    <a class="c-header__link" href="https://www.nature.com/nm.rss" data-track="click" data-track-action="rss feed" data-track-label="link">
                                            <span>RSS feed</span>
                                    </a>
                                </li>
                            
                        </ul>
                    </div>
                </div>
            </div>
        
    </header>


    
    
        <nav class="u-mb-16" aria-label="breadcrumbs">
            <div class="u-container">
                <ol class="c-breadcrumbs" itemscope="" itemtype="https://schema.org/BreadcrumbList">
                    <li class="c-breadcrumbs__item" id="breadcrumb0" itemprop="itemListElement" itemscope="" itemtype="https://schema.org/ListItem"><a class="c-breadcrumbs__link" href="/" itemprop="item" data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:nature"><span itemprop="name">nature</span></a><meta itemprop="position" content="1">
                                    <svg class="c-breadcrumbs__chevron" role="img" aria-hidden="true" focusable="false" height="10" viewBox="0 0 10 10" width="10" xmlns="http://www.w3.org/2000/svg">
                                        <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill="#666" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path>
                                    </svg>
                                </li><li class="c-breadcrumbs__item" id="breadcrumb1" itemprop="itemListElement" itemscope="" itemtype="https://schema.org/ListItem"><a class="c-breadcrumbs__link" href="/nm" itemprop="item" data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:nature medicine"><span itemprop="name">nature medicine</span></a><meta itemprop="position" content="2">
                                    <svg class="c-breadcrumbs__chevron" role="img" aria-hidden="true" focusable="false" height="10" viewBox="0 0 10 10" width="10" xmlns="http://www.w3.org/2000/svg">
                                        <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill="#666" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path>
                                    </svg>
                                </li><li class="c-breadcrumbs__item" id="breadcrumb2" itemprop="itemListElement" itemscope="" itemtype="https://schema.org/ListItem"><a class="c-breadcrumbs__link" href="/nm/articles?type=article" itemprop="item" data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:articles"><span itemprop="name">articles</span></a><meta itemprop="position" content="3">
                                    <svg class="c-breadcrumbs__chevron" role="img" aria-hidden="true" focusable="false" height="10" viewBox="0 0 10 10" width="10" xmlns="http://www.w3.org/2000/svg">
                                        <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill="#666" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path>
                                    </svg>
                                </li><li class="c-breadcrumbs__item" id="breadcrumb3" itemprop="itemListElement" itemscope="" itemtype="https://schema.org/ListItem">
                                    <span itemprop="name">article</span><meta itemprop="position" content="4"></li>
                </ol>
            </div>
        </nav>
    



    

</div>


<div class="u-container u-mt-32 u-mb-32 u-clearfix" id="content" data-component="article-container" data-container-type="article">
    <main class="c-article-main-column u-float-left js-main-column" data-track-component="article body">
        
            
                <div class="c-context-bar u-hide" id="js-enable-context-bar" data-test="context-bar" data-context-bar="" aria-hidden="true">
                    <div class="c-context-bar__container u-container" data-track-context="sticky banner">
                        <div class="c-context-bar__title">
                            Modeling transmission of SARS-CoV-2 Omicron in China
                        </div>
                        
    
        <div class="c-pdf-download u-clear-both js-pdf-download">
            <a href="/articles/s41591-022-01855-7.pdf" class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="download-pdf" data-draft-ignore="true" data-track="content_download" data-track-type="article pdf download" data-track-action="download pdf" data-track-label="link" data-track-external="" download="">
                <span class="c-pdf-download__text">Download PDF</span>
                <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#icon-download"></use></svg>
            </a>
        </div>
    

                    </div>
                </div>
            
        
        <article lang="en">
            
                <div class="c-pdf-button__container u-mb-16 u-hide-at-lg js-context-bar-sticky-point-mobile">
                    <div class="c-pdf-container" data-track-context="article body">
                        
                            
                                
    
        <div class="c-pdf-download u-clear-both js-pdf-download">
            <a href="/articles/s41591-022-01855-7.pdf" class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="download-pdf" data-draft-ignore="true" data-track="content_download" data-track-type="article pdf download" data-track-action="download pdf" data-track-label="link" data-track-external="" download="">
                <span class="c-pdf-download__text">Download PDF</span>
                <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#icon-download"></use></svg>
            </a>
        </div>
    

                            
                        
                    </div>
                </div>
            
            <div class="c-article-header">
                <header>
                    <ul class="c-article-identifiers" data-test="article-identifier">
                        
        <li class="c-article-identifiers__item" data-test="article-category">Article</li>
    
        <li class="c-article-identifiers__item">
            <a href="https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research" data-track="click" data-track-action="open access" data-track-label="link" class="u-color-open-access" data-test="open-access">Open access</a>
        </li>
    
    

                        <li class="c-article-identifiers__item">Published: <time datetime="2022-05-10">10 May 2022</time></li>
                    </ul>

                    <h1 class="c-article-title" data-test="article-title" data-article-title="">Modeling transmission of SARS-CoV-2 Omicron in China</h1>
                    <ul class="c-article-author-list c-article-author-list--short js-no-scroll" data-test="authors-list" data-component-authors-activator="authors-list"><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Jun-Cai-Aff1" data-author-popup="auth-Jun-Cai-Aff1" data-author-search="Cai, Jun" data-track-context="researcher popup with no profile" data-track-index="1_18">Jun Cai</a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="http://orcid.org/0000-0001-9495-1226"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0001-9495-1226</a></span><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup><sup class="u-js-hide">&nbsp;<a href="#na1" tabindex="-1">na1</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Xiaowei-Deng-Aff1" data-author-popup="auth-Xiaowei-Deng-Aff1" data-author-search="Deng, Xiaowei" data-track-context="researcher popup with no profile" data-track-index="2_18">Xiaowei Deng</a><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup><sup class="u-js-hide">&nbsp;<a href="#na1" tabindex="-1">na1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Juan-Yang-Aff1-Aff2" data-author-popup="auth-Juan-Yang-Aff1-Aff2" data-author-search="Yang, Juan" data-track-context="researcher popup with no profile" data-track-index="3_18">Juan Yang</a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="http://orcid.org/0000-0001-5028-2227"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0001-5028-2227</a></span><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a>,<a href="#Aff2" tabindex="-1">2</a></sup><sup class="u-js-hide">&nbsp;<a href="#na1" tabindex="-1">na1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Kaiyuan-Sun-Aff3" data-author-popup="auth-Kaiyuan-Sun-Aff3" data-author-search="Sun, Kaiyuan" data-track-context="researcher popup with no profile" data-track-index="4_18">Kaiyuan Sun</a><sup class="u-js-hide"><a href="#Aff3" tabindex="-1">3</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Hengcong-Liu-Aff1" data-author-popup="auth-Hengcong-Liu-Aff1" data-author-search="Liu, Hengcong" data-track-context="researcher popup with no profile" data-track-index="5_18">Hengcong Liu</a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="http://orcid.org/0000-0003-2591-2201"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0003-2591-2201</a></span><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Zhiyuan-Chen-Aff1" data-author-popup="auth-Zhiyuan-Chen-Aff1" data-author-search="Chen, Zhiyuan" data-track-context="researcher popup with no profile" data-track-index="6_18">Zhiyuan Chen</a><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Cheng-Peng-Aff1" data-author-popup="auth-Cheng-Peng-Aff1" data-author-search="Peng, Cheng" data-track-context="researcher popup with no profile" data-track-index="7_18">Cheng Peng</a><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Xinhua-Chen-Aff1" data-author-popup="auth-Xinhua-Chen-Aff1" data-author-search="Chen, Xinhua" data-track-context="researcher popup with no profile" data-track-index="8_18">Xinhua Chen</a><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Qianhui-Wu-Aff1" data-author-popup="auth-Qianhui-Wu-Aff1" data-author-search="Wu, Qianhui" data-track-context="researcher popup with no profile" data-track-index="9_18">Qianhui Wu</a><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Junyi-Zou-Aff1" data-author-popup="auth-Junyi-Zou-Aff1" data-author-search="Zou, Junyi" data-track-context="researcher popup with no profile" data-track-index="10_18">Junyi Zou</a><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Ruijia-Sun-Aff1" data-author-popup="auth-Ruijia-Sun-Aff1" data-author-search="Sun, Ruijia" data-track-context="researcher popup with no profile" data-track-index="11_18">Ruijia Sun</a><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Wen-Zheng-Aff1" data-author-popup="auth-Wen-Zheng-Aff1" data-author-search="Zheng, Wen" data-track-context="researcher popup with no profile" data-track-index="12_18">Wen Zheng</a><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Zeyao-Zhao-Aff1" data-author-popup="auth-Zeyao-Zhao-Aff1" data-author-search="Zhao, Zeyao" data-track-context="researcher popup with no profile" data-track-index="13_18">Zeyao Zhao</a><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Wanying-Lu-Aff1" data-author-popup="auth-Wanying-Lu-Aff1" data-author-search="Lu, Wanying" data-track-context="researcher popup with no profile" data-track-index="14_18">Wanying Lu</a><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Yuxia-Liang-Aff1" data-author-popup="auth-Yuxia-Liang-Aff1" data-author-search="Liang, Yuxia" data-track-context="researcher popup with no profile" data-track-index="15_18">Yuxia Liang</a><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Xiaoyu-Zhou-Aff1" data-author-popup="auth-Xiaoyu-Zhou-Aff1" data-author-search="Zhou, Xiaoyu" data-track-context="researcher popup with no profile" data-track-index="16_18">Xiaoyu Zhou</a><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Marco-Ajelli-Aff4" data-author-popup="auth-Marco-Ajelli-Aff4" data-author-search="Ajelli, Marco" data-track-context="researcher popup with no profile" data-track-index="17_18">Marco Ajelli</a><sup class="u-js-hide"><a href="#Aff4" tabindex="-1">4</a></sup><sup class="u-js-hide">&nbsp;<a href="#na2" tabindex="-1">na2</a></sup> &amp; </li><li class="c-article-author-list__show-more" aria-label="Show all 18 authors for this article" title="Show all 18 authors for this article">…</li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Hongjie-Yu-Aff1-Aff2" data-author-popup="auth-Hongjie-Yu-Aff1-Aff2" data-author-search="Yu, Hongjie" data-corresp-id="c1" data-track-context="researcher popup with no profile" data-track-index="18_18">Hongjie Yu<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-mail-medium"></use></svg></a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="http://orcid.org/0000-0002-6335-5648"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0002-6335-5648</a></span><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a>,<a href="#Aff2" tabindex="-1">2</a></sup><sup class="u-js-hide">&nbsp;<a href="#na2" tabindex="-1">na2</a></sup>&nbsp;</li></ul><button aria-expanded="false" class="c-article-author-list__button"><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-down-medium"></use></svg><span>Show authors</span></button>

                    

                    <p class="c-article-info-details" data-container-section="info">
                        
    <a data-test="journal-link" href="/nm" data-track="click" data-track-action="journal homepage" data-track-category="article body" data-track-label="link"><i data-test="journal-title">Nature Medicine</i></a>

                        <b data-test="journal-volume"><span class="u-visually-hidden">volume</span>&nbsp;28</b>,&nbsp;<span class="u-visually-hidden">pages </span>1468–1475 (<span data-test="article-publication-year">2022</span>)<a href="#citeas" class="c-article-info-details__cite-as u-hide-print" data-track="click" data-track-action="cite this article" data-track-label="link">Cite this article</a>
                    </p>
                    
        <div class="c-article-metrics-bar__wrapper u-clear-both">
            <ul class="c-article-metrics-bar u-list-reset">
                
                    <li class=" c-article-metrics-bar__item" data-test="access-count">
                        <p class="c-article-metrics-bar__count">152k <span class="c-article-metrics-bar__label">Accesses</span></p>
                    </li>
                
                
                    <li class="c-article-metrics-bar__item" data-test="citation-count">
                        <p class="c-article-metrics-bar__count">191 <span class="c-article-metrics-bar__label">Citations</span></p>
                    </li>
                
                
                    
                        <li class="c-article-metrics-bar__item" data-test="altmetric-score">
                            <p class="c-article-metrics-bar__count">2841 <span class="c-article-metrics-bar__label">Altmetric</span></p>
                        </li>
                    
                
                <li class="c-article-metrics-bar__item">
                    <p class="c-article-metrics-bar__details"><a href="/articles/s41591-022-01855-7/metrics" data-track="click" data-track-action="view metrics" data-track-label="link" rel="nofollow">Metrics <span class="u-visually-hidden">details</span></a></p>
                </li>
            </ul>
        </div>
    
                    
                </header>

                
    

                
    
    

    
    

                
            </div>

        <div class="c-article-body">
            <section aria-labelledby="Abs1" data-title="Abstract" lang="en"><div class="c-article-section" id="Abs1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Abs1">Abstract</h2><div class="c-article-section__content" id="Abs1-content"><p>Having adopted a dynamic zero-COVID strategy to respond to SARS-CoV-2 variants with higher transmissibility since August 2021, China is now considering whether, and for how long, this policy can remain in place. The debate has thus shifted towards the identification of mitigation strategies for minimizing disruption to the healthcare system in the case of a nationwide epidemic. To this aim, we developed an age-structured stochastic compartmental susceptible-latent-infectious-removed-susceptible model of SARS-CoV-2 transmission calibrated on the initial growth phase for the 2022 Omicron outbreak in Shanghai, to project COVID-19 burden (that is, number of cases, patients requiring hospitalization and intensive care, and deaths) under hypothetical mitigation scenarios. The model also considers age-specific vaccine coverage data, vaccine efficacy against different clinical endpoints, waning of immunity, different antiviral therapies and nonpharmaceutical interventions. We find that the level of immunity induced by the March 2022 vaccination campaign would be insufficient to prevent an Omicron wave that would result in exceeding critical care capacity with a projected intensive care unit peak demand of 15.6 times the existing capacity and causing approximately 1.55 million deaths. However, we also estimate that protecting vulnerable individuals by ensuring accessibility to vaccines and antiviral therapies, and maintaining implementation of nonpharmaceutical interventions could be sufficient to prevent overwhelming the healthcare system, suggesting that these factors should be points of emphasis in future mitigation policies.</p></div></div></section>

            
                
            

            
                
                    
        
            <section aria-labelledby="inline-recommendations" data-title="Inline Recommendations" class="c-article-recommendations" data-track-component="inline-recommendations">
                <h3 class="c-article-recommendations-title" id="inline-recommendations">Similar content being viewed by others</h3>
                <div class="c-article-recommendations-list">
                    
                        <div class="c-article-recommendations-list__item">
                            <article class="c-article-recommendations-card" itemscope="" itemtype="http://schema.org/ScholarlyArticle">
                                
                                    <div class="c-article-recommendations-card__img"><img src="https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41591-021-01334-5/MediaObjects/41591_2021_1334_Fig1_HTML.png" loading="lazy" alt=""></div>
                                
                                <div class="c-article-recommendations-card__main">
                                    <h3 class="c-article-recommendations-card__heading" itemprop="name headline">
                                        <a class="c-article-recommendations-card__link" itemprop="url" href="https://www.nature.com/articles/s41591-021-01334-5?fromPaywallRec=false" data-track="select_recommendations_1" data-track-context="inline recommendations" data-track-action="click recommendations inline - 1" data-track-label="10.1038/s41591-021-01334-5">Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy
                                        </a>
                                    </h3>
                                    <div class="c-article-meta-recommendations" data-test="recommendation-info">
                                        <span class="c-article-meta-recommendations__item-type">Article</span>
                                         <span class="c-article-meta-recommendations__access-type">Open access</span>
                                         <span class="c-article-meta-recommendations__date">16 April 2021</span>
                                    </div>
                                </div>
                            </article>
                        </div>
                    
                        <div class="c-article-recommendations-list__item">
                            <article class="c-article-recommendations-card" itemscope="" itemtype="http://schema.org/ScholarlyArticle">
                                
                                    <div class="c-article-recommendations-card__img"><img src="https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41467-022-32404-y/MediaObjects/41467_2022_32404_Fig1_HTML.png" loading="lazy" alt=""></div>
                                
                                <div class="c-article-recommendations-card__main">
                                    <h3 class="c-article-recommendations-card__heading" itemprop="name headline">
                                        <a class="c-article-recommendations-card__link" itemprop="url" href="https://www.nature.com/articles/s41467-022-32404-y?fromPaywallRec=false" data-track="select_recommendations_2" data-track-context="inline recommendations" data-track-action="click recommendations inline - 2" data-track-label="10.1038/s41467-022-32404-y">Modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron era
                                        </a>
                                    </h3>
                                    <div class="c-article-meta-recommendations" data-test="recommendation-info">
                                        <span class="c-article-meta-recommendations__item-type">Article</span>
                                         <span class="c-article-meta-recommendations__access-type">Open access</span>
                                         <span class="c-article-meta-recommendations__date">19 August 2022</span>
                                    </div>
                                </div>
                            </article>
                        </div>
                    
                        <div class="c-article-recommendations-list__item">
                            <article class="c-article-recommendations-card" itemscope="" itemtype="http://schema.org/ScholarlyArticle">
                                
                                    <div class="c-article-recommendations-card__img"><img src="https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41598-022-25635-y/MediaObjects/41598_2022_25635_Fig1_HTML.png" loading="lazy" alt=""></div>
                                
                                <div class="c-article-recommendations-card__main">
                                    <h3 class="c-article-recommendations-card__heading" itemprop="name headline">
                                        <a class="c-article-recommendations-card__link" itemprop="url" href="https://www.nature.com/articles/s41598-022-25635-y?fromPaywallRec=false" data-track="select_recommendations_3" data-track-context="inline recommendations" data-track-action="click recommendations inline - 3" data-track-label="10.1038/s41598-022-25635-y">Evolution of the lethality due to SARS-CoV-2 in Spain according to age group and sex
                                        </a>
                                    </h3>
                                    <div class="c-article-meta-recommendations" data-test="recommendation-info">
                                        <span class="c-article-meta-recommendations__item-type">Article</span>
                                         <span class="c-article-meta-recommendations__access-type">Open access</span>
                                         <span class="c-article-meta-recommendations__date">21 December 2022</span>
                                    </div>
                                </div>
                            </article>
                        </div>
                    
                </div>
            </section>
        
            <script>
                window.dataLayer = window.dataLayer || [];
                window.dataLayer.push({
                    recommendations: {
                        recommender: 'semantic',
                        model: 'specter',
                        policy_id: 'NA',
                        timestamp: 1749523414,
                        embedded_user: 'null'
                    }
                });
            </script>
        
    
                
                
                <div class="main-content">
                    
                        <section data-title="Main"><div class="c-article-section" id="Sec1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec1">Main</h2><div class="c-article-section__content" id="Sec1-content"><p>First discovered in Southern Africa in November 2021 (ref. <sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Viana, R. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature 603, 679–686 (2022)." href="/articles/s41591-022-01855-7#ref-CR1" id="ref-link-section-d72634251e601">1</a></sup>), the Omicron variant of SARS-CoV-2 has spread swiftly across the world and replaced the Delta variant to become the dominant strain globally<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Tracking of VOC Omicron. Global Initiative of Sharing All Influenza Data (GISAID) (29 January 2022); 
                  https://www.gisaid.org/hcov19-variants/
                  
                " href="/articles/s41591-022-01855-7#ref-CR2" id="ref-link-section-d72634251e605">2</a></sup>. Omicron has demonstrated an increased transmissibility relative to Delta<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Viana, R. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature 603, 679–686 (2022)." href="/articles/s41591-022-01855-7#ref-CR1" id="ref-link-section-d72634251e609">1</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Lyngse, F.P. SARS-CoV-2 Omicron VOC transmission in Danish households. Preprint at medRXiv 
                  https://doi.org/10.1101/2021.12.27.21268278
                  
                 (2021)." href="#ref-CR3" id="ref-link-section-d72634251e612">3</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Pearson, C.A.B. et al. Bounding the levels of transmissibility &amp; immune evasion of the Omicron variant in South Africa. Preprint at medRxiv 
                  https://doi.org/10.1101/2021.12.19.21268038
                  
                 (2021)." href="#ref-CR4" id="ref-link-section-d72634251e612_1">4</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 5" title="Gozzi, N. et al. Preliminary modeling estimates of the relative transmissibility and immune escape of the Omicron SARS-CoV-2 variant of concern in South Africa. Preprint at medRxiv 
                  https://doi.org/10.1101/2022.01.04.22268721
                  
                 (2022)." href="/articles/s41591-022-01855-7#ref-CR5" id="ref-link-section-d72634251e615">5</a></sup> and immune escape capability<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Lu, L. et al. Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients. Clin. Infect. Dis. ciab1041 (2021)." href="/articles/s41591-022-01855-7#ref-CR6" id="ref-link-section-d72634251e619">6</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 7" title="Zhang, L. et al. The significant immune escape of pseudotyped SARS-CoV-2 variant omicron. Emerg. Microbes Infect. 11, 1–5 (2022)." href="/articles/s41591-022-01855-7#ref-CR7" id="ref-link-section-d72634251e622">7</a></sup>. Together with the progressive waning of the protection against the infection associated with previous infections and/or vaccination<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Collier, A.-R. Y. et al. Differential kinetics of immune responses elicited by covid-19 vaccines. N. Engl. J. Med. 385, 2010–2012 (2021)." href="#ref-CR8" id="ref-link-section-d72634251e626">8</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Levin, E. G. et al. Waning immune humoral response to BNT162b2 covid-19 vaccine over 6 months. N. Engl. J. Med. 385, e84 (2021)." href="#ref-CR9" id="ref-link-section-d72634251e626_1">9</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Xin, Q. et al. Six-month follow-up of a booster dose of coronavac: two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials. Preprint at SSRN 
                  https://doi.org/10.2139/ssrn.3991627
                  
                 (2021)." href="#ref-CR10" id="ref-link-section-d72634251e626_2">10</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Dan Jennifer, M. et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science 371, eabf4063 (2021)." href="#ref-CR11" id="ref-link-section-d72634251e626_3">11</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 12" title="Wheatley, A. K. et al. Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19. Nat. Commun. 12, 1162 (2021)." href="/articles/s41591-022-01855-7#ref-CR12" id="ref-link-section-d72634251e629">12</a></sup>, these characteristics have led to large Omicron epidemics in most countries<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="WHO Coronavirus (COVID-19) Dashboard. World Health Organization (5 March 2022); 
                  https://covid19.who.int/
                  
                " href="/articles/s41591-022-01855-7#ref-CR13" id="ref-link-section-d72634251e634">13</a></sup>. Despite signs of a possibly lower clinical severity than Delta<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Wolter, N. et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet 399, 437–446 (2022)." href="#ref-CR14" id="ref-link-section-d72634251e638">14</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Maslo, C. et al. Characteristics and outcomes of hospitalized patients in South Africa during the COVID-19 Omicron wave compared with previous waves. JAMA 327, 583–584 (2022)." href="#ref-CR15" id="ref-link-section-d72634251e638_1">15</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="SARS-CoV-2 variants of concern and variants under investigation in England, Technical briefing: update on hospitalisation and vaccine effectiveness for Omicron VOC-21NOV-01 (B.1.1.529). UK Health Security Agency 
                  https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1044481/Technical-Briefing-31-Dec-2021-Omicron_severity_update.pdf
                  
                 (2021)." href="#ref-CR16" id="ref-link-section-d72634251e638_2">16</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Wang, L. et al. Incidence Rates and Clinical Outcomes of SARS-CoV-2 Infection With the Omicron and Delta Variants in Children Younger Than 5 Years in the US. JAMA Pediatr. e220945 (2022)." href="#ref-CR17" id="ref-link-section-d72634251e638_3">17</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="Lewnard, J. A. et al. Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California. Preprint at medRxiv 
                  https://doi.org/10.1101/2022.01.11.22269045
                  
                 (2022)." href="/articles/s41591-022-01855-7#ref-CR18" id="ref-link-section-d72634251e641">18</a></sup>, the sheer volume of Omicron infections has strained healthcare systems worldwide, including in the United States<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 19" title="Iuliano, A. D. et al. Trends in disease severity and health care utilization during the early omicron variant period compared with previous SARS-CoV-2 high transmission periods—United States, December 2020–January 2022. MMWR Morb. Mortal. Wkly Rep. 71, 146–152 (2022)." href="/articles/s41591-022-01855-7#ref-CR19" id="ref-link-section-d72634251e645">19</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 20" title="Marks, K. J. et al. Hospitalizations of children and adolescents with laboratory-confirmed COVID-19—COVID-NET, 14 States, July 2021–January 2022. MMWR Morb. Mortal. Wkly Rep. 71, 271–278 (2022)." href="/articles/s41591-022-01855-7#ref-CR20" id="ref-link-section-d72634251e648">20</a></sup> and the United Kingdom<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 21" title="Coronavirus (COVID-19) latest insights. UK Office for National Statistics . 
                  https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights
                  
                 (2022)." href="/articles/s41591-022-01855-7#ref-CR21" id="ref-link-section-d72634251e652">21</a></sup>. For instance, in the United Kingdom, the Omicron wave has led to higher infection rates than during the second wave in the winter of 2021, with substantial hospitalizations and deaths (over 1,000 deaths reported per week between 14 January and 4 February 2022)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 21" title="Coronavirus (COVID-19) latest insights. UK Office for National Statistics . 
                  https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights
                  
                 (2022)." href="/articles/s41591-022-01855-7#ref-CR21" id="ref-link-section-d72634251e656">21</a></sup>.</p><p>After controlling the initial epidemic wave in Hubei in early 2020, China has deployed multilayer nonpharmaceutical intervention (NPI) protocols to contain sporadic COVID-19 outbreaks, largely introduced from international travelers. Maintaining a low infection rate in the general population throughout the pandemic has provided China time to mass immunize the population against SARS-CoV-2. As of 18 April 2022, 91.4% of the population aged ≥3 years has received the full primary schedule of the COVID-19 vaccination (either inactivated vaccines administered on a two-dose schedule, or recombinant subunit vaccines administered on a three-dose schedule or recombinant adenovirus type-5-vectored vaccines administered as a single dose); 53.7% of those vaccinated have received a booster shot<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Press conference held on situation regarding strict prevention and control of COVID-19 epidemic. The State Council Information Office, P.R.C. (19 April 2022); 
                  http://www.gov.cn/xinwen/gwylflkjz193/index.htm
                  
                " href="/articles/s41591-022-01855-7#ref-CR22" id="ref-link-section-d72634251e663">22</a></sup>. However, vaccine-induced population immunity may be insufficient to prevent COVID-19 outbreaks. From 1 March to 22 April 2022, more than 500,000 local Omicron infections have been reported in almost all provinces across China, with most (about 93%) occurring in Shanghai<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Press conference held on situation regarding strict prevention and control of COVID-19 epidemic. The State Council Information Office, P.R.C. (19 April 2022); 
                  http://www.gov.cn/xinwen/gwylflkjz193/index.htm
                  
                " href="/articles/s41591-022-01855-7#ref-CR22" id="ref-link-section-d72634251e667">22</a></sup>. To contain the highly infectious and immune evasive Omicron variant, additional NPI measures will be required to maintain the dynamic zero-COVID policy. This policy, adopted by China to respond to SARS-CoV-2 variants with higher transmissibility since August 2021, consists of a comprehensive set of measures to identify SARS-CoV-2 infections and stop any transmission chain, thus repeatedly zeroing local transmission<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Liu, J., Liu, M. &amp; Liang, W. The dynamic COVID-zero strategy in China. China CDC Wkly. 4, 74–75 (2022)." href="/articles/s41591-022-01855-7#ref-CR23" id="ref-link-section-d72634251e671">23</a></sup>. Whether, and for how long, a zero-COVID policy can remain in place is questionable and, as recommended by the WHO<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 24" title="COVID-19 Virtual Press conference transcript. World Health Organization (1 February 2022); 
                  https://www.who.int/publications/m/item/covid-19-virtual-press-conference-transcript-1-february-2022
                  
                " href="/articles/s41591-022-01855-7#ref-CR24" id="ref-link-section-d72634251e675">24</a></sup>, every country should be prepared to chart its own path to transit from a pandemic to an endemic phase while accounting for local epidemiology, vaccination levels, population immunity and the strength of health systems. In this regard, as of May 2022, two approved antiviral treatments (BRII-196/BRII-198 combination and nirmatrelvir tablet/ritonavir tablet combination package) have been used in China, providing a new tool against COVID-19 (refs. <sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Emergency approval of Brii Biosciences’ COVID-19 neutralizing antibody combination therapy: amubarvimab/romlusevimab combination (BRII-196/BRII-198) therapy. The National Medical Products Administration (NMPA) of China 
                  https://www.nmpa.gov.cn/yaowen/ypjgyw/20211208212528103.html
                  
                 (2021)." href="/articles/s41591-022-01855-7#ref-CR25" id="ref-link-section-d72634251e679">25</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 26" title="Emergency conditional approval of Pfizer’s COVID-19 therapy: nirmatrelvir tablet/ritonavir tablet combination package (i.e., Paxlovid) importation registration. The National Medical Products Administration (NMPA) of China 
                  https://www.nmpa.gov.cn/yaowen/ypjgyw/20220212085753142.html
                  
                 (2022)." href="/articles/s41591-022-01855-7#ref-CR26" id="ref-link-section-d72634251e682">26</a></sup>).</p><p>Here, we explore the feasibility of a COVID-19 mitigation strategy to safeguard China’s shift from pandemic containment to mitigation, while minimizing the disease burden. Specifically, we leverage a mathematical model (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig6">1</a>) to simulate a hypothetical Omicron wave in China based on data from the 2022 Omicron outbreak in Shanghai (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig7">2</a>), project the demand for hospital beds and intensive care units (ICUs) and explore mitigation strategies combining vaccinations, antiviral therapies and NPIs to reduce COVID-19 burden while preventing the healthcare system being overwhelmed.</p></div></div></section><section data-title="Results"><div class="c-article-section" id="Sec2-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec2">Results</h2><div class="c-article-section__content" id="Sec2-content"><h3 class="c-article__sub-heading" id="Sec3">Baseline scenario</h3><p>The baseline scenario considers a homologous booster vaccination in the absence of strict NPIs and antiviral therapies. Specifically, the following conditions are simulated: (1) the introduction of 20 Omicron-infected individuals into the Chinese population on 1 March 2022; (2) the reproduction number (<i>R</i>) at the beginning of the simulation is set at 3.9 (when considering the partial protection of the population induced by vaccination, the reproduction number decreases to 3.4, in agreement with what we estimated for the early phase (from 1 March to 8 March 2022) of the epidemic in Shanghai (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig7">2</a>), before strict control measures were implemented (<a data-track="click" data-track-label="link" data-track-action="section anchor" href="/articles/s41591-022-01855-7#Sec7">Methods</a>)); (3) booster doses of inactivated vaccines are rolled out at a speed of 5 million doses per day from 1 March 2022 (before that date the daily vaccination rates were informed by the cumulative number of doses administered in China); (4) 90% of individuals who have completed the primary vaccination schedule by at least 6 months receive a booster shot; (5) vaccine efficacy (VE) is set according to the values reported in Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">1</a>, considering a low immune escape scenario with same VEs against hospitalization and deaths between homologous booster and heterologous booster vaccination as observed in Hong Kong<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 27" title="McMenamin, M. E. et al. Vaccine effectiveness of two and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong. Preprint at medRxiv 
                  https://doi.org/10.1101/2022.03.22.22272769
                  
                 (2022)." href="/articles/s41591-022-01855-7#ref-CR27" id="ref-link-section-d72634251e719">27</a></sup> and (6) antiviral therapies are not distributed.</p><p>Our simulated baseline scenario suggests that, in the absence of strict NPIs, the introduction of the Omicron variant in China in March 2022 could have the potential to generate a tsunami of COVID-19 cases. Over a 6-month simulation period, such an epidemic is projected to cause 112.2 million symptomatic cases (79.58 per 1,000 individuals), 5.1 million hospital (non-ICU) admissions (3.60 per 1,000 individuals), 2.7 million ICU admissions (1.89 per 1,000 individuals) and 1.6 million deaths (1.10 per 1,000 individuals), with a main wave occurring between May and July 2022 (Figs. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig1">1</a> and <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig2">2</a>).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-1" data-title="Projected SARS-CoV-2 Omicron burden in China for baseline scenario from March 2022 to September 2022."><figure><figcaption><b id="Fig1" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 1: Projected SARS-CoV-2 Omicron burden in China for baseline scenario from March 2022 to September 2022.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41591-022-01855-7/figures/1" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig1_HTML.png?as=webp"><img aria-describedby="Fig1" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig1_HTML.png" alt="figure 1" loading="lazy" width="685" height="522"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-1-desc"><p><b>a</b>, Daily hospital (non-ICU) admissions per 10,000 individuals. <b>b</b>, Epidemiological status of hospitalized (non-ICU) patients. <b>c</b>, Age distribution of hospitalized (non-ICU) patients. <b>d</b>, Distribution of hospitalized (non-ICU) patients per 10,000 by age group and epidemiological status. <b>e</b>, Daily ICU admissions per 10,000 individuals. <b>f</b>, Epidemiological status of ICU patients. <b>g</b>, Age distribution of ICU patients. <b>h</b>, Distribution of ICU patients per 10,000 by age group and epidemiological status. <b>i</b>, Daily deaths per 10,000 individuals. <b>j</b>, Epidemiological status of deaths. <b>k</b>, Age distribution of deaths. <b>l</b>, Distribution of deaths per 10,000 by age group and epidemiological status. In panels <b>b</b>, <b>f</b> and <b>j</b>, susceptible refers to individuals who do not receive COVID-19 vaccines; primary refers to those individuals who have received at least one dose of COVID-19 vaccine, considering a primary vaccination which entails a two-dose schedule; booster refers to those individuals who have received a third dose; recovery refers to individuals who have recovered from SARS-CoV-2 Omicron infection. Data are presented as median with 2.5% and 97.5% quantiles of <i>n</i> = 200 simulations.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41591-022-01855-7/figures/1" data-track-dest="link:Figure1 Full size image" aria-label="Full size image figure 1" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-2" data-title="Age-specific and overall incidence rates of different clinical outcomes across four settings (China, Shanghai, Shanxi and Shandong) under the baseline scenario from March 2022 to September 2022."><figure><figcaption><b id="Fig2" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 2: Age-specific and overall incidence rates of different clinical outcomes across four settings (China, Shanghai, Shanxi and Shandong) under the baseline scenario from March 2022 to September 2022.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41591-022-01855-7/figures/2" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig2_HTML.png?as=webp"><img aria-describedby="Fig2" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig2_HTML.png" alt="figure 2" loading="lazy" width="685" height="912"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-2-desc"><p><b>a</b>, Cumulative hospital (non-ICU) admissions per 1,000 individuals. <b>b</b>, Cumulative ICU admissions per 1,000 individuals. <b>c</b>, Cumulative deaths per 1,000 individuals. China represents the ‘national average’. Number denotes median, and error bars denote 2.5% and 97.5% quantiles of <i>n</i> = 200 simulations.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41591-022-01855-7/figures/2" data-track-dest="link:Figure2 Full size image" aria-label="Full size image figure 2" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>According to our model simulations, 41.3% of non-ICU hospitalizations and 28.2% of ICU admissions would occur among vaccinated individuals. Most non-ICU hospitalizations are estimated to occur in the adult population (26.6% among individuals aged 18–59 years and 59.1% among individuals aged ≥60 years), while over 90% of ICU admissions would occur among individuals aged ≥60 years (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig1">1</a>). Most deaths (76.7%) are estimated to occur among nonvaccinated individuals, despite representing only 12.1% of the population (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig1">1</a>). Unvaccinated individuals aged ≥60 years are projected to account for 74.7% of the total number of deaths due to the gap in vaccination coverage in this portion of the population; approximately 52 million people aged ≥60 years are not fully vaccinated as of 17 March 2022 (ref. <sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 28" title="Press conference held on situation regarding strict prevention and control of COVID-19 epidemic. The State Council Information Office, P.R.C. (19 March 2022); 
                  http://www.gov.cn/xinwen/gwylflkjz187/index.htm
                  
                " href="/articles/s41591-022-01855-7#ref-CR28" id="ref-link-section-d72634251e841">28</a></sup>).</p><p>In addition to presenting analyses for a national average, we analyze three highly diverse areas of China: Shanghai, Shandong and Shanxi. For each of these areas, we consider a specific vaccination coverage, age structure of the population, contact patterns of the population (Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">1</a>) and number of available hospital beds and ICUs (Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">2</a>). The results show a considerable heterogeneity across the different areas. For example, the number of deaths per 1,000 inhabitants in the baseline scenario is projected to be 1.79 in Shanghai (where, as of 15 April 2022, 62% of individuals aged ≥60 years were fully vaccinated and 38% had received a booster dose<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="Press conference held on situation regarding prevetion and control of COVID-19 epidemic in Shanghai. Shanghai Municipal Health Commission (17 April 2022); 
                  https://j.eastday.com/p/1650166645036759
                  
                " href="/articles/s41591-022-01855-7#ref-CR29" id="ref-link-section-d72634251e854">29</a></sup>) compared with 0.84 in Shandong (the province with the highest vaccination coverage in individuals aged ≥60 years among the four settings; as of 21 March 2022, 89.16% of this population were fully vaccinated and 72.45% had received a booster dose<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 30" title="Press conference held on situation regarding prevetion and control of COVID-19 epidemic in Shandong province. People’s Government of Shandong Province (22 March 2022); 
                  http://www.shandong.gov.cn/vipchat1//home/site/82/3788/article.html
                  
                " href="/articles/s41591-022-01855-7#ref-CR30" id="ref-link-section-d72634251e858">30</a></sup>) (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig2">2</a>).</p><p>To evaluate the impact of an uncontrolled Omicron epidemic on the national healthcare system, we considered that all COVID-19 hospitalizations require hospital beds for respiratory illness and that critically ill cases require ICU beds, and computed the corresponding demands. At the national scale, it is estimated that 1.57 million hospital beds for respiratory illness would be required at the epidemic peak, which is fewer than the number of existing hospital beds for respiratory illness (3.1 million) in China<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 31" title="National Health Commission of China. China Health Statistics Yearbook 2021 (China Union Medical College Press, 2021)." href="/articles/s41591-022-01855-7#ref-CR31" id="ref-link-section-d72634251e869">31</a></sup>. However, the peak demand of ICU beds (1.00 million) corresponds to 15.6 times the number of existing ICU beds in China (that is, 64,000)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 31" title="National Health Commission of China. China Health Statistics Yearbook 2021 (China Union Medical College Press, 2021)." href="/articles/s41591-022-01855-7#ref-CR31" id="ref-link-section-d72634251e873">31</a></sup>. The period of ICU bed shortage is estimated to last for approximately 44 days (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig3">3</a>). In the regional analyses, substantial shortages of ICU beds were also predicted to occur in Shanghai, Shandong and Shanxi province (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig8">3</a>).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-3" data-title="Projected demand and shortage of hospital beds and ICUs when adopting individual mitigation strategies in China under optimistic VE scenario from March 2022 to September 2022."><figure><figcaption><b id="Fig3" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 3: Projected demand and shortage of hospital beds and ICUs when adopting individual mitigation strategies in China under optimistic VE scenario from March 2022 to September 2022.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41591-022-01855-7/figures/3" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig3_HTML.png?as=webp"><img aria-describedby="Fig3" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig3_HTML.png" alt="figure 3" loading="lazy" width="685" height="687"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-3-desc"><p><b>a</b>, Daily demand of hospital (non-ICU) beds. <b>b</b>, Daily demand of ICU beds. In <b>b</b>, the green dashed line indicates the number of ICU beds available in China, and the inset plot shows days of shortage of ICU beds as a function of the number of insufficient ICU beds compared with the capacity of ICU beds. The curves in the inset are smoothed by B-spline with 8 d.f. The scenarios included in legend are as follows: subunit vaccines refer to using a third dose of subunit vaccines as booster after two doses of inactivated vaccines as priming. Vaccinating elderly refers to vaccinating approximately 52 million people aged ≥60 years who have not yet been vaccinated as of 17 March 2022. 50% uptake and 80% efficacy corresponds to a scenario where 50% of symptomatic cases receive an antiviral therapy with an efficacy of 80% in preventing hospitalization and death. 100% uptake and 89% efficacy corresponds to a scenario where all symptomatic cases receive an antiviral therapy with an efficacy of 89% in preventing hospitalization and death. School and workplace closure corresponds to a scenario where, on the top of baseline strategy, all schools and workplaces remain closed for the duration of the epidemic. <i>R</i><sub><i>t</i></sub>: 3.0 and 2.0 correspond to scenarios assuming different levels of NPIs leading to reduced values of the reproduction number. Note that no strict NPI is implemented in the baseline scenario. Data are presented as median with 2.5% and 97.5% quantiles of <i>n</i> = 200 simulations.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41591-022-01855-7/figures/3" data-track-dest="link:Figure3 Full size image" aria-label="Full size image figure 3" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>When considering a more conservative scenario on the immune escape of the Omicron variant (referred as to high immune escape scenario), with (1) lower VEs against all clinical endpoints as compared with low immune escape scenario, and (2) lower VEs against hospitalization and deaths for homologous booster as compared with heterologous booster vaccination (as observed in Brazil<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 32" title="Ranzani, O. T. et al. Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against the Omicron (B.1.1.529) variant. Preprint at medRxiv 
                  https://doi.org/10.1101/2022.03.30.22273193
                  
                 (2022)." href="/articles/s41591-022-01855-7#ref-CR32" id="ref-link-section-d72634251e923">32</a></sup>, Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">1</a>), the projected number of hospitalizations, ICU admissions and deaths at the national level would increase by 77.3%, 62.1% and 50.2%, respectively (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig9">4</a>).</p><h3 class="c-article__sub-heading" id="Sec4">Impact of individual mitigation strategies</h3><p>We investigated separately the impact of three categories of strategies to mitigate COVID-19 burden: (1) vaccination, including heterologous booster doses and promoting vaccination coverage among unvaccinated individuals aged ≥60 years, (2) antiviral therapies and (3) NPIs. Regarding booster vaccination, if we consider the administration of a heterologous booster based on a subunit vaccine (subunit vaccines scenario) in the low immune escape scenario, little difference would be observed in terms of COVID-19 burden (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig4">4</a>); on the other hand, in the high immune escape scenario, a larger decrease of COVID-19 burden (8.4% in the number of deaths and 17.7% in the number of hospital admissions) could be achieved by administrating a heterologous booster based on a subunit vaccine (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig10">5</a>). Filling the gap in the vaccination coverage among the elderly (that is, vaccinating all eligible individuals aged 60 years or more), including both primary and booster vaccination as in the baseline scenario (vaccinating elderly scenario) would lead to a 33.8%, 54.1% and 60.8% decrease in hospital admissions, ICU admissions and deaths, respectively (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig4">4</a>).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-4" data-title="Projected impact of adopting individual mitigation strategies on COVID-19 burden in China under optimistic VE scenario from March 2022 to September 2022."><figure><figcaption><b id="Fig4" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 4: Projected impact of adopting individual mitigation strategies on COVID-19 burden in China under optimistic VE scenario from March 2022 to September 2022.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41591-022-01855-7/figures/4" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig4_HTML.png?as=webp"><img aria-describedby="Fig4" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig4_HTML.png" alt="figure 4" loading="lazy" width="685" height="352"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-4-desc"><p><b>a</b>, Cumulative number of hospital (non-ICU) admissions. <b>b</b>, Cumulative number of ICU admissions. <b>c</b>, Cumulative number of deaths. The scenarios indicated on the <i>y</i> axis are as follows: subunit vaccines refer to using a third dose of subunit vaccines as booster after two doses of inactivated vaccines as priming. Vaccinating elderly refers to vaccinating approximately 52 million people aged ≥60 years have not been vaccinated yet as of 17 March 2022. 50% uptake and 80% efficacy corresponds to a scenario where 50% of symptomatic cases receive an antiviral therapy with an efficacy of 80% in preventing hospitalization and death. 100% uptake and 89% efficacy corresponds to a scenario where all symptomatic cases receive an antiviral therapy with an efficacy of 89% in preventing hospitalization and death. School closure corresponds to a scenario where, on the top of baseline strategy, all schools remain closed for the duration of the epidemic. Similarly, school and workplace closure corresponds to a scenario, where on the top of baseline strategy, all schools and workplaces remain closed for the duration of the epidemic. <i>R</i><sub><i>t</i></sub>: 3.0, 2.5 and 2.0 correspond to scenarios assuming different levels of NPIs leading to reduced values of the reproduction number. Note that no strict NPI is implemented in the baseline scenario. Data are presented as median with 2.5% and 97.5% quantiles of <i>n</i> = 200 simulations.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41591-022-01855-7/figures/4" data-track-dest="link:Figure4 Full size image" aria-label="Full size image figure 4" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>In the absence of NPIs, assuming that 50% of symptomatic cases could be treated with the approved Chinese COVID-19 BRII-196/BRII-198 combination therapy, which has been reported to be 80% effective in preventing hospitalization and death<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 33" title="Brii Bio announces Amubarvimab/Romlusevimab combination received approval from NMPA as first COVID-19 neutralizing antibody combination therapy in China. Brii Biosciences (9 December 2021); 
                  https://www.briibio.com/news-detial.php?id=505
                  
                " href="/articles/s41591-022-01855-7#ref-CR33" id="ref-link-section-d72634251e994">33</a></sup>, a 36.5%, 39.9% and 40.0% decrease in hospital admissions, ICU admissions and deaths is estimated (50% uptake and 80% efficacy scenario). In the best-case scenario in which all symptomatic cases are treated with the highly efficacious oral COVID-19 drug nirmatrelvir tablet/ritonavir tablet combination (which is 89% effective in preventing hospitalization and death<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 34" title="Hammond, J. et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. N. Engl. J. Med. 386, 1397–1408 (2022)." href="/articles/s41591-022-01855-7#ref-CR34" id="ref-link-section-d72634251e998">34</a></sup> and has already been used in China<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 26" title="Emergency conditional approval of Pfizer’s COVID-19 therapy: nirmatrelvir tablet/ritonavir tablet combination package (i.e., Paxlovid) importation registration. The National Medical Products Administration (NMPA) of China 
                  https://www.nmpa.gov.cn/yaowen/ypjgyw/20220212085753142.html
                  
                 (2022)." href="/articles/s41591-022-01855-7#ref-CR26" id="ref-link-section-d72634251e1002">26</a></sup>), the number of hospital admissions, ICU admissions and deaths could be reduced substantially by 81.2%, 88.8% and 88.9% (100% uptake and 89% efficacy scenario) (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig4">4</a>).</p><p>We then modeled the impact of introducing different levels of NPIs (in the presence of vaccination, but absence of antiviral therapies). First, we tested the implementation of a national-level school closure strategy (school closure scenario); although the number of infections decrease by 3.5%, COVID-19 burden does not, due to a shift in the age distribution of infections towards older ages. Additionally, closing all workplaces (school and workplace closure scenario) would lead to a decrease of 23.8%, 13.1% and 22.4% for the number of hospitalizations, ICU admissions and deaths, respectively. Second, we considered a scenario where NPIs equally reduce the risk of infection across all age groups, and we simulated different intensity of NPIs leading to <i>R</i><sub><i>t</i> </sub>≤ 3 (similar to values observed in England<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 35" title="Barnard, R. C., Davies, N. G., Pearson, C. A. B., Jit, M. &amp; Edmunds, W. J. Projected epidemiological consequences of the Omicron SARS-CoV-2 variant in England, December 2021 to April 2022. Preprint at medRxiv 
                  https://doi.org/10.1101/2021.12.15.21267858
                  
                 (2021)." href="/articles/s41591-022-01855-7#ref-CR35" id="ref-link-section-d72634251e1019">35</a></sup> and India<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Ranjan, R. Omicron impact in India: analysis of the ongoing COVID-19 third wave based on global data. Preprint at medRxiv 
                  https://doi.org/10.1101/2022.01.09.22268969
                  
                 (2022)." href="/articles/s41591-022-01855-7#ref-CR36" id="ref-link-section-d72634251e1023">36</a></sup> during the Omicron wave in winter 2021–2022). In this scenario, only the adoption of NPIs capable of reducing <i>R</i><sub><i>t</i></sub> to values ≤2 would lead to a substantial decrease in health outcomes (namely, a decrease of 40.1%, 33.4% and 48.6% of the number of hospitalizations, ICU admissions and deaths, respectively) (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig4">4</a>).</p><p>In summary, none of the scenarios analyzed is estimated to have the potential to reduce the number of COVID-19 deaths to a level closer to the annual influenza-related excess deaths in China (88,000)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 37" title="Li, L. et al. Influenza-associated excess respiratory mortality in China, 2010–15: a population-based study. Lancet Public Health 4, e473–e481 (2019)." href="/articles/s41591-022-01855-7#ref-CR37" id="ref-link-section-d72634251e1040">37</a></sup> (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig4">4</a>). In all scenarios, the peak demand for ICUs is projected to be 1.7–14.8 times the maximum capacity, with a total of 19–48 days of bed shortages (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig3">3b</a>). We emphasize that closing all schools and workplaces as well as implementing stringent NPIs to reduce <i>R</i><sub><i>t</i></sub> to 2 would result in highly delayed epidemics that extend beyond our projection window (6 months); as such, their final impact is not evaluated in this analysis (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig3">3b</a>).</p><h3 class="c-article__sub-heading" id="Sec5">Impact of combined mitigation strategies</h3><p>None of the investigated individual mitigation strategies alone is capable of reducing the death toll to the level of an influenza season or to prevent exceeding critical care capacity (Figs. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig3">3</a> and <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig4">4</a>). Here, we assessed the effects of synergetic strategies leveraging heterologous booster vaccination, increasing vaccination coverage among the unvaccinated individuals aged 60 years or more, distributions of antiviral therapies and adoption of NPIs at the same time (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig5">5</a>).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-5" data-title="Projected healthcare demand and number of deaths for combined mitigation strategies under optimistic VE scenario in China from March 2022 to September 2022."><figure><figcaption><b id="Fig5" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 5: Projected healthcare demand and number of deaths for combined mitigation strategies under optimistic VE scenario in China from March 2022 to September 2022.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41591-022-01855-7/figures/5" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig5_HTML.png?as=webp"><img aria-describedby="Fig5" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig5_HTML.png" alt="figure 5" loading="lazy" width="685" height="739"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-5-desc"><p><b>a</b>, Peak hospital (non-ICU) bed occupancy, with red numbers indicating where peak hospital bed demand is lower than the bed capacity for respiratory illness in China. <b>b</b>, Peak ICU bed occupancy, with red numbers indicating where peak ICU bed demand is below the existing ICU capacity in China. <b>c</b>, Cumulative death tolls, with red numbers indicating where the number of deaths is below the annual influenza-related excess death toll in China (that is, 88,000 deaths<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 37" title="Li, L. et al. Influenza-associated excess respiratory mortality in China, 2010–15: a population-based study. Lancet Public Health 4, e473–e481 (2019)." href="/articles/s41591-022-01855-7#ref-CR37" id="ref-link-section-d72634251e1096">37</a></sup>). The circular-Manhattan plot from the innermost concentric circle to the outermost concentric circle indicates the combinations of adopting different intervention measures: homologous (inactivated) or heterologous (subunit) booster regimen; whether the approximately 52 million people aged ≥60 years who have not been vaccinated yet as of 17 March 2022 are vaccinated or not; receiving antiviral therapies with an efficacy of 80% or 89% in preventing hospitalization and death; 50% or 100% symptomatic cases receiving an antiviral therapy; <i>R</i><sub><i>t</i></sub> representing varying intensity of NPIs. <i>R</i><sub><i>t</i></sub> = 3.9 corresponds to the scenario in the absence of strict NPIs. Data are presented as median of <i>n</i> = 200 simulations.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41591-022-01855-7/figures/5" data-track-dest="link:Figure5 Full size image" aria-label="Full size image figure 5" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>None of the simulated interventions is projected to exceed the national capacity of hospital bed capacity for respiratory illness. Instead, a synergetic effort of combining different strategies would be needed to prevent exceeding ICU capacity and limiting the number of deaths to a value comparable to that of seasonal influenza. According to our analysis, key aspects of this synergetic effort are the increase of vaccine uptake in the elderly and the widespread use of antiviral therapies (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig5">5</a>). If these two conditions are not met, relying on NPIs capable of reducing <i>R</i> to ≤2 is needed to prevent overwhelming the healthcare system.</p></div></div></section><section data-title="Discussion"><div class="c-article-section" id="Sec6-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec6">Discussion</h2><div class="c-article-section__content" id="Sec6-content"><p>Using a stochastic dynamic model of SARS-CoV-2 transmission, our study projects the COVID-19 burden caused by the importation of Omicron infections in mainland China, should the dynamic zero-COVID policy be lifted. In the context of the vaccination strategy adopted until March 2022, we estimated that the introduction of the Omicron variant would cause substantial surges in hospitalizations, ICU admissions and deaths, and would overwhelm the healthcare system with an estimated burden of 15.6 times the available ICU capacity.</p><p>Should an Omicron variant epidemic be allowed to spread uncontrolled in mainland China, we project 1.10 deaths per 1,000 inhabitants over a 6-month period. By comparison, 187,372 deaths have been reported in the United States<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="United States: Coronavirus Pandemic Country Profile. Our World in Data (19 April 2022); 
                  https://ourworldindata.org/coronavirus/country/united-states
                  
                " href="/articles/s41591-022-01855-7#ref-CR38" id="ref-link-section-d72634251e1145">38</a></sup> (that is, 0.57 deaths per 1,000 inhabitants) over the period from 15 December 2021 to 15 April 2022, roughly corresponding to the Omicron wave. We estimate that around 77% of the death toll in China would occur in unvaccinated individuals, with most deaths occurring among unvaccinated individuals aged 60 years or more (52 million people). A similar trend has been observed in the Omicron-driven fifth COVID-19 wave in Hong Kong Special Administrative Region (SAR) of China, which began in early 2022 (ref. <sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Mesfin, Y. et al. Epidemiology of infections with SARS-CoV-2 Omicron BA.2 variant in Hong Kong, January–March 2022. Preprint at medRxiv 
                  https://doi.org/10.1101/2022.04.07.22273595
                  
                 (2022)." href="/articles/s41591-022-01855-7#ref-CR39" id="ref-link-section-d72634251e1149">39</a></sup>). Our findings highlight the key role of increasing vaccine uptake rate among the elderly to limit COVID-19 burden and to prevent overwhelming the healthcare system. A second key factor to reach these goals is represented by the widespread and timely distribution of a highly efficacious antiviral therapy. When both vaccine uptake in the elderly is substantially increased (97%) and 50% or more of symptomatic infections are treated with antiviral therapies, the peak occupancy of ICUs may not exceed the national capacity and the death toll may be comparable to that of seasonal influenza. In the absence of these two conditions, the most optimistic strategy to prevent overwhelming of the healthcare system seems to be reliance on strict NPIs.</p><p>China is a highly diverse country with urban megalopolises on the eastern seaboard and rural areas in the northwest. Such diversity is also reflected by heterogeneous vaccination coverage, demographic structure of the population, mixing patterns and capacity of the healthcare system. When accounting for these heterogeneities, our simulations show considerable differences in the projected COVID-19 burden for different areas of China. According to our projections, the population of Shanghai would experience a COVID-19 burden higher than that of other areas such as Shandong and Shanxi. This increased burden would be led by a much larger incidence of severe infections in the population aged 60 years or older, which is associated with a lower vaccination coverage in this segment of the population. This result confirms the importance of filling the vaccination gap among the elderly and the need to tailor interventions to the specific immunological landscape of the population.</p><p>Our study has several limitations. First, we assumed that the mortality rate remains constant over the projection period; however, studies have suggested that the mortality rate may increase during periods of high strain on hospital services<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 40" title="Rossman, H. et al. Hospital load and increased COVID-19 related mortality in Israel. Nat. Commun. 12, 1904 (2021)." href="/articles/s41591-022-01855-7#ref-CR40" id="ref-link-section-d72634251e1159">40</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 41" title="French, G. et al. Impact of hospital strain on excess deaths during the COVID-19 pandemic – United States, July 2020–July 2021. MMWR Morb. Mortal. Wkly Rep. 70, 1613–1616 (2021)." href="/articles/s41591-022-01855-7#ref-CR41" id="ref-link-section-d72634251e1162">41</a></sup>. Second, although we conducted a comprehensive literature search, the epidemiological characteristics of Omicron, clinical severity, VEs of primary and booster vaccination and its persistence against different clinical endpoints, as well as the effectiveness of antiviral therapies, are not fully understood. For this reason, we have conducted extensive sensitivity analyses to explore the impact of the uncertainty of model parameters. Third, data on antiviral therapy availability by region are unknown and thus not included in our analysis. Possible regional differences in stockpiles of antiviral therapies could widen the already large differences in COVID-19 burden that we have estimated among the study locations.</p><p>In conclusion, should the Omicron outbreak continue unabated, despite a primary vaccination coverage of ≥90% and homologous booster vaccination coverage of ≥40% as of March 2022, we project that the Chinese healthcare system will be overwhelmed with a considerable shortage of ICUs. The contemporary increasing of vaccine uptake in the elderly and widespread distribution of antiviral therapies or the implementation of strict NPIs would be needed to prevent overwhelming of the healthcare system and to reduce the death toll of an epidemic wave to a level comparable with that of an influenza season. Protecting vulnerable individuals by ensuring access to vaccination and antiviral therapies, as well as maintaining implementation of NPIs (for example, mask-wearing, enhanced testing, social distancing and reducing mass gatherings), should be emphasized, together with tailoring region-specific interventions. In the long term, improving ventilation, strengthening critical care capacity and the development of new highly efficacious vaccines with long-term immune persistence would be key priorities.</p></div></div></section><section data-title="Methods"><div class="c-article-section" id="Sec7-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec7">Methods</h2><div class="c-article-section__content" id="Sec7-content"><p>This modeling study relies on publicly available aggregated data only. As such, institutional review and informed consent are waived by the Institutional Review Board of the School of Public Health, Fudan University (Shanghai, China).</p><h3 class="c-article__sub-heading" id="Sec8">Model SARS-CoV-2 transmission and vaccination</h3><p>We developed an age-structured stochastic compartmental susceptible-latent-infectious-removed-susceptible model (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig6">1</a>) to simulate the transmission of the SARS-CoV-2 Omicron variant in China. The model considers 14 age groups (0–2, 3–11, 12–17, 18–24, 25–29, 30–34, 35–39, 40–44, 45–49, 50–54, 55–59, 60–64, 65–69 and ≥70 years) and age-mixing patterns for China before the COVID-19 pandemic<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 42" title="Mistry, D. et al. Inferring high-resolution human mixing patterns for disease modeling. Nat. Commun. 12, 323 (2021)." href="/articles/s41591-022-01855-7#ref-CR42" id="ref-link-section-d72634251e1188">42</a></sup>. The model accounts for primary and booster vaccination, disease progression, antiviral therapies and waning immunity. All compartments and parameters are defined in Supplementary Tables <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">3</a> and <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">4</a>. Transitions between compartments are simulated through a stochastic chain binomial process<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 43" title="Davis, J. T. et al. Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave. Nature 600, 127–132 (2021)." href="/articles/s41591-022-01855-7#ref-CR43" id="ref-link-section-d72634251e1198">43</a></sup>. For instance, susceptible individuals move to the latent compartment at the rate <span class="mathjax-tex">\(\Delta _\mathrm{a}(t)\sim \mathrm{Binomial}\left( {S_\mathrm{a}(t),1 - {\mathrm{e}}^{ - \lambda _\mathrm{a}\left( t \right)}} \right)\)</span>, where <i>λ</i><sub>a</sub>(<i>t</i>) is the force of infection for age group <i>a</i> at time <i>t</i>.</p><p>Baseline simulations were seeded with 20 imported infections on 1 March 2022 and run forward for 6 months. We consider five and ten seeds as sensitivity analyses (Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">2</a>). Upon infection with SARS-CoV-2, susceptible individuals (S) enter an exposed (latent) compartment (L) before becoming infectious. We consider that children and adolescents were less susceptible to infection compared with adults<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Viner, R. M. et al. Susceptibility to SARS-CoV-2 infection among children and adolescents compared with adults: a systematic review and meta-analysis. JAMA Pediatrics 175, 143–156 (2021)." href="/articles/s41591-022-01855-7#ref-CR44" id="ref-link-section-d72634251e1347">44</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 45" title="Davies, N. G. et al. Age-dependent effects in the transmission and control of COVID-19 epidemics. Nat. Med. 26, 1205–1211 (2020)." href="/articles/s41591-022-01855-7#ref-CR45" id="ref-link-section-d72634251e1350">45</a></sup>. A sensitivity analysis considering homogeneous susceptibility across age groups is presented in Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">3</a>. Exposed individuals stay in their compartment for an average of 1/<i>γ</i><sub>E</sub> = 1.2 days before moving to either asymptomatic (I<sub>A</sub>) or symptomatic (I<sub>S</sub>) compartments according to the age-specific probability of being asymptomatic (<span class="mathjax-tex">\(1 - P_a^s\)</span>). No difference in infectiousness between asymptomatic and symptomatic individuals was considered in the main analyses<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 46" title="Hu, S. et al. Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China. Nat. Commun. 12, 1533 (2021)." href="/articles/s41591-022-01855-7#ref-CR46" id="ref-link-section-d72634251e1406">46</a></sup>, whereas asymptomatic individuals were considered to be 65% less infectious than symptomatic ones in a sensitivity analysis<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 47" title="Buitrago-Garcia, D. et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. PLoS Med. 17, e1003346 (2020)." href="/articles/s41591-022-01855-7#ref-CR47" id="ref-link-section-d72634251e1410">47</a></sup> (Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">4</a>). An age-dependent proportion (<span class="mathjax-tex">\(P_a^h\)</span>) of symptomatic cases require hospitalization (H), while the rest of symptomatic cases and all asymptomatic infections recover naturally (R) (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig6">1a</a>). We assume asymptomatic infections and nonhospitalized symptomatic cases to stay in their compartments for an average of 1/<i>γ</i><sub>I</sub> = 5.6 days, thus resulting in mean intrinsic generation time of 6.8 days, as previously estimated for Omicron<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 48" title="Manica, M. et al. Intrinsic generation time of the SARS-CoV-2 Omicron variant: an observational study of household transmission. Preprint at SSRN 
                  https://doi.org/10.2139/ssrn.4068368
                  
                 (2022)." href="/articles/s41591-022-01855-7#ref-CR48" id="ref-link-section-d72634251e1458">48</a></sup> (Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">5</a>).</p><p>For patients requiring hospitalization (H), the average time from symptom onset to hospital admission was 1/<i>γ</i><sub>SH</sub> = 2.2 days (ref. <sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 49" title="Deng, X. et al. Case fatality risk of the first pandemic wave of novel coronavirus disease 2019 (COVID-19) in China. Clin. Infect. Dis. 73, e79–e85 (2021)." href="/articles/s41591-022-01855-7#ref-CR49" id="ref-link-section-d72634251e1472">49</a></sup>). We assume that hospitalized patients do not transmit the virus. We divided the hospital settings (H) into two parts: the general ward (Hosp) and ICU ward (ICU), as illustrated in Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig6">1b</a>. Once admitted to hospital, a patient either remains in the general ward until discharge or is transferred to an ICU according to an age-dependent ICU admission risk. We assume that patients admitted to an ICU entered the ICU on the same day they were admitted to hospital. Patients in the general ward (or ICU) could either stay in the general ward (or ICU) until they are discharged or die, based on the corresponding mortality risk. We assume that all deaths occur among hospitalized patients.</p><p>To capture the potential impact of newly available antiviral therapies, we divided symptomatic cases (I<sub>S</sub>) into two categories: those who timely received an antiviral therapy after symptom onset, and those who did not (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig6">1c</a>).</p><p>All compartments and transition flows are duplicated into parallel branches that represent primary (V) and booster (B) vaccinations (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig6">1d</a>). We assume that only susceptible individuals in compartment S are eligible for primary vaccination. To describe the recommended two-dose primary vaccination (common to the two inactivated vaccines currently widely used in China: Sinovac/CoronaVac and Sinopharm/BBIBP-CorV), compartment V was further stratified into two vaccination strata (V<sub>1</sub> and V<sub>2</sub>), differentiating individuals who have received one or two doses, respectively. Only uninfected individuals who have completed their primary vaccination schedules by 6 months (1/<i>ω</i><sub>P</sub>) will receive a booster shot (B). Each dose produces a vaccine protection (V<sub>1</sub><sup>e</sup>, V<sub>2</sub><sup>e</sup>, B<sup>e</sup>) after an average of 14 days (1/<i>ω</i><sub>1</sub>, 1/<i>ω</i><sub>3</sub> and 1/<i>ω</i><sub>4</sub>).</p><p>We model VE against infection using a ‘leaky’ vaccine in which all vaccinated individuals are exposed to a lower risk of infection, which is 1 – VE times that of nonvaccinated individuals<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 50" title="Halloran, M. E., Longini, I. M., Struchiner, C. J. &amp; Longini, I. M. Design and Analysis of Vaccine Studies (Springer, 2010)." href="/articles/s41591-022-01855-7#ref-CR50" id="ref-link-section-d72634251e1527">50</a></sup>. Like vaccination-induced protection, infection-induced immunity wanes over time (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig6">1d</a>). After an average of 180 days (1/<i>ω</i><sub>P</sub>) since the second dose, primary-vaccinated individuals move to a new compartment (‘waned vaccine effectiveness’, V<sub>2</sub>W); individuals in this compartment are ready for receiving their booster shots. Likewise, 180 days (1/<i>ω</i><sub>B</sub>) after the booster shot, boosted individuals move to a new compartment (‘waned vaccine effectiveness’, BW). Waning of infection-induced immunity acts in a manner different from that of the vaccine. Individuals who have recovered from SARS-CoV-2 infection (R) are protected against reinfection with the same variant for an exponentially distributed duration with mean 1/<i>ω</i><sub>R</sub> days, after which they move back to the susceptible compartment. The transition rates for vaccine- and infection-induced immunity processes are defined in Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">6</a> (ref. <sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 51" title="Hansen, C. H., Michlmayr, D., Gubbels, S. M., Mølbak, K. &amp; Ethelberg, S. Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study. Lancet 397, 1204–1212 (2021)." href="/articles/s41591-022-01855-7#ref-CR51" id="ref-link-section-d72634251e1552">51</a></sup>). The VEs against different clinical endpoints in the different stages of vaccine protection are reported in Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">1</a>. Details are reported in <a data-track="click" data-track-label="link" data-track-action="section anchor" href="/articles/s41591-022-01855-7#Sec15">Vaccine effectiveness</a>.</p><h3 class="c-article__sub-heading" id="Sec9">Model of COVID-19 burden</h3><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec10">Age-specific risks</h4><p>To measure the burden (that is, hospitalizations, ICU admissions and deaths) and the strain of the healthcare system, we rely on the age-specific infection fatality risk (IFR) and infection hospitalization risk among unvaccinated individuals from the Omicron wave in Hong Kong SAR, China<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Mesfin, Y. et al. Epidemiology of infections with SARS-CoV-2 Omicron BA.2 variant in Hong Kong, January–March 2022. Preprint at medRxiv 
                  https://doi.org/10.1101/2022.04.07.22273595
                  
                 (2022)." href="/articles/s41591-022-01855-7#ref-CR39" id="ref-link-section-d72634251e1575">39</a></sup>. The Hong Kong Center for Health Protection publishes reported case fatality ratios by age group and vaccination status<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 52" title="Provisional Data Analysis On COVID-19 Reported Death Cases. Center for Health Protection of the Department of Health (29 April 2022); 
                  https://www.covidvaccine.gov.hk/pdf/death_analysis.pdf
                  
                " href="/articles/s41591-022-01855-7#ref-CR52" id="ref-link-section-d72634251e1579">52</a></sup>, and compares the age profiles of reported cases against resident population<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 53" title="Statistics on 5th Wave of COVID-19. Center for Health Protection of the Department of Health (29 April 2022); 
                  https://www.covidvaccine.gov.hk/pdf/5th_wave_statistics.pdf
                  
                " href="/articles/s41591-022-01855-7#ref-CR53" id="ref-link-section-d72634251e1583">53</a></sup>. Since the age profile of cumulative reported cases is very similar to the resident population by the end of 2021 in Hong Kong SAR, we assume the undetected infections have the same age profile as the reported cases. We thus estimate the age-specific IFR by dividing the age-specific case fatality ratios among unvaccinated individuals by the overall infection-reporting ratio. A modeling report on the fifth wave of COVID-19 in Hong Kong SAR<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 54" title="Modelling the fifth wave of COVID-19 in Hong Kong. D24H@HKSTP and HKU WHO Collaborating Centre on Infectious Disease Epidemiology and Modelling (21 March 2022); 
                  https://sph.hku.hk/en/News-And-Events/Press-Releases/2022/TBC
                  
                " href="/articles/s41591-022-01855-7#ref-CR54" id="ref-link-section-d72634251e1587">54</a></sup> estimates that around 4.5 million residents of Hong Kong had been infected by 21 April 2022, as of which day 1.18 million cumulative case were reported. We further calculate age-specific infection hospitalization risk from the Hong Kong Omicron wave<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Mesfin, Y. et al. Epidemiology of infections with SARS-CoV-2 Omicron BA.2 variant in Hong Kong, January–March 2022. Preprint at medRxiv 
                  https://doi.org/10.1101/2022.04.07.22273595
                  
                 (2022)." href="/articles/s41591-022-01855-7#ref-CR39" id="ref-link-section-d72634251e1591">39</a></sup> by dividing the estimated IFR by the age-specific fatality risk among hospitalized patients who were not fully vaccinated (B. J. Cowling, personal communication, 2022) (Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">7</a>).</p><p>For the age-specific ICU admission risk of hospitalized patients, we adjusted the ICU admission risk associated with the ancestral lineage reported in China<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 55" title="Guan, W.-j et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708–1720 (2020)." href="/articles/s41591-022-01855-7#ref-CR55" id="ref-link-section-d72634251e1602">55</a></sup>, by the ratio of the overall ICU admission risk among unvaccinated hospitalized patients infected with the Omicron variant (19.0% (ref. <sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 56" title="Modes, M. E. et al. Clinical characteristics and outcomes among adults hospitalized with laboratory-confirmed SARS-CoV-2 infection during periods of B. 1.617. 2 (Delta) and B. 1.1. 529 (Omicron) variant predominance—one hospital, California, July 15–September 23, 2021, and December 21, 2021–January 27, 2022. MMWR Morb. Mortal. Wkly Rep. 71, 217–223 (2022)." href="/articles/s41591-022-01855-7#ref-CR56" id="ref-link-section-d72634251e1606">56</a></sup>)) and those infected with the ancestral lineage (6.4% (ref. <sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 55" title="Guan, W.-j et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708–1720 (2020)." href="/articles/s41591-022-01855-7#ref-CR55" id="ref-link-section-d72634251e1610">55</a></sup>)). The estimated age-specific risks of disease progression are presented in Supplementary Tables <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">7</a> and <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">8</a> (ref. <sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 57" title="Piroth, L. et al. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. Lancet Respiratory Med. 9, 251–259 (2021)." href="/articles/s41591-022-01855-7#ref-CR57" id="ref-link-section-d72634251e1621">57</a></sup>).</p><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec11">Duration of hospital and ICU stay</h4><p>We set the length of stay in hospital to 6 days; 8 days are considered for non-ICU hospitalizations with fatal outcomes based on observations in the Hong Kong Omicron wave<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Mesfin, Y. et al. Epidemiology of infections with SARS-CoV-2 Omicron BA.2 variant in Hong Kong, January–March 2022. Preprint at medRxiv 
                  https://doi.org/10.1101/2022.04.07.22273595
                  
                 (2022)." href="/articles/s41591-022-01855-7#ref-CR39" id="ref-link-section-d72634251e1633">39</a></sup> (B. J. Cowling, personal communication, 2022). We assumed the ICU length of stay to be 8 days, consistent with literature reports<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 58" title="Rees, E. M. et al. COVID-19 length of hospital stay: a systematic review and data synthesis. BMC Med. 18, 270 (2020)." href="/articles/s41591-022-01855-7#ref-CR58" id="ref-link-section-d72634251e1637">58</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 59" title="Lefrancq, N. et al. Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: a retrospective national surveillance data analysis. Lancet Regional Health – Eur. 5, 10087 (2021)." href="/articles/s41591-022-01855-7#ref-CR59" id="ref-link-section-d72634251e1640">59</a></sup>.</p><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec12">Healthcare resources</h4><p>As of 2020, a total of 9.1 million hospital beds were available in China. Among them, 3.14 million were reserved for respiratory illness (including hospital beds in departments of internal medicine, pediatrics, infectious disease and ICUs), 64,000 of which are ICUs<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 31" title="National Health Commission of China. China Health Statistics Yearbook 2021 (China Union Medical College Press, 2021)." href="/articles/s41591-022-01855-7#ref-CR31" id="ref-link-section-d72634251e1652">31</a></sup>.</p><h3 class="c-article__sub-heading" id="Sec13">Model validation against the Omicron outbreak in Shanghai</h3><p>We calibrated the transmissibility and proportion of symptomatic cases to the field data of the Omicron BA.2 variant outbreak in Shanghai, China. We used a Bayesian approach<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 60" title="Zhang, J. et al. Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study. Lancet Infect. Dis. 20, 793–802 (2020)." href="/articles/s41591-022-01855-7#ref-CR60" id="ref-link-section-d72634251e1665">60</a></sup> to estimate the net reproduction number <i>R</i><sub><i>t</i></sub> for the initial phase (from 1 March to 8 March 2022) of the epidemic in Shanghai, before strict control measures were implemented. The method is based on the analysis of the epidemic curve of symptomatic cases and on the knowledge of the generation time, which is assumed to be Gamma distributed with mean 6.8 days (shape = 2.39, scale = 2.95) as estimated for the Omicron variant in a previous study<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 48" title="Manica, M. et al. Intrinsic generation time of the SARS-CoV-2 Omicron variant: an observational study of household transmission. Preprint at SSRN 
                  https://doi.org/10.2139/ssrn.4068368
                  
                 (2022)." href="/articles/s41591-022-01855-7#ref-CR48" id="ref-link-section-d72634251e1675">48</a></sup>. The resulting estimate of the average reproduction number <i>R</i><sub><i>t</i></sub> is 3.4. We then follow the approach in Marziano et al.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 61" title="Marziano, V. et al. The effect of COVID-19 vaccination in Italy and perspectives for living with the virus. Nat. Commun. 12, 7272 (2021)." href="/articles/s41591-022-01855-7#ref-CR61" id="ref-link-section-d72634251e1686">61</a></sup> based on the next generation matrix to calculate the model transmission rate from the estimated reproduction number while accounting for the vaccine-induced partial protection of the population. When removing the effect of vaccination, we estimated the reproduction number <i>R</i> of the Omicron BA.2 variant to be 3.9 at the beginning of the 2022 outbreak in Shanghai. Such an estimate is conditional on the situation on the ground at the beginning of March 2022, where, although no strict NPIs were implemented, a mask mandate was still in place and the behavior of the population may have been different from prepandemic standards.</p><p>City-wide screenings are being conducted frequently throughout the course of the Shanghai outbreak allowing the identification of most infected individuals, regardless of the presence/absence of symptoms. Therefore, to estimate the association between symptoms and infection, we simulated our compartmental model for the population of Shanghai (which also considers city-specific vaccination rates) assuming <i>R</i><sub><i>t</i></sub> to be 3.4. We then modulated the age-specific probability of developing symptoms<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 62" title="Poletti, P. et al. Association of age with likelihood of developing symptoms and critical disease among close contacts exposed to patients with confirmed SARS-CoV-2 infection in Italy. JAMA Netw. Open 4, e211085–e211085 (2021)." href="/articles/s41591-022-01855-7#ref-CR62" id="ref-link-section-d72634251e1702">62</a></sup> by a scaling factor that is chosen to fit both the curves of symptomatic and asymptomatic infections in Shanghai between 1 March and 8 April 2022 (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01855-7#Fig7">2</a>). We further adjusted the calibrated age-specific probability of developing symptoms by the ratio of the proportion of confirmed cases among total infections observed in Shanghai during the initial phase (from 1 March to 8 April 2022) (3.50%) to that from 1 March to 28 April 2022 (9.24%)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 63" title="Situation Regarding Prevention and Control of COVID-19 Epidemic in Shanghai. Shanghai Municipal Health Commission (29 April 2022); 
                  http://wsjkw.sh.gov.cn/xwfbh/index.html
                  
                " href="/articles/s41591-022-01855-7#ref-CR63" id="ref-link-section-d72634251e1709">63</a></sup>.</p><p>Finally, as a sensitivity analysis, we also calibrated the model using a shorter generation time, in line with estimates for the Delta variant in the United Kingdom (4.7 days; ref. <sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 64" title="Hart, W. S. et al. Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis. Lancet Infect. Dis. 22, P603–P610 (2022)." href="/articles/s41591-022-01855-7#ref-CR64" id="ref-link-section-d72634251e1716">64</a></sup>) (Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">5</a>).</p><h3 class="c-article__sub-heading" id="Sec14">Mitigation with vaccination</h3><p>A mass vaccination campaign has been launched in China since December 2020 (ref. <sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 65" title="Yang, J. et al. Despite vaccination, China needs non-pharmaceutical interventions to prevent widespread outbreaks of COVID-19 in 2021. Nat. Hum. Behav. 5, 1009–1020 (2021)." href="/articles/s41591-022-01855-7#ref-CR65" id="ref-link-section-d72634251e1732">65</a></sup>). On 3 October 2021, a homologous booster vaccination campaign (relying on the same vaccine as the initial inactivated vaccine shots) has been initiated among individuals aged ≥18 years who completed primary vaccination at least 6 months earlier<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 66" title="Press conference held on situation regarding prevetion and control of COVID-19 epidemics in the coming autumn and winter season and vaccination. The State Council Information Office, P.R.C. (24 October 2021); 
                  http://www.gov.cn/xinwen/gwylflkjz169/index.htm
                  
                " href="/articles/s41591-022-01855-7#ref-CR66" id="ref-link-section-d72634251e1736">66</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 67" title="FAQ on booster immunization for COVID-19 vaccines. National Health Commission of China (15 November 2021); 
                  http://www.nhc.gov.cn/xcs/s7847/202111/67a59e40580d4b4687b3ed738333f6a9.shtml
                  
                " href="/articles/s41591-022-01855-7#ref-CR67" id="ref-link-section-d72634251e1739">67</a></sup>. As of 12 April 2022, &gt;90% of populations aged ≥3 years have completed primary vaccination and &gt;50% of the populations has received a booster dose<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 68" title="Press conference held on situation regarding strict prevetion and control of COVID-19 epidemic. The State Council Information Office, P.R.C. (12 April 2022); 
                  http://www.gov.cn/xinwen/gwylflkjz192/index.htm
                  
                " href="/articles/s41591-022-01855-7#ref-CR68" id="ref-link-section-d72634251e1743">68</a></sup>. Compared with other age groups (86.4%, 100% and 92.3% fully vaccinated individuals for the age groups 3–11, 12–17 and 18–59 years, respectively), individuals aged ≥60 years have the lowest vaccination coverage (about 80%)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 69" title="Relevant requirements on organization and implementation of COVID-19 booster vaccination. National Health Commission of China (17 February 2022); 
                  https://m.weibo.cn/status/4737882239533991
                  
                " href="/articles/s41591-022-01855-7#ref-CR69" id="ref-link-section-d72634251e1747">69</a></sup>, corresponding to approximately 52 million unvaccinated individuals<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 28" title="Press conference held on situation regarding strict prevention and control of COVID-19 epidemic. The State Council Information Office, P.R.C. (19 March 2022); 
                  http://www.gov.cn/xinwen/gwylflkjz187/index.htm
                  
                " href="/articles/s41591-022-01855-7#ref-CR28" id="ref-link-section-d72634251e1751">28</a></sup>.</p><p>From 1 March 2022 onwards, homologous booster rollout was set at 5 million doses per day in the baseline analysis. Sensitivity analyses on heterologous booster vaccination using subunit, mRNA, and vector vaccines were conducted (Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">6</a>). The only difference between heterologous and homologous booster considered in the model is VE (values reported in Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">1</a>). Vaccine coverage over time and by age group for the baseline scenario is presented in Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">7</a>.</p><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec15">Vaccine effectiveness</h4><p>We considered different VEs against different clinical endpoints (namely, infection, symptomatic illness, hospitalization and death) and onward transmission. As shown in Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">1</a>, VEs against these clinical outcomes at the following five time points are considered: 14 days after receiving the first dose, 14 days after receiving the second dose, 14 days after the booster dose, 6 months after the second dose of primary 2-dose vaccination (2W) and 6 months after the booster dose (BW). To account for the decay of VEs, either 6 months after the second dose of primary vaccination or after the booster dose, vaccinated individuals move to the ‘waned vaccine effectiveness’ compartments V<sub>2</sub>W and BW, respectively.</p><p>VEs against symptomatic disease, hospitalization and death after receiving two doses of inactivated vaccines, a homologous booster using inactivated vaccines and a heterologous booster using mRNA vaccines were estimated during the Omicron waves in Hong Kong or Brazil<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 27" title="McMenamin, M. E. et al. Vaccine effectiveness of two and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong. Preprint at medRxiv 
                  https://doi.org/10.1101/2022.03.22.22272769
                  
                 (2022)." href="/articles/s41591-022-01855-7#ref-CR27" id="ref-link-section-d72634251e1782">27</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 32" title="Ranzani, O. T. et al. Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against the Omicron (B.1.1.529) variant. Preprint at medRxiv 
                  https://doi.org/10.1101/2022.03.30.22273193
                  
                 (2022)." href="/articles/s41591-022-01855-7#ref-CR32" id="ref-link-section-d72634251e1785">32</a></sup>. For other VEs without field estimates, we used a verified statistical model<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 70" title="Chen, X. et al. Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint. BMC Med. 20, 36 (2022)." href="/articles/s41591-022-01855-7#ref-CR70" id="ref-link-section-d72634251e1789">70</a></sup> to predict vaccine protection based on the levels of neutralizing antibody titers (NATs) against Omicron between different booster regimens and time points summarized in Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">9</a> (refs. <sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Wang, K. et al. Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants. Nature 603, 919–925 (2022)." href="#ref-CR71" id="ref-link-section-d72634251e1796">71</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Zhang, Y. et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect. Dis. 21, 181–192 (2021)." href="#ref-CR72" id="ref-link-section-d72634251e1796_1">72</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Cao, Y. et al. Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine. Cell Res. 32, 107–109 (2022)." href="#ref-CR73" id="ref-link-section-d72634251e1796_2">73</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 74" title="Pérez-Then, E. et al. Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination. Nat. Med. 28, 481–485 (2022)." href="/articles/s41591-022-01855-7#ref-CR74" id="ref-link-section-d72634251e1799">74</a></sup>). The Omicron variant shows very high immune escape potential. Peiris et al.<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 75" title="Peiris, M. et al. Neutralizing antibody titres to SARS-CoV-2 Omicron variant and wild-type virus in those with past infection or vaccinated or boosted with mRNA BNT162b2 or inactivated CoronaVac vaccines. Preprint at Res. Sq. 
                  https://doi.org/10.21203/rs.3.rs-1207071/v1
                  
                 (2022)." href="/articles/s41591-022-01855-7#ref-CR75" id="ref-link-section-d72634251e1803">75</a></sup> found a 6.4-fold and 9.7-fold decrease in the level of NATs against Omicron 6 months after administering two doses and 1 month after administering a booster dose of inactivated vaccines, respectively, compared with those against the ancestral lineage (low immune escape scenario). We further conducted a sensitivity analysis for a high immune escape scenario, which considers a 19.1-fold decrease in the NAT against Omicron both after administering two doses and a booster dose of inactivated vaccines, compared with that against the ancestral lineage<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 76" title="Cameroni, E. et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature 602, 664–670 (2022)." href="/articles/s41591-022-01855-7#ref-CR76" id="ref-link-section-d72634251e1808">76</a></sup>. For VEs against symptomatic illness, hospitalization, and death, we use conditional VEs, which are calculated according to the formulas presented in Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">10</a>.</p><h3 class="c-article__sub-heading" id="Sec16">Mitigation through antiviral therapies</h3><p>A homegrown monoclonal neutralizing antibody therapy (BRII-196/BRII-198 combination) and an imported antiviral therapy (nirmatrelvir tablet/ritonavir tablet combination) have been approved for emergency use in China<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Emergency approval of Brii Biosciences’ COVID-19 neutralizing antibody combination therapy: amubarvimab/romlusevimab combination (BRII-196/BRII-198) therapy. The National Medical Products Administration (NMPA) of China 
                  https://www.nmpa.gov.cn/yaowen/ypjgyw/20211208212528103.html
                  
                 (2021)." href="/articles/s41591-022-01855-7#ref-CR25" id="ref-link-section-d72634251e1824">25</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 26" title="Emergency conditional approval of Pfizer’s COVID-19 therapy: nirmatrelvir tablet/ritonavir tablet combination package (i.e., Paxlovid) importation registration. The National Medical Products Administration (NMPA) of China 
                  https://www.nmpa.gov.cn/yaowen/ypjgyw/20220212085753142.html
                  
                 (2022)." href="/articles/s41591-022-01855-7#ref-CR26" id="ref-link-section-d72634251e1827">26</a></sup>. In the baseline scenario, we do not consider antiviral therapies. To quantify the mitigating effect of antiviral therapies, we simulated two alternative scenarios: (1) 50% of symptomatic cases will receive an antiviral therapy with an efficacy of 80% in preventing hospitalizations and deaths (in agreement with the estimate for the Chinese manufactured BRII-196/BRII-198 combination)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 33" title="Brii Bio announces Amubarvimab/Romlusevimab combination received approval from NMPA as first COVID-19 neutralizing antibody combination therapy in China. Brii Biosciences (9 December 2021); 
                  https://www.briibio.com/news-detial.php?id=505
                  
                " href="/articles/s41591-022-01855-7#ref-CR33" id="ref-link-section-d72634251e1831">33</a></sup>, and (2) 100% of symptomatic cases will receive an antiviral therapy with an efficacy of 89% in preventing hospitalizations and deaths (in agreement with the estimate for the imported nirmatrelvir tablet/ritonavir tablet combination<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 34" title="Hammond, J. et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. N. Engl. J. Med. 386, 1397–1408 (2022)." href="/articles/s41591-022-01855-7#ref-CR34" id="ref-link-section-d72634251e1835">34</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 77" title="Pfizer’s novel COVID-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of phase 2/3 EPIC-HR study. Pfizer (5 November 2021); 
                  https://www.pfizer.com/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate
                  
                " href="/articles/s41591-022-01855-7#ref-CR77" id="ref-link-section-d72634251e1838">77</a></sup>). Only symptomatic cases of patients aged ≥12 years are eligible to receive COVID-19 antiviral therapies<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Emergency approval of Brii Biosciences’ COVID-19 neutralizing antibody combination therapy: amubarvimab/romlusevimab combination (BRII-196/BRII-198) therapy. The National Medical Products Administration (NMPA) of China 
                  https://www.nmpa.gov.cn/yaowen/ypjgyw/20211208212528103.html
                  
                 (2021)." href="/articles/s41591-022-01855-7#ref-CR25" id="ref-link-section-d72634251e1842">25</a></sup> (Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">6</a>). The rationale for the 50% treatment uptake scenario is that not all symptomatic cases may be promptly identified, thus leading either to receive the treatment well after symptom onset (and thus the effectiveness of the antiviral therapy is reduced) or to entirely missing potential eligible individuals. The 100% treatment uptake scenario represents an ideal scenario where all eligible symptomatic infections receive the treatment at the peak of its efficacy.</p><h3 class="c-article__sub-heading" id="Sec17">Mitigation through NPIs</h3><p>We tested the impact of NPIs in two ways: (1) implementing a national school closure or a national school and workplace closure by removing contacts that occurred in schools or workplaces from the baseline mixing patterns (Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">1</a>) and (2) reducing effective contacts equally across age groups, which is modeled as a reduction in the reproduction number; specifically, we considered <i>R</i><sub><i>t</i></sub> = 2.0, 2.5, 3.0 and 3.9 that represent varying intensities of NPIs (Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">5</a>).</p><h3 class="c-article__sub-heading" id="Sec18">Geographical heterogeneity across the Chinese population</h3><p>To account for within-China heterogeneity, we run the baseline analysis for three other highly diverse contexts: (1) an urbanized setting with a relatively low vaccine coverage (Shanghai), (2) a rural setting with a relatively low vaccine coverage (Shanxi, a central province in China) and (3) a high vaccination setting (Shandong, an eastern coastal province). In our analysis, these settings differ in terms of primary and booster vaccination coverages, age structure of the population, contact patterns of the population<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 42" title="Mistry, D. et al. Inferring high-resolution human mixing patterns for disease modeling. Nat. Commun. 12, 323 (2021)." href="/articles/s41591-022-01855-7#ref-CR42" id="ref-link-section-d72634251e1877">42</a></sup>, number of available hospital beds and ICUs<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 31" title="National Health Commission of China. China Health Statistics Yearbook 2021 (China Union Medical College Press, 2021)." href="/articles/s41591-022-01855-7#ref-CR31" id="ref-link-section-d72634251e1881">31</a></sup> (Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">2</a> and Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">1</a>). The overall and age-specific incidence rates of different clinical endpoints over a 6-month simulated period across the three settings are compared with the ‘national average’.</p><h3 class="c-article__sub-heading" id="Sec19">Statistical analysis</h3><p>For each scenario, we performed 200 stochastic simulations. The outcomes of these simulations determined the distribution of the number of symptomatic infections, hospital admissions, ICU admissions and deaths by age. We defined 95% credible intervals as quantiles 0.025 and 0.975 of the estimated distributions.</p><h3 class="c-article__sub-heading" id="Sec20">Reporting summary</h3><p>Further information on research design is available in the <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM2">Nature Research Reporting summary</a> linked to this article.</p></div></div></section>
                    
                </div>
            

            <div class="u-mt-32">
                <section data-title="Data availability"><div class="c-article-section" id="data-availability-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="data-availability">Data availability</h2><div class="c-article-section__content" id="data-availability-content">
              
              <p>The data used in the study are provided in Supplementary Information and are available with the code on GitHub at <a href="https://github.com/DXW-sola1015/Model_Omicron_China">https://github.com/DXW-sola1015/Model_Omicron_China</a>.</p>
            </div></div></section><section data-title="Code availability"><div class="c-article-section" id="code-availability-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="code-availability">Code availability</h2><div class="c-article-section__content" id="code-availability-content">
              
              <p>The codes used in this study are available on GitHub at <a href="https://github.com/DXW-sola1015/Model_Omicron_China">https://github.com/DXW-sola1015/Model_Omicron_China</a>.</p>
            </div></div></section><div id="MagazineFulltextArticleBodySuffix"><section aria-labelledby="Bib1" data-title="References"><div class="c-article-section" id="Bib1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Bib1">References</h2><div class="c-article-section__content" id="Bib1-content"><div data-container-section="references"><ol class="c-article-references" data-track-component="outbound reference" data-track-context="references section"><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="1."><p class="c-article-references__text" id="ref-CR1">Viana, R. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. <i>Nature</i> <b>603</b>, 679–686 (2022).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41586-022-04411-y" data-track-item_id="10.1038/s41586-022-04411-y" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41586-022-04411-y" aria-label="Article reference 1" data-doi="10.1038/s41586-022-04411-y">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XntlWnsLk%3D" aria-label="CAS reference 1">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35042229" aria-label="PubMed reference 1">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942855" aria-label="PubMed Central reference 1">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 1" href="http://scholar.google.com/scholar_lookup?&amp;title=Rapid%20epidemic%20expansion%20of%20the%20SARS-CoV-2%20Omicron%20variant%20in%20southern%20Africa&amp;journal=Nature&amp;doi=10.1038%2Fs41586-022-04411-y&amp;volume=603&amp;pages=679-686&amp;publication_year=2022&amp;author=Viana%2CR">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="2."><p class="c-article-references__text" id="ref-CR2">Tracking of VOC Omicron. <i>Global Initiative of Sharing All Influenza Data (GISAID)</i> (29 January 2022); <a href="https://www.gisaid.org/hcov19-variants/" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.gisaid.org/hcov19-variants/">https://www.gisaid.org/hcov19-variants/</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="3."><p class="c-article-references__text" id="ref-CR3">Lyngse, F.P. SARS-CoV-2 Omicron VOC transmission in Danish households. Preprint at <i>medRXiv</i> <a href="https://doi.org/10.1101/2021.12.27.21268278" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2021.12.27.21268278">https://doi.org/10.1101/2021.12.27.21268278</a> (2021).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="4."><p class="c-article-references__text" id="ref-CR4">Pearson, C.A.B. et al. Bounding the levels of transmissibility &amp; immune evasion of the Omicron variant in South Africa. Preprint at <i>medRxiv</i> <a href="https://doi.org/10.1101/2021.12.19.21268038" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2021.12.19.21268038">https://doi.org/10.1101/2021.12.19.21268038</a> (2021).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="5."><p class="c-article-references__text" id="ref-CR5">Gozzi, N. et al. Preliminary modeling estimates of the relative transmissibility and immune escape of the Omicron SARS-CoV-2 variant of concern in South Africa. Preprint at <i>medRxiv</i> <a href="https://doi.org/10.1101/2022.01.04.22268721" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2022.01.04.22268721">https://doi.org/10.1101/2022.01.04.22268721</a> (2022).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="6."><p class="c-article-references__text" id="ref-CR6">Lu, L. et al. Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients. <i>Clin. Infect. Dis.</i> ciab1041 (2021).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="7."><p class="c-article-references__text" id="ref-CR7">Zhang, L. et al. The significant immune escape of pseudotyped SARS-CoV-2 variant omicron. <i>Emerg. Microbes Infect.</i> <b>11</b>, 1–5 (2022).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1080/22221751.2021.2017757" data-track-item_id="10.1080/22221751.2021.2017757" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1080%2F22221751.2021.2017757" aria-label="Article reference 7" data-doi="10.1080/22221751.2021.2017757">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38Xms1SksQ%3D%3D" aria-label="CAS reference 7">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34890524" aria-label="PubMed reference 7">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 7" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20significant%20immune%20escape%20of%20pseudotyped%20SARS-CoV-2%20variant%20omicron&amp;journal=Emerg.%20Microbes%20Infect.&amp;doi=10.1080%2F22221751.2021.2017757&amp;volume=11&amp;pages=1-5&amp;publication_year=2022&amp;author=Zhang%2CL">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="8."><p class="c-article-references__text" id="ref-CR8">Collier, A.-R. Y. et al. Differential kinetics of immune responses elicited by covid-19 vaccines. <i>N. Engl. J. Med.</i> <b>385</b>, 2010–2012 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1056/NEJMc2115596" data-track-item_id="10.1056/NEJMc2115596" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1056%2FNEJMc2115596" aria-label="Article reference 8" data-doi="10.1056/NEJMc2115596">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34648703" aria-label="PubMed reference 8">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 8" href="http://scholar.google.com/scholar_lookup?&amp;title=Differential%20kinetics%20of%20immune%20responses%20elicited%20by%20covid-19%20vaccines&amp;journal=N.%20Engl.%20J.%20Med.&amp;doi=10.1056%2FNEJMc2115596&amp;volume=385&amp;pages=2010-2012&amp;publication_year=2021&amp;author=Collier%2CA-RY">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="9."><p class="c-article-references__text" id="ref-CR9">Levin, E. G. et al. Waning immune humoral response to BNT162b2 covid-19 vaccine over 6 months. <i>N. Engl. J. Med.</i> <b>385</b>, e84 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1056/NEJMoa2114583" data-track-item_id="10.1056/NEJMoa2114583" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1056%2FNEJMoa2114583" aria-label="Article reference 9" data-doi="10.1056/NEJMoa2114583">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXislKlsbrN" aria-label="CAS reference 9">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34614326" aria-label="PubMed reference 9">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 9" href="http://scholar.google.com/scholar_lookup?&amp;title=Waning%20immune%20humoral%20response%20to%20BNT162b2%20covid-19%20vaccine%20over%206%20months&amp;journal=N.%20Engl.%20J.%20Med.&amp;doi=10.1056%2FNEJMoa2114583&amp;volume=385&amp;publication_year=2021&amp;author=Levin%2CEG">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="10."><p class="c-article-references__text" id="ref-CR10">Xin, Q. et al. Six-month follow-up of a booster dose of coronavac: two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials. Preprint at <i>SSRN</i> <a href="https://doi.org/10.2139/ssrn.3991627" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.2139/ssrn.3991627">https://doi.org/10.2139/ssrn.3991627</a> (2021).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="11."><p class="c-article-references__text" id="ref-CR11">Dan Jennifer, M. et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. <i>Science</i> <b>371</b>, eabf4063 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/science.abf4063" data-track-item_id="10.1126/science.abf4063" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fscience.abf4063" aria-label="Article reference 11" data-doi="10.1126/science.abf4063">Article</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 11" href="http://scholar.google.com/scholar_lookup?&amp;title=Immunological%20memory%20to%20SARS-CoV-2%20assessed%20for%20up%20to%208%20months%20after%20infection&amp;journal=Science&amp;doi=10.1126%2Fscience.abf4063&amp;volume=371&amp;publication_year=2021&amp;author=Jennifer%2CM">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="12."><p class="c-article-references__text" id="ref-CR12">Wheatley, A. K. et al. Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19. <i>Nat. Commun.</i> <b>12</b>, 1162 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41467-021-21444-5" data-track-item_id="10.1038/s41467-021-21444-5" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41467-021-21444-5" aria-label="Article reference 12" data-doi="10.1038/s41467-021-21444-5">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXltV2htLc%3D" aria-label="CAS reference 12">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33608522" aria-label="PubMed reference 12">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896046" aria-label="PubMed Central reference 12">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 12" href="http://scholar.google.com/scholar_lookup?&amp;title=Evolution%20of%20immune%20responses%20to%20SARS-CoV-2%20in%20mild-moderate%20COVID-19&amp;journal=Nat.%20Commun.&amp;doi=10.1038%2Fs41467-021-21444-5&amp;volume=12&amp;publication_year=2021&amp;author=Wheatley%2CAK">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="13."><p class="c-article-references__text" id="ref-CR13">WHO Coronavirus (COVID-19) Dashboard. <i>World Health Organization</i> (5 March 2022); <a href="https://covid19.who.int/" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://covid19.who.int/">https://covid19.who.int/</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="14."><p class="c-article-references__text" id="ref-CR14">Wolter, N. et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. <i>Lancet</i> <b>399</b>, 437–446 (2022).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S0140-6736(22)00017-4" data-track-item_id="10.1016/S0140-6736(22)00017-4" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS0140-6736%2822%2900017-4" aria-label="Article reference 14" data-doi="10.1016/S0140-6736(22)00017-4">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XhvFCru7Y%3D" aria-label="CAS reference 14">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35065011" aria-label="PubMed reference 14">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769664" aria-label="PubMed Central reference 14">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 14" href="http://scholar.google.com/scholar_lookup?&amp;title=Early%20assessment%20of%20the%20clinical%20severity%20of%20the%20SARS-CoV-2%20omicron%20variant%20in%20South%20Africa%3A%20a%20data%20linkage%20study&amp;journal=Lancet&amp;doi=10.1016%2FS0140-6736%2822%2900017-4&amp;volume=399&amp;pages=437-446&amp;publication_year=2022&amp;author=Wolter%2CN">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="15."><p class="c-article-references__text" id="ref-CR15">Maslo, C. et al. Characteristics and outcomes of hospitalized patients in South Africa during the COVID-19 Omicron wave compared with previous waves. <i>JAMA</i> <b>327</b>, 583–584 (2022).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1001/jama.2021.24868" data-track-item_id="10.1001/jama.2021.24868" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1001%2Fjama.2021.24868" aria-label="Article reference 15" data-doi="10.1001/jama.2021.24868">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XktFSgs7o%3D" aria-label="CAS reference 15">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34967859" aria-label="PubMed reference 15">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 15" href="http://scholar.google.com/scholar_lookup?&amp;title=Characteristics%20and%20outcomes%20of%20hospitalized%20patients%20in%20South%20Africa%20during%20the%20COVID-19%20Omicron%20wave%20compared%20with%20previous%20waves&amp;journal=JAMA&amp;doi=10.1001%2Fjama.2021.24868&amp;volume=327&amp;pages=583-584&amp;publication_year=2022&amp;author=Maslo%2CC">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="16."><p class="c-article-references__text" id="ref-CR16">SARS-CoV-2 variants of concern and variants under investigation in England, Technical briefing: update on hospitalisation and vaccine effectiveness for Omicron VOC-21NOV-01 (B.1.1.529). <i>UK Health Security Agency</i> <a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1044481/Technical-Briefing-31-Dec-2021-Omicron_severity_update.pdf" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1044481/Technical-Briefing-31-Dec-2021-Omicron_severity_update.pdf">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1044481/Technical-Briefing-31-Dec-2021-Omicron_severity_update.pdf</a> (2021).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="17."><p class="c-article-references__text" id="ref-CR17">Wang, L. et al. Incidence Rates and Clinical Outcomes of SARS-CoV-2 Infection With the Omicron and Delta Variants in Children Younger Than 5 Years in the US. <i>JAMA Pediatr.</i> e220945 (2022).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="18."><p class="c-article-references__text" id="ref-CR18">Lewnard, J. A. et al. Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California. Preprint at <i>medRxiv</i> <a href="https://doi.org/10.1101/2022.01.11.22269045" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2022.01.11.22269045">https://doi.org/10.1101/2022.01.11.22269045</a> (2022).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="19."><p class="c-article-references__text" id="ref-CR19">Iuliano, A. D. et al. Trends in disease severity and health care utilization during the early omicron variant period compared with previous SARS-CoV-2 high transmission periods—United States, December 2020–January 2022. <i>MMWR Morb. Mortal. Wkly Rep</i>. <b>71</b>, 146–152 (2022).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="20."><p class="c-article-references__text" id="ref-CR20">Marks, K. J. et al. Hospitalizations of children and adolescents with laboratory-confirmed COVID-19—COVID-NET, 14 States, July 2021–January 2022. <i>MMWR Morb. Mortal. Wkly Rep.</i> <b>71</b>, 271–278 (2022).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.15585/mmwr.mm7107e4" data-track-item_id="10.15585/mmwr.mm7107e4" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.15585%2Fmmwr.mm7107e4" aria-label="Article reference 20" data-doi="10.15585/mmwr.mm7107e4">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XlvV2lsbs%3D" aria-label="CAS reference 20">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35176003" aria-label="PubMed reference 20">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853476" aria-label="PubMed Central reference 20">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 20" href="http://scholar.google.com/scholar_lookup?&amp;title=Hospitalizations%20of%20children%20and%20adolescents%20with%20laboratory-confirmed%20COVID-19%E2%80%94COVID-NET%2C%2014%20States%2C%20July%202021%E2%80%93January%202022&amp;journal=MMWR%20Morb.%20Mortal.%20Wkly%20Rep.&amp;doi=10.15585%2Fmmwr.mm7107e4&amp;volume=71&amp;pages=271-278&amp;publication_year=2022&amp;author=Marks%2CKJ">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="21."><p class="c-article-references__text" id="ref-CR21">Coronavirus (COVID-19) latest insights. <i>UK Office for National Statistics</i> . <a href="https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights">https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights</a> (2022).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="22."><p class="c-article-references__text" id="ref-CR22">Press conference held on situation regarding strict prevention and control of COVID-19 epidemic. <i>The State Council Information Office, P.R.C.</i> (19 April 2022); <a href="http://www.gov.cn/xinwen/gwylflkjz193/index.htm" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="http://www.gov.cn/xinwen/gwylflkjz193/index.htm">http://www.gov.cn/xinwen/gwylflkjz193/index.htm</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="23."><p class="c-article-references__text" id="ref-CR23">Liu, J., Liu, M. &amp; Liang, W. The dynamic COVID-zero strategy in China. <i>China CDC Wkly.</i> <b>4</b>, 74–75 (2022).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.46234/ccdcw2022.015" data-track-item_id="10.46234/ccdcw2022.015" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.46234%2Fccdcw2022.015" aria-label="Article reference 23" data-doi="10.46234/ccdcw2022.015">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35186372" aria-label="PubMed reference 23">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837441" aria-label="PubMed Central reference 23">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 23" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20dynamic%20COVID-zero%20strategy%20in%20China&amp;journal=China%20CDC%20Wkly.&amp;doi=10.46234%2Fccdcw2022.015&amp;volume=4&amp;pages=74-75&amp;publication_year=2022&amp;author=Liu%2CJ&amp;author=Liu%2CM&amp;author=Liang%2CW">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="24."><p class="c-article-references__text" id="ref-CR24">COVID-19 Virtual Press conference transcript. <i>World Health Organization</i> (1 February 2022); <a href="https://www.who.int/publications/m/item/covid-19-virtual-press-conference-transcript-1-february-2022" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.who.int/publications/m/item/covid-19-virtual-press-conference-transcript-1-february-2022">https://www.who.int/publications/m/item/covid-19-virtual-press-conference-transcript-1-february-2022</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="25."><p class="c-article-references__text" id="ref-CR25">Emergency approval of Brii Biosciences’ COVID-19 neutralizing antibody combination therapy: amubarvimab/romlusevimab combination (BRII-196/BRII-198) therapy. <i>The National Medical Products Administration (NMPA) of China</i> <a href="https://www.nmpa.gov.cn/yaowen/ypjgyw/20211208212528103.html" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.nmpa.gov.cn/yaowen/ypjgyw/20211208212528103.html">https://www.nmpa.gov.cn/yaowen/ypjgyw/20211208212528103.html</a> (2021).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="26."><p class="c-article-references__text" id="ref-CR26">Emergency conditional approval of Pfizer’s COVID-19 therapy: nirmatrelvir tablet/ritonavir tablet combination package (i.e., Paxlovid) importation registration. <i>The National Medical Products Administration (NMPA) of China</i> <a href="https://www.nmpa.gov.cn/yaowen/ypjgyw/20220212085753142.html" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.nmpa.gov.cn/yaowen/ypjgyw/20220212085753142.html">https://www.nmpa.gov.cn/yaowen/ypjgyw/20220212085753142.html</a> (2022).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="27."><p class="c-article-references__text" id="ref-CR27">McMenamin, M. E. et al. Vaccine effectiveness of two and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong. Preprint at <i>medRxiv</i> <a href="https://doi.org/10.1101/2022.03.22.22272769" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2022.03.22.22272769">https://doi.org/10.1101/2022.03.22.22272769</a> (2022).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="28."><p class="c-article-references__text" id="ref-CR28">Press conference held on situation regarding strict prevention and control of COVID-19 epidemic. <i>The State Council Information Office, P.R.C.</i> (19 March 2022); <a href="http://www.gov.cn/xinwen/gwylflkjz187/index.htm" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="http://www.gov.cn/xinwen/gwylflkjz187/index.htm">http://www.gov.cn/xinwen/gwylflkjz187/index.htm</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="29."><p class="c-article-references__text" id="ref-CR29">Press conference held on situation regarding prevetion and control of COVID-19 epidemic in Shanghai. <i>Shanghai Municipal Health Commission</i> (17 April 2022); <a href="https://j.eastday.com/p/1650166645036759" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://j.eastday.com/p/1650166645036759">https://j.eastday.com/p/1650166645036759</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="30."><p class="c-article-references__text" id="ref-CR30">Press conference held on situation regarding prevetion and control of COVID-19 epidemic in Shandong province. <i>People’s Government of Shandong Province (</i>22 March 2022); <a href="http://www.shandong.gov.cn/vipchat1//home/site/82/3788/article.html" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="http://www.shandong.gov.cn/vipchat1//home/site/82/3788/article.html">http://www.shandong.gov.cn/vipchat1//home/site/82/3788/article.html</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="31."><p class="c-article-references__text" id="ref-CR31">National Health Commission of China. <i>China Health Statistics Yearbook 2021</i> (China Union Medical College Press, 2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 31" href="http://scholar.google.com/scholar_lookup?&amp;title=China%20Health%20Statistics%20Yearbook%202021&amp;publication_year=2021">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="32."><p class="c-article-references__text" id="ref-CR32">Ranzani, O. T. et al. Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against the Omicron (B.1.1.529) variant. Preprint at <i>medRxiv</i> <a href="https://doi.org/10.1101/2022.03.30.22273193" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2022.03.30.22273193">https://doi.org/10.1101/2022.03.30.22273193</a> (2022).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="33."><p class="c-article-references__text" id="ref-CR33">Brii Bio announces Amubarvimab/Romlusevimab combination received approval from NMPA as first COVID-19 neutralizing antibody combination therapy in China. <i>Brii Biosciences</i> (9 December 2021); <a href="https://www.briibio.com/news-detial.php?id=505" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.briibio.com/news-detial.php?id=505">https://www.briibio.com/news-detial.php?id=505</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="34."><p class="c-article-references__text" id="ref-CR34">Hammond, J. et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. <i>N. Engl. J. Med.</i> <b>386</b>, 1397–1408 (2022).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1056/NEJMoa2118542" data-track-item_id="10.1056/NEJMoa2118542" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1056%2FNEJMoa2118542" aria-label="Article reference 34" data-doi="10.1056/NEJMoa2118542">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XhtFShu73O" aria-label="CAS reference 34">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35172054" aria-label="PubMed reference 34">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 34" href="http://scholar.google.com/scholar_lookup?&amp;title=Oral%20nirmatrelvir%20for%20high-risk%2C%20nonhospitalized%20adults%20with%20Covid-19&amp;journal=N.%20Engl.%20J.%20Med.&amp;doi=10.1056%2FNEJMoa2118542&amp;volume=386&amp;pages=1397-1408&amp;publication_year=2022&amp;author=Hammond%2CJ">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="35."><p class="c-article-references__text" id="ref-CR35">Barnard, R. C., Davies, N. G., Pearson, C. A. B., Jit, M. &amp; Edmunds, W. J. Projected epidemiological consequences of the Omicron SARS-CoV-2 variant in England, December 2021 to April 2022. Preprint at <i>medRxiv</i> <a href="https://doi.org/10.1101/2021.12.15.21267858" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2021.12.15.21267858">https://doi.org/10.1101/2021.12.15.21267858</a> (2021).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="36."><p class="c-article-references__text" id="ref-CR36">Ranjan, R. Omicron impact in India: analysis of the ongoing COVID-19 third wave based on global data. Preprint at <i>medRxiv</i> <a href="https://doi.org/10.1101/2022.01.09.22268969" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2022.01.09.22268969">https://doi.org/10.1101/2022.01.09.22268969</a> (2022).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="37."><p class="c-article-references__text" id="ref-CR37">Li, L. et al. Influenza-associated excess respiratory mortality in China, 2010–15: a population-based study. <i>Lancet Public Health</i> <b>4</b>, e473–e481 (2019).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S2468-2667(19)30163-X" data-track-item_id="10.1016/S2468-2667(19)30163-X" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS2468-2667%2819%2930163-X" aria-label="Article reference 37" data-doi="10.1016/S2468-2667(19)30163-X">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31493844" aria-label="PubMed reference 37">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8736690" aria-label="PubMed Central reference 37">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 37" href="http://scholar.google.com/scholar_lookup?&amp;title=Influenza-associated%20excess%20respiratory%20mortality%20in%20China%2C%202010%E2%80%9315%3A%20a%20population-based%20study&amp;journal=Lancet%20Public%20Health&amp;doi=10.1016%2FS2468-2667%2819%2930163-X&amp;volume=4&amp;pages=e473-e481&amp;publication_year=2019&amp;author=Li%2CL">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="38."><p class="c-article-references__text" id="ref-CR38">United States: Coronavirus Pandemic Country Profile. <i>Our World in Data</i> (19 April 2022); <a href="https://ourworldindata.org/coronavirus/country/united-states" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://ourworldindata.org/coronavirus/country/united-states">https://ourworldindata.org/coronavirus/country/united-states</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="39."><p class="c-article-references__text" id="ref-CR39">Mesfin, Y. et al. Epidemiology of infections with SARS-CoV-2 Omicron BA.2 variant in Hong Kong, January–March 2022. Preprint at <i>medRxiv</i> <a href="https://doi.org/10.1101/2022.04.07.22273595" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2022.04.07.22273595">https://doi.org/10.1101/2022.04.07.22273595</a> (2022).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="40."><p class="c-article-references__text" id="ref-CR40">Rossman, H. et al. Hospital load and increased COVID-19 related mortality in Israel. <i>Nat. Commun.</i> <b>12</b>, 1904 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41467-021-22214-z" data-track-item_id="10.1038/s41467-021-22214-z" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41467-021-22214-z" aria-label="Article reference 40" data-doi="10.1038/s41467-021-22214-z">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33771988" aria-label="PubMed reference 40">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997985" aria-label="PubMed Central reference 40">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 40" href="http://scholar.google.com/scholar_lookup?&amp;title=Hospital%20load%20and%20increased%20COVID-19%20related%20mortality%20in%20Israel&amp;journal=Nat.%20Commun.&amp;doi=10.1038%2Fs41467-021-22214-z&amp;volume=12&amp;publication_year=2021&amp;author=Rossman%2CH">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="41."><p class="c-article-references__text" id="ref-CR41">French, G. et al. Impact of hospital strain on excess deaths during the COVID-19 pandemic – United States, July 2020–July 2021. <i>MMWR Morb. Mortal. Wkly Rep.</i> <b>70</b>, 1613–1616 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.15585/mmwr.mm7046a5" data-track-item_id="10.15585/mmwr.mm7046a5" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.15585%2Fmmwr.mm7046a5" aria-label="Article reference 41" data-doi="10.15585/mmwr.mm7046a5">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXislCnsLbL" aria-label="CAS reference 41">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34793414" aria-label="PubMed reference 41">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601411" aria-label="PubMed Central reference 41">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 41" href="http://scholar.google.com/scholar_lookup?&amp;title=Impact%20of%20hospital%20strain%20on%20excess%20deaths%20during%20the%20COVID-19%20pandemic%20%E2%80%93%20United%20States%2C%20July%202020%E2%80%93July%202021&amp;journal=MMWR%20Morb.%20Mortal.%20Wkly%20Rep.&amp;doi=10.15585%2Fmmwr.mm7046a5&amp;volume=70&amp;pages=1613-1616&amp;publication_year=2021&amp;author=French%2CG">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="42."><p class="c-article-references__text" id="ref-CR42">Mistry, D. et al. Inferring high-resolution human mixing patterns for disease modeling. <i>Nat. Commun.</i> <b>12</b>, 323 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41467-020-20544-y" data-track-item_id="10.1038/s41467-020-20544-y" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41467-020-20544-y" aria-label="Article reference 42" data-doi="10.1038/s41467-020-20544-y">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXhsVels7w%3D" aria-label="CAS reference 42">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33436609" aria-label="PubMed reference 42">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803761" aria-label="PubMed Central reference 42">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 42" href="http://scholar.google.com/scholar_lookup?&amp;title=Inferring%20high-resolution%20human%20mixing%20patterns%20for%20disease%20modeling&amp;journal=Nat.%20Commun.&amp;doi=10.1038%2Fs41467-020-20544-y&amp;volume=12&amp;publication_year=2021&amp;author=Mistry%2CD">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="43."><p class="c-article-references__text" id="ref-CR43">Davis, J. T. et al. Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave. <i>Nature</i> <b>600</b>, 127–132 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41586-021-04130-w" data-track-item_id="10.1038/s41586-021-04130-w" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41586-021-04130-w" aria-label="Article reference 43" data-doi="10.1038/s41586-021-04130-w">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXisFyrsbfK" aria-label="CAS reference 43">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34695837" aria-label="PubMed reference 43">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636257" aria-label="PubMed Central reference 43">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 43" href="http://scholar.google.com/scholar_lookup?&amp;title=Cryptic%20transmission%20of%20SARS-CoV-2%20and%20the%20first%20COVID-19%20wave&amp;journal=Nature&amp;doi=10.1038%2Fs41586-021-04130-w&amp;volume=600&amp;pages=127-132&amp;publication_year=2021&amp;author=Davis%2CJT">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="44."><p class="c-article-references__text" id="ref-CR44">Viner, R. M. et al. Susceptibility to SARS-CoV-2 infection among children and adolescents compared with adults: a systematic review and meta-analysis. <i>JAMA Pediatrics</i> <b>175</b>, 143–156 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1001/jamapediatrics.2020.4573" data-track-item_id="10.1001/jamapediatrics.2020.4573" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1001%2Fjamapediatrics.2020.4573" aria-label="Article reference 44" data-doi="10.1001/jamapediatrics.2020.4573">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32975552" aria-label="PubMed reference 44">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 44" href="http://scholar.google.com/scholar_lookup?&amp;title=Susceptibility%20to%20SARS-CoV-2%20infection%20among%20children%20and%20adolescents%20compared%20with%20adults%3A%20a%20systematic%20review%20and%20meta-analysis&amp;journal=JAMA%20Pediatrics&amp;doi=10.1001%2Fjamapediatrics.2020.4573&amp;volume=175&amp;pages=143-156&amp;publication_year=2021&amp;author=Viner%2CRM">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="45."><p class="c-article-references__text" id="ref-CR45">Davies, N. G. et al. Age-dependent effects in the transmission and control of COVID-19 epidemics. <i>Nat. Med.</i> <b>26</b>, 1205–1211 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41591-020-0962-9" data-track-item_id="10.1038/s41591-020-0962-9" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41591-020-0962-9" aria-label="Article reference 45" data-doi="10.1038/s41591-020-0962-9">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXhtFOqtL3E" aria-label="CAS reference 45">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32546824" aria-label="PubMed reference 45">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 45" href="http://scholar.google.com/scholar_lookup?&amp;title=Age-dependent%20effects%20in%20the%20transmission%20and%20control%20of%20COVID-19%20epidemics&amp;journal=Nat.%20Med.&amp;doi=10.1038%2Fs41591-020-0962-9&amp;volume=26&amp;pages=1205-1211&amp;publication_year=2020&amp;author=Davies%2CNG">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="46."><p class="c-article-references__text" id="ref-CR46">Hu, S. et al. Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China. <i>Nat. Commun.</i> <b>12</b>, 1533 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41467-021-21710-6" data-track-item_id="10.1038/s41467-021-21710-6" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41467-021-21710-6" aria-label="Article reference 46" data-doi="10.1038/s41467-021-21710-6">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXmsVCksbg%3D" aria-label="CAS reference 46">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33750783" aria-label="PubMed reference 46">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943579" aria-label="PubMed Central reference 46">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 46" href="http://scholar.google.com/scholar_lookup?&amp;title=Infectivity%2C%20susceptibility%2C%20and%20risk%20factors%20associated%20with%20SARS-CoV-2%20transmission%20under%20intensive%20contact%20tracing%20in%20Hunan%2C%20China&amp;journal=Nat.%20Commun.&amp;doi=10.1038%2Fs41467-021-21710-6&amp;volume=12&amp;publication_year=2021&amp;author=Hu%2CS">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="47."><p class="c-article-references__text" id="ref-CR47">Buitrago-Garcia, D. et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. <i>PLoS Med.</i> <b>17</b>, e1003346 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1371/journal.pmed.1003346" data-track-item_id="10.1371/journal.pmed.1003346" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1371%2Fjournal.pmed.1003346" aria-label="Article reference 47" data-doi="10.1371/journal.pmed.1003346">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXitVCgurzK" aria-label="CAS reference 47">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32960881" aria-label="PubMed reference 47">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508369" aria-label="PubMed Central reference 47">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 47" href="http://scholar.google.com/scholar_lookup?&amp;title=Occurrence%20and%20transmission%20potential%20of%20asymptomatic%20and%20presymptomatic%20SARS-CoV-2%20infections%3A%20a%20living%20systematic%20review%20and%20meta-analysis&amp;journal=PLoS%20Med.&amp;doi=10.1371%2Fjournal.pmed.1003346&amp;volume=17&amp;publication_year=2020&amp;author=Buitrago-Garcia%2CD">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="48."><p class="c-article-references__text" id="ref-CR48">Manica, M. et al. Intrinsic generation time of the SARS-CoV-2 Omicron variant: an observational study of household transmission. Preprint at <i>SSRN</i> <a href="https://doi.org/10.2139/ssrn.4068368" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.2139/ssrn.4068368">https://doi.org/10.2139/ssrn.4068368</a> (2022).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="49."><p class="c-article-references__text" id="ref-CR49">Deng, X. et al. Case fatality risk of the first pandemic wave of novel coronavirus disease 2019 (COVID-19) in China. <i>Clin. Infect. Dis.</i> <b>73</b>, e79–e85 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1093/cid/ciaa578" data-track-item_id="10.1093/cid/ciaa578" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1093%2Fcid%2Fciaa578" aria-label="Article reference 49" data-doi="10.1093/cid/ciaa578">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXhsFSitbnP" aria-label="CAS reference 49">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32409826" aria-label="PubMed reference 49">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 49" href="http://scholar.google.com/scholar_lookup?&amp;title=Case%20fatality%20risk%20of%20the%20first%20pandemic%20wave%20of%20novel%20coronavirus%20disease%202019%20%28COVID-19%29%20in%20China&amp;journal=Clin.%20Infect.%20Dis.&amp;doi=10.1093%2Fcid%2Fciaa578&amp;volume=73&amp;pages=e79-e85&amp;publication_year=2021&amp;author=Deng%2CX">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="50."><p class="c-article-references__text" id="ref-CR50">Halloran, M. E., Longini, I. M., Struchiner, C. J. &amp; Longini, I. M. <i>Design and Analysis of Vaccine Studies</i> (Springer, 2010).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="51."><p class="c-article-references__text" id="ref-CR51">Hansen, C. H., Michlmayr, D., Gubbels, S. M., Mølbak, K. &amp; Ethelberg, S. Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study. <i>Lancet</i> <b>397</b>, 1204–1212 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S0140-6736(21)00575-4" data-track-item_id="10.1016/S0140-6736(21)00575-4" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS0140-6736%2821%2900575-4" aria-label="Article reference 51" data-doi="10.1016/S0140-6736(21)00575-4">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXntFOnsrg%3D" aria-label="CAS reference 51">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33743221" aria-label="PubMed reference 51">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969130" aria-label="PubMed Central reference 51">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 51" href="http://scholar.google.com/scholar_lookup?&amp;title=Assessment%20of%20protection%20against%20reinfection%20with%20SARS-CoV-2%20among%204%20million%20PCR-tested%20individuals%20in%20Denmark%20in%202020%3A%20a%20population-level%20observational%20study&amp;journal=Lancet&amp;doi=10.1016%2FS0140-6736%2821%2900575-4&amp;volume=397&amp;pages=1204-1212&amp;publication_year=2021&amp;author=Hansen%2CCH&amp;author=Michlmayr%2CD&amp;author=Gubbels%2CSM&amp;author=M%C3%B8lbak%2CK&amp;author=Ethelberg%2CS">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="52."><p class="c-article-references__text" id="ref-CR52">Provisional Data Analysis On COVID-19 Reported Death Cases. <i>Center for Health Protection of the Department of Health</i> (29 April 2022); <a href="https://www.covidvaccine.gov.hk/pdf/death_analysis.pdf" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.covidvaccine.gov.hk/pdf/death_analysis.pdf">https://www.covidvaccine.gov.hk/pdf/death_analysis.pdf</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="53."><p class="c-article-references__text" id="ref-CR53">Statistics on 5th Wave of COVID-19. <i>Center for Health Protection of the Department of Health</i> (29 April 2022); <a href="https://www.covidvaccine.gov.hk/pdf/5th_wave_statistics.pdf" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.covidvaccine.gov.hk/pdf/5th_wave_statistics.pdf">https://www.covidvaccine.gov.hk/pdf/5th_wave_statistics.pdf</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="54."><p class="c-article-references__text" id="ref-CR54">Modelling the fifth wave of COVID-19 in Hong Kong. <i>D24H@HKSTP and HKU WHO Collaborating Centre on Infectious Disease Epidemiology and Modelling</i> (21 March 2022); <a href="https://sph.hku.hk/en/News-And-Events/Press-Releases/2022/TBC" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://sph.hku.hk/en/News-And-Events/Press-Releases/2022/TBC">https://sph.hku.hk/en/News-And-Events/Press-Releases/2022/TBC</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="55."><p class="c-article-references__text" id="ref-CR55">Guan, W.-j et al. Clinical characteristics of coronavirus disease 2019 in China. <i>N. Engl. J. Med.</i> <b>382</b>, 1708–1720 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1056/NEJMoa2002032" data-track-item_id="10.1056/NEJMoa2002032" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1056%2FNEJMoa2002032" aria-label="Article reference 55" data-doi="10.1056/NEJMoa2002032">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXovVSjsb8%3D" aria-label="CAS reference 55">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32109013" aria-label="PubMed reference 55">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 55" href="http://scholar.google.com/scholar_lookup?&amp;title=Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China&amp;journal=N.%20Engl.%20J.%20Med.&amp;doi=10.1056%2FNEJMoa2002032&amp;volume=382&amp;pages=1708-1720&amp;publication_year=2020&amp;author=Guan%2CW-j">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="56."><p class="c-article-references__text" id="ref-CR56">Modes, M. E. et al. Clinical characteristics and outcomes among adults hospitalized with laboratory-confirmed SARS-CoV-2 infection during periods of B. 1.617. 2 (Delta) and B. 1.1. 529 (Omicron) variant predominance—one hospital, California, July 15–September 23, 2021, and December 21, 2021–January 27, 2022. <i>MMWR Morb. Mortal. Wkly Rep.</i> <b>71</b>, 217–223 (2022).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.15585/mmwr.mm7106e2" data-track-item_id="10.15585/mmwr.mm7106e2" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.15585%2Fmmwr.mm7106e2" aria-label="Article reference 56" data-doi="10.15585/mmwr.mm7106e2">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XlvV2mtbk%3D" aria-label="CAS reference 56">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35143466" aria-label="PubMed reference 56">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830624" aria-label="PubMed Central reference 56">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 56" href="http://scholar.google.com/scholar_lookup?&amp;title=Clinical%20characteristics%20and%20outcomes%20among%20adults%20hospitalized%20with%20laboratory-confirmed%20SARS-CoV-2%20infection%20during%20periods%20of%20B.%201.617.%202%20%28Delta%29%20and%20B.%201.1.%20529%20%28Omicron%29%20variant%20predominance%E2%80%94one%20hospital%2C%20California%2C%20July%2015%E2%80%93September%2023%2C%202021%2C%20and%20December%2021%2C%202021%E2%80%93January%2027%2C%202022&amp;journal=MMWR%20Morb.%20Mortal.%20Wkly%20Rep.&amp;doi=10.15585%2Fmmwr.mm7106e2&amp;volume=71&amp;pages=217-223&amp;publication_year=2022&amp;author=Modes%2CME">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="57."><p class="c-article-references__text" id="ref-CR57">Piroth, L. et al. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. <i>Lancet Respiratory Med.</i> <b>9</b>, 251–259 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S2213-2600(20)30527-0" data-track-item_id="10.1016/S2213-2600(20)30527-0" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS2213-2600%2820%2930527-0" aria-label="Article reference 57" data-doi="10.1016/S2213-2600(20)30527-0">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXks1WlsQ%3D%3D" aria-label="CAS reference 57">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 57" href="http://scholar.google.com/scholar_lookup?&amp;title=Comparison%20of%20the%20characteristics%2C%20morbidity%2C%20and%20mortality%20of%20COVID-19%20and%20seasonal%20influenza%3A%20a%20nationwide%2C%20population-based%20retrospective%20cohort%20study&amp;journal=Lancet%20Respiratory%20Med.&amp;doi=10.1016%2FS2213-2600%2820%2930527-0&amp;volume=9&amp;pages=251-259&amp;publication_year=2021&amp;author=Piroth%2CL">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="58."><p class="c-article-references__text" id="ref-CR58">Rees, E. M. et al. COVID-19 length of hospital stay: a systematic review and data synthesis. <i>BMC Med.</i> <b>18</b>, 270 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1186/s12916-020-01726-3" data-track-item_id="10.1186/s12916-020-01726-3" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s12916-020-01726-3" aria-label="Article reference 58" data-doi="10.1186/s12916-020-01726-3">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXhslOgsbbI" aria-label="CAS reference 58">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32878619" aria-label="PubMed reference 58">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467845" aria-label="PubMed Central reference 58">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 58" href="http://scholar.google.com/scholar_lookup?&amp;title=COVID-19%20length%20of%20hospital%20stay%3A%20a%20systematic%20review%20and%20data%20synthesis&amp;journal=BMC%20Med.&amp;doi=10.1186%2Fs12916-020-01726-3&amp;volume=18&amp;publication_year=2020&amp;author=Rees%2CEM">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="59."><p class="c-article-references__text" id="ref-CR59">Lefrancq, N. et al. Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: a retrospective national surveillance data analysis. <i>Lancet Regional Health – Eur.</i> <b>5</b>, 10087 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 59" href="http://scholar.google.com/scholar_lookup?&amp;title=Evolution%20of%20outcomes%20for%20patients%20hospitalised%20during%20the%20first%209%20months%20of%20the%20SARS-CoV-2%20pandemic%20in%20France%3A%20a%20retrospective%20national%20surveillance%20data%20analysis&amp;journal=Lancet%20Regional%20Health%20%E2%80%93%20Eur.&amp;volume=5&amp;publication_year=2021&amp;author=Lefrancq%2CN">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="60."><p class="c-article-references__text" id="ref-CR60">Zhang, J. et al. Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study. <i>Lancet Infect. Dis.</i> <b>20</b>, 793–802 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S1473-3099(20)30230-9" data-track-item_id="10.1016/S1473-3099(20)30230-9" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS1473-3099%2820%2930230-9" aria-label="Article reference 60" data-doi="10.1016/S1473-3099(20)30230-9">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXmsVChsLs%3D" aria-label="CAS reference 60">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32247326" aria-label="PubMed reference 60">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269887" aria-label="PubMed Central reference 60">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 60" href="http://scholar.google.com/scholar_lookup?&amp;title=Evolving%20epidemiology%20and%20transmission%20dynamics%20of%20coronavirus%20disease%202019%20outside%20Hubei%20province%2C%20China%3A%20a%20descriptive%20and%20modelling%20study&amp;journal=Lancet%20Infect.%20Dis.&amp;doi=10.1016%2FS1473-3099%2820%2930230-9&amp;volume=20&amp;pages=793-802&amp;publication_year=2020&amp;author=Zhang%2CJ">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="61."><p class="c-article-references__text" id="ref-CR61">Marziano, V. et al. The effect of COVID-19 vaccination in Italy and perspectives for living with the virus. <i>Nat. Commun.</i> <b>12</b>, 7272 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41467-021-27532-w" data-track-item_id="10.1038/s41467-021-27532-w" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41467-021-27532-w" aria-label="Article reference 61" data-doi="10.1038/s41467-021-27532-w">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXislCjtb3N" aria-label="CAS reference 61">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34907206" aria-label="PubMed reference 61">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671442" aria-label="PubMed Central reference 61">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 61" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20effect%20of%20COVID-19%20vaccination%20in%20Italy%20and%20perspectives%20for%20living%20with%20the%20virus&amp;journal=Nat.%20Commun.&amp;doi=10.1038%2Fs41467-021-27532-w&amp;volume=12&amp;publication_year=2021&amp;author=Marziano%2CV">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="62."><p class="c-article-references__text" id="ref-CR62">Poletti, P. et al. Association of age with likelihood of developing symptoms and critical disease among close contacts exposed to patients with confirmed SARS-CoV-2 infection in Italy. <i>JAMA Netw. Open</i> <b>4</b>, e211085–e211085 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1001/jamanetworkopen.2021.1085" data-track-item_id="10.1001/jamanetworkopen.2021.1085" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1001%2Fjamanetworkopen.2021.1085" aria-label="Article reference 62" data-doi="10.1001/jamanetworkopen.2021.1085">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33688964" aria-label="PubMed reference 62">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948061" aria-label="PubMed Central reference 62">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 62" href="http://scholar.google.com/scholar_lookup?&amp;title=Association%20of%20age%20with%20likelihood%20of%20developing%20symptoms%20and%20critical%20disease%20among%20close%20contacts%20exposed%20to%20patients%20with%20confirmed%20SARS-CoV-2%20infection%20in%20Italy&amp;journal=JAMA%20Netw.%20Open&amp;doi=10.1001%2Fjamanetworkopen.2021.1085&amp;volume=4&amp;pages=e211085-e211085&amp;publication_year=2021&amp;author=Poletti%2CP">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="63."><p class="c-article-references__text" id="ref-CR63">Situation Regarding Prevention and Control of COVID-19 Epidemic in Shanghai. <i>Shanghai Municipal Health Commission</i> (29 April 2022); <a href="http://wsjkw.sh.gov.cn/xwfbh/index.html" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="http://wsjkw.sh.gov.cn/xwfbh/index.html">http://wsjkw.sh.gov.cn/xwfbh/index.html</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="64."><p class="c-article-references__text" id="ref-CR64">Hart, W. S. et al. Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis. <i>Lancet Infect. Dis.</i> <b>22</b>, P603–P610 (2022).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S1473-3099(22)00001-9" data-track-item_id="10.1016/S1473-3099(22)00001-9" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS1473-3099%2822%2900001-9" aria-label="Article reference 64" data-doi="10.1016/S1473-3099(22)00001-9">Article</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 64" href="http://scholar.google.com/scholar_lookup?&amp;title=Generation%20time%20of%20the%20alpha%20and%20delta%20SARS-CoV-2%20variants%3A%20an%20epidemiological%20analysis&amp;journal=Lancet%20Infect.%20Dis.&amp;doi=10.1016%2FS1473-3099%2822%2900001-9&amp;volume=22&amp;pages=P603-P610&amp;publication_year=2022&amp;author=Hart%2CWS">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="65."><p class="c-article-references__text" id="ref-CR65">Yang, J. et al. Despite vaccination, China needs non-pharmaceutical interventions to prevent widespread outbreaks of COVID-19 in 2021. <i>Nat. Hum. Behav.</i> <b>5</b>, 1009–1020 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41562-021-01155-z" data-track-item_id="10.1038/s41562-021-01155-z" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41562-021-01155-z" aria-label="Article reference 65" data-doi="10.1038/s41562-021-01155-z">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34158650" aria-label="PubMed reference 65">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373613" aria-label="PubMed Central reference 65">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 65" href="http://scholar.google.com/scholar_lookup?&amp;title=Despite%20vaccination%2C%20China%20needs%20non-pharmaceutical%20interventions%20to%20prevent%20widespread%20outbreaks%20of%20COVID-19%20in%202021&amp;journal=Nat.%20Hum.%20Behav.&amp;doi=10.1038%2Fs41562-021-01155-z&amp;volume=5&amp;pages=1009-1020&amp;publication_year=2021&amp;author=Yang%2CJ">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="66."><p class="c-article-references__text" id="ref-CR66">Press conference held on situation regarding prevetion and control of COVID-19 epidemics in the coming autumn and winter season and vaccination. <i>The State Council Information Office, P.R.C.</i> (24 October 2021); <a href="http://www.gov.cn/xinwen/gwylflkjz169/index.htm" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="http://www.gov.cn/xinwen/gwylflkjz169/index.htm">http://www.gov.cn/xinwen/gwylflkjz169/index.htm</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="67."><p class="c-article-references__text" id="ref-CR67">FAQ on booster immunization for COVID-19 vaccines. <i>National Health Commission of China</i> (15 November 2021); <a href="http://www.nhc.gov.cn/xcs/s7847/202111/67a59e40580d4b4687b3ed738333f6a9.shtml" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="http://www.nhc.gov.cn/xcs/s7847/202111/67a59e40580d4b4687b3ed738333f6a9.shtml">http://www.nhc.gov.cn/xcs/s7847/202111/67a59e40580d4b4687b3ed738333f6a9.shtml</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="68."><p class="c-article-references__text" id="ref-CR68">Press conference held on situation regarding strict prevetion and control of COVID-19 epidemic. <i>The State Council Information Office, P.R.C.</i> (12 April 2022); <a href="http://www.gov.cn/xinwen/gwylflkjz192/index.htm" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="http://www.gov.cn/xinwen/gwylflkjz192/index.htm">http://www.gov.cn/xinwen/gwylflkjz192/index.htm</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="69."><p class="c-article-references__text" id="ref-CR69">Relevant requirements on organization and implementation of COVID-19 booster vaccination. <i>National Health Commission of China</i> (17 February 2022); <a href="https://m.weibo.cn/status/4737882239533991" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://m.weibo.cn/status/4737882239533991">https://m.weibo.cn/status/4737882239533991</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="70."><p class="c-article-references__text" id="ref-CR70">Chen, X. et al. Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint. <i>BMC Med.</i> <b>20</b>, 36 (2022).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1186/s12916-022-02249-9" data-track-item_id="10.1186/s12916-022-02249-9" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s12916-022-02249-9" aria-label="Article reference 70" data-doi="10.1186/s12916-022-02249-9">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35086547" aria-label="PubMed reference 70">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794738" aria-label="PubMed Central reference 70">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 70" href="http://scholar.google.com/scholar_lookup?&amp;title=Prediction%20of%20long-term%20kinetics%20of%20vaccine-elicited%20neutralizing%20antibody%20and%20time-varying%20vaccine-specific%20efficacy%20against%20the%20SARS-CoV-2%20Delta%20variant%20by%20clinical%20endpoint&amp;journal=BMC%20Med.&amp;doi=10.1186%2Fs12916-022-02249-9&amp;volume=20&amp;publication_year=2022&amp;author=Chen%2CX">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="71."><p class="c-article-references__text" id="ref-CR71">Wang, K. et al. Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants. <i>Nature</i> <b>603</b>, 919–925 (2022).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41586-022-04466-x" data-track-item_id="10.1038/s41586-022-04466-x" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41586-022-04466-x" aria-label="Article reference 71" data-doi="10.1038/s41586-022-04466-x">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XnsFGjsbg%3D" aria-label="CAS reference 71">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35090164" aria-label="PubMed reference 71">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967717" aria-label="PubMed Central reference 71">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 71" href="http://scholar.google.com/scholar_lookup?&amp;title=Memory%20B%20cell%20repertoire%20from%20triple%20vaccinees%20against%20diverse%20SARS-CoV-2%20variants&amp;journal=Nature&amp;doi=10.1038%2Fs41586-022-04466-x&amp;volume=603&amp;pages=919-925&amp;publication_year=2022&amp;author=Wang%2CK">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="72."><p class="c-article-references__text" id="ref-CR72">Zhang, Y. et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. <i>Lancet Infect. Dis.</i> <b>21</b>, 181–192 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S1473-3099(20)30843-4" data-track-item_id="10.1016/S1473-3099(20)30843-4" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS1473-3099%2820%2930843-4" aria-label="Article reference 72" data-doi="10.1016/S1473-3099(20)30843-4">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXisVert77M" aria-label="CAS reference 72">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33217362" aria-label="PubMed reference 72">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 72" href="http://scholar.google.com/scholar_lookup?&amp;title=Safety%2C%20tolerability%2C%20and%20immunogenicity%20of%20an%20inactivated%20SARS-CoV-2%20vaccine%20in%20healthy%20adults%20aged%2018-59%20years%3A%20a%20randomised%2C%20double-blind%2C%20placebo-controlled%2C%20phase%201%2F2%20clinical%20trial&amp;journal=Lancet%20Infect.%20Dis.&amp;doi=10.1016%2FS1473-3099%2820%2930843-4&amp;volume=21&amp;pages=181-192&amp;publication_year=2021&amp;author=Zhang%2CY">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="73."><p class="c-article-references__text" id="ref-CR73">Cao, Y. et al. Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine. <i>Cell Res.</i> <b>32</b>, 107–109 (2022).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41422-021-00596-5" data-track-item_id="10.1038/s41422-021-00596-5" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41422-021-00596-5" aria-label="Article reference 73" data-doi="10.1038/s41422-021-00596-5">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XlsVCju7Y%3D" aria-label="CAS reference 73">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34862467" aria-label="PubMed reference 73">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 73" href="http://scholar.google.com/scholar_lookup?&amp;title=Humoral%20immunogenicity%20and%20reactogenicity%20of%20CoronaVac%20or%20ZF2001%20booster%20after%20two%20doses%20of%20inactivated%20vaccine&amp;journal=Cell%20Res.&amp;doi=10.1038%2Fs41422-021-00596-5&amp;volume=32&amp;pages=107-109&amp;publication_year=2022&amp;author=Cao%2CY">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="74."><p class="c-article-references__text" id="ref-CR74">Pérez-Then, E. et al. Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination. <i>Nat. Med.</i> <b>28</b>, 481–485 (2022).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41591-022-01705-6" data-track-item_id="10.1038/s41591-022-01705-6" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41591-022-01705-6" aria-label="Article reference 74" data-doi="10.1038/s41591-022-01705-6">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35051990" aria-label="PubMed reference 74">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938264" aria-label="PubMed Central reference 74">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 74" href="http://scholar.google.com/scholar_lookup?&amp;title=Neutralizing%20antibodies%20against%20the%20SARS-CoV-2%20Delta%20and%20Omicron%20variants%20following%20heterologous%20CoronaVac%20plus%20BNT162b2%20booster%20vaccination&amp;journal=Nat.%20Med.&amp;doi=10.1038%2Fs41591-022-01705-6&amp;volume=28&amp;pages=481-485&amp;publication_year=2022&amp;author=P%C3%A9rez-Then%2CE">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="75."><p class="c-article-references__text" id="ref-CR75">Peiris, M. et al. Neutralizing antibody titres to SARS-CoV-2 Omicron variant and wild-type virus in those with past infection or vaccinated or boosted with mRNA BNT162b2 or inactivated CoronaVac vaccines. Preprint at <i>Res. Sq.</i> <a href="https://doi.org/10.21203/rs.3.rs-1207071/v1" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.21203/rs.3.rs-1207071/v1">https://doi.org/10.21203/rs.3.rs-1207071/v1</a> (2022).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="76."><p class="c-article-references__text" id="ref-CR76">Cameroni, E. et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. <i>Nature</i> <b>602</b>, 664–670 (2022).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41586-021-04386-2" data-track-item_id="10.1038/s41586-021-04386-2" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41586-021-04386-2" aria-label="Article reference 76" data-doi="10.1038/s41586-021-04386-2">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XjvFOktLY%3D" aria-label="CAS reference 76">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35016195" aria-label="PubMed reference 76">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 76" href="http://scholar.google.com/scholar_lookup?&amp;title=Broadly%20neutralizing%20antibodies%20overcome%20SARS-CoV-2%20Omicron%20antigenic%20shift&amp;journal=Nature&amp;doi=10.1038%2Fs41586-021-04386-2&amp;volume=602&amp;pages=664-670&amp;publication_year=2022&amp;author=Cameroni%2CE">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="77."><p class="c-article-references__text" id="ref-CR77">Pfizer’s novel COVID-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of phase 2/3 EPIC-HR study. <i>Pfizer</i> (5 November 2021); <a href="https://www.pfizer.com/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.pfizer.com/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate">https://www.pfizer.com/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate</a></p></li></ol><p class="c-article-references__download u-hide-print"><a data-track="click" data-track-action="download citation references" data-track-label="link" rel="nofollow" href="https://citation-needed.springer.com/v2/references/10.1038/s41591-022-01855-7?format=refman&amp;flavour=references">Download references<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-download-medium"></use></svg></a></p></div></div></div></section></div><section data-title="Acknowledgements"><div class="c-article-section" id="Ack1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Ack1">Acknowledgements</h2><div class="c-article-section__content" id="Ack1-content"><p>This study was supported by grants from the Key Program of the National Natural Science Foundation of China (82130093). We would like to thank B. J. Cowling, School of Public Health, Li Ka Shing Faculty of Medicine, University of Hong Kong for providing severity parameters. We would also like to thank L. Yi for assistance in figure preparation. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US National Institutes of Health.</p></div></div></section><section aria-labelledby="author-information" data-title="Author information"><div class="c-article-section" id="author-information-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="author-information">Author information</h2><div class="c-article-section__content" id="author-information-content"><span class="c-article-author-information__subtitle u-visually-hidden" id="author-notes">Author notes</span><ol class="c-article-author-information__list"><li class="c-article-author-information__item" id="na1"><p>These authors contributed equally: Jun Cai, Xiaowei Deng, Juan Yang.</p></li><li class="c-article-author-information__item" id="na2"><p>These authors jointly supervised this work: Marco Ajelli, Hongjie Yu.</p></li></ol><h3 class="c-article__sub-heading" id="affiliations">Authors and Affiliations</h3><ol class="c-article-author-affiliation__list"><li id="Aff1"><p class="c-article-author-affiliation__address">School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China</p><p class="c-article-author-affiliation__authors-list">Jun Cai,&nbsp;Xiaowei Deng,&nbsp;Juan Yang,&nbsp;Hengcong Liu,&nbsp;Zhiyuan Chen,&nbsp;Cheng Peng,&nbsp;Xinhua Chen,&nbsp;Qianhui Wu,&nbsp;Junyi Zou,&nbsp;Ruijia Sun,&nbsp;Wen Zheng,&nbsp;Zeyao Zhao,&nbsp;Wanying Lu,&nbsp;Yuxia Liang,&nbsp;Xiaoyu Zhou&nbsp;&amp;&nbsp;Hongjie Yu</p></li><li id="Aff2"><p class="c-article-author-affiliation__address">Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China</p><p class="c-article-author-affiliation__authors-list">Juan Yang&nbsp;&amp;&nbsp;Hongjie Yu</p></li><li id="Aff3"><p class="c-article-author-affiliation__address">Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD, USA</p><p class="c-article-author-affiliation__authors-list">Kaiyuan Sun</p></li><li id="Aff4"><p class="c-article-author-affiliation__address">Laboratory for Computational Epidemiology and Public Health, Department of Epidemiology and Biostatistics, Indiana University School of Public Health, Bloomington, IN, USA</p><p class="c-article-author-affiliation__authors-list">Marco Ajelli</p></li></ol><div class="u-js-hide u-hide-print" data-test="author-info"><span class="c-article__sub-heading">Authors</span><ol class="c-article-authors-search u-list-reset"><li id="auth-Jun-Cai-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Jun Cai</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Jun%20Cai" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Jun%20Cai" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Jun%20Cai%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Xiaowei-Deng-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Xiaowei Deng</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Xiaowei%20Deng" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Xiaowei%20Deng" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Xiaowei%20Deng%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Juan-Yang-Aff1-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Juan Yang</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Juan%20Yang" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Juan%20Yang" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Juan%20Yang%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Kaiyuan-Sun-Aff3"><span class="c-article-authors-search__title u-h3 js-search-name">Kaiyuan Sun</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Kaiyuan%20Sun" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Kaiyuan%20Sun" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Kaiyuan%20Sun%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Hengcong-Liu-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Hengcong Liu</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Hengcong%20Liu" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Hengcong%20Liu" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Hengcong%20Liu%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Zhiyuan-Chen-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Zhiyuan Chen</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Zhiyuan%20Chen" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Zhiyuan%20Chen" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Zhiyuan%20Chen%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Cheng-Peng-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Cheng Peng</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Cheng%20Peng" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Cheng%20Peng" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Cheng%20Peng%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Xinhua-Chen-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Xinhua Chen</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Xinhua%20Chen" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Xinhua%20Chen" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Xinhua%20Chen%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Qianhui-Wu-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Qianhui Wu</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Qianhui%20Wu" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Qianhui%20Wu" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Qianhui%20Wu%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Junyi-Zou-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Junyi Zou</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Junyi%20Zou" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Junyi%20Zou" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Junyi%20Zou%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Ruijia-Sun-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Ruijia Sun</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Ruijia%20Sun" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Ruijia%20Sun" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Ruijia%20Sun%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Wen-Zheng-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Wen Zheng</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Wen%20Zheng" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Wen%20Zheng" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Wen%20Zheng%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Zeyao-Zhao-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Zeyao Zhao</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Zeyao%20Zhao" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Zeyao%20Zhao" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Zeyao%20Zhao%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Wanying-Lu-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Wanying Lu</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Wanying%20Lu" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Wanying%20Lu" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Wanying%20Lu%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Yuxia-Liang-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Yuxia Liang</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Yuxia%20Liang" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Yuxia%20Liang" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Yuxia%20Liang%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Xiaoyu-Zhou-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Xiaoyu Zhou</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Xiaoyu%20Zhou" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Xiaoyu%20Zhou" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Xiaoyu%20Zhou%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Marco-Ajelli-Aff4"><span class="c-article-authors-search__title u-h3 js-search-name">Marco Ajelli</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Marco%20Ajelli" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Marco%20Ajelli" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Marco%20Ajelli%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Hongjie-Yu-Aff1-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Hongjie Yu</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Hongjie%20Yu" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Hongjie%20Yu" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Hongjie%20Yu%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li></ol></div><h3 class="c-article__sub-heading" id="contributions">Contributions</h3><p>H.Y. conceived, designed and supervised the study. J.C. designed the model. X.D. and H.L. developed the model. J.C., X.D., J.Y., X.C., Q.W., J.Z., W.Z., Z.Z., Z.C., W.L., Y.L. and X.Z. collected the data. K.S. and M.A. contributed to the methodology. X.D. and J.C. analyzed the model output. J.C., X.D., J.Y., K.S., M.A. and H.Y. interpreted the results. Z.C., X.D., C.P., J.C. and R.S. prepared the figures. J.C., J.Y., X.D., Z.C. and H.L. wrote the first draft of the manuscript. M.A. and K.S. critically revised the content. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.</p><h3 class="c-article__sub-heading" id="corresponding-author">Corresponding author</h3><p id="corresponding-author-list">Correspondence to
                <a id="corresp-c1" href="mailto:yhj@fudan.edu.cn">Hongjie Yu</a>.</p></div></div></section><section data-title="Ethics declarations"><div class="c-article-section" id="ethics-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="ethics">Ethics declarations</h2><div class="c-article-section__content" id="ethics-content">
              
                <h3 class="c-article__sub-heading" id="FPar4">Competing interests</h3>
                <p>H.Y. received research funding from Sanofi Pasteur, GlaxoSmithKline, Yichang HEC Changjiang Pharmaceutical Company, Shanghai Roche Pharmaceutical Company and SINOVAC Biotech Ltd. Except for research funding from SINOVAC Biotech Ltd, which is related to the data analysis of clinical trials of immunogenicity and safety of CoronaVac, the others are not related to COVID-19. M.A. has received research funding from Seqirus; the funding is not related to COVID-19. All the other authors have no competing interests.</p>
              
            </div></div></section><section data-title="Peer review"><div class="c-article-section" id="peer-review-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="peer-review">Peer review</h2><div class="c-article-section__content" id="peer-review-content">
              
              
                <h3 class="c-article__sub-heading" id="FPar3">Peer review information</h3>
                <p><i>Nature Medicine</i> thanks Gabriel Leung and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Primary handling editor: Jennifer Sargent, in collaboration with the Nature Medicine team.</p>
              
            </div></div></section><section data-title="Additional information"><div class="c-article-section" id="additional-information-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="additional-information">Additional information</h2><div class="c-article-section__content" id="additional-information-content"><p><b>Publisher’s note</b> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div></div></section><section data-title="Extended data"><div class="c-article-section" id="Sec22-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec22">Extended data</h2><div class="c-article-section__content" id="Sec22-content"><div data-test="supplementary-info"><div id="figshareContainer" class="c-article-figshare-container" data-test="figshare-container"></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig6"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 1 model structure flow diagram " href="/articles/s41591-022-01855-7/figures/6" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig6_ESM.jpg">Extended Data Fig. 1 Model structure flow diagram with transition rates between states.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p><b>a</b>, Overview of extended SEIR transmission model. <b>b</b>, Diagram of hospitalization provided symptomatic infections. <b>c</b>, Diagram of antiviral therapies provided symptomatic infections. <b>d</b>, Diagram of vaccination and waning immunity. Note that the complex infection dynamic as shown in <b>a</b> has been encapsulated within a single pink box. All states and parameters are defined in Supplementary Tables <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">3</a> and <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01855-7#MOESM1">4</a>.</p></div></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig7"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 2 comparisons between the obser" href="/articles/s41591-022-01855-7/figures/7" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig7_ESM.jpg">Extended Data Fig. 2 Comparisons between the observed epidemic curves in Shanghai and model output.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p><b>a</b>, Confirmed infections. <b>b</b>, Symptomatic infections. All data are presented as median with 2.5% and 97.5% quantiles of <i>n</i>=200 simulations.</p></div></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig8"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 3 projected demand and shortage" href="/articles/s41591-022-01855-7/figures/8" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig8_ESM.jpg">Extended Data Fig. 3 Projected demand and shortage of hospital beds and ICUs for baseline scenario across four settings from March 2022 to September 2022.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p><b>a</b>, Daily demand of hospital (non-ICU) beds per 100,000. <b>b</b>, Daily demand of ICU beds per 100,000. In <b>b</b>, the dashed lines indicate the existing number of ICU beds per 100,000 in four settings, and the inset plot shows days of shortage of ICU beds as a function of the number of insufficient ICU beds compared with the capacity of ICU beds in each setting. The curves in the inset are smoothed by B-spline with 8 d.f. China represents the ‘national average’. All data are presented as median with 2.5% and 97.5% quantiles of <i>n</i>=200 simulations.</p></div></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig9"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 4 projected covid-19 burden and" href="/articles/s41591-022-01855-7/figures/9" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig9_ESM.jpg">Extended Data Fig. 4 Projected COVID-19 burden and demands in hospital and ICU beds in China under pessimistic VE scenario compared to the baseline scenario (optimistic VE) from March 2022 to September 2022.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p><b>a</b>, Cumulative hospital (non-ICU) admissions. <b>b</b>, Cumulative ICU admissions. <b>c</b>, Cumulative deaths. <b>d</b>, Daily demand in hospital (non-ICU) beds. <b>e</b>, Daily demand in ICU beds. In <b>e</b>, the green dashed line indicates the number of ICU beds available in China. All data are presented as median with 2.5% and 97.5% quantiles of <i>n</i>=200 simulations.</p></div></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig10"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 5 projected impact of adopting " href="/articles/s41591-022-01855-7/figures/10" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig10_ESM.jpg">Extended Data Fig. 5 Projected impact of adopting individual mitigation strategies on COVID-19 burden in China under pessimistic VE scenario from March 2022 to September 2022.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p><b>a</b>, Cumulative number of hospital (non-ICU) admissions. <b>b</b>, Cumulative number of ICU admissions. <b>c</b>, Cumulative number of deaths. The scenarios indicated on <i>y</i> axis are as follows: subunit vaccines refer to using a third dose of subunit vaccines as booster after two doses of inactivated vaccines as priming. Vaccinating elderly refers to vaccinating approximately 52 million people aged ≥60 years who have not been vaccinated yet as of March 17, 2022. 50% uptake and 80% efficacy corresponds to a scenario where 50% of symptomatic cases receive an antiviral therapy with an efficacy of 80% in preventing hospitalization and death. 100% uptake and 89% efficacy corresponds to a scenario where all symptomatic cases receive an antiviral therapy with an efficacy of 89% in preventing hospitalization and death. School closure corresponds to a scenario where, on the top of baseline strategy, all schools remain closed for the duration of the epidemic. Similarly, school and workplace closure corresponds to a scenario, where on the top of baseline strategy, all schools and workplaces remain closed for the duration of the epidemic. <i>R</i><sub><i>t</i></sub>: 3.0, 2.5, and 2.0 correspond to scenarios assuming different levels of NPIs leading to reduced values of the reproduction number. Note that no strict NPIs is implemented in the baseline scenario. All data are presented as median with 2.5% and 97.5% quantiles of <i>n</i>=200 simulations.</p></div></div></div></div></div></section><section data-title="Supplementary information"><div class="c-article-section" id="Sec23-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec23">Supplementary information</h2><div class="c-article-section__content" id="Sec23-content"><div data-test="supplementary-info"><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM1"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="supplementary information" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_MOESM1_ESM.pdf" data-supp-info-image="">Supplementary Information</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Supplementary Tables 1–10 and Figs. 1–7.</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM2"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="reporting summary" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_MOESM2_ESM.pdf" data-supp-info-image="">Reporting Summary</a></h3></div></div></div></div></section><section data-title="Rights and permissions"><div class="c-article-section" id="rightslink-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="rightslink">Rights and permissions</h2><div class="c-article-section__content" id="rightslink-content">
                <p><b>Open Access</b>  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <a href="http://creativecommons.org/licenses/by/4.0/" rel="license">http://creativecommons.org/licenses/by/4.0/</a>.</p>
              <p class="c-article-rights"><a data-track="click" data-track-action="view rights and permissions" data-track-label="link" href="https://s100.copyright.com/AppDispatchServlet?title=Modeling%20transmission%20of%20SARS-CoV-2%20Omicron%20in%20China&amp;author=Jun%20Cai%20et%20al&amp;contentID=10.1038%2Fs41591-022-01855-7&amp;copyright=The%20Author%28s%29&amp;publication=1078-8956&amp;publicationDate=2022-05-10&amp;publisherName=SpringerNature&amp;orderBeanReset=true&amp;oa=CC%20BY">Reprints and permissions</a></p></div></div></section><section aria-labelledby="article-info" data-title="About this article"><div class="c-article-section" id="article-info-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="article-info">About this article</h2><div class="c-article-section__content" id="article-info-content"><div class="c-bibliographic-information"><div class="u-hide-print c-bibliographic-information__column c-bibliographic-information__column--border"><a data-crossmark="10.1038/s41591-022-01855-7" target="_blank" rel="noopener" href="https://crossmark.crossref.org/dialog/?doi=10.1038/s41591-022-01855-7" data-track="click" data-track-action="Click Crossmark" data-track-label="link" data-test="crossmark"><img loading="lazy" width="57" height="81" alt="Check for updates. Verify currency and authenticity via CrossMark" src="data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg>"></a></div><div class="c-bibliographic-information__column"><h3 class="c-article__sub-heading" id="citeas">Cite this article</h3><p class="c-bibliographic-information__citation">Cai, J., Deng, X., Yang, J. <i>et al.</i> Modeling transmission of SARS-CoV-2 Omicron in China.
                    <i>Nat Med</i> <b>28</b>, 1468–1475 (2022). https://doi.org/10.1038/s41591-022-01855-7</p><p class="c-bibliographic-information__download-citation u-hide-print"><a data-test="citation-link" data-track="click" data-track-action="download article citation" data-track-label="link" data-track-external="" rel="nofollow" href="https://citation-needed.springer.com/v2/references/10.1038/s41591-022-01855-7?format=refman&amp;flavour=citation">Download citation<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-download-medium"></use></svg></a></p><ul class="c-bibliographic-information__list" data-test="publication-history"><li class="c-bibliographic-information__list-item"><p>Received<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2022-03-22">22 March 2022</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Accepted<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2022-05-03">03 May 2022</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Published<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2022-05-10">10 May 2022</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Issue Date<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2022-07">July 2022</time></span></p></li><li class="c-bibliographic-information__list-item c-bibliographic-information__list-item--full-width"><p><abbr title="Digital Object Identifier">DOI</abbr><span class="u-hide">: </span><span class="c-bibliographic-information__value">https://doi.org/10.1038/s41591-022-01855-7</span></p></li></ul><div data-component="share-box"><div class="c-article-share-box u-display-block"><h3 class="c-article__sub-heading">Share this article</h3><p class="c-article-share-box__description">Anyone you share the following link with will be able to read this content:</p><button class="js-get-share-url c-article-share-box__button" type="button" id="get-share-url" data-track="click" data-track-label="button" data-track-external="" data-track-action="get shareable link">Get shareable link</button><div class="js-no-share-url-container u-display-none" hidden=""><p class="js-c-article-share-box__no-sharelink-info c-article-share-box__no-sharelink-info">Sorry, a shareable link is not currently available for this article.</p></div><div class="js-share-url-container u-display-none" hidden=""><p class="js-share-url c-article-share-box__only-read-input" id="share-url" data-track="click" data-track-label="button" data-track-action="select share url"></p><button class="js-copy-share-url c-article-share-box__button--link-like" type="button" id="copy-share-url" data-track="click" data-track-label="button" data-track-action="copy share url" data-track-external="">Copy to clipboard</button></div><p class="js-c-article-share-box__additional-info c-article-share-box__additional-info">
                            Provided by the Springer Nature SharedIt content-sharing initiative
                        </p></div></div><div data-component="article-info-list">
        <h3 class="c-article__sub-heading">Subjects</h3>
        <ul class="c-article-subject-list">
            <li class="c-article-subject-list__subject"><a href="/subjects/epidemiology" data-track="click" data-track-action="view subject" data-track-label="link">Epidemiology</a></li><li class="c-article-subject-list__subject"><a href="/subjects/viral-infection" data-track="click" data-track-action="view subject" data-track-label="link">Viral infection</a></li>
        </ul>
    </div></div></div></div></div></section>
            </div>

            
        <section>
            <div class="c-article-section js-article-section" id="further-reading-section" data-test="further-reading-section">
                <h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="further-reading">This article is cited by</h2>
                <div class="c-article-section__content js-collapsible-section" id="further-reading-content">
                    <ul class="c-article-further-reading__list" id="further-reading-list">
                        
                            <li class="c-article-further-reading__item js-ref-item">
                            
                                <h3 class="c-article-further-reading__title" data-test="article-title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article" data-track-label="link:Modeling-based design of adaptive control strategy for the effective preparation of ‘Disease X’" href="https://doi.org/10.1186/s12911-025-02920-0">
                                        Modeling-based design of adaptive control strategy for the effective preparation of ‘Disease X’
                                    </a>
                                </h3>
                            
                                
                                    <ul data-test="author-list" class="app-author-list app-author-list--compact app-author-list--truncated u-sans-serif u-mb-4 u-mt-auto">
                                        <li>Hao Wang</li><li>Weike Zhou</li><li>Biao Tang</li>
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>BMC Medical Informatics and Decision Making</i> (2025)</p>
                            </li>
                        
                            <li class="c-article-further-reading__item js-ref-item">
                            
                                <h3 class="c-article-further-reading__title" data-test="article-title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article" data-track-label="link:Risk perceptions, health, and policy support in China: an analysis of WeChat group posts during the COVID-19 pandemic in 2022" href="https://doi.org/10.1186/s12982-025-00474-0">
                                        Risk perceptions, health, and policy support in China: an analysis of WeChat group posts during the COVID-19 pandemic in 2022
                                    </a>
                                </h3>
                            
                                
                                    <ul data-test="author-list" class="app-author-list app-author-list--compact u-sans-serif u-mb-4 u-mt-auto">
                                        <li>Xiao Wang</li>
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>Discover Public Health</i> (2025)</p>
                            </li>
                        
                            <li class="c-article-further-reading__item js-ref-item">
                            
                                <h3 class="c-article-further-reading__title" data-test="article-title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article" data-track-label="link:Azvudine versus paxlovid for oral treatment of COVID-19 in Chinese patients" href="https://doi.org/10.1186/s12879-023-08828-2">
                                        Azvudine versus paxlovid for oral treatment of COVID-19 in Chinese patients
                                    </a>
                                </h3>
                            
                                
                                    <ul data-test="author-list" class="app-author-list app-author-list--compact u-sans-serif u-mb-4 u-mt-auto">
                                        <li>Peng Su</li><li>Cong-xian Yang</li><li>Xing-guang Wang</li>
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>BMC Infectious Diseases</i> (2024)</p>
                            </li>
                        
                            <li class="c-article-further-reading__item js-ref-item">
                            
                                <h3 class="c-article-further-reading__title" data-test="article-title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article" data-track-label="link:Clinical outcomes of Omicron infection and vaccine acceptance among pediatric liver transplant recipients: insights from a cross-sectional survey" href="https://doi.org/10.1186/s12985-024-02531-7">
                                        Clinical outcomes of Omicron infection and vaccine acceptance among pediatric liver transplant recipients: insights from a cross-sectional survey
                                    </a>
                                </h3>
                            
                                
                                    <ul data-test="author-list" class="app-author-list app-author-list--compact app-author-list--truncated u-sans-serif u-mb-4 u-mt-auto">
                                        <li>Zhigang Zheng</li><li>Yefeng Lu</li><li>Feng Xue</li>
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>Virology Journal</i> (2024)</p>
                            </li>
                        
                            <li class="c-article-further-reading__item js-ref-item">
                            
                                <h3 class="c-article-further-reading__title" data-test="article-title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article" data-track-label="link:IgG antibody response to SARS-CoV-2 infection and its influencing factors in lymphoma patients" href="https://doi.org/10.1186/s12865-024-00596-1">
                                        IgG antibody response to SARS-CoV-2 infection and its influencing factors in lymphoma patients
                                    </a>
                                </h3>
                            
                                
                                    <ul data-test="author-list" class="app-author-list app-author-list--compact app-author-list--truncated u-sans-serif u-mb-4 u-mt-auto">
                                        <li>Huan Xie</li><li>Jing Zhang</li><li>Dongfeng Zeng</li>
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>BMC Immunology</i> (2024)</p>
                            </li>
                        
                    </ul>
                </div>
            </div>
        </section>
    

        </div>
</article>
</main>

<aside class="c-article-extras u-hide-print" aria-label="Article navigation" data-component-reading-companion="" data-container-type="reading-companion" data-track-component="reading companion">
    <div class="js-context-bar-sticky-point-desktop" data-track-context="reading companion">
        

        
            
                
                    
    
        <div class="c-pdf-download u-clear-both js-pdf-download">
            <a href="/articles/s41591-022-01855-7.pdf" class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="download-pdf" data-draft-ignore="true" data-track="content_download" data-track-type="article pdf download" data-track-action="download pdf" data-track-label="link" data-track-external="" download="">
                <span class="c-pdf-download__text">Download PDF</span>
                <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#icon-download"></use></svg>
            </a>
        </div>
    

                
            
        
    </div>

    
        
    

    
    

    <div class="c-reading-companion">
        <div class="c-reading-companion__sticky" data-component="reading-companion-sticky" data-test="reading-companion-sticky" style="top: 40px;">
            <ul class="c-reading-companion__tabs" role="tablist"><li role="presentation"><button data-tab-target="sections" role="tab" id="tab-sections" aria-controls="tabpanel-sections" aria-selected="true" class="c-reading-companion__tab c-reading-companion__tab--active" data-track="click" data-track-action="sections tab" data-track-label="tab">Sections</button></li><li role="presentation"><button data-tab-target="figures" role="tab" id="tab-figures" aria-controls="tabpanel-figures" aria-selected="false" tabindex="-1" class="c-reading-companion__tab" data-track="click" data-track-action="figures tab" data-track-label="tab">Figures</button></li><li role="presentation"><button data-tab-target="references" role="tab" id="tab-references" aria-controls="tabpanel-references" aria-selected="false" tabindex="-1" class="c-reading-companion__tab" data-track="click" data-track-action="references tab" data-track-label="tab">References</button></li></ul><div class="c-reading-companion__panel c-reading-companion__sections c-reading-companion__panel--active" id="tabpanel-sections" aria-labelledby="tab-sections" role="tabpanel"><div class="c-reading-companion__scroll-pane" style="max-height: none;"><ul class="c-reading-companion__sections-list"><li id="rc-sec-Abs1" class="c-reading-companion__section-item"><a href="#Abs1" data-track="click" data-track-action="section anchor" data-track-label="link:Abstract">Abstract</a></li><li id="rc-sec-Sec1" class="c-reading-companion__section-item"><a href="#Sec1" data-track="click" data-track-action="section anchor" data-track-label="link:Main">Main</a></li><li id="rc-sec-Sec2" class="c-reading-companion__section-item"><a href="#Sec2" data-track="click" data-track-action="section anchor" data-track-label="link:Results">Results</a></li><li id="rc-sec-Sec6" class="c-reading-companion__section-item"><a href="#Sec6" data-track="click" data-track-action="section anchor" data-track-label="link:Discussion">Discussion</a></li><li id="rc-sec-Sec7" class="c-reading-companion__section-item"><a href="#Sec7" data-track="click" data-track-action="section anchor" data-track-label="link:Methods">Methods</a></li><li id="rc-sec-data-availability" class="c-reading-companion__section-item"><a href="#data-availability" data-track="click" data-track-action="section anchor" data-track-label="link:Data availability">Data availability</a></li><li id="rc-sec-code-availability" class="c-reading-companion__section-item"><a href="#code-availability" data-track="click" data-track-action="section anchor" data-track-label="link:Code availability">Code availability</a></li><li id="rc-sec-Bib1" class="c-reading-companion__section-item"><a href="#Bib1" data-track="click" data-track-action="section anchor" data-track-label="link:References">References</a></li><li id="rc-sec-Ack1" class="c-reading-companion__section-item"><a href="#Ack1" data-track="click" data-track-action="section anchor" data-track-label="link:Acknowledgements">Acknowledgements</a></li><li id="rc-sec-author-information" class="c-reading-companion__section-item"><a href="#author-information" data-track="click" data-track-action="section anchor" data-track-label="link:Author information">Author information</a></li><li id="rc-sec-ethics" class="c-reading-companion__section-item"><a href="#ethics" data-track="click" data-track-action="section anchor" data-track-label="link:Ethics declarations">Ethics declarations</a></li><li id="rc-sec-peer-review" class="c-reading-companion__section-item"><a href="#peer-review" data-track="click" data-track-action="section anchor" data-track-label="link:Peer review">Peer review</a></li><li id="rc-sec-additional-information" class="c-reading-companion__section-item"><a href="#additional-information" data-track="click" data-track-action="section anchor" data-track-label="link:Additional information">Additional information</a></li><li id="rc-sec-Sec22" class="c-reading-companion__section-item"><a href="#Sec22" data-track="click" data-track-action="section anchor" data-track-label="link:Extended data">Extended data</a></li><li id="rc-sec-Sec23" class="c-reading-companion__section-item"><a href="#Sec23" data-track="click" data-track-action="section anchor" data-track-label="link:Supplementary information">Supplementary information</a></li><li id="rc-sec-rightslink" class="c-reading-companion__section-item"><a href="#rightslink" data-track="click" data-track-action="section anchor" data-track-label="link:Rights and permissions">Rights and permissions</a></li><li id="rc-sec-article-info" class="c-reading-companion__section-item"><a href="#article-info" data-track="click" data-track-action="section anchor" data-track-label="link:About this article">About this article</a></li><li id="rc-sec-further-reading" class="c-reading-companion__section-item"><a href="#further-reading" data-track="click" data-track-action="section anchor" data-track-label="link:This article is cited by">This article is cited by</a></li></ul></div>
                <div class="u-lazy-ad-wrapper u-mt-16 u-show" data-component-mpu="" style="display: none !important;">
                    <div class="c-ad c-ad--300x250">
                        <div class="c-ad__inner">
                            <p class="c-ad__label">Advertisement</p>
                            
    <div id="div-gpt-ad-right-2" class="div-gpt-ad advert medium-rectangle js-ad text-center hide-print grade-c-hide" data-ad-type="right" data-test="right-ad" data-pa11y-ignore="" data-gpt="" data-gpt-unitpath="/285/medicine.nature.com/article" data-gpt-sizes="300x250" data-gpt-targeting="type=article;pos=right;artid=s41591-022-01855-7;doi=10.1038/s41591-022-01855-7;subjmeta=174,2514,255,308,692,699;kwrd=Epidemiology,Viral+infection">
        <noscript>
            <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/285/medicine.nature.com/article&amp;sz=300x250&amp;c=1075053391&amp;t=pos%3Dright%26type%3Darticle%26artid%3Ds41591-022-01855-7%26doi%3D10.1038/s41591-022-01855-7%26subjmeta%3D174,2514,255,308,692,699%26kwrd%3DEpidemiology,Viral+infection">
                <img data-test="gpt-advert-fallback-img"
                     src="//pubads.g.doubleclick.net/gampad/ad?iu=/285/medicine.nature.com/article&amp;sz=300x250&amp;c=1075053391&amp;t=pos%3Dright%26type%3Darticle%26artid%3Ds41591-022-01855-7%26doi%3D10.1038/s41591-022-01855-7%26subjmeta%3D174,2514,255,308,692,699%26kwrd%3DEpidemiology,Viral+infection"
                     alt="Advertisement"
                     width="300"
                     height="250"></a>
        </noscript>
    </div>

                        </div>
                    </div>
                </div>
            </div>
            <div class="c-reading-companion__panel c-reading-companion__figures c-reading-companion__panel--full-width" id="tabpanel-figures" aria-labelledby="tab-figures" role="tabpanel"><div class="c-reading-companion__scroll-pane"><ul class="c-reading-companion__figures-list"><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig1">Fig. 1: Projected SARS-CoV-2 Omicron burden in China for baseline scenario from March 2022 to September 2022.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig1_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig1_HTML.png" alt="figure 1" aria-describedby="rc-Fig1"></picture><p class="c-reading-companion__figure-links"><a href="#Fig1" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01855-7/figures/1" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig2">Fig. 2: Age-specific and overall incidence rates of different clinical outcomes across four settings (China, Shanghai, Shanxi and Shandong) under the baseline scenario from March 2022 to September 2022.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig2_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig2_HTML.png" alt="figure 2" aria-describedby="rc-Fig2"></picture><p class="c-reading-companion__figure-links"><a href="#Fig2" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01855-7/figures/2" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig3">Fig. 3: Projected demand and shortage of hospital beds and ICUs when adopting individual mitigation strategies in China under optimistic VE scenario from March 2022 to September 2022.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig3_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig3_HTML.png" alt="figure 3" aria-describedby="rc-Fig3"></picture><p class="c-reading-companion__figure-links"><a href="#Fig3" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01855-7/figures/3" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig4">Fig. 4: Projected impact of adopting individual mitigation strategies on COVID-19 burden in China under optimistic VE scenario from March 2022 to September 2022.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig4_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig4_HTML.png" alt="figure 4" aria-describedby="rc-Fig4"></picture><p class="c-reading-companion__figure-links"><a href="#Fig4" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01855-7/figures/4" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig5">Fig. 5: Projected healthcare demand and number of deaths for combined mitigation strategies under optimistic VE scenario in China from March 2022 to September 2022.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig5_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig5_HTML.png" alt="figure 5" aria-describedby="rc-Fig5"></picture><p class="c-reading-companion__figure-links"><a href="#Fig5" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01855-7/figures/5" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig6">Extended Data Fig. 1 Model structure flow diagram with transition rates between states.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig6_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig6_ESM.jpg" alt="extended data figure 6" aria-describedby="rc-Fig6"></picture><p class="c-reading-companion__figure-links"><a href="#Fig6" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01855-7/figures/6" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig7">Extended Data Fig. 2 Comparisons between the observed epidemic curves in Shanghai and model output.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig7_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig7_ESM.jpg" alt="extended data figure 7" aria-describedby="rc-Fig7"></picture><p class="c-reading-companion__figure-links"><a href="#Fig7" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01855-7/figures/7" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig8">Extended Data Fig. 3 Projected demand and shortage of hospital beds and ICUs for baseline scenario across four settings from March 2022 to September 2022.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig8_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig8_ESM.jpg" alt="extended data figure 8" aria-describedby="rc-Fig8"></picture><p class="c-reading-companion__figure-links"><a href="#Fig8" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01855-7/figures/8" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig9">Extended Data Fig. 4 Projected COVID-19 burden and demands in hospital and ICU beds in China under pessimistic VE scenario compared to the baseline scenario (optimistic VE) from March 2022 to September 2022.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig9_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig9_ESM.jpg" alt="extended data figure 9" aria-describedby="rc-Fig9"></picture><p class="c-reading-companion__figure-links"><a href="#Fig9" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01855-7/figures/9" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig10">Extended Data Fig. 5 Projected impact of adopting individual mitigation strategies on COVID-19 burden in China under pessimistic VE scenario from March 2022 to September 2022.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig10_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01855-7/MediaObjects/41591_2022_1855_Fig10_ESM.jpg" alt="extended data figure 10" aria-describedby="rc-Fig10"></picture><p class="c-reading-companion__figure-links"><a href="#Fig10" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01855-7/figures/10" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li></ul></div></div>
            <div class="c-reading-companion__panel c-reading-companion__references c-reading-companion__panel--full-width" id="tabpanel-references" aria-labelledby="tab-references" role="tabpanel"><div class="c-reading-companion__scroll-pane"><ol class="c-reading-companion__references-list c-reading-companion__references-list--numeric" data-track-context="article references sidebar"><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR1">Viana, R. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. <i>Nature</i> <b>603</b>, 679–686 (2022).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41586-022-04411-y" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41586-022-04411-y" data-track-item_id="10.1038/s41586-022-04411-y">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XntlWnsLk%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35042229" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942855" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Rapid%20epidemic%20expansion%20of%20the%20SARS-CoV-2%20Omicron%20variant%20in%20southern%20Africa&amp;journal=Nature&amp;doi=10.1038%2Fs41586-022-04411-y&amp;volume=603&amp;pages=679-686&amp;publication_year=2022&amp;author=Viana%2CR" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR2">Tracking of VOC Omicron. <i>Global Initiative of Sharing All Influenza Data (GISAID)</i> (29 January 2022); <a href="https://www.gisaid.org/hcov19-variants/" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.gisaid.org/hcov19-variants/">https://www.gisaid.org/hcov19-variants/</a></p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR3">Lyngse, F.P. SARS-CoV-2 Omicron VOC transmission in Danish households. Preprint at <i>medRXiv</i> <a href="https://doi.org/10.1101/2021.12.27.21268278" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2021.12.27.21268278">https://doi.org/10.1101/2021.12.27.21268278</a> (2021).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR4">Pearson, C.A.B. et al. Bounding the levels of transmissibility &amp; immune evasion of the Omicron variant in South Africa. Preprint at <i>medRxiv</i> <a href="https://doi.org/10.1101/2021.12.19.21268038" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2021.12.19.21268038">https://doi.org/10.1101/2021.12.19.21268038</a> (2021).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR5">Gozzi, N. et al. Preliminary modeling estimates of the relative transmissibility and immune escape of the Omicron SARS-CoV-2 variant of concern in South Africa. Preprint at <i>medRxiv</i> <a href="https://doi.org/10.1101/2022.01.04.22268721" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2022.01.04.22268721">https://doi.org/10.1101/2022.01.04.22268721</a> (2022).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR6">Lu, L. et al. Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients. <i>Clin. Infect. Dis.</i> ciab1041 (2021).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR7">Zhang, L. et al. The significant immune escape of pseudotyped SARS-CoV-2 variant omicron. <i>Emerg. Microbes Infect.</i> <b>11</b>, 1–5 (2022).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1080%2F22221751.2021.2017757" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1080/22221751.2021.2017757" data-track-item_id="10.1080/22221751.2021.2017757">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38Xms1SksQ%3D%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34890524" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=The%20significant%20immune%20escape%20of%20pseudotyped%20SARS-CoV-2%20variant%20omicron&amp;journal=Emerg.%20Microbes%20Infect.&amp;doi=10.1080%2F22221751.2021.2017757&amp;volume=11&amp;pages=1-5&amp;publication_year=2022&amp;author=Zhang%2CL" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR8">Collier, A.-R. Y. et al. Differential kinetics of immune responses elicited by covid-19 vaccines. <i>N. Engl. J. Med.</i> <b>385</b>, 2010–2012 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1056%2FNEJMc2115596" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1056/NEJMc2115596" data-track-item_id="10.1056/NEJMc2115596">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34648703" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Differential%20kinetics%20of%20immune%20responses%20elicited%20by%20covid-19%20vaccines&amp;journal=N.%20Engl.%20J.%20Med.&amp;doi=10.1056%2FNEJMc2115596&amp;volume=385&amp;pages=2010-2012&amp;publication_year=2021&amp;author=Collier%2CA-RY" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR9">Levin, E. G. et al. Waning immune humoral response to BNT162b2 covid-19 vaccine over 6 months. <i>N. Engl. J. Med.</i> <b>385</b>, e84 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1056%2FNEJMoa2114583" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1056/NEJMoa2114583" data-track-item_id="10.1056/NEJMoa2114583">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXislKlsbrN" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34614326" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Waning%20immune%20humoral%20response%20to%20BNT162b2%20covid-19%20vaccine%20over%206%20months&amp;journal=N.%20Engl.%20J.%20Med.&amp;doi=10.1056%2FNEJMoa2114583&amp;volume=385&amp;publication_year=2021&amp;author=Levin%2CEG" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR10">Xin, Q. et al. Six-month follow-up of a booster dose of coronavac: two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials. Preprint at <i>SSRN</i> <a href="https://doi.org/10.2139/ssrn.3991627" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.2139/ssrn.3991627">https://doi.org/10.2139/ssrn.3991627</a> (2021).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR11">Dan Jennifer, M. et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. <i>Science</i> <b>371</b>, eabf4063 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1126%2Fscience.abf4063" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1126/science.abf4063" data-track-item_id="10.1126/science.abf4063">Article</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Immunological%20memory%20to%20SARS-CoV-2%20assessed%20for%20up%20to%208%20months%20after%20infection&amp;journal=Science&amp;doi=10.1126%2Fscience.abf4063&amp;volume=371&amp;publication_year=2021&amp;author=Jennifer%2CM" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR12">Wheatley, A. K. et al. Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19. <i>Nat. Commun.</i> <b>12</b>, 1162 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41467-021-21444-5" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41467-021-21444-5" data-track-item_id="10.1038/s41467-021-21444-5">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXltV2htLc%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33608522" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896046" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Evolution%20of%20immune%20responses%20to%20SARS-CoV-2%20in%20mild-moderate%20COVID-19&amp;journal=Nat.%20Commun.&amp;doi=10.1038%2Fs41467-021-21444-5&amp;volume=12&amp;publication_year=2021&amp;author=Wheatley%2CAK" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR13">WHO Coronavirus (COVID-19) Dashboard. <i>World Health Organization</i> (5 March 2022); <a href="https://covid19.who.int/" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://covid19.who.int/">https://covid19.who.int/</a></p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR14">Wolter, N. et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. <i>Lancet</i> <b>399</b>, 437–446 (2022).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2FS0140-6736%2822%2900017-4" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/S0140-6736(22)00017-4" data-track-item_id="10.1016/S0140-6736(22)00017-4">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XhvFCru7Y%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35065011" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769664" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Early%20assessment%20of%20the%20clinical%20severity%20of%20the%20SARS-CoV-2%20omicron%20variant%20in%20South%20Africa%3A%20a%20data%20linkage%20study&amp;journal=Lancet&amp;doi=10.1016%2FS0140-6736%2822%2900017-4&amp;volume=399&amp;pages=437-446&amp;publication_year=2022&amp;author=Wolter%2CN" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR15">Maslo, C. et al. Characteristics and outcomes of hospitalized patients in South Africa during the COVID-19 Omicron wave compared with previous waves. <i>JAMA</i> <b>327</b>, 583–584 (2022).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1001%2Fjama.2021.24868" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1001/jama.2021.24868" data-track-item_id="10.1001/jama.2021.24868">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XktFSgs7o%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34967859" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Characteristics%20and%20outcomes%20of%20hospitalized%20patients%20in%20South%20Africa%20during%20the%20COVID-19%20Omicron%20wave%20compared%20with%20previous%20waves&amp;journal=JAMA&amp;doi=10.1001%2Fjama.2021.24868&amp;volume=327&amp;pages=583-584&amp;publication_year=2022&amp;author=Maslo%2CC" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR16">SARS-CoV-2 variants of concern and variants under investigation in England, Technical briefing: update on hospitalisation and vaccine effectiveness for Omicron VOC-21NOV-01 (B.1.1.529). <i>UK Health Security Agency</i> <a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1044481/Technical-Briefing-31-Dec-2021-Omicron_severity_update.pdf" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1044481/Technical-Briefing-31-Dec-2021-Omicron_severity_update.pdf">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1044481/Technical-Briefing-31-Dec-2021-Omicron_severity_update.pdf</a> (2021).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR17">Wang, L. et al. Incidence Rates and Clinical Outcomes of SARS-CoV-2 Infection With the Omicron and Delta Variants in Children Younger Than 5 Years in the US. <i>JAMA Pediatr.</i> e220945 (2022).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR18">Lewnard, J. A. et al. Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California. Preprint at <i>medRxiv</i> <a href="https://doi.org/10.1101/2022.01.11.22269045" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2022.01.11.22269045">https://doi.org/10.1101/2022.01.11.22269045</a> (2022).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR19">Iuliano, A. D. et al. Trends in disease severity and health care utilization during the early omicron variant period compared with previous SARS-CoV-2 high transmission periods—United States, December 2020–January 2022. <i>MMWR Morb. Mortal. Wkly Rep</i>. <b>71</b>, 146–152 (2022).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR20">Marks, K. J. et al. Hospitalizations of children and adolescents with laboratory-confirmed COVID-19—COVID-NET, 14 States, July 2021–January 2022. <i>MMWR Morb. Mortal. Wkly Rep.</i> <b>71</b>, 271–278 (2022).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.15585%2Fmmwr.mm7107e4" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.15585/mmwr.mm7107e4" data-track-item_id="10.15585/mmwr.mm7107e4">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XlvV2lsbs%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35176003" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853476" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Hospitalizations%20of%20children%20and%20adolescents%20with%20laboratory-confirmed%20COVID-19%E2%80%94COVID-NET%2C%2014%20States%2C%20July%202021%E2%80%93January%202022&amp;journal=MMWR%20Morb.%20Mortal.%20Wkly%20Rep.&amp;doi=10.15585%2Fmmwr.mm7107e4&amp;volume=71&amp;pages=271-278&amp;publication_year=2022&amp;author=Marks%2CKJ" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR21">Coronavirus (COVID-19) latest insights. <i>UK Office for National Statistics</i> . <a href="https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights">https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights</a> (2022).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR22">Press conference held on situation regarding strict prevention and control of COVID-19 epidemic. <i>The State Council Information Office, P.R.C.</i> (19 April 2022); <a href="http://www.gov.cn/xinwen/gwylflkjz193/index.htm" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="http://www.gov.cn/xinwen/gwylflkjz193/index.htm">http://www.gov.cn/xinwen/gwylflkjz193/index.htm</a></p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR23">Liu, J., Liu, M. &amp; Liang, W. The dynamic COVID-zero strategy in China. <i>China CDC Wkly.</i> <b>4</b>, 74–75 (2022).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.46234%2Fccdcw2022.015" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.46234/ccdcw2022.015" data-track-item_id="10.46234/ccdcw2022.015">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35186372" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837441" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=The%20dynamic%20COVID-zero%20strategy%20in%20China&amp;journal=China%20CDC%20Wkly.&amp;doi=10.46234%2Fccdcw2022.015&amp;volume=4&amp;pages=74-75&amp;publication_year=2022&amp;author=Liu%2CJ&amp;author=Liu%2CM&amp;author=Liang%2CW" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR24">COVID-19 Virtual Press conference transcript. <i>World Health Organization</i> (1 February 2022); <a href="https://www.who.int/publications/m/item/covid-19-virtual-press-conference-transcript-1-february-2022" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.who.int/publications/m/item/covid-19-virtual-press-conference-transcript-1-february-2022">https://www.who.int/publications/m/item/covid-19-virtual-press-conference-transcript-1-february-2022</a></p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR25">Emergency approval of Brii Biosciences’ COVID-19 neutralizing antibody combination therapy: amubarvimab/romlusevimab combination (BRII-196/BRII-198) therapy. <i>The National Medical Products Administration (NMPA) of China</i> <a href="https://www.nmpa.gov.cn/yaowen/ypjgyw/20211208212528103.html" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.nmpa.gov.cn/yaowen/ypjgyw/20211208212528103.html">https://www.nmpa.gov.cn/yaowen/ypjgyw/20211208212528103.html</a> (2021).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR26">Emergency conditional approval of Pfizer’s COVID-19 therapy: nirmatrelvir tablet/ritonavir tablet combination package (i.e., Paxlovid) importation registration. <i>The National Medical Products Administration (NMPA) of China</i> <a href="https://www.nmpa.gov.cn/yaowen/ypjgyw/20220212085753142.html" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.nmpa.gov.cn/yaowen/ypjgyw/20220212085753142.html">https://www.nmpa.gov.cn/yaowen/ypjgyw/20220212085753142.html</a> (2022).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR27">McMenamin, M. E. et al. Vaccine effectiveness of two and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong. Preprint at <i>medRxiv</i> <a href="https://doi.org/10.1101/2022.03.22.22272769" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2022.03.22.22272769">https://doi.org/10.1101/2022.03.22.22272769</a> (2022).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR28">Press conference held on situation regarding strict prevention and control of COVID-19 epidemic. <i>The State Council Information Office, P.R.C.</i> (19 March 2022); <a href="http://www.gov.cn/xinwen/gwylflkjz187/index.htm" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="http://www.gov.cn/xinwen/gwylflkjz187/index.htm">http://www.gov.cn/xinwen/gwylflkjz187/index.htm</a></p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR29">Press conference held on situation regarding prevetion and control of COVID-19 epidemic in Shanghai. <i>Shanghai Municipal Health Commission</i> (17 April 2022); <a href="https://j.eastday.com/p/1650166645036759" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://j.eastday.com/p/1650166645036759">https://j.eastday.com/p/1650166645036759</a></p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR30">Press conference held on situation regarding prevetion and control of COVID-19 epidemic in Shandong province. <i>People’s Government of Shandong Province (</i>22 March 2022); <a href="http://www.shandong.gov.cn/vipchat1//home/site/82/3788/article.html" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="http://www.shandong.gov.cn/vipchat1//home/site/82/3788/article.html">http://www.shandong.gov.cn/vipchat1//home/site/82/3788/article.html</a></p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR31">National Health Commission of China. <i>China Health Statistics Yearbook 2021</i> (China Union Medical College Press, 2021).</p><p class="c-reading-companion__reference-links"><a href="http://scholar.google.com/scholar_lookup?&amp;title=China%20Health%20Statistics%20Yearbook%202021&amp;publication_year=2021" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR32">Ranzani, O. T. et al. Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against the Omicron (B.1.1.529) variant. Preprint at <i>medRxiv</i> <a href="https://doi.org/10.1101/2022.03.30.22273193" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2022.03.30.22273193">https://doi.org/10.1101/2022.03.30.22273193</a> (2022).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR33">Brii Bio announces Amubarvimab/Romlusevimab combination received approval from NMPA as first COVID-19 neutralizing antibody combination therapy in China. <i>Brii Biosciences</i> (9 December 2021); <a href="https://www.briibio.com/news-detial.php?id=505" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.briibio.com/news-detial.php?id=505">https://www.briibio.com/news-detial.php?id=505</a></p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR34">Hammond, J. et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. <i>N. Engl. J. Med.</i> <b>386</b>, 1397–1408 (2022).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1056%2FNEJMoa2118542" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1056/NEJMoa2118542" data-track-item_id="10.1056/NEJMoa2118542">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XhtFShu73O" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35172054" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Oral%20nirmatrelvir%20for%20high-risk%2C%20nonhospitalized%20adults%20with%20Covid-19&amp;journal=N.%20Engl.%20J.%20Med.&amp;doi=10.1056%2FNEJMoa2118542&amp;volume=386&amp;pages=1397-1408&amp;publication_year=2022&amp;author=Hammond%2CJ" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR35">Barnard, R. C., Davies, N. G., Pearson, C. A. B., Jit, M. &amp; Edmunds, W. J. Projected epidemiological consequences of the Omicron SARS-CoV-2 variant in England, December 2021 to April 2022. Preprint at <i>medRxiv</i> <a href="https://doi.org/10.1101/2021.12.15.21267858" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2021.12.15.21267858">https://doi.org/10.1101/2021.12.15.21267858</a> (2021).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR36">Ranjan, R. Omicron impact in India: analysis of the ongoing COVID-19 third wave based on global data. Preprint at <i>medRxiv</i> <a href="https://doi.org/10.1101/2022.01.09.22268969" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2022.01.09.22268969">https://doi.org/10.1101/2022.01.09.22268969</a> (2022).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR37">Li, L. et al. Influenza-associated excess respiratory mortality in China, 2010–15: a population-based study. <i>Lancet Public Health</i> <b>4</b>, e473–e481 (2019).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2FS2468-2667%2819%2930163-X" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/S2468-2667(19)30163-X" data-track-item_id="10.1016/S2468-2667(19)30163-X">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31493844" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8736690" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Influenza-associated%20excess%20respiratory%20mortality%20in%20China%2C%202010%E2%80%9315%3A%20a%20population-based%20study&amp;journal=Lancet%20Public%20Health&amp;doi=10.1016%2FS2468-2667%2819%2930163-X&amp;volume=4&amp;pages=e473-e481&amp;publication_year=2019&amp;author=Li%2CL" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR38">United States: Coronavirus Pandemic Country Profile. <i>Our World in Data</i> (19 April 2022); <a href="https://ourworldindata.org/coronavirus/country/united-states" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://ourworldindata.org/coronavirus/country/united-states">https://ourworldindata.org/coronavirus/country/united-states</a></p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR39">Mesfin, Y. et al. Epidemiology of infections with SARS-CoV-2 Omicron BA.2 variant in Hong Kong, January–March 2022. Preprint at <i>medRxiv</i> <a href="https://doi.org/10.1101/2022.04.07.22273595" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1101/2022.04.07.22273595">https://doi.org/10.1101/2022.04.07.22273595</a> (2022).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR40">Rossman, H. et al. Hospital load and increased COVID-19 related mortality in Israel. <i>Nat. Commun.</i> <b>12</b>, 1904 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41467-021-22214-z" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41467-021-22214-z" data-track-item_id="10.1038/s41467-021-22214-z">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33771988" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997985" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Hospital%20load%20and%20increased%20COVID-19%20related%20mortality%20in%20Israel&amp;journal=Nat.%20Commun.&amp;doi=10.1038%2Fs41467-021-22214-z&amp;volume=12&amp;publication_year=2021&amp;author=Rossman%2CH" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR41">French, G. et al. Impact of hospital strain on excess deaths during the COVID-19 pandemic – United States, July 2020–July 2021. <i>MMWR Morb. Mortal. Wkly Rep.</i> <b>70</b>, 1613–1616 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.15585%2Fmmwr.mm7046a5" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.15585/mmwr.mm7046a5" data-track-item_id="10.15585/mmwr.mm7046a5">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXislCnsLbL" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34793414" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601411" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Impact%20of%20hospital%20strain%20on%20excess%20deaths%20during%20the%20COVID-19%20pandemic%20%E2%80%93%20United%20States%2C%20July%202020%E2%80%93July%202021&amp;journal=MMWR%20Morb.%20Mortal.%20Wkly%20Rep.&amp;doi=10.15585%2Fmmwr.mm7046a5&amp;volume=70&amp;pages=1613-1616&amp;publication_year=2021&amp;author=French%2CG" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR42">Mistry, D. et al. Inferring high-resolution human mixing patterns for disease modeling. <i>Nat. Commun.</i> <b>12</b>, 323 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41467-020-20544-y" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41467-020-20544-y" data-track-item_id="10.1038/s41467-020-20544-y">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhsVels7w%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33436609" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803761" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Inferring%20high-resolution%20human%20mixing%20patterns%20for%20disease%20modeling&amp;journal=Nat.%20Commun.&amp;doi=10.1038%2Fs41467-020-20544-y&amp;volume=12&amp;publication_year=2021&amp;author=Mistry%2CD" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR43">Davis, J. T. et al. Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave. <i>Nature</i> <b>600</b>, 127–132 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41586-021-04130-w" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41586-021-04130-w" data-track-item_id="10.1038/s41586-021-04130-w">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXisFyrsbfK" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34695837" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636257" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Cryptic%20transmission%20of%20SARS-CoV-2%20and%20the%20first%20COVID-19%20wave&amp;journal=Nature&amp;doi=10.1038%2Fs41586-021-04130-w&amp;volume=600&amp;pages=127-132&amp;publication_year=2021&amp;author=Davis%2CJT" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR44">Viner, R. M. et al. Susceptibility to SARS-CoV-2 infection among children and adolescents compared with adults: a systematic review and meta-analysis. <i>JAMA Pediatrics</i> <b>175</b>, 143–156 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1001%2Fjamapediatrics.2020.4573" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1001/jamapediatrics.2020.4573" data-track-item_id="10.1001/jamapediatrics.2020.4573">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32975552" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Susceptibility%20to%20SARS-CoV-2%20infection%20among%20children%20and%20adolescents%20compared%20with%20adults%3A%20a%20systematic%20review%20and%20meta-analysis&amp;journal=JAMA%20Pediatrics&amp;doi=10.1001%2Fjamapediatrics.2020.4573&amp;volume=175&amp;pages=143-156&amp;publication_year=2021&amp;author=Viner%2CRM" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR45">Davies, N. G. et al. Age-dependent effects in the transmission and control of COVID-19 epidemics. <i>Nat. Med.</i> <b>26</b>, 1205–1211 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41591-020-0962-9" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41591-020-0962-9" data-track-item_id="10.1038/s41591-020-0962-9">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhtFOqtL3E" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32546824" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Age-dependent%20effects%20in%20the%20transmission%20and%20control%20of%20COVID-19%20epidemics&amp;journal=Nat.%20Med.&amp;doi=10.1038%2Fs41591-020-0962-9&amp;volume=26&amp;pages=1205-1211&amp;publication_year=2020&amp;author=Davies%2CNG" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR46">Hu, S. et al. Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China. <i>Nat. Commun.</i> <b>12</b>, 1533 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41467-021-21710-6" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41467-021-21710-6" data-track-item_id="10.1038/s41467-021-21710-6">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXmsVCksbg%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33750783" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943579" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Infectivity%2C%20susceptibility%2C%20and%20risk%20factors%20associated%20with%20SARS-CoV-2%20transmission%20under%20intensive%20contact%20tracing%20in%20Hunan%2C%20China&amp;journal=Nat.%20Commun.&amp;doi=10.1038%2Fs41467-021-21710-6&amp;volume=12&amp;publication_year=2021&amp;author=Hu%2CS" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR47">Buitrago-Garcia, D. et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. <i>PLoS Med.</i> <b>17</b>, e1003346 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1371%2Fjournal.pmed.1003346" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1371/journal.pmed.1003346" data-track-item_id="10.1371/journal.pmed.1003346">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXitVCgurzK" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32960881" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508369" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Occurrence%20and%20transmission%20potential%20of%20asymptomatic%20and%20presymptomatic%20SARS-CoV-2%20infections%3A%20a%20living%20systematic%20review%20and%20meta-analysis&amp;journal=PLoS%20Med.&amp;doi=10.1371%2Fjournal.pmed.1003346&amp;volume=17&amp;publication_year=2020&amp;author=Buitrago-Garcia%2CD" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR48">Manica, M. et al. Intrinsic generation time of the SARS-CoV-2 Omicron variant: an observational study of household transmission. Preprint at <i>SSRN</i> <a href="https://doi.org/10.2139/ssrn.4068368" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.2139/ssrn.4068368">https://doi.org/10.2139/ssrn.4068368</a> (2022).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR49">Deng, X. et al. Case fatality risk of the first pandemic wave of novel coronavirus disease 2019 (COVID-19) in China. <i>Clin. Infect. Dis.</i> <b>73</b>, e79–e85 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1093%2Fcid%2Fciaa578" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1093/cid/ciaa578" data-track-item_id="10.1093/cid/ciaa578">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXhsFSitbnP" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32409826" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Case%20fatality%20risk%20of%20the%20first%20pandemic%20wave%20of%20novel%20coronavirus%20disease%202019%20%28COVID-19%29%20in%20China&amp;journal=Clin.%20Infect.%20Dis.&amp;doi=10.1093%2Fcid%2Fciaa578&amp;volume=73&amp;pages=e79-e85&amp;publication_year=2021&amp;author=Deng%2CX" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR50">Halloran, M. E., Longini, I. M., Struchiner, C. J. &amp; Longini, I. M. <i>Design and Analysis of Vaccine Studies</i> (Springer, 2010).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR51">Hansen, C. H., Michlmayr, D., Gubbels, S. M., Mølbak, K. &amp; Ethelberg, S. Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study. <i>Lancet</i> <b>397</b>, 1204–1212 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2FS0140-6736%2821%2900575-4" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/S0140-6736(21)00575-4" data-track-item_id="10.1016/S0140-6736(21)00575-4">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXntFOnsrg%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33743221" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969130" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Assessment%20of%20protection%20against%20reinfection%20with%20SARS-CoV-2%20among%204%20million%20PCR-tested%20individuals%20in%20Denmark%20in%202020%3A%20a%20population-level%20observational%20study&amp;journal=Lancet&amp;doi=10.1016%2FS0140-6736%2821%2900575-4&amp;volume=397&amp;pages=1204-1212&amp;publication_year=2021&amp;author=Hansen%2CCH&amp;author=Michlmayr%2CD&amp;author=Gubbels%2CSM&amp;author=M%C3%B8lbak%2CK&amp;author=Ethelberg%2CS" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR52">Provisional Data Analysis On COVID-19 Reported Death Cases. <i>Center for Health Protection of the Department of Health</i> (29 April 2022); <a href="https://www.covidvaccine.gov.hk/pdf/death_analysis.pdf" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.covidvaccine.gov.hk/pdf/death_analysis.pdf">https://www.covidvaccine.gov.hk/pdf/death_analysis.pdf</a></p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR53">Statistics on 5th Wave of COVID-19. <i>Center for Health Protection of the Department of Health</i> (29 April 2022); <a href="https://www.covidvaccine.gov.hk/pdf/5th_wave_statistics.pdf" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.covidvaccine.gov.hk/pdf/5th_wave_statistics.pdf">https://www.covidvaccine.gov.hk/pdf/5th_wave_statistics.pdf</a></p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR54">Modelling the fifth wave of COVID-19 in Hong Kong. <i>D24H@HKSTP and HKU WHO Collaborating Centre on Infectious Disease Epidemiology and Modelling</i> (21 March 2022); <a href="https://sph.hku.hk/en/News-And-Events/Press-Releases/2022/TBC" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://sph.hku.hk/en/News-And-Events/Press-Releases/2022/TBC">https://sph.hku.hk/en/News-And-Events/Press-Releases/2022/TBC</a></p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR55">Guan, W.-j et al. Clinical characteristics of coronavirus disease 2019 in China. <i>N. Engl. J. Med.</i> <b>382</b>, 1708–1720 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1056%2FNEJMoa2002032" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1056/NEJMoa2002032" data-track-item_id="10.1056/NEJMoa2002032">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXovVSjsb8%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32109013" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China&amp;journal=N.%20Engl.%20J.%20Med.&amp;doi=10.1056%2FNEJMoa2002032&amp;volume=382&amp;pages=1708-1720&amp;publication_year=2020&amp;author=Guan%2CW-j" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR56">Modes, M. E. et al. Clinical characteristics and outcomes among adults hospitalized with laboratory-confirmed SARS-CoV-2 infection during periods of B. 1.617. 2 (Delta) and B. 1.1. 529 (Omicron) variant predominance—one hospital, California, July 15–September 23, 2021, and December 21, 2021–January 27, 2022. <i>MMWR Morb. Mortal. Wkly Rep.</i> <b>71</b>, 217–223 (2022).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.15585%2Fmmwr.mm7106e2" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.15585/mmwr.mm7106e2" data-track-item_id="10.15585/mmwr.mm7106e2">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XlvV2mtbk%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35143466" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830624" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Clinical%20characteristics%20and%20outcomes%20among%20adults%20hospitalized%20with%20laboratory-confirmed%20SARS-CoV-2%20infection%20during%20periods%20of%20B.%201.617.%202%20%28Delta%29%20and%20B.%201.1.%20529%20%28Omicron%29%20variant%20predominance%E2%80%94one%20hospital%2C%20California%2C%20July%2015%E2%80%93September%2023%2C%202021%2C%20and%20December%2021%2C%202021%E2%80%93January%2027%2C%202022&amp;journal=MMWR%20Morb.%20Mortal.%20Wkly%20Rep.&amp;doi=10.15585%2Fmmwr.mm7106e2&amp;volume=71&amp;pages=217-223&amp;publication_year=2022&amp;author=Modes%2CME" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR57">Piroth, L. et al. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. <i>Lancet Respiratory Med.</i> <b>9</b>, 251–259 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2FS2213-2600%2820%2930527-0" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/S2213-2600(20)30527-0" data-track-item_id="10.1016/S2213-2600(20)30527-0">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXks1WlsQ%3D%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Comparison%20of%20the%20characteristics%2C%20morbidity%2C%20and%20mortality%20of%20COVID-19%20and%20seasonal%20influenza%3A%20a%20nationwide%2C%20population-based%20retrospective%20cohort%20study&amp;journal=Lancet%20Respiratory%20Med.&amp;doi=10.1016%2FS2213-2600%2820%2930527-0&amp;volume=9&amp;pages=251-259&amp;publication_year=2021&amp;author=Piroth%2CL" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR58">Rees, E. M. et al. COVID-19 length of hospital stay: a systematic review and data synthesis. <i>BMC Med.</i> <b>18</b>, 270 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://link.springer.com/doi/10.1186/s12916-020-01726-3" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1186/s12916-020-01726-3" data-track-item_id="10.1186/s12916-020-01726-3">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhslOgsbbI" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32878619" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467845" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=COVID-19%20length%20of%20hospital%20stay%3A%20a%20systematic%20review%20and%20data%20synthesis&amp;journal=BMC%20Med.&amp;doi=10.1186%2Fs12916-020-01726-3&amp;volume=18&amp;publication_year=2020&amp;author=Rees%2CEM" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR59">Lefrancq, N. et al. Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: a retrospective national surveillance data analysis. <i>Lancet Regional Health – Eur.</i> <b>5</b>, 10087 (2021).</p><p class="c-reading-companion__reference-links"><a href="http://scholar.google.com/scholar_lookup?&amp;title=Evolution%20of%20outcomes%20for%20patients%20hospitalised%20during%20the%20first%209%20months%20of%20the%20SARS-CoV-2%20pandemic%20in%20France%3A%20a%20retrospective%20national%20surveillance%20data%20analysis&amp;journal=Lancet%20Regional%20Health%20%E2%80%93%20Eur.&amp;volume=5&amp;publication_year=2021&amp;author=Lefrancq%2CN" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR60">Zhang, J. et al. Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study. <i>Lancet Infect. Dis.</i> <b>20</b>, 793–802 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2FS1473-3099%2820%2930230-9" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/S1473-3099(20)30230-9" data-track-item_id="10.1016/S1473-3099(20)30230-9">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXmsVChsLs%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32247326" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269887" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Evolving%20epidemiology%20and%20transmission%20dynamics%20of%20coronavirus%20disease%202019%20outside%20Hubei%20province%2C%20China%3A%20a%20descriptive%20and%20modelling%20study&amp;journal=Lancet%20Infect.%20Dis.&amp;doi=10.1016%2FS1473-3099%2820%2930230-9&amp;volume=20&amp;pages=793-802&amp;publication_year=2020&amp;author=Zhang%2CJ" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR61">Marziano, V. et al. The effect of COVID-19 vaccination in Italy and perspectives for living with the virus. <i>Nat. Commun.</i> <b>12</b>, 7272 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41467-021-27532-w" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41467-021-27532-w" data-track-item_id="10.1038/s41467-021-27532-w">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3MXislCjtb3N" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34907206" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671442" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=The%20effect%20of%20COVID-19%20vaccination%20in%20Italy%20and%20perspectives%20for%20living%20with%20the%20virus&amp;journal=Nat.%20Commun.&amp;doi=10.1038%2Fs41467-021-27532-w&amp;volume=12&amp;publication_year=2021&amp;author=Marziano%2CV" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR62">Poletti, P. et al. Association of age with likelihood of developing symptoms and critical disease among close contacts exposed to patients with confirmed SARS-CoV-2 infection in Italy. <i>JAMA Netw. Open</i> <b>4</b>, e211085–e211085 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1001%2Fjamanetworkopen.2021.1085" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1001/jamanetworkopen.2021.1085" data-track-item_id="10.1001/jamanetworkopen.2021.1085">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33688964" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948061" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Association%20of%20age%20with%20likelihood%20of%20developing%20symptoms%20and%20critical%20disease%20among%20close%20contacts%20exposed%20to%20patients%20with%20confirmed%20SARS-CoV-2%20infection%20in%20Italy&amp;journal=JAMA%20Netw.%20Open&amp;doi=10.1001%2Fjamanetworkopen.2021.1085&amp;volume=4&amp;pages=e211085-e211085&amp;publication_year=2021&amp;author=Poletti%2CP" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR63">Situation Regarding Prevention and Control of COVID-19 Epidemic in Shanghai. <i>Shanghai Municipal Health Commission</i> (29 April 2022); <a href="http://wsjkw.sh.gov.cn/xwfbh/index.html" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="http://wsjkw.sh.gov.cn/xwfbh/index.html">http://wsjkw.sh.gov.cn/xwfbh/index.html</a></p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR64">Hart, W. S. et al. Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis. <i>Lancet Infect. Dis.</i> <b>22</b>, P603–P610 (2022).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2FS1473-3099%2822%2900001-9" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/S1473-3099(22)00001-9" data-track-item_id="10.1016/S1473-3099(22)00001-9">Article</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Generation%20time%20of%20the%20alpha%20and%20delta%20SARS-CoV-2%20variants%3A%20an%20epidemiological%20analysis&amp;journal=Lancet%20Infect.%20Dis.&amp;doi=10.1016%2FS1473-3099%2822%2900001-9&amp;volume=22&amp;pages=P603-P610&amp;publication_year=2022&amp;author=Hart%2CWS" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR65">Yang, J. et al. Despite vaccination, China needs non-pharmaceutical interventions to prevent widespread outbreaks of COVID-19 in 2021. <i>Nat. Hum. Behav.</i> <b>5</b>, 1009–1020 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41562-021-01155-z" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41562-021-01155-z" data-track-item_id="10.1038/s41562-021-01155-z">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34158650" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373613" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Despite%20vaccination%2C%20China%20needs%20non-pharmaceutical%20interventions%20to%20prevent%20widespread%20outbreaks%20of%20COVID-19%20in%202021&amp;journal=Nat.%20Hum.%20Behav.&amp;doi=10.1038%2Fs41562-021-01155-z&amp;volume=5&amp;pages=1009-1020&amp;publication_year=2021&amp;author=Yang%2CJ" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR66">Press conference held on situation regarding prevetion and control of COVID-19 epidemics in the coming autumn and winter season and vaccination. <i>The State Council Information Office, P.R.C.</i> (24 October 2021); <a href="http://www.gov.cn/xinwen/gwylflkjz169/index.htm" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="http://www.gov.cn/xinwen/gwylflkjz169/index.htm">http://www.gov.cn/xinwen/gwylflkjz169/index.htm</a></p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR67">FAQ on booster immunization for COVID-19 vaccines. <i>National Health Commission of China</i> (15 November 2021); <a href="http://www.nhc.gov.cn/xcs/s7847/202111/67a59e40580d4b4687b3ed738333f6a9.shtml" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="http://www.nhc.gov.cn/xcs/s7847/202111/67a59e40580d4b4687b3ed738333f6a9.shtml">http://www.nhc.gov.cn/xcs/s7847/202111/67a59e40580d4b4687b3ed738333f6a9.shtml</a></p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR68">Press conference held on situation regarding strict prevetion and control of COVID-19 epidemic. <i>The State Council Information Office, P.R.C.</i> (12 April 2022); <a href="http://www.gov.cn/xinwen/gwylflkjz192/index.htm" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="http://www.gov.cn/xinwen/gwylflkjz192/index.htm">http://www.gov.cn/xinwen/gwylflkjz192/index.htm</a></p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR69">Relevant requirements on organization and implementation of COVID-19 booster vaccination. <i>National Health Commission of China</i> (17 February 2022); <a href="https://m.weibo.cn/status/4737882239533991" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://m.weibo.cn/status/4737882239533991">https://m.weibo.cn/status/4737882239533991</a></p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR70">Chen, X. et al. Prediction of long-term kinetics of vaccine-elicited neutralizing antibody and time-varying vaccine-specific efficacy against the SARS-CoV-2 Delta variant by clinical endpoint. <i>BMC Med.</i> <b>20</b>, 36 (2022).</p><p class="c-reading-companion__reference-links"><a href="https://link.springer.com/doi/10.1186/s12916-022-02249-9" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1186/s12916-022-02249-9" data-track-item_id="10.1186/s12916-022-02249-9">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35086547" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794738" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Prediction%20of%20long-term%20kinetics%20of%20vaccine-elicited%20neutralizing%20antibody%20and%20time-varying%20vaccine-specific%20efficacy%20against%20the%20SARS-CoV-2%20Delta%20variant%20by%20clinical%20endpoint&amp;journal=BMC%20Med.&amp;doi=10.1186%2Fs12916-022-02249-9&amp;volume=20&amp;publication_year=2022&amp;author=Chen%2CX" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR71">Wang, K. et al. Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants. <i>Nature</i> <b>603</b>, 919–925 (2022).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41586-022-04466-x" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41586-022-04466-x" data-track-item_id="10.1038/s41586-022-04466-x">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XnsFGjsbg%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35090164" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967717" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Memory%20B%20cell%20repertoire%20from%20triple%20vaccinees%20against%20diverse%20SARS-CoV-2%20variants&amp;journal=Nature&amp;doi=10.1038%2Fs41586-022-04466-x&amp;volume=603&amp;pages=919-925&amp;publication_year=2022&amp;author=Wang%2CK" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR72">Zhang, Y. et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. <i>Lancet Infect. Dis.</i> <b>21</b>, 181–192 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2FS1473-3099%2820%2930843-4" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/S1473-3099(20)30843-4" data-track-item_id="10.1016/S1473-3099(20)30843-4">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXisVert77M" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33217362" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Safety%2C%20tolerability%2C%20and%20immunogenicity%20of%20an%20inactivated%20SARS-CoV-2%20vaccine%20in%20healthy%20adults%20aged%2018-59%20years%3A%20a%20randomised%2C%20double-blind%2C%20placebo-controlled%2C%20phase%201%2F2%20clinical%20trial&amp;journal=Lancet%20Infect.%20Dis.&amp;doi=10.1016%2FS1473-3099%2820%2930843-4&amp;volume=21&amp;pages=181-192&amp;publication_year=2021&amp;author=Zhang%2CY" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR73">Cao, Y. et al. Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine. <i>Cell Res.</i> <b>32</b>, 107–109 (2022).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41422-021-00596-5" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41422-021-00596-5" data-track-item_id="10.1038/s41422-021-00596-5">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XlsVCju7Y%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34862467" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Humoral%20immunogenicity%20and%20reactogenicity%20of%20CoronaVac%20or%20ZF2001%20booster%20after%20two%20doses%20of%20inactivated%20vaccine&amp;journal=Cell%20Res.&amp;doi=10.1038%2Fs41422-021-00596-5&amp;volume=32&amp;pages=107-109&amp;publication_year=2022&amp;author=Cao%2CY" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR74">Pérez-Then, E. et al. Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination. <i>Nat. Med.</i> <b>28</b>, 481–485 (2022).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41591-022-01705-6" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41591-022-01705-6" data-track-item_id="10.1038/s41591-022-01705-6">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35051990" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938264" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Neutralizing%20antibodies%20against%20the%20SARS-CoV-2%20Delta%20and%20Omicron%20variants%20following%20heterologous%20CoronaVac%20plus%20BNT162b2%20booster%20vaccination&amp;journal=Nat.%20Med.&amp;doi=10.1038%2Fs41591-022-01705-6&amp;volume=28&amp;pages=481-485&amp;publication_year=2022&amp;author=P%C3%A9rez-Then%2CE" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR75">Peiris, M. et al. Neutralizing antibody titres to SARS-CoV-2 Omicron variant and wild-type virus in those with past infection or vaccinated or boosted with mRNA BNT162b2 or inactivated CoronaVac vaccines. Preprint at <i>Res. Sq.</i> <a href="https://doi.org/10.21203/rs.3.rs-1207071/v1" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.21203/rs.3.rs-1207071/v1">https://doi.org/10.21203/rs.3.rs-1207071/v1</a> (2022).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR76">Cameroni, E. et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. <i>Nature</i> <b>602</b>, 664–670 (2022).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fs41586-021-04386-2" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/s41586-021-04386-2" data-track-item_id="10.1038/s41586-021-04386-2">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB38XjvFOktLY%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35016195" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Broadly%20neutralizing%20antibodies%20overcome%20SARS-CoV-2%20Omicron%20antigenic%20shift&amp;journal=Nature&amp;doi=10.1038%2Fs41586-021-04386-2&amp;volume=602&amp;pages=664-670&amp;publication_year=2022&amp;author=Cameroni%2CE" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR77">Pfizer’s novel COVID-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of phase 2/3 EPIC-HR study. <i>Pfizer</i> (5 November 2021); <a href="https://www.pfizer.com/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.pfizer.com/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate">https://www.pfizer.com/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate</a></p></li></ol></div></div>
        </div>
    </div>
</aside>
</div>


    
        
    
    
        
            
        

        
            
        
    
    <script>
        window.dataLayer = window.dataLayer || [];
        window.dataLayer.push({
            page: {
                content: {
                    fundingWidget: "true",
                        }
                    }
                });
    </script>




<footer class="composite-layer" itemscope="" itemtype="http://schema.org/Periodical">
        <meta itemprop="publisher" content="Springer Nature">
        

        <div class="u-mt-16 u-mb-16">
    <div class="u-container">
        <div class="u-display-flex u-flex-wrap u-justify-content-space-between">
            

            <div class="c-meta u-ma-0 u-flex-shrink">
                <p class="c-meta__item c-meta__type u-mt-0">
                    <span itemprop="name">
                        Nature Medicine
                    </span>
                    (<i itemprop="alternateName">Nat Med</i>)
                </p>
                
    
        <p class="c-meta__item u-mt-0">
            <abbr title="International Standard Serial Number">ISSN</abbr> <span itemprop="issn">1546-170X</span> (online)
        </p>
    

                
    
        <p class="c-meta__item u-mt-0">
            <abbr title="International Standard Serial Number">ISSN</abbr> <span itemprop="issn">1078-8956</span> (print)
        </p>
    

            </div>
        </div>
    </div>
</div>

    <div class="c-footer">
        <div class="u-hide-print" data-track-component="footer">
    <h2 class="u-visually-hidden">nature.com sitemap</h2>
    <div class="c-footer__container">
        <div class="c-footer__grid c-footer__group--separator">
            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">About Nature Portfolio</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/npg_/company_info/index.html" data-track="click" data-track-action="about us" data-track-label="link">About us</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/npg_/press_room/press_releases.html" data-track="click" data-track-action="press releases" data-track-label="link">Press releases</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://press.nature.com/" data-track="click" data-track-action="press office" data-track-label="link">Press office</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://support.nature.com/support/home" data-track="click" data-track-action="contact us" data-track-label="link">Contact us</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Discover content</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/siteindex" data-track="click" data-track-action="journals a-z" data-track-label="link">Journals A-Z</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/subjects" data-track="click" data-track-action="article by subject" data-track-label="link">Articles by subject</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.protocols.io/" data-track="click" data-track-action="protocols.io" data-track-label="link">protocols.io</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.natureindex.com/" data-track="click" data-track-action="nature index" data-track-label="link">Nature Index</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Publishing policies</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/authors/editorial_policies" data-track="click" data-track-action="Nature portfolio policies" data-track-label="link">Nature portfolio policies</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/nature-research/open-access" data-track="click" data-track-action="open access" data-track-label="link">Open access</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Author &amp; Researcher services</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/reprints" data-track="click" data-track-action="reprints and permissions" data-track-label="link">Reprints &amp; permissions</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/gp/authors/research-data" data-track="click" data-track-action="data research service" data-track-label="link">Research data</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://authorservices.springernature.com/language-editing/" data-track="click" data-track-action="language editing" data-track-label="link">Language editing</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://authorservices.springernature.com/scientific-editing/" data-track="click" data-track-action="scientific editing" data-track-label="link">Scientific editing</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://masterclasses.nature.com/" data-track="click" data-track-action="nature masterclasses" data-track-label="link">Nature Masterclasses</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://solutions.springernature.com/" data-track="click" data-track-action="research solutions" data-track-label="link">Research Solutions</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Libraries &amp; institutions</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/gp/librarians/tools-services" data-track="click" data-track-action="librarian service and tools" data-track-label="link">Librarian service &amp; tools</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/gp/librarians/manage-your-account/librarianportal" data-track="click" data-track-action="librarian portal" data-track-label="link">Librarian portal</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/openresearch/about-open-access/information-for-institutions" data-track="click" data-track-action="open research" data-track-label="link">Open research</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/gp/librarians/recommend-to-your-library" data-track="click" data-track-action="Recommend to library" data-track-label="link">Recommend to library</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Advertising &amp; partnerships</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://partnerships.nature.com/product/digital-advertising/" data-track="click" data-track-action="advertising" data-track-label="link">Advertising</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://partnerships.nature.com/" data-track="click" data-track-action="partnerships and services" data-track-label="link">Partnerships &amp; Services</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://partnerships.nature.com/media-kits/" data-track="click" data-track-action="media kits" data-track-label="link">Media kits</a>
                    </li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://partnerships.nature.com/product/branded-content-native-advertising/" data-track-action="branded content" data-track-label="link">Branded
                        content</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Professional development</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/naturecareers/" data-track="click" data-track-action="nature careers" data-track-label="link">Nature Careers</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://conferences.nature.com" data-track="click" data-track-action="nature conferences" data-track-label="link">Nature<span class="u-visually-hidden"> </span>
                        Conferences</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Regional websites</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/natafrica" data-track="click" data-track-action="nature africa" data-track-label="link">Nature Africa</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="http://www.naturechina.com" data-track="click" data-track-action="nature china" data-track-label="link">Nature China</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/nindia" data-track="click" data-track-action="nature india" data-track-label="link">Nature India</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/natitaly" data-track="click" data-track-action="nature Italy" data-track-label="link">Nature Italy</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.natureasia.com/ja-jp" data-track="click" data-track-action="nature japan" data-track-label="link">Nature Japan</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/nmiddleeast" data-track="click" data-track-action="nature middle east" data-track-label="link">Nature Middle East</a></li>
                </ul>
            </div>

        </div>
    </div>
    <div class="c-footer__container">
        <ul class="c-footer__links">
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/privacy" data-track="click" data-track-action="privacy policy" data-track-label="link">Privacy
                Policy</a></li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/cookies" data-track="click" data-track-action="use of cookies" data-track-label="link">Use
                of cookies</a></li>
            <li class="c-footer__item">
                <button class="optanon-toggle-display c-footer__link" onclick="javascript:;" data-cc-action="preferences" data-track="click" data-track-action="manage cookies" data-track-label="link">Your privacy choices/Manage cookies
                </button>
            </li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/legal-notice" data-track="click" data-track-action="legal notice" data-track-label="link">Legal
                notice</a></li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/accessibility-statement" data-track="click" data-track-action="accessibility statement" data-track-label="link">Accessibility
                statement</a></li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/terms-and-conditions" data-track="click" data-track-action="terms and conditions" data-track-label="link">Terms &amp; Conditions</a></li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/ccpa" data-track="click" data-track-action="california privacy statement" data-track-label="link">Your US state privacy rights</a></li>
            
        </ul>
    </div>
</div>


        <div class="c-footer__container">
    <a href="https://www.springernature.com/" class="c-footer__link">
        <img src="/static/images/logos/sn-logo-white-ea63208b81.svg" alt="Springer Nature" loading="lazy" width="200" height="20">
    </a>
    <p class="c-footer__legal" data-test="copyright">© 2025 Springer Nature Limited</p>
</div>

    </div>
    <div class="u-visually-hidden" aria-hidden="true">
    
    <!--?xml version="1.0" encoding="UTF-8"?--><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><defs><path id="a" d="M0 .74h56.72v55.24H0z"></path></defs><symbol id="icon-access" viewBox="0 0 18 18"><path d="m14 8c.5522847 0 1 .44771525 1 1v7h2.5c.2761424 0 .5.2238576.5.5v1.5h-18v-1.5c0-.2761424.22385763-.5.5-.5h2.5v-7c0-.55228475.44771525-1 1-1s1 .44771525 1 1v6.9996556h8v-6.9996556c0-.55228475.4477153-1 1-1zm-8 0 2 1v5l-2 1zm6 0v7l-2-1v-5zm-2.42653766-7.59857636 7.03554716 4.92488299c.4162533.29137735.5174853.86502537.226108 1.28127873-.1721584.24594054-.4534847.39241464-.7536934.39241464h-14.16284822c-.50810197 0-.92-.41189803-.92-.92 0-.30020869.1464741-.58153499.39241464-.75369337l7.03554714-4.92488299c.34432015-.2410241.80260453-.2410241 1.14692468 0zm-.57346234 2.03988748-3.65526982 2.55868888h7.31053962z" fill-rule="evenodd"></path></symbol><symbol id="icon-account" viewBox="0 0 18 18"><path d="m10.2379028 16.9048051c1.3083556-.2032362 2.5118471-.7235183 3.5294683-1.4798399-.8731327-2.5141501-2.0638925-3.935978-3.7673711-4.3188248v-1.27684611c1.1651924-.41183641 2-1.52307546 2-2.82929429 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.30621883.83480763 2.41745788 2 2.82929429v1.27684611c-1.70347856.3828468-2.89423845 1.8046747-3.76737114 4.3188248 1.01762123.7563216 2.22111275 1.2766037 3.52946833 1.4798399.40563808.0629726.81921174.0951949 1.23790281.0951949s.83226473-.0322223 1.2379028-.0951949zm4.3421782-2.1721994c1.4927655-1.4532925 2.419919-3.484675 2.419919-5.7326057 0-4.418278-3.581722-8-8-8s-8 3.581722-8 8c0 2.2479307.92715352 4.2793132 2.41991895 5.7326057.75688473-2.0164459 1.83949951-3.6071894 3.48926591-4.3218837-1.14534283-.70360829-1.90918486-1.96796271-1.90918486-3.410722 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.44275929-.763842 2.70711371-1.9091849 3.410722 1.6497664.7146943 2.7323812 2.3054378 3.4892659 4.3218837zm-5.580081 3.2673943c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"></path></symbol><symbol id="icon-alert" viewBox="0 0 18 18"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-broad" viewBox="0 0 16 16"><path d="m6.10307866 2.97190702v7.69043288l2.44965196-2.44676915c.38776071-.38730439 1.0088052-.39493524 1.38498697-.01919617.38609051.38563612.38643641 1.01053024-.00013864 1.39665039l-4.12239817 4.11754683c-.38616704.3857126-1.01187344.3861062-1.39846576-.0000311l-4.12258206-4.11773056c-.38618426-.38572979-.39254614-1.00476697-.01636437-1.38050605.38609047-.38563611 1.01018509-.38751562 1.4012233.00306241l2.44985644 2.4469734v-8.67638639c0-.54139983.43698413-.98042709.98493125-.98159081l7.89910522-.0043627c.5451687 0 .9871152.44142642.9871152.98595351s-.4419465.98595351-.9871152.98595351z" fill-rule="evenodd" transform="matrix(-1 0 0 -1 14 15)"></path></symbol><symbol id="icon-arrow-down" viewBox="0 0 16 16"><path d="m3.28337502 11.5302405 4.03074001 4.176208c.37758093.3912076.98937525.3916069 1.367372-.0000316l4.03091977-4.1763942c.3775978-.3912252.3838182-1.0190815.0160006-1.4001736-.3775061-.39113013-.9877245-.39303641-1.3700683.003106l-2.39538585 2.4818345v-11.6147896l-.00649339-.11662112c-.055753-.49733869-.46370161-.88337888-.95867408-.88337888-.49497246 0-.90292107.38604019-.95867408.88337888l-.00649338.11662112v11.6147896l-2.39518594-2.4816273c-.37913917-.39282218-.98637524-.40056175-1.35419292-.0194697-.37750607.3911302-.37784433 1.0249269.00013556 1.4165479z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-left" viewBox="0 0 16 16"><path d="m4.46975946 3.28337502-4.17620792 4.03074001c-.39120768.37758093-.39160691.98937525.0000316 1.367372l4.1763942 4.03091977c.39122514.3775978 1.01908149.3838182 1.40017357.0160006.39113012-.3775061.3930364-.9877245-.00310603-1.3700683l-2.48183446-2.39538585h11.61478958l.1166211-.00649339c.4973387-.055753.8833789-.46370161.8833789-.95867408 0-.49497246-.3860402-.90292107-.8833789-.95867408l-.1166211-.00649338h-11.61478958l2.4816273-2.39518594c.39282216-.37913917.40056173-.98637524.01946965-1.35419292-.39113012-.37750607-1.02492687-.37784433-1.41654791.00013556z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-right" viewBox="0 0 16 16"><path d="m11.5302405 12.716625 4.176208-4.03074003c.3912076-.37758093.3916069-.98937525-.0000316-1.367372l-4.1763942-4.03091981c-.3912252-.37759778-1.0190815-.38381821-1.4001736-.01600053-.39113013.37750607-.39303641.98772445.003106 1.37006824l2.4818345 2.39538588h-11.6147896l-.11662112.00649339c-.49733869.055753-.88337888.46370161-.88337888.95867408 0 .49497246.38604019.90292107.88337888.95867408l.11662112.00649338h11.6147896l-2.4816273 2.39518592c-.39282218.3791392-.40056175.9863753-.0194697 1.3541929.3911302.3775061 1.0249269.3778444 1.4165479-.0001355z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-sub" viewBox="0 0 16 16"><path d="m7.89692134 4.97190702v7.69043288l-2.44965196-2.4467692c-.38776071-.38730434-1.0088052-.39493519-1.38498697-.0191961-.38609047.3856361-.38643643 1.0105302.00013864 1.3966504l4.12239817 4.1175468c.38616704.3857126 1.01187344.3861062 1.39846576-.0000311l4.12258202-4.1177306c.3861843-.3857298.3925462-1.0047669.0163644-1.380506-.3860905-.38563612-1.0101851-.38751563-1.4012233.0030624l-2.44985643 2.4469734v-8.67638639c0-.54139983-.43698413-.98042709-.98493125-.98159081l-7.89910525-.0043627c-.54516866 0-.98711517.44142642-.98711517.98595351s.44194651.98595351.98711517.98595351z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-up" viewBox="0 0 16 16"><path d="m12.716625 4.46975946-4.03074003-4.17620792c-.37758093-.39120768-.98937525-.39160691-1.367372.0000316l-4.03091981 4.1763942c-.37759778.39122514-.38381821 1.01908149-.01600053 1.40017357.37750607.39113012.98772445.3930364 1.37006824-.00310603l2.39538588-2.48183446v11.61478958l.00649339.1166211c.055753.4973387.46370161.8833789.95867408.8833789.49497246 0 .90292107-.3860402.95867408-.8833789l.00649338-.1166211v-11.61478958l2.39518592 2.4816273c.3791392.39282216.9863753.40056173 1.3541929.01946965.3775061-.39113012.3778444-1.02492687-.0001355-1.41654791z" fill-rule="evenodd"></path></symbol><symbol id="icon-article" viewBox="0 0 18 18"><path d="m13 15v-12.9906311c0-.0073595-.0019884-.0093689.0014977-.0093689l-11.00158888.00087166v13.00506804c0 .5482678.44615281.9940603.99415146.9940603h10.27350412c-.1701701-.2941734-.2675644-.6357129-.2675644-1zm-12 .0059397v-13.00506804c0-.5562408.44704472-1.00087166.99850233-1.00087166h11.00299537c.5510129 0 .9985023.45190985.9985023 1.0093689v2.9906311h3v9.9914698c0 1.1065798-.8927712 2.0085302-1.9940603 2.0085302h-12.01187942c-1.09954652 0-1.99406028-.8927712-1.99406028-1.9940603zm13-9.0059397v9c0 .5522847.4477153 1 1 1s1-.4477153 1-1v-9zm-10-2h7v4h-7zm1 1v2h5v-2zm-1 4h7v1h-7zm0 2h7v1h-7zm0 2h7v1h-7z" fill-rule="evenodd"></path></symbol><symbol id="icon-audio" viewBox="0 0 18 18"><path d="m13.0957477 13.5588459c-.195279.1937043-.5119137.193729-.7072234.0000551-.1953098-.193674-.1953346-.5077061-.0000556-.7014104 1.0251004-1.0168342 1.6108711-2.3905226 1.6108711-3.85745208 0-1.46604976-.5850634-2.83898246-1.6090736-3.85566829-.1951894-.19379323-.1950192-.50782531.0003802-.70141028.1953993-.19358497.512034-.19341614.7072234.00037709 1.2094886 1.20083761 1.901635 2.8250555 1.901635 4.55670148 0 1.73268608-.6929822 3.35779608-1.9037571 4.55880738zm2.1233994 2.1025159c-.195234.193749-.5118687.1938462-.7072235.0002171-.1953548-.1936292-.1954528-.5076613-.0002189-.7014104 1.5832215-1.5711805 2.4881302-3.6939808 2.4881302-5.96012998 0-2.26581266-.9046382-4.3883241-2.487443-5.95944795-.1952117-.19377107-.1950777-.50780316.0002993-.70141031s.5120117-.19347426.7072234.00029682c1.7683321 1.75528196 2.7800854 4.12911258 2.7800854 6.66056144 0 2.53182498-1.0120556 4.90597838-2.7808529 6.66132328zm-14.21898205-3.6854911c-.5523759 0-1.00016505-.4441085-1.00016505-.991944v-3.96777631c0-.54783558.44778915-.99194407 1.00016505-.99194407h2.0003301l5.41965617-3.8393633c.44948677-.31842296 1.07413994-.21516983 1.39520191.23062232.12116339.16823446.18629727.36981184.18629727.57655577v12.01603479c0 .5478356-.44778914.9919441-1.00016505.9919441-.20845738 0-.41170538-.0645985-.58133413-.184766l-5.41965617-3.8393633zm0-.991944h2.32084805l5.68047235 4.0241292v-12.01603479l-5.68047235 4.02412928h-2.32084805z" fill-rule="evenodd"></path></symbol><symbol id="icon-block" viewBox="0 0 24 24"><path d="m0 0h24v24h-24z" fill-rule="evenodd"></path></symbol><symbol id="icon-book" viewBox="0 0 18 18"><path d="m4 13v-11h1v11h11v-11h-13c-.55228475 0-1 .44771525-1 1v10.2675644c.29417337-.1701701.63571286-.2675644 1-.2675644zm12 1h-13c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1h13zm0 3h-13c-1.1045695 0-2-.8954305-2-2v-12c0-1.1045695.8954305-2 2-2h13c.5522847 0 1 .44771525 1 1v14c0 .5522847-.4477153 1-1 1zm-8.5-13h6c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1 2h4c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-4c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"></path></symbol><symbol id="icon-broad" viewBox="0 0 24 24"><path d="m9.18274226 7.81v7.7999954l2.48162734-2.4816273c.3928221-.3928221 1.0219731-.4005617 1.4030652-.0194696.3911301.3911301.3914806 1.0249268-.0001404 1.4165479l-4.17620796 4.1762079c-.39120769.3912077-1.02508144.3916069-1.41671995-.0000316l-4.1763942-4.1763942c-.39122514-.3912251-.39767006-1.0190815-.01657798-1.4001736.39113012-.3911301 1.02337106-.3930364 1.41951349.0031061l2.48183446 2.4818344v-8.7999954c0-.54911294.4426881-.99439484.99778758-.99557515l8.00221246-.00442485c.5522847 0 1 .44771525 1 1s-.4477153 1-1 1z" fill-rule="evenodd" transform="matrix(-1 0 0 -1 20.182742 24.805206)"></path></symbol><symbol id="icon-calendar" viewBox="0 0 18 18"><path d="m12.5 0c.2761424 0 .5.21505737.5.49047852v.50952148h2c1.1072288 0 2 .89451376 2 2v12c0 1.1072288-.8945138 2-2 2h-12c-1.1072288 0-2-.8945138-2-2v-12c0-1.1072288.89451376-2 2-2h1v1h-1c-.55393837 0-1 .44579254-1 1v3h14v-3c0-.55393837-.4457925-1-1-1h-2v1.50952148c0 .27088381-.2319336.49047852-.5.49047852-.2761424 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.2319336-.49047852.5-.49047852zm3.5 7h-14v8c0 .5539384.44579254 1 1 1h12c.5539384 0 1-.4457925 1-1zm-11 6v1h-1v-1zm3 0v1h-1v-1zm3 0v1h-1v-1zm-6-2v1h-1v-1zm3 0v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-3-2v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-5.5-9c.27614237 0 .5.21505737.5.49047852v.50952148h5v1h-5v1.50952148c0 .27088381-.23193359.49047852-.5.49047852-.27614237 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.23193359-.49047852.5-.49047852z" fill-rule="evenodd"></path></symbol><symbol id="icon-cart" viewBox="0 0 18 18"><path d="m5 14c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm10 0c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm-10 1c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1 1-.4477153 1-1-.44771525-1-1-1zm10 0c-.5522847 0-1 .4477153-1 1s.4477153 1 1 1 1-.4477153 1-1-.4477153-1-1-1zm-12.82032249-15c.47691417 0 .88746157.33678127.98070211.80449199l.23823144 1.19501025 13.36277974.00045554c.5522847.00001882.9999659.44774934.9999659 1.00004222 0 .07084994-.0075361.14150708-.022474.2107727l-1.2908094 5.98534344c-.1007861.46742419-.5432548.80388386-1.0571651.80388386h-10.24805106c-.59173366 0-1.07142857.4477153-1.07142857 1 0 .5128358.41361449.9355072.94647737.9932723l.1249512.0067277h10.35933776c.2749512 0 .4979349.2228539.4979349.4978051 0 .2749417-.2227336.4978951-.4976753.4980063l-10.35959736.0041886c-1.18346732 0-2.14285714-.8954305-2.14285714-2 0-.6625717.34520317-1.24989198.87690425-1.61383592l-1.63768102-8.19004794c-.01312273-.06561364-.01950005-.131011-.0196107-.19547395l-1.71961253-.00064219c-.27614237 0-.5-.22385762-.5-.5 0-.27614237.22385763-.5.5-.5zm14.53193359 2.99950224h-13.11300004l1.20580469 6.02530174c.11024034-.0163252.22327998-.02480398.33844139-.02480398h10.27064786z"></path></symbol><symbol id="icon-chevron-less" viewBox="0 0 10 10"><path d="m5.58578644 4-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 -1 -1 0 9 9)"></path></symbol><symbol id="icon-chevron-more" viewBox="0 0 10 10"><path d="m5.58578644 6-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4.00000002c-.39052429.3905243-1.02368927.3905243-1.41421356 0s-.39052429-1.02368929 0-1.41421358z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 1)"></path></symbol><symbol id="icon-chevron-right" viewBox="0 0 10 10"><path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path></symbol><symbol id="icon-circle-fill" viewBox="0 0 16 16"><path d="m8 14c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule="evenodd"></path></symbol><symbol id="icon-circle" viewBox="0 0 16 16"><path d="m8 12c2.209139 0 4-1.790861 4-4s-1.790861-4-4-4-4 1.790861-4 4 1.790861 4 4 4zm0 2c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule="evenodd"></path></symbol><symbol id="icon-citation" viewBox="0 0 18 18"><path d="m8.63593473 5.99995183c2.20913897 0 3.99999997 1.79084375 3.99999997 3.99996146 0 1.40730761-.7267788 2.64486871-1.8254829 3.35783281 1.6240224.6764218 2.8754442 2.0093871 3.4610603 3.6412466l-1.0763845.000006c-.5310008-1.2078237-1.5108121-2.1940153-2.7691712-2.7181346l-.79002167-.329052v-1.023992l.63016577-.4089232c.8482885-.5504661 1.3698342-1.4895187 1.3698342-2.51898361 0-1.65683828-1.3431457-2.99996146-2.99999997-2.99996146-1.65685425 0-3 1.34312318-3 2.99996146 0 1.02946491.52154569 1.96851751 1.36983419 2.51898361l.63016581.4089232v1.023992l-.79002171.329052c-1.25835905.5241193-2.23817037 1.5103109-2.76917113 2.7181346l-1.07638453-.000006c.58561612-1.6318595 1.8370379-2.9648248 3.46106024-3.6412466-1.09870405-.7129641-1.82548287-1.9505252-1.82548287-3.35783281 0-2.20911771 1.790861-3.99996146 4-3.99996146zm7.36897597-4.99995183c1.1018574 0 1.9950893.89353404 1.9950893 2.00274083v5.994422c0 1.10608317-.8926228 2.00274087-1.9950893 2.00274087l-3.0049107-.0009037v-1l3.0049107.00091329c.5490631 0 .9950893-.44783123.9950893-1.00275046v-5.994422c0-.55646537-.4450595-1.00275046-.9950893-1.00275046h-14.00982141c-.54906309 0-.99508929.44783123-.99508929 1.00275046v5.9971821c0 .66666024.33333333.99999036 1 .99999036l2-.00091329v1l-2 .0009037c-1 0-2-.99999041-2-1.99998077v-5.9971821c0-1.10608322.8926228-2.00274083 1.99508929-2.00274083zm-8.5049107 2.9999711c.27614237 0 .5.22385547.5.5 0 .2761349-.22385763.5-.5.5h-4c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm3 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-1c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm4 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238651-.5-.5 0-.27614453.2238576-.5.5-.5z" fill-rule="evenodd"></path></symbol><symbol id="icon-close" viewBox="0 0 16 16"><path d="m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z" fill-rule="evenodd"></path></symbol><symbol id="icon-collections" viewBox="0 0 18 18"><path d="m15 4c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2h1c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-1v-1zm-4-3c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2v-9c0-1.1045695.8954305-2 2-2zm0 1h-8c-.51283584 0-.93550716.38604019-.99327227.88337887l-.00672773.11662113v9c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227zm-1.5 7c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"></path></symbol><symbol id="icon-compare" viewBox="0 0 18 18"><path d="m12 3c3.3137085 0 6 2.6862915 6 6s-2.6862915 6-6 6c-1.0928452 0-2.11744941-.2921742-2.99996061-.8026704-.88181407.5102749-1.90678042.8026704-3.00003939.8026704-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6c1.09325897 0 2.11822532.29239547 3.00096303.80325037.88158756-.51107621 1.90619177-.80325037 2.99903697-.80325037zm-6 1c-2.76142375 0-5 2.23857625-5 5 0 2.7614237 2.23857625 5 5 5 .74397391 0 1.44999672-.162488 2.08451611-.4539116-1.27652344-1.1000812-2.08451611-2.7287264-2.08451611-4.5460884s.80799267-3.44600721 2.08434391-4.5463015c-.63434719-.29121054-1.34037-.4536985-2.08434391-.4536985zm6 0c-.7439739 0-1.4499967.16248796-2.08451611.45391156 1.27652341 1.10008123 2.08451611 2.72872644 2.08451611 4.54608844s-.8079927 3.4460072-2.08434391 4.5463015c.63434721.2912105 1.34037001.4536985 2.08434391.4536985 2.7614237 0 5-2.2385763 5-5 0-2.76142375-2.2385763-5-5-5zm-1.4162763 7.0005324h-3.16744736c.15614659.3572676.35283837.6927622.58425872 1.0006671h1.99892988c.23142036-.3079049.42811216-.6433995.58425876-1.0006671zm.4162763-2.0005324h-4c0 .34288501.0345146.67770871.10025909 1.0011864h3.79948181c.0657445-.32347769.1002591-.65830139.1002591-1.0011864zm-.4158423-1.99953894h-3.16831543c-.13859957.31730812-.24521946.651783-.31578599.99935097h3.79988742c-.0705665-.34756797-.1771864-.68204285-.315786-.99935097zm-1.58295822-1.999926-.08316107.06199199c-.34550042.27081213-.65446126.58611297-.91825862.93727862h2.00044041c-.28418626-.37830727-.6207872-.71499149-.99902072-.99927061z" fill-rule="evenodd"></path></symbol><symbol id="icon-download-file" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.5046024 4c.27614237 0 .5.21637201.5.49209595v6.14827645l1.7462789-1.77990922c.1933927-.1971171.5125222-.19455839.7001689-.0069117.1932998.19329992.1910058.50899492-.0027774.70277812l-2.59089271 2.5908927c-.19483374.1948337-.51177825.1937771-.70556873-.0000133l-2.59099079-2.5909908c-.19484111-.1948411-.19043735-.5151448-.00279066-.70279146.19329987-.19329987.50465175-.19237083.70018565.00692852l1.74638684 1.78001764v-6.14827695c0-.27177709.23193359-.49209595.5-.49209595z" fill-rule="evenodd"></path></symbol><symbol id="icon-download" viewBox="0 0 16 16"><path d="m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z" fill-rule="evenodd"></path></symbol><symbol id="icon-editors" viewBox="0 0 18 18"><path d="m8.72592184 2.54588137c-.48811714-.34391207-1.08343326-.54588137-1.72592184-.54588137-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400182l-.79002171.32905522c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274v.9009805h-1v-.9009805c0-2.5479714 1.54557359-4.79153984 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4 1.09079823 0 2.07961816.43662103 2.80122451 1.1446278-.37707584.09278571-.7373238.22835063-1.07530267.40125357zm-2.72592184 14.45411863h-1v-.9009805c0-2.5479714 1.54557359-4.7915398 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.40732121-.7267788 2.64489414-1.8254829 3.3578652 2.2799093.9496145 3.8254829 3.1931829 3.8254829 5.7411543v.9009805h-1v-.9009805c0-2.1155483-1.2760206-4.0125067-3.2099783-4.8180274l-.7900217-.3290552v-1.02400184l.6301658-.40892721c.8482885-.55047139 1.3698342-1.489533 1.3698342-2.51900785 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400184l-.79002171.3290552c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274z" fill-rule="evenodd"></path></symbol><symbol id="icon-email" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-.0049107 2.55749512v1.44250488l-7 4-7-4v-1.44250488l7 4z" fill-rule="evenodd"></path></symbol><symbol id="icon-error" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z" fill-rule="evenodd"></path></symbol><symbol id="icon-ethics" viewBox="0 0 18 18"><path d="m6.76384967 1.41421356.83301651-.8330165c.77492941-.77492941 2.03133823-.77492941 2.80626762 0l.8330165.8330165c.3750728.37507276.8837806.58578644 1.4142136.58578644h1.3496361c1.1045695 0 2 .8954305 2 2v1.34963611c0 .53043298.2107137 1.03914081.5857864 1.41421356l.8330165.83301651c.7749295.77492941.7749295 2.03133823 0 2.80626762l-.8330165.8330165c-.3750727.3750728-.5857864.8837806-.5857864 1.4142136v1.3496361c0 1.1045695-.8954305 2-2 2h-1.3496361c-.530433 0-1.0391408.2107137-1.4142136.5857864l-.8330165.8330165c-.77492939.7749295-2.03133821.7749295-2.80626762 0l-.83301651-.8330165c-.37507275-.3750727-.88378058-.5857864-1.41421356-.5857864h-1.34963611c-1.1045695 0-2-.8954305-2-2v-1.3496361c0-.530433-.21071368-1.0391408-.58578644-1.4142136l-.8330165-.8330165c-.77492941-.77492939-.77492941-2.03133821 0-2.80626762l.8330165-.83301651c.37507276-.37507275.58578644-.88378058.58578644-1.41421356v-1.34963611c0-1.1045695.8954305-2 2-2h1.34963611c.53043298 0 1.03914081-.21071368 1.41421356-.58578644zm-1.41421356 1.58578644h-1.34963611c-.55228475 0-1 .44771525-1 1v1.34963611c0 .79564947-.31607052 1.55871121-.87867966 2.12132034l-.8330165.83301651c-.38440512.38440512-.38440512 1.00764896 0 1.39205408l.8330165.83301646c.56260914.5626092.87867966 1.3256709.87867966 2.1213204v1.3496361c0 .5522847.44771525 1 1 1h1.34963611c.79564947 0 1.55871121.3160705 2.12132034.8786797l.83301651.8330165c.38440512.3844051 1.00764896.3844051 1.39205408 0l.83301646-.8330165c.5626092-.5626092 1.3256709-.8786797 2.1213204-.8786797h1.3496361c.5522847 0 1-.4477153 1-1v-1.3496361c0-.7956495.3160705-1.5587112.8786797-2.1213204l.8330165-.83301646c.3844051-.38440512.3844051-1.00764896 0-1.39205408l-.8330165-.83301651c-.5626092-.56260913-.8786797-1.32567087-.8786797-2.12132034v-1.34963611c0-.55228475-.4477153-1-1-1h-1.3496361c-.7956495 0-1.5587112-.31607052-2.1213204-.87867966l-.83301646-.8330165c-.38440512-.38440512-1.00764896-.38440512-1.39205408 0l-.83301651.8330165c-.56260913.56260914-1.32567087.87867966-2.12132034.87867966zm3.58698944 11.4960218c-.02081224.002155-.04199226.0030286-.06345763.002542-.98766446-.0223875-1.93408568-.3063547-2.75885125-.8155622-.23496767-.1450683-.30784554-.4531483-.16277726-.688116.14506827-.2349677.45314827-.3078455.68811595-.1627773.67447084.4164161 1.44758575.6483839 2.25617384.6667123.01759529.0003988.03495764.0017019.05204365.0038639.01713363-.0017748.03452416-.0026845.05212715-.0026845 2.4852814 0 4.5-2.0147186 4.5-4.5 0-1.04888973-.3593547-2.04134635-1.0074477-2.83787157-.1742817-.21419731-.1419238-.5291218.0722736-.70340353.2141973-.17428173.5291218-.14192375.7034035.07227357.7919032.97327203 1.2317706 2.18808682 1.2317706 3.46900153 0 3.0375661-2.4624339 5.5-5.5 5.5-.02146768 0-.04261937-.0013529-.06337445-.0039782zm1.57975095-10.78419583c.2654788.07599731.419084.35281842.3430867.61829728-.0759973.26547885-.3528185.419084-.6182973.3430867-.37560116-.10752146-.76586237-.16587951-1.15568824-.17249193-2.5587807-.00064534-4.58547766 2.00216524-4.58547766 4.49928198 0 .62691557.12797645 1.23496.37274865 1.7964426.11035133.2531347-.0053975.5477984-.25853224.6581497-.25313473.1103514-.54779841-.0053975-.65814974-.2585322-.29947131-.6869568-.45606667-1.43097603-.45606667-2.1960601 0-3.05211432 2.47714695-5.50006595 5.59399617-5.49921198.48576182.00815502.96289603.0795037 1.42238033.21103795zm-1.9766658 6.41091303 2.69835-2.94655317c.1788432-.21040373.4943901-.23598862.7047939-.05714545.2104037.17884318.2359886.49439014.0571454.70479387l-3.01637681 3.34277395c-.18039088.1999106-.48669547.2210637-.69285412.0478478l-1.93095347-1.62240047c-.21213845-.17678204-.24080048-.49206439-.06401844-.70420284.17678204-.21213844.49206439-.24080048.70420284-.06401844z" fill-rule="evenodd"></path></symbol><symbol id="icon-expand"><path d="M7.498 11.918a.997.997 0 0 0-.003-1.411.995.995 0 0 0-1.412-.003l-4.102 4.102v-3.51A1 1 0 0 0 .98 10.09.992.992 0 0 0 0 11.092V17c0 .554.448 1.002 1.002 1.002h5.907c.554 0 1.002-.45 1.002-1.003 0-.539-.45-.978-1.006-.978h-3.51zm3.005-5.835a.997.997 0 0 0 .003 1.412.995.995 0 0 0 1.411.003l4.103-4.103v3.51a1 1 0 0 0 1.001 1.006A.992.992 0 0 0 18 6.91V1.002A1 1 0 0 0 17 0h-5.907a1.003 1.003 0 0 0-1.002 1.003c0 .539.45.978 1.006.978h3.51z" fill-rule="evenodd"></path></symbol><symbol id="icon-explore" viewBox="0 0 18 18"><path d="m9 17c4.418278 0 8-3.581722 8-8s-3.581722-8-8-8-8 3.581722-8 8 3.581722 8 8 8zm0 1c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9zm0-2.5c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5c2.969509 0 5.400504-2.3575119 5.497023-5.31714844.0090007-.27599565.2400359-.49243782.5160315-.48343711.2759957.0090007.4924378.2400359.4834371.51603155-.114093 3.4985237-2.9869632 6.284554-6.4964916 6.284554zm-.29090657-12.99359748c.27587424-.01216621.50937715.20161139.52154336.47748563.01216621.27587423-.20161139.50937715-.47748563.52154336-2.93195733.12930094-5.25315116 2.54886451-5.25315116 5.49456849 0 .27614237-.22385763.5-.5.5s-.5-.22385763-.5-.5c0-3.48142406 2.74307146-6.34074398 6.20909343-6.49359748zm1.13784138 8.04763908-1.2004882-1.20048821c-.19526215-.19526215-.19526215-.51184463 0-.70710678s.51184463-.19526215.70710678 0l1.20048821 1.2004882 1.6006509-4.00162734-4.50670359 1.80268144-1.80268144 4.50670359zm4.10281269-6.50378907-2.6692597 6.67314927c-.1016411.2541026-.3029834.4554449-.557086.557086l-6.67314927 2.6692597 2.66925969-6.67314926c.10164107-.25410266.30298336-.45544495.55708602-.55708602z" fill-rule="evenodd"></path></symbol><symbol id="icon-filter" viewBox="0 0 16 16"><path d="m14.9738641 0c.5667192 0 1.0261359.4477136 1.0261359 1 0 .24221858-.0902161.47620768-.2538899.65849851l-5.6938314 6.34147206v5.49997973c0 .3147562-.1520673.6111434-.4104543.7999971l-2.05227171 1.4999945c-.45337535.3313696-1.09655869.2418269-1.4365902-.1999993-.13321514-.1730955-.20522717-.3836284-.20522717-.5999978v-6.99997423l-5.69383133-6.34147206c-.3731872-.41563511-.32996891-1.0473954.09653074-1.41107611.18705584-.15950448.42716133-.2474224.67571519-.2474224zm-5.9218641 8.5h-2.105v6.491l.01238459.0070843.02053271.0015705.01955278-.0070558 2.0532976-1.4990996zm-8.02585008-7.5-.01564945.00240169 5.83249953 6.49759831h2.313l5.836-6.499z"></path></symbol><symbol id="icon-home" viewBox="0 0 18 18"><path d="m9 5-6 6v5h4v-4h4v4h4v-5zm7 6.5857864v4.4142136c0 .5522847-.4477153 1-1 1h-5v-4h-2v4h-5c-.55228475 0-1-.4477153-1-1v-4.4142136c-.25592232 0-.51184464-.097631-.70710678-.2928932l-.58578644-.5857864c-.39052429-.3905243-.39052429-1.02368929 0-1.41421358l8.29289322-8.29289322 8.2928932 8.29289322c.3905243.39052429.3905243 1.02368928 0 1.41421358l-.5857864.5857864c-.1952622.1952622-.4511845.2928932-.7071068.2928932zm-7-9.17157284-7.58578644 7.58578644.58578644.5857864 7-6.99999996 7 6.99999996.5857864-.5857864z" fill-rule="evenodd"></path></symbol><symbol id="icon-image" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm-3.49645283 10.1752453-3.89407257 6.7495552c.11705545.048464.24538859.0751995.37998328.0751995h10.60290092l-2.4329715-4.2154691-1.57494129 2.7288098zm8.49779013 6.8247547c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v13.98991071l4.50814957-7.81026689 3.08089884 5.33809539 1.57494129-2.7288097 3.5875735 6.2159812zm-3.0059397-11c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm0 1c-.5522847 0-1 .44771525-1 1s.4477153 1 1 1 1-.44771525 1-1-.4477153-1-1-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-info" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule="evenodd"></path></symbol><symbol id="icon-institution" viewBox="0 0 18 18"><path d="m7 16.9998189v-2.0003623h4v2.0003623h2v-3.0005434h-8v3.0005434zm-3-10.00181122h-1.52632364c-.27614237 0-.5-.22389817-.5-.50009056 0-.13995446.05863589-.27350497.16166338-.36820841l1.23156713-1.13206327h-2.36690687v12.00217346h3v-2.0003623h-3v-1.0001811h3v-1.0001811h1v-4.00072448h-1zm10 0v2.00036224h-1v4.00072448h1v1.0001811h3v1.0001811h-3v2.0003623h3v-12.00217346h-2.3695309l1.2315671 1.13206327c.2033191.186892.2166633.50325042.0298051.70660631-.0946863.10304615-.2282126.16169266-.3681417.16169266zm3-3.00054336c.5522847 0 1 .44779634 1 1.00018112v13.00235456h-18v-13.00235456c0-.55238478.44771525-1.00018112 1-1.00018112h3.45499992l4.20535144-3.86558216c.19129876-.17584288.48537447-.17584288.67667324 0l4.2053514 3.86558216zm-4 3.00054336h-8v1.00018112h8zm-2 6.00108672h1v-4.00072448h-1zm-1 0v-4.00072448h-2v4.00072448zm-3 0v-4.00072448h-1v4.00072448zm8-4.00072448c.5522847 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.4477153-1.00018112 1-1.00018112zm-12 0c.55228475 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.44771525-1.00018112 1-1.00018112zm5.99868798-7.81907007-5.24205601 4.81852671h10.48411203zm.00131202 3.81834559c-.55228475 0-1-.44779634-1-1.00018112s.44771525-1.00018112 1-1.00018112 1 .44779634 1 1.00018112-.44771525 1.00018112-1 1.00018112zm-1 11.00199236v1.0001811h2v-1.0001811z" fill-rule="evenodd"></path></symbol><symbol id="icon-location" viewBox="0 0 18 18"><path d="m9.39521328 16.2688008c.79596342-.7770119 1.59208152-1.6299956 2.33285652-2.5295081 1.4020032-1.7024324 2.4323601-3.3624519 2.9354918-4.871847.2228715-.66861448.3364384-1.29323246.3364384-1.8674457 0-3.3137085-2.6862915-6-6-6-3.36356866 0-6 2.60156856-6 6 0 .57421324.11356691 1.19883122.3364384 1.8674457.50313169 1.5093951 1.53348863 3.1694146 2.93549184 4.871847.74077492.8995125 1.53689309 1.7524962 2.33285648 2.5295081.13694479.1336842.26895677.2602648.39521328.3793207.12625651-.1190559.25826849-.2456365.39521328-.3793207zm-.39521328 1.7311992s-7-6-7-11c0-4 3.13400675-7 7-7 3.8659932 0 7 3.13400675 7 7 0 5-7 11-7 11zm0-8c-1.65685425 0-3-1.34314575-3-3s1.34314575-3 3-3c1.6568542 0 3 1.34314575 3 3s-1.3431458 3-3 3zm0-1c1.1045695 0 2-.8954305 2-2s-.8954305-2-2-2-2 .8954305-2 2 .8954305 2 2 2z" fill-rule="evenodd"></path></symbol><symbol id="icon-minus" viewBox="0 0 16 16"><path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-newsletter" viewBox="0 0 18 18"><path d="m9 11.8482489 2-1.1428571v-1.7053918h-4v1.7053918zm-3-1.7142857v-2.1339632h6v2.1339632l3-1.71428574v-6.41967746h-12v6.41967746zm10-5.3839632 1.5299989.95624934c.2923814.18273835.4700011.50320827.4700011.8479983v8.44575236c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-8.44575236c0-.34479003.1776197-.66525995.47000106-.8479983l1.52999894-.95624934v-2.75c0-.55228475.44771525-1 1-1h12c.5522847 0 1 .44771525 1 1zm0 1.17924764v3.07075236l-7 4-7-4v-3.07075236l-1 .625v8.44575236c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-8.44575236zm-10-1.92924764h6v1h-6zm-1 2h8v1h-8z" fill-rule="evenodd"></path></symbol><symbol id="icon-orcid" viewBox="0 0 18 18"><path d="m9 1c4.418278 0 8 3.581722 8 8s-3.581722 8-8 8-8-3.581722-8-8 3.581722-8 8-8zm-2.90107518 5.2732337h-1.41865256v7.1712107h1.41865256zm4.55867178.02508949h-2.99247027v7.14612121h2.91062487c.7673039 0 1.4476365-.1483432 2.0410182-.445034s1.0511995-.7152915 1.3734671-1.2558144c.3222677-.540523.4833991-1.1603247.4833991-1.85942385 0-.68545815-.1602789-1.30270225-.4808414-1.85175082-.3205625-.54904856-.7707074-.97532211-1.3504481-1.27883343-.5797408-.30351132-1.2413173-.45526471-1.9847495-.45526471zm-.1892674 1.07933542c.7877654 0 1.4143875.22336734 1.8798852.67010873.4654977.44674138.698243 1.05546001.698243 1.82617415 0 .74343221-.2310402 1.34447791-.6931277 1.80315511-.4620874.4586773-1.0750688.6880124-1.8389625.6880124h-1.46810075v-4.98745039zm-5.08652545-3.71099194c-.21825533 0-.410525.08444276-.57681478.25333081-.16628977.16888806-.24943341.36245684-.24943341.58071218 0 .22345188.08314364.41961891.24943341.58850696.16628978.16888806.35855945.25333082.57681478.25333082.233845 0 .43390938-.08314364.60019916-.24943342.16628978-.16628977.24943342-.36375592.24943342-.59240436 0-.233845-.08314364-.43131115-.24943342-.59240437s-.36635416-.24163862-.60019916-.24163862z" fill-rule="evenodd"></path></symbol><symbol id="icon-plus" viewBox="0 0 16 16"><path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-print" viewBox="0 0 18 18"><path d="m16.0049107 5h-14.00982141c-.54941618 0-.99508929.4467783-.99508929.99961498v6.00077002c0 .5570958.44271433.999615.99508929.999615h1.00491071v-3h12v3h1.0049107c.5494162 0 .9950893-.4467783.9950893-.999615v-6.00077002c0-.55709576-.4427143-.99961498-.9950893-.99961498zm-2.0049107-1v-2.00208688c0-.54777062-.4519464-.99791312-1.0085302-.99791312h-7.9829396c-.55661731 0-1.0085302.44910695-1.0085302.99791312v2.00208688zm1 10v2.0018986c0 1.103521-.9019504 1.9981014-2.0085302 1.9981014h-7.9829396c-1.1092806 0-2.0085302-.8867064-2.0085302-1.9981014v-2.0018986h-1.00491071c-1.10185739 0-1.99508929-.8874333-1.99508929-1.999615v-6.00077002c0-1.10435686.8926228-1.99961498 1.99508929-1.99961498h1.00491071v-2.00208688c0-1.10341695.90195036-1.99791312 2.0085302-1.99791312h7.9829396c1.1092806 0 2.0085302.89826062 2.0085302 1.99791312v2.00208688h1.0049107c1.1018574 0 1.9950893.88743329 1.9950893 1.99961498v6.00077002c0 1.1043569-.8926228 1.999615-1.9950893 1.999615zm-1-3h-10v5.0018986c0 .5546075.44702548.9981014 1.0085302.9981014h7.9829396c.5565964 0 1.0085302-.4491701 1.0085302-.9981014zm-9 1h8v1h-8zm0 2h5v1h-5zm9-5c-.5522847 0-1-.44771525-1-1s.4477153-1 1-1 1 .44771525 1 1-.4477153 1-1 1z" fill-rule="evenodd"></path></symbol><symbol id="icon-search" viewBox="0 0 22 22"><path d="M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z" fill-rule="evenodd"></path></symbol><symbol id="icon-social-facebook" viewBox="0 0 24 24"><path d="m6.00368507 20c-1.10660471 0-2.00368507-.8945138-2.00368507-1.9940603v-12.01187942c0-1.10128908.89451376-1.99406028 1.99406028-1.99406028h12.01187942c1.1012891 0 1.9940603.89451376 1.9940603 1.99406028v12.01187942c0 1.1012891-.88679 1.9940603-2.0032184 1.9940603h-2.9570132v-6.1960818h2.0797387l.3114113-2.414723h-2.39115v-1.54164807c0-.69911803.1941355-1.1755439 1.1966615-1.1755439l1.2786739-.00055875v-2.15974763l-.2339477-.02492088c-.3441234-.03134957-.9500153-.07025255-1.6293054-.07025255-1.8435726 0-3.1057323 1.12531866-3.1057323 3.19187953v1.78079225h-2.0850778v2.414723h2.0850778v6.1960818z" fill-rule="evenodd"></path></symbol><symbol id="icon-social-twitter" viewBox="0 0 24 24"><path d="m18.8767135 6.87445248c.7638174-.46908424 1.351611-1.21167363 1.6250764-2.09636345-.7135248.43394112-1.50406.74870123-2.3464594.91677702-.6695189-.73342162-1.6297913-1.19486605-2.6922204-1.19486605-2.0399895 0-3.6933555 1.69603749-3.6933555 3.78628909 0 .29642457.0314329.58673729.0942985.8617704-3.06469922-.15890802-5.78835241-1.66547825-7.60988389-3.9574208-.3174714.56076194-.49978171 1.21167363-.49978171 1.90536824 0 1.31404706.65223085 2.47224203 1.64236444 3.15218497-.60350999-.0198635-1.17401554-.1925232-1.67222562-.47366811v.04583885c0 1.83355406 1.27302891 3.36609966 2.96411421 3.71294696-.31118484.0886217-.63651445.1329326-.97441718.1329326-.2357461 0-.47149219-.0229194-.69466516-.0672303.47149219 1.5065703 1.83253297 2.6036468 3.44975116 2.632678-1.2651707 1.0160946-2.85724264 1.6196394-4.5891906 1.6196394-.29861172 0-.59093688-.0152796-.88011875-.0504227 1.63450624 1.0726291 3.57548241 1.6990934 5.66104951 1.6990934 6.79263079 0 10.50641749-5.7711113 10.50641749-10.7751859l-.0094298-.48894775c.7229547-.53478659 1.3516109-1.20250585 1.8419628-1.96190282-.6632323.30100846-1.3751855.50422736-2.1217148.59590507z" fill-rule="evenodd"></path></symbol><symbol id="icon-social-youtube" viewBox="0 0 24 24"><path d="m10.1415 14.3973208-.0005625-5.19318431 4.863375 2.60554491zm9.963-7.92753362c-.6845625-.73643756-1.4518125-.73990314-1.803375-.7826454-2.518875-.18714178-6.2971875-.18714178-6.2971875-.18714178-.007875 0-3.7861875 0-6.3050625.18714178-.352125.04274226-1.1188125.04620784-1.8039375.7826454-.5394375.56084773-.7149375 1.8344515-.7149375 1.8344515s-.18 1.49597903-.18 2.99138042v1.4024082c0 1.495979.18 2.9913804.18 2.9913804s.1755 1.2736038.7149375 1.8344515c.685125.7364376 1.5845625.7133337 1.9850625.7901542 1.44.1420891 6.12.1859866 6.12.1859866s3.78225-.005776 6.301125-.1929178c.3515625-.0433198 1.1188125-.0467854 1.803375-.783223.5394375-.5608477.7155-1.8344515.7155-1.8344515s.18-1.4954014.18-2.9913804v-1.4024082c0-1.49540139-.18-2.99138042-.18-2.99138042s-.1760625-1.27360377-.7155-1.8344515z" fill-rule="evenodd"></path></symbol><symbol id="icon-subject-medicine" viewBox="0 0 18 18"><path d="m12.5 8h-6.5c-1.65685425 0-3 1.34314575-3 3v1c0 1.6568542 1.34314575 3 3 3h1v-2h-.5c-.82842712 0-1.5-.6715729-1.5-1.5s.67157288-1.5 1.5-1.5h1.5 2 1 2c1.6568542 0 3-1.34314575 3-3v-1c0-1.65685425-1.3431458-3-3-3h-2v2h1.5c.8284271 0 1.5.67157288 1.5 1.5s-.6715729 1.5-1.5 1.5zm-5.5-1v-1h-3.5c-1.38071187 0-2.5-1.11928813-2.5-2.5s1.11928813-2.5 2.5-2.5h1.02786405c.46573528 0 .92507448.10843528 1.34164078.31671843l1.13382424.56691212c.06026365-1.05041141.93116291-1.88363055 1.99667093-1.88363055 1.1045695 0 2 .8954305 2 2h2c2.209139 0 4 1.790861 4 4v1c0 2.209139-1.790861 4-4 4h-2v1h2c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2h-2c0 1.1045695-.8954305 2-2 2s-2-.8954305-2-2h-1c-2.209139 0-4-1.790861-4-4v-1c0-2.209139 1.790861-4 4-4zm0-2v-2.05652691c-.14564246-.03538148-.28733393-.08714006-.42229124-.15461871l-1.15541752-.57770876c-.27771087-.13885544-.583937-.21114562-.89442719-.21114562h-1.02786405c-.82842712 0-1.5.67157288-1.5 1.5s.67157288 1.5 1.5 1.5zm4 1v1h1.5c.2761424 0 .5-.22385763.5-.5s-.2238576-.5-.5-.5zm-1 1v-5c0-.55228475-.44771525-1-1-1s-1 .44771525-1 1v5zm-2 4v5c0 .5522847.44771525 1 1 1s1-.4477153 1-1v-5zm3 2v2h2c.5522847 0 1-.4477153 1-1s-.4477153-1-1-1zm-4-1v-1h-.5c-.27614237 0-.5.2238576-.5.5s.22385763.5.5.5zm-3.5-9h1c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"></path></symbol><symbol id="icon-success" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm3.4860198 4.98163161-4.71802968 5.50657859-2.62834168-2.02300024c-.42862421-.36730544-1.06564993-.30775346-1.42283677.13301307-.35718685.44076653-.29927542 1.0958383.12934879 1.46314377l3.40735508 2.7323063c.42215801.3385221 1.03700951.2798252 1.38749189-.1324571l5.38450527-6.33394549c.3613513-.43716226.3096573-1.09278382-.115462-1.46437175-.4251192-.37158792-1.0626796-.31842941-1.4240309.11873285z" fill-rule="evenodd"></path></symbol><symbol id="icon-table" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587l-4.0059107-.001.001.001h-1l-.001-.001h-5l.001.001h-1l-.001-.001-3.00391071.001c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm-11.0059107 5h-3.999v6.9941413c0 .5572961.44630695 1.0058587.99508929 1.0058587h3.00391071zm6 0h-5v8h5zm5.0059107-4h-4.0059107v3h5.001v1h-5.001v7.999l4.0059107.001c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-12.5049107 9c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.22385763-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1.499-5h-5v3h5zm-6 0h-3.00391071c-.54871518 0-.99508929.44887827-.99508929 1.00585866v1.99414134h3.999z" fill-rule="evenodd"></path></symbol><symbol id="icon-tick-circle" viewBox="0 0 24 24"><path d="m12 2c5.5228475 0 10 4.4771525 10 10s-4.4771525 10-10 10-10-4.4771525-10-10 4.4771525-10 10-10zm0 1c-4.97056275 0-9 4.02943725-9 9 0 4.9705627 4.02943725 9 9 9 4.9705627 0 9-4.0294373 9-9 0-4.97056275-4.0294373-9-9-9zm4.2199868 5.36606669c.3613514-.43716226.9989118-.49032077 1.424031-.11873285s.4768133 1.02720949.115462 1.46437175l-6.093335 6.94397871c-.3622945.4128716-.9897871.4562317-1.4054264.0971157l-3.89719065-3.3672071c-.42862421-.3673054-.48653564-1.0223772-.1293488-1.4631437s.99421256-.5003185 1.42283677-.1330131l3.11097438 2.6987741z" fill-rule="evenodd"></path></symbol><symbol id="icon-tick" viewBox="0 0 16 16"><path d="m6.76799012 9.21106946-3.1109744-2.58349728c-.42862421-.35161617-1.06564993-.29460792-1.42283677.12733148s-.29927541 1.04903009.1293488 1.40064626l3.91576307 3.23873978c.41034319.3393961 1.01467563.2976897 1.37450571-.0948578l6.10568327-6.660841c.3613513-.41848908.3096572-1.04610608-.115462-1.4018218-.4251192-.35571573-1.0626796-.30482786-1.424031.11366122z" fill-rule="evenodd"></path></symbol><symbol id="icon-update" viewBox="0 0 18 18"><path d="m1 13v1c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-1h-1v-10h-14v10zm16-1h1v2c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-2h1v-9c0-.55228475.44771525-1 1-1h14c.5522847 0 1 .44771525 1 1zm-1 0v1h-4.5857864l-1 1h-2.82842716l-1-1h-4.58578644v-1h5l1 1h2l1-1zm-13-8h12v7h-12zm1 1v5h10v-5zm1 1h4v1h-4zm0 2h4v1h-4z" fill-rule="evenodd"></path></symbol><symbol id="icon-upload" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.85576936 4.14572769c.19483374-.19483375.51177826-.19377714.70556874.00001334l2.59099082 2.59099079c.1948411.19484112.1904373.51514474.0027906.70279143-.1932998.19329987-.5046517.19237083-.7001856-.00692852l-1.74638687-1.7800176v6.14827687c0 .2717771-.23193359.492096-.5.492096-.27614237 0-.5-.216372-.5-.492096v-6.14827641l-1.74627892 1.77990922c-.1933927.1971171-.51252214.19455839-.70016883.0069117-.19329987-.19329988-.19100584-.50899493.00277731-.70277808z" fill-rule="evenodd"></path></symbol><symbol id="icon-video" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-8.30912922 2.24944486 4.60460462 2.73982242c.9365543.55726659.9290753 1.46522435 0 2.01804082l-4.60460462 2.7398224c-.93655425.5572666-1.69578148.1645632-1.69578148-.8937585v-5.71016863c0-1.05087579.76670616-1.446575 1.69578148-.89375851zm-.67492769.96085624v5.5750128c0 .2995102-.10753745.2442517.16578928.0847713l4.58452283-2.67497259c.3050619-.17799716.3051624-.21655446 0-.39461026l-4.58452283-2.67497264c-.26630747-.15538481-.16578928-.20699944-.16578928.08477139z" fill-rule="evenodd"></path></symbol><symbol id="icon-warning" viewBox="0 0 18 18"><path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"></path></symbol><symbol id="icon-checklist-banner" viewBox="0 0 56.69 56.69"><path style="fill:none" d="M0 0h56.69v56.69H0z"></path><clipPath id="b"><use xlink:href="#a" style="overflow:visible"></use></clipPath><path d="M21.14 34.46c0-6.77 5.48-12.26 12.24-12.26s12.24 5.49 12.24 12.26-5.48 12.26-12.24 12.26c-6.76-.01-12.24-5.49-12.24-12.26zm19.33 10.66 10.23 9.22s1.21 1.09 2.3-.12l2.09-2.32s1.09-1.21-.12-2.3l-10.23-9.22m-19.29-5.92c0-4.38 3.55-7.94 7.93-7.94s7.93 3.55 7.93 7.94c0 4.38-3.55 7.94-7.93 7.94-4.38-.01-7.93-3.56-7.93-7.94zm17.58 12.99 4.14-4.81" style="clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round"></path><path d="M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5m14.42-5.2V4.86s0-2.93-2.93-2.93H4.13s-2.93 0-2.93 2.93v37.57s0 2.93 2.93 2.93h15.01M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5" style="clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round;stroke-linejoin:round"></path></symbol><symbol id="icon-chevron-down" viewBox="0 0 16 16"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 1)"></path></symbol><symbol id="icon-eds-i-arrow-right-medium" viewBox="0 0 24 24"><path d="m12.728 3.293 7.98 7.99a.996.996 0 0 1 .281.561l.011.157c0 .32-.15.605-.384.788l-7.908 7.918a1 1 0 0 1-1.416-1.414L17.576 13H4a1 1 0 0 1 0-2h13.598l-6.285-6.293a1 1 0 0 1-.082-1.32l.083-.095a1 1 0 0 1 1.414.001Z"></path></symbol><symbol id="icon-eds-i-check-circle-medium" viewBox="0 0 24 24"><path d="M12 1c6.075 0 11 4.925 11 11s-4.925 11-11 11S1 18.075 1 12 5.925 1 12 1Zm0 2a9 9 0 1 0 0 18 9 9 0 0 0 0-18Zm5.125 4.72a1 1 0 0 1 .156 1.405l-6 7.5a1 1 0 0 1-1.421.143l-3-2.5a1 1 0 0 1 1.28-1.536l2.217 1.846 5.362-6.703a1 1 0 0 1 1.406-.156Z"></path></symbol><symbol id="icon-eds-i-chevron-down-medium" viewBox="0 0 16 16"><path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-chevron-down-small" viewBox="0 0 16 16"><path d="M13.692 5.278a1 1 0 0 1 .03 1.414L9.103 11.51a1.491 1.491 0 0 1-2.188.019L2.278 6.692a1 1 0 0 1 1.444-1.384L8 9.771l4.278-4.463a1 1 0 0 1 1.318-.111l.096.081Z"></path></symbol><symbol id="icon-eds-i-chevron-right-medium" viewBox="0 0 10 10"><path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path></symbol><symbol id="icon-eds-i-chevron-right-small" viewBox="0 0 10 10"><path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path></symbol><symbol id="icon-eds-i-chevron-up-medium" viewBox="0 0 16 16"><path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-close-medium" viewBox="0 0 16 16"><path d="m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-copy-link" viewBox="0 0 24 24"><path fill-rule="evenodd" clip-rule="evenodd" d="M19.4594 8.57015C19.0689 8.17963 19.0689 7.54646 19.4594 7.15594L20.2927 6.32261C20.2927 6.32261 20.2927 6.32261 20.2927 6.32261C21.0528 5.56252 21.0528 4.33019 20.2928 3.57014C19.5327 2.81007 18.3004 2.81007 17.5404 3.57014L16.7071 4.40347C16.3165 4.794 15.6834 4.794 15.2928 4.40348C14.9023 4.01296 14.9023 3.3798 15.2928 2.98927L16.1262 2.15594C17.6673 0.614803 20.1659 0.614803 21.707 2.15593C23.2481 3.69705 23.248 6.19569 21.707 7.7368L20.8737 8.57014C20.4831 8.96067 19.85 8.96067 19.4594 8.57015Z"></path><path fill-rule="evenodd" clip-rule="evenodd" d="M18.0944 5.90592C18.4849 6.29643 18.4849 6.9296 18.0944 7.32013L16.4278 8.9868C16.0373 9.37733 15.4041 9.37734 15.0136 8.98682C14.6231 8.59631 14.6231 7.96314 15.0136 7.57261L16.6802 5.90594C17.0707 5.51541 17.7039 5.5154 18.0944 5.90592Z"></path><path fill-rule="evenodd" clip-rule="evenodd" d="M13.5113 6.32243C13.9018 6.71295 13.9018 7.34611 13.5113 7.73664L12.678 8.56997C12.678 8.56997 12.678 8.56997 12.678 8.56997C11.9179 9.33006 11.9179 10.5624 12.6779 11.3224C13.438 12.0825 14.6703 12.0825 15.4303 11.3224L16.2636 10.4891C16.6542 10.0986 17.2873 10.0986 17.6779 10.4891C18.0684 10.8796 18.0684 11.5128 17.6779 11.9033L16.8445 12.7366C15.3034 14.2778 12.8048 14.2778 11.2637 12.7366C9.72262 11.1955 9.72266 8.69689 11.2637 7.15578L12.097 6.32244C12.4876 5.93191 13.1207 5.93191 13.5113 6.32243Z"></path><path d="M8 20V22H19.4619C20.136 22 20.7822 21.7311 21.2582 21.2529C21.7333 20.7757 22 20.1289 22 19.4549V15C22 14.4477 21.5523 14 21 14C20.4477 14 20 14.4477 20 15V19.4549C20 19.6004 19.9426 19.7397 19.8408 19.842C19.7399 19.9433 19.6037 20 19.4619 20H8Z"></path><path d="M4 13H2V19.4619C2 20.136 2.26889 20.7822 2.74705 21.2582C3.22434 21.7333 3.87105 22 4.5451 22H9C9.55228 22 10 21.5523 10 21C10 20.4477 9.55228 20 9 20H4.5451C4.39957 20 4.26028 19.9426 4.15804 19.8408C4.05668 19.7399 4 19.6037 4 19.4619V13Z"></path><path d="M4 13H2V4.53808C2 3.86398 2.26889 3.21777 2.74705 2.74178C3.22434 2.26666 3.87105 2 4.5451 2H9C9.55228 2 10 2.44772 10 3C10 3.55228 9.55228 4 9 4H4.5451C4.39957 4 4.26028 4.05743 4.15804 4.15921C4.05668 4.26011 4 4.39633 4 4.53808V13Z"></path></symbol><symbol id="icon-eds-i-download-medium" viewBox="0 0 16 16"><path d="m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-info-filled-medium" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-institution-medium" viewBox="0 0 24 24"><g><path fill-rule="evenodd" clip-rule="evenodd" d="M11.9967 1C11.6364 1 11.279 1.0898 10.961 1.2646C10.9318 1.28061 10.9035 1.29806 10.8761 1.31689L2.79765 6.87C2.46776 7.08001 2.20618 7.38466 2.07836 7.76668C1.94823 8.15561 1.98027 8.55648 2.12665 8.90067C2.42086 9.59246 3.12798 10 3.90107 10H4.99994V16H4.49994C3.11923 16 1.99994 17.1193 1.99994 18.5V19.5C1.99994 20.8807 3.11923 22 4.49994 22H19.4999C20.8807 22 21.9999 20.8807 21.9999 19.5V18.5C21.9999 17.1193 20.8807 16 19.4999 16H18.9999V10H20.0922C20.8653 10 21.5725 9.59252 21.8667 8.90065C22.0131 8.55642 22.0451 8.15553 21.9149 7.7666C21.7871 7.38459 21.5255 7.07997 21.1956 6.86998L13.1172 1.31689C13.0898 1.29806 13.0615 1.28061 13.0324 1.2646C12.7143 1.0898 12.357 1 11.9967 1ZM4.6844 8L11.9472 3.00755C11.9616 3.00295 11.9783 3 11.9967 3C12.015 3 12.0318 3.00295 12.0461 3.00755L19.3089 8H4.6844ZM16.9999 16V10H14.9999V16H16.9999ZM12.9999 16V10H10.9999V16H12.9999ZM8.99994 16V10H6.99994V16H8.99994ZM3.99994 18.5C3.99994 18.2239 4.2238 18 4.49994 18H19.4999C19.7761 18 19.9999 18.2239 19.9999 18.5V19.5C19.9999 19.7761 19.7761 20 19.4999 20H4.49994C4.2238 20 3.99994 19.7761 3.99994 19.5V18.5Z"></path></g></symbol><symbol id="icon-eds-i-mail-medium" viewBox="0 0 24 24"><path d="m19.462 0c1.413 0 2.538 1.184 2.538 2.619v12.762c0 1.435-1.125 2.619-2.538 2.619h-16.924c-1.413 0-2.538-1.184-2.538-2.619v-12.762c0-1.435 1.125-2.619 2.538-2.619zm.538 5.158-7.378 6.258a2.549 2.549 0 0 1 -3.253-.008l-7.369-6.248v10.222c0 .353.253.619.538.619h16.924c.285 0 .538-.266.538-.619zm-.538-3.158h-16.924c-.264 0-.5.228-.534.542l8.65 7.334c.2.165.492.165.684.007l8.656-7.342-.001-.025c-.044-.3-.274-.516-.531-.516z"></path></symbol><symbol id="icon-eds-i-menu-medium" viewBox="0 0 24 24"><path d="M21 4a1 1 0 0 1 0 2H3a1 1 0 1 1 0-2h18Zm-4 7a1 1 0 0 1 0 2H3a1 1 0 0 1 0-2h14Zm4 7a1 1 0 0 1 0 2H3a1 1 0 0 1 0-2h18Z"></path></symbol><symbol id="icon-eds-i-search-medium" viewBox="0 0 24 24"><path d="M11 1c5.523 0 10 4.477 10 10 0 2.4-.846 4.604-2.256 6.328l3.963 3.965a1 1 0 0 1-1.414 1.414l-3.965-3.963A9.959 9.959 0 0 1 11 21C5.477 21 1 16.523 1 11S5.477 1 11 1Zm0 2a8 8 0 1 0 0 16 8 8 0 0 0 0-16Z"></path></symbol><symbol id="icon-eds-i-user-single-medium" viewBox="0 0 24 24"><path d="M12 1a5 5 0 1 1 0 10 5 5 0 0 1 0-10Zm0 2a3 3 0 1 0 0 6 3 3 0 0 0 0-6Zm-.406 9.008a8.965 8.965 0 0 1 6.596 2.494A9.161 9.161 0 0 1 21 21.025V22a1 1 0 0 1-1 1H4a1 1 0 0 1-1-1v-.985c.05-4.825 3.815-8.777 8.594-9.007Zm.39 1.992-.299.006c-3.63.175-6.518 3.127-6.678 6.775L5 21h13.998l-.009-.268a7.157 7.157 0 0 0-1.97-4.573l-.214-.213A6.967 6.967 0 0 0 11.984 14Z"></path></symbol><symbol id="icon-eds-i-warning-filled-medium" viewBox="0 0 18 18"><path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"></path></symbol><symbol id="icon-expand-image" viewBox="0 0 18 18"><path d="m7.49754099 11.9178212c.38955542-.3895554.38761957-1.0207846-.00290473-1.4113089-.39324695-.3932469-1.02238878-.3918247-1.41130883-.0029047l-4.10273549 4.1027355.00055454-3.5103985c.00008852-.5603185-.44832171-1.006032-1.00155062-1.0059446-.53903074.0000852-.97857527.4487442-.97866268 1.0021075l-.00093318 5.9072465c-.00008751.553948.44841131 1.001882 1.00174994 1.0017946l5.906983-.0009331c.5539233-.0000875 1.00197907-.4486389 1.00206646-1.0018679.00008515-.5390307-.45026621-.9784332-1.00588841-.9783454l-3.51010549.0005545zm3.00571741-5.83449376c-.3895554.38955541-.3876196 1.02078454.0029047 1.41130883.393247.39324696 1.0223888.39182478 1.4113089.00290473l4.1027355-4.10273549-.0005546 3.5103985c-.0000885.56031852.4483217 1.006032 1.0015506 1.00594461.5390308-.00008516.9785753-.44874418.9786627-1.00210749l.0009332-5.9072465c.0000875-.553948-.4484113-1.00188204-1.0017499-1.00179463l-5.906983.00093313c-.5539233.00008751-1.0019791.44863892-1.0020665 1.00186784-.0000852.53903074.4502662.97843325 1.0058884.97834547l3.5101055-.00055449z" fill-rule="evenodd"></path></symbol><symbol id="icon-github" viewBox="0 0 100 100"><path fill-rule="evenodd" clip-rule="evenodd" d="M48.854 0C21.839 0 0 22 0 49.217c0 21.756 13.993 40.172 33.405 46.69 2.427.49 3.316-1.059 3.316-2.362 0-1.141-.08-5.052-.08-9.127-13.59 2.934-16.42-5.867-16.42-5.867-2.184-5.704-5.42-7.17-5.42-7.17-4.448-3.015.324-3.015.324-3.015 4.934.326 7.523 5.052 7.523 5.052 4.367 7.496 11.404 5.378 14.235 4.074.404-3.178 1.699-5.378 3.074-6.6-10.839-1.141-22.243-5.378-22.243-24.283 0-5.378 1.94-9.778 5.014-13.2-.485-1.222-2.184-6.275.486-13.038 0 0 4.125-1.304 13.426 5.052a46.97 46.97 0 0 1 12.214-1.63c4.125 0 8.33.571 12.213 1.63 9.302-6.356 13.427-5.052 13.427-5.052 2.67 6.763.97 11.816.485 13.038 3.155 3.422 5.015 7.822 5.015 13.2 0 18.905-11.404 23.06-22.324 24.283 1.78 1.548 3.316 4.481 3.316 9.126 0 6.6-.08 11.897-.08 13.526 0 1.304.89 2.853 3.316 2.364 19.412-6.52 33.405-24.935 33.405-46.691C97.707 22 75.788 0 48.854 0z"></path></symbol><symbol id="icon-springer-arrow-left"><path d="M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z"></path></symbol><symbol id="icon-springer-arrow-right"><path d="M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z"></path></symbol><symbol id="icon-submit-open" viewBox="0 0 16 17"><path d="M12 0c1.10457 0 2 .895431 2 2v5c0 .276142-.223858.5-.5.5S13 7.276142 13 7V2c0-.512836-.38604-.935507-.883379-.993272L12 1H6v3c0 1.10457-.89543 2-2 2H1v8c0 .512836.38604.935507.883379.993272L2 15h6.5c.276142 0 .5.223858.5.5s-.223858.5-.5.5H2c-1.104569 0-2-.89543-2-2V5.828427c0-.530433.210714-1.039141.585786-1.414213L4.414214.585786C4.789286.210714 5.297994 0 5.828427 0H12Zm3.41 11.14c.250899.250899.250274.659726 0 .91-.242954.242954-.649606.245216-.9-.01l-1.863671-1.900337.001043 5.869492c0 .356992-.289839.637138-.647372.637138-.347077 0-.647371-.285256-.647371-.637138l-.001043-5.869492L9.5 12.04c-.253166.258042-.649726.260274-.9.01-.242954-.242954-.252269-.657731 0-.91l2.942184-2.951303c.250908-.250909.66127-.252277.91353-.000017L15.41 11.14ZM5 1.413 1.413 5H4c.552285 0 1-.447715 1-1V1.413ZM11 3c.276142 0 .5.223858.5.5s-.223858.5-.5.5H7.5c-.276142 0-.5-.223858-.5-.5s.223858-.5.5-.5H11Zm0 2c.276142 0 .5.223858.5.5s-.223858.5-.5.5H7.5c-.276142 0-.5-.223858-.5-.5s.223858-.5.5-.5H11Z" fill-rule="nonzero"></path></symbol></svg>
</div>
</footer>




    

    

<div class="c-site-messages message u-hide u-hide-print c-site-messages--nature-briefing c-site-messages--nature-briefing-email-variant c-site-messages--nature-briefing-redesign-2020 sans-serif " data-component-id="nature-briefing-banner" data-component-expirydays="30" data-component-trigger-scroll-percentage="15" data-track="in-view" data-track-action="in-view" data-track-category="nature briefing" data-track-label="Briefing banner visible: Flagship">

    
    <div class="c-site-messages__banner-large">

        
<div class="c-site-messages__close-container">
    <button class="c-site-messages__close" data-track="click" data-track-category="nature briefing" data-track-label="Briefing banner dismiss: Flagship">
        <svg width="25px" height="25px" focusable="false" aria-hidden="true" viewBox="0 0 25 25" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
            <title>Close banner</title>
            <defs></defs>
            <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd">
                <rect opacity="0" x="0" y="0" width="25" height="25"></rect>
                <path d="M6.29679575,16.2772478 C5.90020818,16.6738354 5.90240728,17.3100587 6.29617427,17.7038257 C6.69268654,18.100338 7.32864195,18.0973145 7.72275218,17.7032043 L12,13.4259564 L16.2772478,17.7032043 C16.6738354,18.0997918 17.3100587,18.0975927 17.7038257,17.7038257 C18.100338,17.3073135 18.0973145,16.671358 17.7032043,16.2772478 L13.4259564,12 L17.7032043,7.72275218 C18.0997918,7.32616461 18.0975927,6.68994127 17.7038257,6.29617427 C17.3073135,5.89966201 16.671358,5.90268552 16.2772478,6.29679575 L12,10.5740436 L7.72275218,6.29679575 C7.32616461,5.90020818 6.68994127,5.90240728 6.29617427,6.29617427 C5.89966201,6.69268654 5.90268552,7.32864195 6.29679575,7.72275218 L10.5740436,12 L6.29679575,16.2772478 Z" fill="#ffffff"></path>
            </g>
        </svg>
        <span class="visually-hidden">Close</span>
    </button>
</div>


        <div class="c-site-messages__form-container">

            <div class="grid grid-12 last">
                <div class="grid grid-4">
                    <img alt="Nature Briefing" src="/static/images/logos/nature-briefing-logo-n150-white-d81c9da3ec.svg" width="250" height="40">
                    <p class="c-site-messages--nature-briefing__strapline extra-tight-line-height">Sign up for the <em>Nature Briefing</em> newsletter — what matters in science, free to your inbox daily.</p>
                </div>
                <div class="grid grid-8 last">
                    <form action="https://www.nature.com/briefing/briefing" method="post" data-location="banner" data-track="signup_nature_briefing_banner" data-track-action="transmit-form" data-track-category="nature briefing" data-track-label="Briefing banner submit: Flagship">
                        <input id="briefing-banner-signup-form-input-track-originReferralPoint" type="hidden" name="track_originReferralPoint" value="MainBriefingBanner">
                        <input id="briefing-banner-signup-form-input-track-formType" type="hidden" name="track_formType" value="DirectEmailBanner">

                        <input type="hidden" value="false" name="gdpr_tick" id="gdpr_tick_banner">
                        <input type="hidden" value="false" name="marketing" id="marketing_input_banner">
                        <input type="hidden" value="false" name="marketing_tick" id="marketing_tick_banner">
                        <input type="hidden" value="MainBriefingBanner" name="brieferEntryPoint" id="brieferEntryPoint_banner">

                        <label class="nature-briefing-banner__email-label" for="emailAddress">Email address</label>

                        <div class="nature-briefing-banner__email-wrapper">
                            <input class="nature-briefing-banner__email-input box-sizing text14" type="email" id="emailAddress" name="emailAddress" value="" placeholder="e.g. jo.smith@university.ac.uk" required="" data-test-element="briefing-emailbanner-email-input">
                            
                            <input type="hidden" value="true" name="N:nature_briefing_daily" id="defaultNewsletter_banner">
                            <button type="submit" class="nature-briefing-banner__submit-button box-sizing text14" data-test-element="briefing-emailbanner-signup-button">Sign up</button>
                        </div>

                        <div class="nature-briefing-banner__checkbox-wrapper grid grid-12 last">
                            <input class="nature-briefing-banner__checkbox-checkbox" id="gdpr-briefing-banner-checkbox" type="checkbox" name="gdpr" value="true" data-test-element="briefing-emailbanner-gdpr-checkbox" required="">
                            <label class="nature-briefing-banner__checkbox-label box-sizing text13 sans-serif block tighten-line-height" for="gdpr-briefing-banner-checkbox">I agree my information will be processed in accordance with the <em>Nature</em> and Springer Nature Limited <a href="https://www.nature.com/info/privacy">Privacy Policy</a>.</label>
                        </div>
                    </form>
                </div>
            </div>

        </div>

    </div>

    
    <div class="c-site-messages__banner-small">

        
<div class="c-site-messages__close-container">
    <button class="c-site-messages__close" data-track="click" data-track-category="nature briefing" data-track-label="Briefing banner dismiss: Flagship">
        <svg width="25px" height="25px" focusable="false" aria-hidden="true" viewBox="0 0 25 25" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
            <title>Close banner</title>
            <defs></defs>
            <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd">
                <rect opacity="0" x="0" y="0" width="25" height="25"></rect>
                <path d="M6.29679575,16.2772478 C5.90020818,16.6738354 5.90240728,17.3100587 6.29617427,17.7038257 C6.69268654,18.100338 7.32864195,18.0973145 7.72275218,17.7032043 L12,13.4259564 L16.2772478,17.7032043 C16.6738354,18.0997918 17.3100587,18.0975927 17.7038257,17.7038257 C18.100338,17.3073135 18.0973145,16.671358 17.7032043,16.2772478 L13.4259564,12 L17.7032043,7.72275218 C18.0997918,7.32616461 18.0975927,6.68994127 17.7038257,6.29617427 C17.3073135,5.89966201 16.671358,5.90268552 16.2772478,6.29679575 L12,10.5740436 L7.72275218,6.29679575 C7.32616461,5.90020818 6.68994127,5.90240728 6.29617427,6.29617427 C5.89966201,6.69268654 5.90268552,7.32864195 6.29679575,7.72275218 L10.5740436,12 L6.29679575,16.2772478 Z" fill="#ffffff"></path>
            </g>
        </svg>
        <span class="visually-hidden">Close</span>
    </button>
</div>


        <div class="c-site-messages__content text14">
            <span class="c-site-messages--nature-briefing__strapline strong">Get the most important science stories of the day, free in your inbox.</span>
            <a class="nature-briefing__link text14 sans-serif" data-track="click" data-track-category="nature briefing" data-track-label="Small-screen banner CTA to site" data-test-element="briefing-banner-link" target="_blank" rel="noreferrer noopener" href="https://www.nature.com/briefing/signup/?brieferEntryPoint=MainBriefingBanner">Sign up for Nature Briefing
            </a>
        </div>

    </div>

</div>






<noscript>
    <img hidden src="https://verify.nature.com/verify/nature.png" width="0" height="0" style="display: none" alt="">
</noscript>




<script src="//content.readcube.com/ping?doi=10.1038/s41591-022-01855-7&amp;format=js&amp;last_modified=2022-05-10" async=""></script>

<ski-qxskudxdxgmb></ski-qxskudxdxgmb><div data-cc-ghost="" style="height: 352px;"></div><script src="https://verify.nature.com/verify/nature.min.js"></script><script type="text/javascript" id="fetch-contextual-ads-campaign-data" charset="">(function(){var g=function(a){a=new CustomEvent("campaignDataLoaded",{detail:a});document.dispatchEvent(a)},b=google_tag_manager["rm"]["50443292"](18);if(b){var k=1500;b=google_tag_manager["rm"]["50443292"](19);b="link"===b?google_tag_manager["rm"]["50443292"](20):google_tag_manager["rm"]["50443292"](21);var m=function(a,c){var h=!1,l=setTimeout(function(){h=!0;c(null)},k),d=new XMLHttpRequest;d.onload=function(){var e=null,f=[];if(200===d.status){try{e=JSON.parse(d.responseText)}catch(p){e={}}f=e.campaigns||[]}h||(clearTimeout(l),c(f.length?f.join(","):null))};d.open("GET",
"/platform/contextual?doi\x3d"+a);d.send()},n=function(a,c){a&&-1===a.indexOf("not set")?m(a,c):setTimeout(c,1)};n(b,function(a){window.campaignsForContextualAds=a;g(a);window.dataLayer.push({content:{article:{campaignID:a}}})})}else window.campaignsForContextualAds="",g(null)})();</script>
<script type="text/javascript" id="gtm-setup-accessdetailsloaded-handler" charset="">document.addEventListener("accessdetailsloaded",function(a){a=a.detail||{};var b={event:"update-access-details"};a.institutional_business_partner_ids&&a.resolved_by||console.log("BPID data could not be retrieved from /exposed-details");a.logged_in_to_sn_profile||console.log("logged_in_to_sn_profile could not be retrieved from /exposed-details");var c=a.institutional_business_partner_ids&&a.institutional_business_partner_ids.join?a.institutional_business_partner_ids.join(";"):"",d=a.resolved_by&&a.resolved_by.join?
a.resolved_by.join(";"):"",e=a.personal_business_partner_id_found,f=a.logged_in_to_sn_profile,g=a.snid;b.user={};b.user.profile={};b.user.profile.profileInfo={resolvedBy:d||null,bpid:c||null,personal:e||null,logged_in_to_sn_profile:f,snid:g||null};b.session={};b.session.authentication={};b.session.authentication.token=a.token||null;b.session.authentication.legacy={};window.dataLayer.push(b);window.idpUserDataLoaded=!0},!1);window.dataLayer.push({event:"accessdetailsloaded-handler-added"});
window.accessDetailsLoadedHandlerAdded=!0;</script><script type="text/javascript" id="gtm-mediatrust" charset="">var s=document.getElementsByTagName("script")[0],p=document.createElement("script");p.async="async";p.src="https://scripts.webcontentassessor.com/scripts/93dabb8d80079a87fec7bb6f67b807fce90e1688f8957ad7ad152bfd58ea01c2";s.parentNode.insertBefore(p,s);</script><script id="crossmark-script" text="" charset="" type="text/javascript" src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script><script type="text/javascript" id="polyfill-matches" charset="">Element.prototype.matches||(Element.prototype.matches=Element.prototype.matchesSelector||Element.prototype.mozMatchesSelector||Element.prototype.msMatchesSelector||Element.prototype.oMatchesSelector||Element.prototype.webkitMatchesSelector||function(a){a=(this.document||this.ownerDocument).querySelectorAll(a);for(var b=a.length;0<=--b&&a.item(b)!==this;);return-1<b});</script><script type="text/javascript" id="fetch-idp-user-data" charset="">(function(a){if("function"===typeof window.CustomEvent)return!1;var c=function(d,b){b=b||{};var e=document.createEvent("CustomEvent");e.initCustomEvent(d,b.bubbles||!1,b.cancelable||!1,b.detail||a);return e};c.prototype=window.Event.prototype;window.CustomEvent=c})();var parse=function(a,c){try{return 200===a?JSON.parse(c):null}catch(d){return null}},dispatch=function(a){a=new CustomEvent("accessdetailsloaded",{detail:a});document.dispatchEvent(a)},site=google_tag_manager["rm"]["50443292"](59),idpUrl;
switch(site){case "nature":idpUrl=-1<window.location.hostname.indexOf("local-www")||-1<window.location.hostname.indexOf("test-www")?"https://staging-idp.nature.com/exposed-details":"https://idp.nature.com/exposed-details";break;case "link":idpUrl=-1<window.location.hostname.indexOf("link-qa")?"https://staging-idp.springer.com/exposed-details":"https://idp.springer.com/exposed-details";break;case "springer":idpUrl=-1<window.location.hostname.indexOf("local-www")||-1<window.location.hostname.indexOf("test-www")?
"https://staging-idp.springer.com/exposed-details":"https://idp.springer.com/exposed-details"}if(void 0!==idpUrl){var transport=new XMLHttpRequest;transport.open("GET",idpUrl,!0);transport.withCredentials=!0;transport.onreadystatechange=function(){4===transport.readyState&&dispatch(parse(transport.status,transport.responseText))};transport.send()}else dispatch(null);</script><script type="text/javascript" id="create-ad-slots" charset="">function createAndLoadAds(){function h(b){"nature"===a&&google_tag_manager["rm"]["50443292"](87)(b);"bmc"!==a&&"springeropen"!==a||google_tag_manager["rm"]["50443292"](99)(b);("link"===a&&"oscar"===google_tag_manager["rm"]["50443292"](100)||"springer"===a||"link"===a&&!0===google_tag_manager["rm"]["50443292"](101))&&google_tag_manager["rm"]["50443292"](126)(b);"link"===a&&"bunsen"===google_tag_manager["rm"]["50443292"](127)&&google_tag_manager["rm"]["50443292"](152)(b);"link"===a&&"Core"===google_tag_manager["rm"]["50443292"](153)&&google_tag_manager["rm"]["50443292"](165)(b)}window.googletag=window.googletag||{cmd:[]};var a=google_tag_manager["rm"]["50443292"](166),e=google_tag_manager["rm"]["50443292"](168);
if(-1===window.location.search.indexOf("hide_ads\x3dtrue"))if(window.adSlots&&0!==Object.keys(window.adSlots).length)console.log("Ads previously loaded. Will not update ad slots until next page load.");else{window.adSlots||(window.adSlots={});window.getAd=function(b,f){for(var c in window.adSlots)if(-1<c.indexOf(b)){if("object"===f)return adSlots[c];if("slot"===f)return adSlots[c].slot}};googletag.cmd.push(function(){googletag.pubads().setPrivacySettings({limitedAds:e});console.log("limitedAds is ",
e);googletag.pubads().setRequestNonPersonalizedAds(google_tag_manager["rm"]["50443292"](170));googletag.pubads().enableSingleRequest();googletag.pubads().disableInitialLoad()});for(var g=document.querySelectorAll("[data-gpt]"),d=0;g[d];++d)h(g[d]);googletag.cmd.push(function(){googletag.enableServices()})}}createAndLoadAds();</script>
</body></html>